data_2gdw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gdw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 112.578 0.584 . . . . 99.989999999999995 112.578 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.86 25.05 4.93 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 118.286 2.698 . . . . 99.989999999999995 118.286 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -46.26 -36.04 5.81 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 117.858 2.54 . . . . 99.989999999999995 117.858 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.1 t80 177.2 -60.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.162 0.985 . . . . 99.989999999999995 111.699 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 57.33 79.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.139 2.176 . . . . 99.989999999999995 113.68 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.33 89.44 41.08 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.513 -0.767 . . . . 99.989999999999995 111.493 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.76 -152.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.596 2.864 . . . . 0.0 113.792 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.82 -83.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.666 0.786 . . . . 99.989999999999995 109.343 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -109.65 -175.19 2.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.487 1.115 . . . . 99.989999999999995 112.203 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.91 -58.24 5.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.435 1.094 . . . . 99.989999999999995 113.171 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.19 -49.87 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 111.307 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -50.6 -62.67 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.661 1.184 . . . . 99.989999999999995 113.068 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 t -67.98 -47.28 69.0 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.409 -0.814 . . . . 99.989999999999995 112.909 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -61.69 -47.06 87.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.83 0.852 . . . . 99.989999999999995 111.616 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.2 mm? -68.02 -36.58 80.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.685 1.365 . . . . 99.989999999999995 114.685 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.07 85.51 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.113 0.415 . . . . 99.989999999999995 111.649 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -55.11 39.36 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.544 1.538 . . . . 99.989999999999995 111.829 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.7 mm -55.27 -51.04 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 110.892 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -55.98 -55.95 26.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 118.399 -0.81 . . . . 99.989999999999995 112.943 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -61.2 -28.04 68.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.844 1.794 . . . . 99.989999999999995 115.844 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -76.69 -61.15 2.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.324 1.05 . . . . 99.989999999999995 111.59 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.64 -40.69 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.602 1.561 . . . . 99.989999999999995 112.637 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -61.09 -19.3 61.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.984 1.313 . . . . 99.989999999999995 114.238 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.71 0.92 Allowed Glycine 0 N--CA 1.474 1.187 0 N-CA-C 108.735 -1.746 . . . . 99.989999999999995 108.735 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 p -13.83 90.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.422 2.289 . . . . 99.989999999999995 115.53 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 p -141.89 -69.37 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 112.816 -1.993 . . . . 99.989999999999995 114.501 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 126.99 94.72 0.89 Allowed Glycine 0 N--CA 1.48 1.617 0 O-C-N 123.943 0.777 . . . . 99.989999999999995 112.58 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 pt -101.74 -177.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 115.334 -0.433 . . . . 99.989999999999995 111.822 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.37 171.67 18.76 Favored Glycine 0 N--CA 1.477 1.368 0 CA-C-N 115.126 -0.943 . . . . 99.989999999999995 111.119 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.7 mm -57.33 -48.65 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.353 1.061 . . . . 99.989999999999995 111.884 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.2 -6.53 2.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.881 1.673 . . . . 99.989999999999995 114.399 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 54.46 -154.06 0.28 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.715 2.006 . . . . 99.989999999999995 110.059 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' PHE . 29.0 t-20 -101.24 13.74 34.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.258 -0.276 . . . . 99.989999999999995 111.311 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.256 50.1 p90 37.56 5.38 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 120.986 3.699 . . . . 99.989999999999995 120.986 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' ASN . 60.4 t80 -116.38 -79.25 0.59 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.768 1.227 . . . . 99.989999999999995 111.741 175.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -53.6 -31.55 47.41 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 118.588 2.811 . . . . 99.989999999999995 118.588 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -32.7 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.976 1.102 . . . . 99.989999999999995 113.976 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.93 -53.18 28.32 Favored Glycine 0 CA--C 1.538 1.488 0 O-C-N 124.076 0.86 . . . . 99.989999999999995 112.659 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.63 105.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.755 1.062 . . . . 99.989999999999995 115.755 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -75.08 53.88 0.64 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.498 1.519 . . . . 99.989999999999995 114.118 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.5 p -163.59 -146.92 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.629 1.972 . . . . 99.989999999999995 109.002 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -54.41 -25.24 23.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.431 1.271 . . . . 99.989999999999995 114.431 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -50.22 -55.38 15.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.338 1.055 . . . . 99.989999999999995 113.72 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 -42.79 38.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.012 1.115 . . . . 99.989999999999995 114.012 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.48 -53.02 39.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.46 1.104 . . . . 99.989999999999995 112.988 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.161 0.985 . . . . 99.989999999999995 112.889 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.27 -42.9 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.649 0.78 . . . . 99.989999999999995 110.18 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.25 72.47 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.078 0.77 . . . . 99.989999999999995 113.078 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.67 81.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.801 0.667 . . . . 99.989999999999995 112.801 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -64.09 -46.92 82.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.643 1.177 . . . . 99.989999999999995 112.579 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 59.5 t -61.45 -28.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.167 1.387 . . . . 99.989999999999995 112.318 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.24 -77.92 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.625 0.77 . . . . 99.989999999999995 110.727 166.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -59.72 -37.87 80.1 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 118.45 2.759 . . . . 99.989999999999995 118.45 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.49 -30.51 9.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.553 0.946 . . . . 99.989999999999995 113.553 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' HH ' ' HG ' ' A' ' 19' ' ' LEU . 2.9 m-30 -93.92 -27.44 16.38 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.025 1.491 . . . . 99.989999999999995 115.025 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 61.73 1.91 0.66 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.842 2.457 . . . . 99.989999999999995 116.684 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.07 -12.44 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 112.502 0.556 . . . . 99.989999999999995 112.502 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.94 41.53 3.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 120.076 3.362 . . . . 99.989999999999995 120.076 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 63' ' ' LEU . 2.4 pt? -109.82 93.01 13.59 Favored Pre-proline 0 N--CA 1.482 1.138 0 N-CA-C 115.885 1.809 . . . . 99.989999999999995 115.885 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.35 149.67 84.84 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.493 2.795 . . . . 0.0 111.97 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 60.98 -46.87 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.251 2.22 . . . . 99.989999999999995 114.917 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -55.97 -65.47 0.59 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.722 1.209 . . . . 99.989999999999995 112.436 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.417 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -62.65 -25.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.721 1.008 . . . . 99.989999999999995 113.721 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.21 -41.6 66.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.951 1.7 . . . . 99.989999999999995 113.579 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -103.71 -39.54 6.64 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.673 1.36 . . . . 99.989999999999995 114.673 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.63 62.44 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.741 0.645 . . . . 99.989999999999995 112.741 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 11.3 mp0 -119.57 61.93 6.81 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.944 0.498 . . . . 99.989999999999995 111.654 171.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -79.87 38.17 0.72 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.175 3.25 . . . . 0.0 114.081 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -157.15 131.72 8.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.142 2.177 . . . . 99.989999999999995 108.864 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.289 0.5 OUTLIER -62.37 -21.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.841 -1.072 . . . . 99.989999999999995 113.244 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.67 -53.62 56.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.343 0.657 . . . . 99.989999999999995 110.69 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.8 74.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.86 0.689 . . . . 99.989999999999995 112.86 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.35 -48.97 73.44 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.51 0.724 . . . . 99.989999999999995 112.579 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.35 93.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.003 0.921 . . . . 99.989999999999995 112.717 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.03 -26.93 68.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.518 1.673 . . . . 99.989999999999995 115.518 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -77.72 -27.03 50.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.278 1.955 . . . . 99.989999999999995 116.278 169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.35 -30.18 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 118.168 2.655 . . . . 99.989999999999995 118.168 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.42 56.13 0.8 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.477 1.608 . . . . 99.989999999999995 109.89 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 m -162.35 -65.55 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.495 -1.684 . . . . 99.989999999999995 108.988 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.53 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -101.53 -33.17 10.04 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.386 1.254 . . . . 99.989999999999995 114.386 171.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 114.823 1.416 . . . . 99.989999999999995 114.823 172.491 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.203 0.525 . . . . 99.989999999999995 111.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.76 -179.8 4.98 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.061 1.745 . . . . 99.989999999999995 114.508 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -168.58 -99.51 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.06 1.744 . . . . 99.989999999999995 108.903 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.43 -57.28 12.85 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.466 1.654 . . . . 99.989999999999995 115.466 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t 56.25 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 126.352 1.861 . . . . 99.989999999999995 113.897 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.08 98.24 33.53 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 115.618 -0.719 . . . . 99.989999999999995 111.23 168.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.75 -154.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.752 2.968 . . . . 0.0 113.994 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.73 -85.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.003 0.521 . . . . 99.989999999999995 110.202 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -107.9 -176.89 3.19 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.389 0.676 . . . . 99.989999999999995 111.481 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.15 -51.98 16.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.295 1.038 . . . . 99.989999999999995 113.071 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.37 -54.53 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.512 1.125 . . . . 99.989999999999995 111.46 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -49.93 -59.9 3.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.233 . . . . 99.989999999999995 112.255 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.1 m -65.17 -44.85 87.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.893 1.071 . . . . 99.989999999999995 113.893 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -57.98 -58.51 8.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.413 1.485 . . . . 99.989999999999995 110.539 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.81 -33.77 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.951 1.093 . . . . 99.989999999999995 113.951 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.17 84.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.056 0.391 . . . . 99.989999999999995 112.056 170.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.1 -48.95 79.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.557 1.143 . . . . 99.989999999999995 111.763 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 mm -54.44 -54.77 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.099 0.96 . . . . 99.989999999999995 110.685 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -56.56 -53.32 58.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.882 0.873 . . . . 99.989999999999995 113.332 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -60.27 -30.12 69.24 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.076 1.88 . . . . 99.989999999999995 116.076 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -77.01 -63.72 1.3 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.972 1.42 . . . . 99.989999999999995 111.148 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.6 -43.45 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.498 1.519 . . . . 99.989999999999995 113.204 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 -14.98 62.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.234 1.939 . . . . 99.989999999999995 116.234 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.31 72.46 0.18 Allowed Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.552 1.157 . . . . 99.989999999999995 110.789 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.9 p -10.45 87.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 128.314 2.646 . . . . 99.989999999999995 116.968 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 -50.66 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.299 -1.773 . . . . 99.989999999999995 115.496 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 125.57 3.0 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.69 -0.964 . . . . 99.989999999999995 110.69 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -125.72 165.17 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 113.07 0.766 . . . . 99.989999999999995 113.07 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.34 162.4 14.41 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 113.867 -1.515 . . . . 99.989999999999995 111.295 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.97 -40.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.321 0.648 . . . . 99.989999999999995 111.734 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.2 -21.07 58.89 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.706 1.373 . . . . 99.989999999999995 114.706 167.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 56.96 -163.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.441 1.897 . . . . 99.989999999999995 111.788 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -101.58 1.11 37.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.576 -0.738 . . . . 99.989999999999995 112.295 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.307 53.5 p90 53.97 -38.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.298 2.703 . . . . 99.989999999999995 118.298 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.09 -81.57 0.06 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.364 1.466 . . . . 99.989999999999995 112.252 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.19 21.98 0.07 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 117.76 2.504 . . . . 99.989999999999995 117.76 -173.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.23 -44.95 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 112.62 0.6 . . . . 99.989999999999995 112.62 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.22 -40.9 60.66 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.964 0.79 . . . . 99.989999999999995 113.642 170.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.69 116.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.671 1.029 . . . . 99.989999999999995 115.671 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.55 46.63 1.08 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.924 -1.638 . . . . 99.989999999999995 114.041 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.8 p -150.48 -150.51 0.35 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.848 1.659 . . . . 99.989999999999995 109.608 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -55.56 -18.65 7.9 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.577 1.325 . . . . 99.989999999999995 114.577 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -48.49 -51.14 28.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.055 0.942 . . . . 99.989999999999995 112.261 172.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.14 -47.03 62.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.597 1.332 . . . . 99.989999999999995 114.597 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 ptm -70.53 -41.6 72.32 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.628 1.344 . . . . 99.989999999999995 114.628 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.86 97.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.292 0.637 . . . . 99.989999999999995 112.483 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.08 -47.64 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.915 0.886 . . . . 99.989999999999995 109.7 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.81 -39.84 62.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.252 0.834 . . . . 99.989999999999995 113.252 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.89 -57.3 12.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.682 0.793 . . . . 99.989999999999995 112.775 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.32 -34.69 78.92 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.623 0.971 . . . . 99.989999999999995 113.623 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.638 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 92.0 t -64.7 -27.82 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.653 1.181 . . . . 99.989999999999995 112.908 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -77.13 -63.21 1.42 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.72 0.808 . . . . 99.989999999999995 112.166 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -70.92 -38.98 72.95 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 118.661 2.837 . . . . 99.989999999999995 118.661 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.22 -36.38 6.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.625 0.77 . . . . 99.989999999999995 112.745 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m-85 -84.81 -27.92 26.48 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.632 1.345 . . . . 99.989999999999995 114.632 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 65.69 -36.39 0.23 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.174 2.589 . . . . 99.989999999999995 116.661 -175.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 t -57.73 -23.45 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.311 1.444 . . . . 99.989999999999995 114.646 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 45.89 67.92 0.67 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.788 1.773 . . . . 99.989999999999995 115.788 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -136.96 87.4 19.16 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 115.425 1.639 . . . . 99.989999999999995 115.425 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.82 148.05 89.81 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.431 2.754 . . . . 0.0 112.096 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 tt 62.37 -43.96 0.18 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.403 2.281 . . . . 99.989999999999995 114.584 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.16 -68.76 0.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.248 1.419 . . . . 99.989999999999995 113.117 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.87 12.93 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 114.193 1.182 . . . . 99.989999999999995 114.193 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.7 -41.65 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 99.989999999999995 111.935 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -106.83 -45.87 4.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.027 1.331 . . . . 99.989999999999995 113.329 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.86 73.68 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.882 0.697 . . . . 99.989999999999995 112.882 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -120.24 65.53 11.1 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.846 0.684 . . . . 99.989999999999995 112.846 170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -80.24 27.55 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.571 2.847 . . . . 0.0 114.973 -170.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -139.68 136.31 34.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 110.568 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.278 0.4 OUTLIER -61.85 -19.77 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.217 -1.356 . . . . 99.989999999999995 113.752 175.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.63 -61.9 2.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 99.989999999999995 110.348 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.46 80.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.499 0.926 . . . . 99.989999999999995 113.499 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.03 -46.55 85.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.146 0.578 . . . . 99.989999999999995 112.262 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.62 85.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.277 1.031 . . . . 99.989999999999995 112.755 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -62.3 -40.6 96.84 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.856 1.058 . . . . 99.989999999999995 113.856 170.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.81 -39.23 87.64 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.321 1.6 . . . . 99.989999999999995 115.321 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.0 m -99.59 -40.37 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 117.062 2.245 . . . . 99.989999999999995 117.062 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.87 50.9 0.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.174 1.464 . . . . 99.989999999999995 110.451 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 69.0 m -160.26 -55.11 0.06 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 113.664 -1.607 . . . . 99.989999999999995 109.553 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -35.02 5.79 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.145 1.905 . . . . 99.989999999999995 116.145 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 116.009 -1.948 . . . . 99.989999999999995 116.027 175.105 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 112.365 0.505 . . . . 99.989999999999995 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.43 -71.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.607 1.963 . . . . 99.989999999999995 111.903 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.306 4.8 pt20 46.38 -56.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 121.425 3.861 . . . . 99.989999999999995 121.425 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -175.99 -65.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.674 1.59 . . . . 99.989999999999995 111.471 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t 57.99 95.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 126.339 1.856 . . . . 99.989999999999995 112.888 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.85 81.58 19.39 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 112.775 0.658 . . . . 99.989999999999995 112.775 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -67.67 147.59 76.25 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 122.904 2.403 . . . . 99.989999999999995 112.473 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -80.31 0.59 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.526 -1.215 . . . . 99.989999999999995 111.475 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -113.86 -176.51 2.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.54 1.136 . . . . 99.989999999999995 112.335 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.25 19.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.253 1.021 . . . . 99.989999999999995 113.585 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.94 -54.22 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.161 0.984 . . . . 99.989999999999995 110.424 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -49.26 -59.62 3.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.678 1.191 . . . . 99.989999999999995 113.339 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -68.34 -51.12 48.0 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.791 1.034 . . . . 99.989999999999995 113.791 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.48 -40.68 96.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.976 . . . . 99.989999999999995 112.425 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -43.86 84.71 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 118.42 -0.8 . . . . 99.989999999999995 112.69 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.06 77.74 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.53 0.567 . . . . 99.989999999999995 112.53 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -57.2 -57.05 14.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.499 1.519 . . . . 99.989999999999995 111.721 170.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 2.5 pp -62.64 -36.99 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.059 0.763 . . . . 99.989999999999995 113.059 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -56.69 -58.11 9.51 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.057 0.943 . . . . 99.989999999999995 112.119 173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -59.85 -30.02 68.68 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.233 1.568 . . . . 99.989999999999995 115.233 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -71.48 -62.65 1.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.195 1.398 . . . . 99.989999999999995 112.033 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.9 -37.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 125.713 1.605 . . . . 99.989999999999995 113.251 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.86 -23.16 51.65 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.006 1.323 . . . . 99.989999999999995 113.488 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.58 73.24 0.39 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.938 -1.265 . . . . 99.989999999999995 109.938 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.6 p 1.62 79.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 128.244 2.618 . . . . 99.989999999999995 116.304 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -123.52 -47.31 1.98 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 117.311 2.337 . . . . 99.989999999999995 117.311 -172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.14 91.9 2.23 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 111.349 -0.701 . . . . 99.989999999999995 111.349 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.5 pt -119.96 167.17 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 120.727 0.299 . . . . 99.989999999999995 111.117 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.73 168.97 24.09 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 123.116 1.398 . . . . 99.989999999999995 113.901 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.7 mm -48.68 -36.6 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 111.833 -2.184 . . . . 99.989999999999995 112.804 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.12 -20.11 64.88 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.57 1.548 . . . . 99.989999999999995 114.307 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 58.77 -156.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.721 1.608 . . . . 99.989999999999995 109.865 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -119.1 13.38 12.92 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.499 0.926 . . . . 99.989999999999995 113.499 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 36.87 34.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.889 2.181 . . . . 99.989999999999995 116.889 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -152.49 -81.42 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.769 -1.559 . . . . 99.989999999999995 109.775 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -70.94 29.91 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.053 2.612 . . . . 99.989999999999995 118.053 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.82 -40.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 112.766 0.654 . . . . 99.989999999999995 112.766 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 -40.3 97.73 Favored Glycine 0 N--CA 1.48 1.603 0 O-C-N 123.813 0.696 . . . . 99.989999999999995 113.279 166.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.69 149.64 0.11 Allowed Glycine 0 N--CA 1.477 1.4 0 O-C-N 125.101 1.118 . . . . 99.989999999999995 114.022 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.05 45.95 1.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 113.627 -1.286 . . . . 99.989999999999995 112.189 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -174.94 -159.76 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.28 1.832 . . . . 99.989999999999995 111.38 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.04 -5.44 0.45 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.132 2.641 . . . . 99.989999999999995 118.132 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -52.63 -51.97 57.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.066 0.947 . . . . 99.989999999999995 110.901 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.74 60.93 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.965 1.469 . . . . 99.989999999999995 114.965 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.0 mmt -68.74 -47.41 66.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.967 0.907 . . . . 99.989999999999995 112.896 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.99 80.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.497 0.719 . . . . 99.989999999999995 111.835 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.87 -47.81 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.603 -0.726 . . . . 99.989999999999995 111.024 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.37 -42.82 64.27 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.803 0.729 . . . . 99.989999999999995 112.225 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -60.48 -52.18 66.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.951 1.093 . . . . 99.989999999999995 113.951 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.01 -38.94 92.59 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.816 1.043 . . . . 99.989999999999995 113.816 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.56 -28.64 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.498 1.119 . . . . 99.989999999999995 112.203 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -66.51 -59.25 3.82 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.209 -0.424 . . . . 99.989999999999995 111.327 167.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.418 HH21 ' HB1' ' A' ' 53' ' ' ALA . 11.6 ptp180 -71.84 -46.46 57.98 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.655 2.465 . . . . 99.989999999999995 117.655 -173.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -100.41 -30.69 11.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.632 1.573 . . . . 99.989999999999995 112.609 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -94.65 -30.83 14.12 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.211 1.189 . . . . 99.989999999999995 114.211 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.9 12.72 2.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.275 2.23 . . . . 99.989999999999995 115.998 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.39 12.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 121.172 0.511 . . . . 99.989999999999995 111.867 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 6.99 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 119.846 3.276 . . . . 99.989999999999995 119.846 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -121.31 87.18 44.38 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 114.364 1.246 . . . . 99.989999999999995 114.364 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.65 154.78 72.29 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 123.02 2.48 . . . . 99.989999999999995 111.214 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt 66.53 -44.45 0.42 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.639 1.976 . . . . 99.989999999999995 114.332 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.59 -61.11 2.52 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.406 0.682 . . . . 99.989999999999995 112.776 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.57 -8.93 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 116.591 2.071 . . . . 99.989999999999995 116.591 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.72 -24.49 12.93 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.306 1.443 . . . . 99.989999999999995 114.871 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.91 -40.92 2.94 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.261 1.208 . . . . 99.989999999999995 114.261 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.41 -49.12 14.09 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.609 0.764 . . . . 99.989999999999995 112.801 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -121.43 59.18 8.86 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 115.108 1.521 . . . . 99.989999999999995 115.108 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.35 19.18 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.335 3.357 . . . . 99.989999999999995 116.777 -170.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.7 p -120.86 137.36 54.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.869 -1.16 . . . . 99.989999999999995 107.869 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.333 0.5 OUTLIER -63.19 -20.99 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.719 1.007 . . . . 99.989999999999995 113.719 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -52.55 -66.33 0.4 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.759 1.224 . . . . 99.989999999999995 109.567 165.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.98 85.79 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.165 -0.925 . . . . 99.989999999999995 113.173 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -58.18 -44.75 88.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.313 0.645 . . . . 99.989999999999995 112.648 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.31 98.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.5 0.72 . . . . 99.989999999999995 112.34 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.35 -39.89 94.61 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.128 1.159 . . . . 99.989999999999995 114.128 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -71.44 -29.84 65.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.658 2.096 . . . . 99.989999999999995 116.658 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.275 33.4 m -116.83 -41.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.057 2.614 . . . . 99.989999999999995 118.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.408 ' C ' ' HG1' ' A' ' 83' ' ' THR . . . -99.62 57.27 1.01 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 123.335 1.54 . . . . 99.989999999999995 109.476 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 82' ' ' ALA . 92.1 m -165.46 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.128 -1.851 . . . . 99.989999999999995 109.205 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.508 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.2 -31.16 8.01 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.129 1.9 . . . . 99.989999999999995 116.129 174.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.969 1.47 . . . . 99.989999999999995 114.969 176.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.371 0.508 . . . . 99.989999999999995 112.371 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.11 72.01 0.3 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.243 1.817 . . . . 99.989999999999995 115.187 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -78.7 -75.43 0.23 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.381 -1.736 . . . . 99.989999999999995 112.946 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -121.54 -44.58 2.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.926 1.824 . . . . 99.989999999999995 115.926 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 t 48.94 82.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.444 1.898 . . . . 99.989999999999995 114.057 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.36 88.47 54.27 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 115.694 -0.684 . . . . 99.989999999999995 111.865 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.48 149.97 75.07 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 122.988 2.459 . . . . 0.0 112.642 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.35 -84.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.72 -1.127 . . . . 99.989999999999995 110.843 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -109.9 -178.02 3.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.606 0.762 . . . . 99.989999999999995 111.404 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.06 -45.54 43.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.849 1.055 . . . . 99.989999999999995 113.849 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.87 -58.79 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.06 0.944 . . . . 99.989999999999995 110.392 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 74' ' ' ILE . 52.5 mm-40 -51.08 -56.03 14.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.261 1.024 . . . . 99.989999999999995 112.604 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.84 -57.85 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.164 0.986 . . . . 99.989999999999995 113.537 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -66.51 -36.55 82.98 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.21 0.819 . . . . 99.989999999999995 113.21 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.83 -45.94 76.68 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 118.763 -0.637 . . . . 99.989999999999995 112.601 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.71 78.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.561 0.578 . . . . 99.989999999999995 112.561 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -56.57 -58.8 6.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.474 1.51 . . . . 99.989999999999995 111.229 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.268 2.6 pp -60.89 -38.39 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 118.319 -0.848 . . . . 99.989999999999995 112.81 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -55.85 -59.08 5.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.505 0.722 . . . . 99.989999999999995 112.266 172.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.43 -30.29 71.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.507 1.669 . . . . 99.989999999999995 115.507 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -75.9 -58.19 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.02 0.928 . . . . 99.989999999999995 112.335 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.09 -35.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.963 1.305 . . . . 99.989999999999995 112.557 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.33 -21.34 59.62 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.097 1.147 . . . . 99.989999999999995 114.097 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.51 72.1 0.29 Allowed Glycine 0 N--CA 1.476 1.333 0 N-CA-C 110.129 -1.188 . . . . 99.989999999999995 110.129 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.4 p 0.91 80.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 128.484 2.714 . . . . 99.989999999999995 116.187 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 m -119.74 -70.44 0.79 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.594 -2.094 . . . . 99.989999999999995 115.098 -172.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.75 101.98 1.51 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 110.975 -0.85 . . . . 99.989999999999995 110.975 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.6 pt -125.05 167.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.997 1.11 . . . . 99.989999999999995 113.997 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.37 157.91 53.48 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.283 -1.326 . . . . 99.989999999999995 112.911 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -57.01 -40.99 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.727 -0.737 . . . . 99.989999999999995 112.273 164.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.61 13.52 0.09 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.062 1.504 . . . . 99.989999999999995 115.062 162.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.76 -140.48 0.84 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.143 1.777 . . . . 99.989999999999995 110.348 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -115.77 22.67 12.89 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 111.05 154.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.255 53.1 p90 42.11 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 1 N-CA-C 122.135 4.124 . . . . 99.989999999999995 122.135 -178.523 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -112.8 -84.02 0.59 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.065 1.346 . . . . 99.989999999999995 112.335 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -48.24 -31.84 6.41 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 118.628 2.825 . . . . 99.989999999999995 118.628 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.42 -34.31 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.695 1.739 . . . . 99.989999999999995 115.695 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.97 75.2 Favored Glycine 0 N--CA 1.478 1.447 0 O-C-N 123.9 0.75 . . . . 99.989999999999995 113.029 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.98 127.08 0.01 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 117.319 1.688 . . . . 99.989999999999995 117.319 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 53.38 2.63 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.516 -2.342 . . . . 99.989999999999995 112.555 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -169.89 -152.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.052 1.741 . . . . 99.989999999999995 110.369 -174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.32 -22.13 2.64 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.333 1.975 . . . . 99.989999999999995 116.333 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.8 mptt -48.19 -62.1 1.65 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.917 1.287 . . . . 99.989999999999995 111.818 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.23 -45.66 44.89 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.445 1.646 . . . . 99.989999999999995 115.445 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 ptm -69.81 -41.34 75.14 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.082 1.512 . . . . 99.989999999999995 115.082 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.09 86.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.159 0.584 . . . . 99.989999999999995 112.06 171.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG12 HD12 ' A' ' 68' ' ' LEU . 6.0 t -67.82 -43.75 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.806 -0.634 . . . . 99.989999999999995 110.576 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.39 -42.58 64.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.552 0.615 . . . . 99.989999999999995 112.385 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.73 68.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.883 1.068 . . . . 99.989999999999995 113.883 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -66.68 -38.58 87.09 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.094 1.146 . . . . 99.989999999999995 114.094 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.83 -27.31 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.657 1.183 . . . . 99.989999999999995 112.254 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -70.34 -61.46 1.76 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.385 0.274 . . . . 99.989999999999995 111.445 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.38 -42.05 93.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.22 2.304 . . . . 99.989999999999995 117.22 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -107.15 -32.74 7.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.868 1.267 . . . . 99.989999999999995 113.076 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -94.69 -20.58 19.42 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.407 1.262 . . . . 99.989999999999995 114.407 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 61.96 -47.69 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.17 2.285 . . . . 99.989999999999995 117.17 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.68 28.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 N-CA-C 116.598 2.073 . . . . 99.989999999999995 116.598 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -9.9 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.457 3.132 . . . . 99.989999999999995 119.457 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -123.44 82.69 52.97 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 115.411 1.634 . . . . 99.989999999999995 115.411 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.11 148.39 85.24 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 123.401 2.734 . . . . 0.0 111.52 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.0 tt 63.31 -47.84 0.23 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.731 2.012 . . . . 99.989999999999995 113.563 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -46.24 -66.82 0.35 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.068 1.747 . . . . 99.989999999999995 112.207 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -68.27 -4.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 115.376 1.621 . . . . 99.989999999999995 115.376 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD12 HG12 ' A' ' 51' ' ' VAL . 3.1 mm? -107.86 -31.45 8.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.235 1.569 . . . . 99.989999999999995 115.235 -175.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -107.8 -37.27 6.17 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.649 0.981 . . . . 99.989999999999995 113.649 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.78 -44.17 56.77 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.55 0.34 . . . . 99.989999999999995 111.856 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.1 pm0 -123.21 71.83 45.69 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 113.992 1.108 . . . . 99.989999999999995 113.992 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.57 38.33 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.567 3.511 . . . . 0.0 115.924 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 t -144.44 133.55 22.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.569 1.548 . . . . 99.989999999999995 110.59 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 16' ' ' GLU 0.277 0.4 OUTLIER -63.91 -23.11 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 114.878 -1.056 . . . . 99.989999999999995 113.544 178.878 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.59 -61.96 2.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.85 0.86 . . . . 99.989999999999995 110.131 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.6 76.23 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.81 -1.086 . . . . 99.989999999999995 113.707 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.09 -47.46 77.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.79 0.436 . . . . 99.989999999999995 112.154 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.55 94.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.523 0.729 . . . . 99.989999999999995 112.866 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -61.03 -43.51 98.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.146 1.165 . . . . 99.989999999999995 114.146 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.15 -26.49 67.45 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.296 1.962 . . . . 99.989999999999995 116.296 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.329 7.2 m -114.98 -73.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.29 1.959 . . . . 99.989999999999995 116.29 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.81 64.48 0.67 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 123.471 1.605 . . . . 99.989999999999995 112.563 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 88.4 m -169.4 -53.53 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 129.075 2.95 . . . . 99.989999999999995 108.622 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.97 -28.91 6.5 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 117.708 2.484 . . . . 99.989999999999995 117.708 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.465 2.024 . . . . 99.989999999999995 116.465 -175.274 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 6' ' ' ALA . 7.9 pm0 . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 113.062 0.764 . . . . 99.989999999999995 113.062 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -72.15 172.15 10.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.721 1.208 . . . . 99.989999999999995 112.957 164.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -169.54 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.739 1.616 . . . . 99.989999999999995 107.422 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -60.92 -64.03 1.1 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.286 1.587 . . . . 99.989999999999995 115.286 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t 57.55 82.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 126.49 1.916 . . . . 99.989999999999995 113.456 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.01 91.6 49.06 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-N 115.844 -0.616 . . . . 99.989999999999995 112.063 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.38 143.21 47.2 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.121 2.547 . . . . 0.0 113.696 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -106.02 -81.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 114.475 -1.239 . . . . 99.989999999999995 111.911 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -116.44 -174.36 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.932 0.716 . . . . 99.989999999999995 112.932 -170.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.91 -57.01 6.25 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 117.393 -1.289 . . . . 99.989999999999995 113.099 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.6 -52.41 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.323 1.049 . . . . 99.989999999999995 111.023 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -55.08 -60.32 3.53 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.661 0.986 . . . . 99.989999999999995 113.661 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 t -64.33 -43.68 93.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.003 0.815 . . . . 99.989999999999995 113.197 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -57.74 -57.03 14.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 99.989999999999995 110.659 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.35 -38.71 92.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.41 0.893 . . . . 99.989999999999995 113.41 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.99 90.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.734 0.642 . . . . 99.989999999999995 112.734 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.73 -50.82 71.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.734 1.214 . . . . 99.989999999999995 111.573 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -54.82 -54.24 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.962 0.905 . . . . 99.989999999999995 110.357 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -56.2 -52.45 64.36 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.312 -0.852 . . . . 99.989999999999995 113.015 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -60.75 -30.26 69.89 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.788 1.773 . . . . 99.989999999999995 115.788 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -74.26 -62.47 1.5 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.096 1.358 . . . . 99.989999999999995 111.065 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.2 -45.76 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.785 1.634 . . . . 99.989999999999995 113.412 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.14 -25.61 46.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.086 1.754 . . . . 99.989999999999995 113.87 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.89 81.5 0.33 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.992 -1.643 . . . . 99.989999999999995 108.992 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 13.1 p -17.02 92.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.959 2.504 . . . . 99.989999999999995 116.197 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 p -149.86 -49.0 0.14 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 113.139 -1.846 . . . . 99.989999999999995 115.933 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.36 119.01 2.32 Favored Glycine 0 N--CA 1.481 1.664 0 O-C-N 123.695 0.622 . . . . 99.989999999999995 111.758 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.66 158.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 113.17 0.804 . . . . 99.989999999999995 113.17 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.17 152.23 24.32 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 113.758 -1.564 . . . . 99.989999999999995 112.695 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm -50.02 -40.32 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.318 1.047 . . . . 99.989999999999995 112.445 168.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -50.46 -34.4 24.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.583 1.553 . . . . 99.989999999999995 113.786 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.17 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.631 1.972 . . . . 99.989999999999995 113.356 -168.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.796 ' ND2' HE21 ' A' ' 40' ' ' GLN . 26.5 t-20 -57.17 -22.04 37.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.456 -1.247 . . . . 99.989999999999995 113.562 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.282 38.0 p90 60.42 -7.47 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 117.959 2.577 . . . . 99.989999999999995 117.959 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.8 -71.97 0.74 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.424 1.09 . . . . 99.989999999999995 112.261 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.796 HE21 ' ND2' ' A' ' 37' ' ' ASN . 25.8 pt20 -72.69 11.79 0.59 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.311 1.967 . . . . 99.989999999999995 116.311 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -51.48 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.915 0.709 . . . . 99.989999999999995 112.915 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.01 14.85 4.32 Favored Glycine 0 CA--C 1.541 1.709 0 O-C-N 124.288 0.993 . . . . 99.989999999999995 114.559 167.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.97 62.31 4.39 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.65 -0.58 . . . . 99.989999999999995 111.65 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -125.18 -130.22 0.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.747 -1.226 . . . . 99.989999999999995 108.473 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 p -110.01 -86.42 0.53 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.771 0.828 . . . . 99.989999999999995 111.273 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.89 -18.95 37.8 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.776 1.769 . . . . 99.989999999999995 115.776 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -56.1 -36.35 68.07 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.71 1.374 . . . . 99.989999999999995 114.71 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.97 74.15 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.278 0.473 . . . . 99.989999999999995 112.278 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.59 -48.2 67.51 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.906 1.282 . . . . 99.989999999999995 112.483 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.59 85.76 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.357 0.873 . . . . 99.989999999999995 113.357 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.26 -49.52 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.176 0.99 . . . . 99.989999999999995 110.225 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.52 -41.36 66.29 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.304 0.853 . . . . 99.989999999999995 113.304 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -54.52 43.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.363 1.065 . . . . 99.989999999999995 112.367 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.86 -43.63 90.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.338 1.055 . . . . 99.989999999999995 112.896 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 48.2 t -68.1 -25.58 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.81 1.244 . . . . 99.989999999999995 113.353 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -85.2 -27.01 26.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.26 1.207 . . . . 99.989999999999995 114.26 172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -97.64 -56.19 2.59 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 116.376 1.991 . . . . 99.989999999999995 116.376 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.25 -32.17 17.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.642 1.177 . . . . 99.989999999999995 112.315 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.3 m-85 -85.72 -33.18 21.55 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.897 1.073 . . . . 99.989999999999995 113.897 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 58.02 3.65 0.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.662 2.467 . . . . 99.989999999999995 117.662 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.16 10.99 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.021 1.489 . . . . 99.989999999999995 115.021 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 15.47 81.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 118.151 2.648 . . . . 99.989999999999995 118.151 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.4 pt? -128.39 77.59 76.89 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.626 1.343 . . . . 99.989999999999995 114.626 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.57 145.95 88.2 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 123.361 2.707 . . . . 0.0 111.987 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.281 3.0 pp 58.75 -39.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.843 2.457 . . . . 99.989999999999995 115.861 -170.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.8 -65.6 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.065 2.146 . . . . 99.989999999999995 110.517 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.541 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 3.0 p -61.94 -22.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 114.846 1.424 . . . . 99.989999999999995 114.846 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 tp -95.4 -26.88 15.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.803 1.641 . . . . 99.989999999999995 115.123 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -114.88 -38.96 3.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.386 1.074 . . . . 99.989999999999995 113.603 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.35 49.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.6 0.592 . . . . 99.989999999999995 112.6 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -121.56 59.45 9.52 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 114.309 1.226 . . . . 99.989999999999995 114.309 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -75.63 24.32 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.953 3.769 . . . . 0.0 116.68 -168.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 t -126.0 138.85 53.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 99.989999999999995 110.159 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.258 0.4 OUTLIER -60.64 -27.39 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.357 0.873 . . . . 99.989999999999995 113.357 -178.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -55.16 -55.37 31.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.386 0.675 . . . . 99.989999999999995 110.855 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.19 75.88 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 99.989999999999995 113.422 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.2 -46.34 75.9 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.535 0.734 . . . . 99.989999999999995 112.173 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.51 85.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.179 0.992 . . . . 99.989999999999995 112.317 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.79 -32.75 74.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.145 1.535 . . . . 99.989999999999995 115.145 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -69.47 -16.08 63.4 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.986 1.847 . . . . 99.989999999999995 115.986 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.274 15.6 m -117.72 -71.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.235 1.569 . . . . 99.989999999999995 115.235 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 61.11 3.16 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.797 1.761 . . . . 99.989999999999995 111.622 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.1 m -165.44 -57.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.616 2.367 . . . . 99.989999999999995 108.338 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.77 -27.88 7.98 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.962 2.208 . . . . 99.989999999999995 116.962 177.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.575 -1.679 . . . . 99.989999999999995 115.149 -174.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 114.121 1.156 . . . . 99.989999999999995 114.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.61 21.03 5.39 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.488 2.773 . . . . 99.989999999999995 118.488 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -38.76 -35.74 0.22 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 119.373 3.101 . . . . 99.989999999999995 119.373 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.8 t80 176.96 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.072 1.349 . . . . 99.989999999999995 110.697 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 t 65.72 93.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 127.092 2.157 . . . . 99.989999999999995 112.785 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.68 82.15 67.8 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 115.651 -0.704 . . . . 99.989999999999995 111.784 169.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 137.38 32.56 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.602 2.201 . . . . 0.0 112.539 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -76.37 0.55 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.185 -1.37 . . . . 99.989999999999995 111.612 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -118.84 -176.49 3.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.618 1.167 . . . . 99.989999999999995 112.582 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.11 54.25 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 99.989999999999995 113.889 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -57.08 -56.22 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.346 1.058 . . . . 99.989999999999995 110.022 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -48.96 -56.38 9.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 113.555 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 t -67.42 -55.04 15.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.158 0.983 . . . . 99.989999999999995 113.561 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -64.18 -38.67 91.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.854 0.862 . . . . 99.989999999999995 112.889 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.24 -45.83 83.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 118.473 -0.775 . . . . 99.989999999999995 112.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.75 76.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 112.693 0.627 . . . . 99.989999999999995 112.693 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -57.92 -58.88 6.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.211 1.404 . . . . 99.989999999999995 111.677 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -61.5 -38.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.685 0.624 . . . . 99.989999999999995 112.685 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.06 -57.39 12.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 99.989999999999995 112.161 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.18 -31.55 71.3 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.569 1.322 . . . . 99.989999999999995 114.569 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -69.38 -62.0 1.56 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.752 1.282 . . . . 99.989999999999995 111.927 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.6 -37.88 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.576 1.551 . . . . 99.989999999999995 113.193 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.69 -25.5 60.39 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.377 1.071 . . . . 99.989999999999995 113.623 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.4 62.19 0.14 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.155 0.909 . . . . 99.989999999999995 111.587 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.262 10.3 p 16.67 67.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 127.888 2.475 . . . . 99.989999999999995 114.997 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -109.9 -49.86 3.04 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 112.372 -2.194 . . . . 99.989999999999995 116.667 -167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 92.07 2.21 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 111.216 -0.754 . . . . 99.989999999999995 111.216 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.66 159.23 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.978 1.103 . . . . 99.989999999999995 113.978 -170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.24 153.3 41.15 Favored Glycine 0 N--CA 1.475 1.285 0 CA-C-N 113.889 -1.505 . . . . 99.989999999999995 113.34 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 mm -48.56 -40.99 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.753 1.221 . . . . 99.989999999999995 113.121 167.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.13 -14.09 33.51 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.705 1.602 . . . . 99.989999999999995 114.753 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.04 -158.8 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.097 2.159 . . . . 99.989999999999995 110.455 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 39' ' ' PHE . 22.8 t-20 -111.25 17.92 19.79 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.045 0.387 . . . . 99.989999999999995 112.045 171.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 p90 40.51 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 119.889 3.292 . . . . 99.989999999999995 119.889 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 37' ' ' ASN . 88.9 t80 -124.27 -85.91 0.64 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 99.989999999999995 111.605 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -71.81 33.22 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 119.441 3.126 . . . . 99.989999999999995 119.441 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.02 -40.26 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 115.731 -0.668 . . . . 99.989999999999995 111.948 172.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.64 -64.26 4.26 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.918 0.761 . . . . 99.989999999999995 112.966 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.55 100.05 0.14 Allowed Glycine 0 N--CA 1.476 1.361 0 CA-C-N 114.471 -0.865 . . . . 99.989999999999995 113.49 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.22 -36.91 85.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.34 0.656 . . . . 99.989999999999995 112.459 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -151.12 -90.4 0.06 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.398 1.479 . . . . 99.989999999999995 108.932 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.8 pt? -93.92 -11.0 31.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.837 2.162 . . . . 99.989999999999995 116.837 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -42.29 -37.21 1.45 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 116.336 1.976 . . . . 99.989999999999995 116.336 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.21 -38.69 41.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.136 1.161 . . . . 99.989999999999995 114.136 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 79.3 mtm -71.49 -45.37 62.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.294 0.85 . . . . 99.989999999999995 113.294 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.04 88.35 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.667 0.787 . . . . 99.989999999999995 112.385 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.27 -42.59 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.808 -0.633 . . . . 99.989999999999995 110.699 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -38.42 63.81 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.422 0.555 . . . . 99.989999999999995 112.406 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.56 -58.16 8.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.721 0.808 . . . . 99.989999999999995 112.525 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.55 -37.48 87.49 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.985 1.106 . . . . 99.989999999999995 113.985 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 94.3 t -66.03 -24.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.671 1.188 . . . . 99.989999999999995 112.93 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -87.18 -58.35 2.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.238 0.615 . . . . 99.989999999999995 112.272 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -68.78 -37.91 79.65 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 116.77 2.137 . . . . 99.989999999999995 116.77 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -106.64 -46.62 3.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.367 1.067 . . . . 99.989999999999995 111.759 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-85 -75.76 -32.49 59.98 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.653 1.353 . . . . 99.989999999999995 114.653 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.25 94.6 mt-30 66.97 -31.49 0.17 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.753 2.501 . . . . 99.989999999999995 117.753 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.49 -30.3 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.176 1.39 . . . . 99.989999999999995 113.47 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 47.61 79.19 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.181 1.792 . . . . 99.989999999999995 115.368 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.19 83.32 12.45 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 115.827 1.788 . . . . 99.989999999999995 115.827 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -63.87 152.82 79.01 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.132 2.555 . . . . 0.0 110.939 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 64' ' ' PRO 0.303 3.7 pp 60.65 -41.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.7 2.4 . . . . 99.989999999999995 116.724 -172.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -56.83 -67.01 0.35 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.89 1.276 . . . . 99.989999999999995 111.897 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.13 13.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.053 1.131 . . . . 99.989999999999995 114.053 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -123.85 -35.54 2.85 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.789 2.144 . . . . 99.989999999999995 116.789 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.89 -48.26 3.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.68 1.192 . . . . 99.989999999999995 110.979 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.42 76.02 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.784 0.661 . . . . 99.989999999999995 112.784 170.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -121.33 55.8 5.43 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.836 1.421 . . . . 99.989999999999995 114.836 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -76.32 24.54 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.387 3.391 . . . . 0.0 116.58 -167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -132.94 141.11 48.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.092 1.357 . . . . 99.989999999999995 110.169 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER -62.99 -22.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 115.246 -0.888 . . . . 99.989999999999995 113.092 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -57.82 -52.0 67.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 110.793 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.43 74.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.211 1.005 . . . . 99.989999999999995 113.403 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.02 -47.67 77.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.274 0.63 . . . . 99.989999999999995 111.897 172.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.33 98.73 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 99.989999999999995 112.705 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -54.59 -44.95 73.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.221 1.008 . . . . 99.989999999999995 112.796 171.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -71.31 -22.54 61.92 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.171 2.286 . . . . 99.989999999999995 117.171 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.28 11.6 m -108.42 -70.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.174 1.546 . . . . 99.989999999999995 115.174 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.18 60.0 3.52 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.416 1.579 . . . . 99.989999999999995 111.748 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 98.8 m -166.37 -60.56 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 128.202 2.601 . . . . 99.989999999999995 108.384 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -27.61 7.62 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.837 2.532 . . . . 99.989999999999995 117.837 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 116.226 1.936 . . . . 99.989999999999995 116.226 -174.641 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 114.978 1.473 . . . . 99.989999999999995 114.978 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.94 35.13 11.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.893 2.077 . . . . 99.989999999999995 116.375 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -42.25 -46.73 4.58 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.632 2.086 . . . . 99.989999999999995 116.632 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.6 t80 172.88 -59.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.775 1.23 . . . . 99.989999999999995 112.463 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.319 5.4 p 56.56 98.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.864 2.465 . . . . 99.989999999999995 116.199 -175.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.21 84.81 34.92 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 114.736 -1.12 . . . . 99.989999999999995 111.982 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.08 153.15 78.6 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.151 2.567 . . . . 0.0 112.744 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.23 -82.41 0.57 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.581 -1.19 . . . . 99.989999999999995 110.938 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -113.2 -177.39 3.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.758 1.223 . . . . 99.989999999999995 112.034 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -55.74 10.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.411 1.084 . . . . 99.989999999999995 113.444 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.27 -51.29 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.232 1.013 . . . . 99.989999999999995 111.089 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 74' ' ' ILE . 43.2 mm-40 -50.93 -58.73 5.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.345 1.058 . . . . 99.989999999999995 112.581 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -67.94 -50.35 56.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.309 -0.86 . . . . 99.989999999999995 113.257 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -57.75 -50.38 73.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.194 1.397 . . . . 99.989999999999995 112.066 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.5 mm? -66.45 -43.79 84.6 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.43 -0.795 . . . . 99.989999999999995 112.747 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.96 83.82 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.689 0.626 . . . . 99.989999999999995 112.689 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.02 -60.28 3.82 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.745 1.618 . . . . 99.989999999999995 110.673 171.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 2.6 pp -60.51 -36.75 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 113.338 0.866 . . . . 99.989999999999995 113.338 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.95 -63.91 1.0 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.802 0.841 . . . . 99.989999999999995 111.552 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 17.9 pt-20 -61.44 -33.97 74.63 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.088 1.514 . . . . 99.989999999999995 115.088 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -67.71 -63.29 1.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.137 1.375 . . . . 99.989999999999995 111.717 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.29 -30.03 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.038 1.335 . . . . 99.989999999999995 112.469 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.88 -34.8 70.17 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.748 1.018 . . . . 99.989999999999995 113.748 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.24 61.96 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 111.557 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.255 7.4 p 17.7 62.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 128.615 2.766 . . . . 99.989999999999995 115.272 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -102.91 -47.36 4.4 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.121 -1.854 . . . . 99.989999999999995 115.473 -165.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' A' ' 24' ' ' GLU . . . 92.55 105.22 1.59 Allowed Glycine 0 N--CA 1.48 1.6 0 N-CA-C 110.698 -0.961 . . . . 99.989999999999995 110.698 -174.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 pt -120.28 -151.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 112.468 0.544 . . . . 99.989999999999995 112.468 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.89 160.41 18.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.602 -0.599 . . . . 99.989999999999995 111.602 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.18 -40.48 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.144 0.794 . . . . 99.989999999999995 113.144 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD22 ' HG1' ' A' ' 73' ' ' THR . 63.5 mt -67.96 -0.69 4.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.612 1.708 . . . . 99.989999999999995 115.612 170.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.95 -145.58 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.287 1.835 . . . . 99.989999999999995 111.6 -174.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -139.76 42.05 1.99 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.773 0.429 . . . . 99.989999999999995 111.835 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -6.01 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.427 2.291 . . . . 99.989999999999995 117.027 -169.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 t80 173.67 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 112.597 -2.092 . . . . 99.989999999999995 108.814 -171.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -70.83 19.33 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.285 3.068 . . . . 99.989999999999995 119.285 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -104.22 -40.55 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 112.831 0.678 . . . . 99.989999999999995 112.831 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.23 63.39 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.715 -0.675 . . . . 99.989999999999995 113.85 166.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.99 -162.71 26.55 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.445 -0.878 . . . . 99.989999999999995 111.413 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.594 ' HE2' ' HG ' ' A' ' 46' ' ' LEU . 9.6 p80 -70.8 -44.23 67.03 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.682 0.993 . . . . 99.989999999999995 113.682 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.5 p -174.83 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.317 1.969 . . . . 99.989999999999995 116.317 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.594 ' HG ' ' HE2' ' A' ' 44' ' ' HIS . 4.2 pp -61.2 -36.76 80.78 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.315 1.228 . . . . 99.989999999999995 114.315 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -58.87 -49.89 76.05 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 118.404 -0.808 . . . . 99.989999999999995 112.822 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -37.64 57.14 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.208 1.188 . . . . 99.989999999999995 114.208 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -63.12 -50.72 69.36 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.668 0.988 . . . . 99.989999999999995 113.668 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.548 0.739 . . . . 99.989999999999995 112.492 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 -50.49 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.746 1.218 . . . . 99.989999999999995 110.077 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.56 -42.9 67.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.221 0.608 . . . . 99.989999999999995 112.531 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB2' HH21 ' A' ' 57' ' ' ARG . . . -61.2 -51.51 68.7 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.2 1.185 . . . . 99.989999999999995 114.2 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -66.98 -38.6 86.35 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.477 1.288 . . . . 99.989999999999995 114.477 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 93.3 t -66.38 -30.01 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.088 . . . . 99.989999999999995 111.816 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -69.29 -68.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.827 0.451 . . . . 99.989999999999995 111.285 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.496 HH21 ' HB2' ' A' ' 53' ' ' ALA . 10.9 ptp180 -59.38 -42.52 91.88 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.744 2.128 . . . . 99.989999999999995 116.744 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.55 -38.93 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.16 0.8 . . . . 99.989999999999995 113.16 -170.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -78.02 -25.04 47.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.257 1.206 . . . . 99.989999999999995 114.257 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 69.92 -44.84 0.57 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.639 2.776 . . . . 99.989999999999995 114.998 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.03 27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 126.663 1.985 . . . . 99.989999999999995 116.14 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -8.93 77.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 120.335 3.457 . . . . 99.989999999999995 120.335 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -125.72 91.46 48.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 114.905 1.446 . . . . 99.989999999999995 114.905 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.42 152.03 81.83 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.986 2.457 . . . . 0.0 111.891 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tt 65.15 -42.29 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.068 2.147 . . . . 99.989999999999995 116.051 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -54.1 -71.69 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.328 0.862 . . . . 99.989999999999995 113.328 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.255 4.0 p -84.63 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 123.819 1.771 . . . . 99.989999999999995 110.464 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.6 tp -162.5 -49.76 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.765 -2.016 . . . . 99.989999999999995 112.402 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.63 -62.59 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.527 1.131 . . . . 99.989999999999995 111.566 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.31 78.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.307 0.643 . . . . 99.989999999999995 112.624 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -120.9 83.2 36.71 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 111.201 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -85.62 26.78 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.223 2.615 . . . . 0.0 114.776 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.405 ' HG1' HD22 ' A' ' 35' ' ' LEU . 2.8 t -136.21 136.08 39.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.033 0.533 . . . . 99.989999999999995 111.404 -171.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 16' ' ' GLU 0.264 0.4 OUTLIER -62.73 -22.34 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.701 -1.136 . . . . 99.989999999999995 112.911 177.268 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -58.52 -57.56 12.4 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.184 0.594 . . . . 99.989999999999995 110.097 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.51 81.07 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.906 1.076 . . . . 99.989999999999995 113.906 174.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.24 -46.12 89.33 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.585 0.354 . . . . 99.989999999999995 110.876 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.87 85.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.065 0.946 . . . . 99.989999999999995 112.844 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.521 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -59.39 -39.93 84.97 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.065 1.135 . . . . 99.989999999999995 114.065 169.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.81 -38.35 79.86 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.506 1.669 . . . . 99.989999999999995 115.506 172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.314 28.1 m -106.59 -57.18 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 117.115 2.265 . . . . 99.989999999999995 117.115 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' C ' ' HG1' ' A' ' 83' ' ' THR . . . -85.38 49.27 1.72 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 122.963 1.364 . . . . 99.989999999999995 111.369 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 86.5 m -161.38 -65.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.556 1.942 . . . . 99.989999999999995 109.212 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 -30.04 8.64 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 117.198 2.295 . . . . 99.989999999999995 117.198 174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.592 1.701 . . . . 99.989999999999995 115.592 174.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.884 0.327 . . . . 99.989999999999995 111.884 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.0 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.831 2.052 . . . . 99.989999999999995 111.423 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.314 5.1 pt20 46.82 -45.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 120.856 3.651 . . . . 99.989999999999995 120.856 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -175.32 -67.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.935 1.694 . . . . 99.989999999999995 111.757 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.15 84.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 126.573 1.949 . . . . 99.989999999999995 112.406 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 88.93 30.19 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 115.131 -0.94 . . . . 99.989999999999995 111.005 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.64 146.96 75.14 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.875 2.384 . . . . 0.0 112.17 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 -79.85 0.5 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.376 -1.284 . . . . 99.989999999999995 110.297 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -116.51 178.23 4.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.046 0.938 . . . . 99.989999999999995 111.304 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.24 37.06 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.84 1.052 . . . . 99.989999999999995 113.84 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.88 -60.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.879 1.272 . . . . 99.989999999999995 110.586 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -53.08 -49.85 65.57 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.136 0.974 . . . . 99.989999999999995 112.941 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -61.68 -55.6 28.67 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.071 0.949 . . . . 99.989999999999995 113.165 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.24 -44.12 97.77 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.053 0.941 . . . . 99.989999999999995 112.242 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.63 -47.55 80.88 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.278 0.844 . . . . 99.989999999999995 113.278 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.17 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.124 0.416 . . . . 99.989999999999995 112.124 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -57.84 -58.08 9.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.92 1.288 . . . . 99.989999999999995 111.942 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 pt -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.043 0.757 . . . . 99.989999999999995 113.043 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -59.4 -46.55 88.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.907 1.077 . . . . 99.989999999999995 113.907 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.8 -26.83 67.87 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.055 1.502 . . . . 99.989999999999995 115.055 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -46.42 20.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.314 1.045 . . . . 99.989999999999995 111.42 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.48 -42.4 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.683 1.593 . . . . 99.989999999999995 112.173 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.77 -25.14 39.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.713 1.205 . . . . 99.989999999999995 114.096 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.63 87.13 1.46 Allowed Glycine 0 CA--C 1.531 1.074 0 N-CA-C 106.804 -2.518 . . . . 99.989999999999995 106.804 -166.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -18.15 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 127.288 2.235 . . . . 99.989999999999995 115.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 p -140.96 -52.44 0.47 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 112.77 -2.014 . . . . 99.989999999999995 114.873 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 98.22 2.06 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 115.515 -0.766 . . . . 99.989999999999995 112.736 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.52 146.63 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.532 0.682 . . . . 99.989999999999995 111.732 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.22 164.27 47.61 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 113.732 -1.577 . . . . 99.989999999999995 112.758 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -50.42 -34.57 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 113.36 -1.42 . . . . 99.989999999999995 112.598 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.87 -23.89 67.37 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.846 1.424 . . . . 99.989999999999995 114.846 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.23 -175.3 0.15 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.247 1.819 . . . . 99.989999999999995 111.323 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -96.06 14.15 24.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.925 1.083 . . . . 99.989999999999995 113.925 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 p90 32.36 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.291 2.33 . . . . 99.989999999999995 117.291 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -162.58 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.458 -1.701 . . . . 99.989999999999995 109.83 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.06 43.17 0.35 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.982 2.216 . . . . 99.989999999999995 116.982 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 -43.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.803 -1.09 . . . . 99.989999999999995 111.128 170.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.32 -51.43 43.51 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.521 -0.763 . . . . 99.989999999999995 114.214 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.23 102.14 0.17 Allowed Glycine 0 N--CA 1.476 1.331 0 O-C-N 124.526 0.78 . . . . 99.989999999999995 114.857 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -29.12 70.32 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.394 -0.903 . . . . 99.989999999999995 112.09 156.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.2 p 174.19 -93.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 130.723 3.609 . . . . 99.989999999999995 108.14 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -26.64 68.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.941 2.2 . . . . 99.989999999999995 116.941 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -39.5 -38.72 0.61 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.202 1.927 . . . . 99.989999999999995 116.202 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 -55.04 18.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.065 0.765 . . . . 99.989999999999995 113.065 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ptm -70.96 -41.19 71.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.277 1.214 . . . . 99.989999999999995 114.277 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.94 92.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.782 . . . . 99.989999999999995 112.989 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.8 -39.73 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 118.442 -0.789 . . . . 99.989999999999995 110.262 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.69 68.95 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.846 1.054 . . . . 99.989999999999995 113.846 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.37 -43.78 79.51 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.518 0.727 . . . . 99.989999999999995 112.871 173.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.37 -43.22 74.0 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.813 1.245 . . . . 99.989999999999995 112.372 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 57.0 t -58.41 -31.3 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.41 1.084 . . . . 99.989999999999995 111.33 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.49 -80.06 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.504 0.722 . . . . 99.989999999999995 111.378 165.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.9 -31.49 66.81 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 117.265 2.321 . . . . 99.989999999999995 117.265 -168.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -109.15 -37.41 5.8 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.148 0.979 . . . . 99.989999999999995 112.983 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 4.1 m-30 -94.72 -18.8 20.95 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.314 1.968 . . . . 99.989999999999995 116.314 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 68.63 -39.03 0.4 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.239 2.616 . . . . 99.989999999999995 115.722 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.84 -23.49 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 125.072 1.349 . . . . 99.989999999999995 113.712 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 50.57 23.22 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 121.271 3.804 . . . . 99.989999999999995 121.271 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.1 104.93 51.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.034 1.864 . . . . 99.989999999999995 116.034 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.73 152.63 79.66 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 123.509 2.806 . . . . 0.0 112.132 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt 63.81 -56.65 0.21 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.7 2.0 . . . . 99.989999999999995 114.241 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.12 -64.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.431 1.493 . . . . 99.989999999999995 113.082 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 4.7 p -60.94 -29.57 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 114.562 1.319 . . . . 99.989999999999995 114.562 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.51 -24.24 34.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.006 1.854 . . . . 99.989999999999995 116.006 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -109.33 -37.51 5.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.948 1.462 . . . . 99.989999999999995 114.948 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.75 77.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.726 0.41 . . . . 99.989999999999995 111.655 173.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.4 pm0 -123.62 73.06 52.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 115.651 -0.704 . . . . 99.989999999999995 112.063 168.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.71 24.63 0.37 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.62 3.547 . . . . 0.0 117.158 -170.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t -135.2 137.0 42.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.105 1.362 . . . . 99.989999999999995 110.697 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -26.3 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.657 -1.156 . . . . 99.989999999999995 112.56 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -58.61 -50.03 75.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.844 0.458 . . . . 99.989999999999995 110.962 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.91 68.48 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.03 0.752 . . . . 99.989999999999995 113.03 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.32 -43.16 78.71 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.955 0.902 . . . . 99.989999999999995 113.201 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.7 79.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 99.989999999999995 112.42 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.61 -37.41 84.82 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.195 1.183 . . . . 99.989999999999995 114.195 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -60.91 -17.85 53.33 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.734 1.753 . . . . 99.989999999999995 115.734 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.267 16.5 m -110.75 -73.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.901 1.075 . . . . 99.989999999999995 113.901 170.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.92 74.54 6.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.392 1.568 . . . . 99.989999999999995 111.353 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 m -173.27 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 129.409 3.084 . . . . 99.989999999999995 107.341 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.69 -30.18 6.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.09 2.255 . . . . 99.989999999999995 117.09 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 116.148 1.907 . . . . 99.989999999999995 116.148 -177.388 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 114.704 1.372 . . . . 99.989999999999995 114.704 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.91 20.39 8.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.264 2.32 . . . . 99.989999999999995 117.264 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.43 -28.11 0.83 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 120.19 3.404 . . . . 99.989999999999995 120.19 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 t80 176.2 -70.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.326 1.45 . . . . 99.989999999999995 110.921 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 62.75 85.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 126.926 2.09 . . . . 99.989999999999995 113.009 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.11 90.61 48.93 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 115.418 -0.81 . . . . 99.989999999999995 112.563 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.71 156.72 44.28 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 123.341 2.694 . . . . 0.0 113.466 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.3 -83.35 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.558 -1.201 . . . . 99.989999999999995 112.056 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.86 -171.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.677 0.791 . . . . 99.989999999999995 112.457 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.79 -50.8 55.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.198 0.999 . . . . 99.989999999999995 113.467 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.7 -53.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.11 0.964 . . . . 99.989999999999995 110.235 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.72 -62.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 113.176 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -64.58 -51.45 62.71 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.881 1.067 . . . . 99.989999999999995 113.881 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.6 -45.73 89.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.584 0.754 . . . . 99.989999999999995 112.197 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.0 -39.3 90.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.431 0.9 . . . . 99.989999999999995 113.431 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.87 85.34 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.209 0.459 . . . . 99.989999999999995 112.054 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.33 -53.72 54.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.7 1.2 . . . . 99.989999999999995 111.068 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -53.67 -53.46 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.34 1.056 . . . . 99.989999999999995 110.638 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.439 ' HE1' HD13 ' A' ' 74' ' ' ILE . 21.3 m95 -54.28 -60.4 3.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.266 1.027 . . . . 99.989999999999995 112.779 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -58.66 -31.98 68.67 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.221 1.563 . . . . 99.989999999999995 115.221 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -69.87 -63.81 1.01 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 99.989999999999995 111.376 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.85 -36.45 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.149 1.38 . . . . 99.989999999999995 112.801 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tt -56.92 -24.5 52.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.666 1.586 . . . . 99.989999999999995 113.956 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.19 71.29 0.24 Allowed Glycine 0 N--CA 1.476 1.314 0 N-CA-C 110.336 -1.106 . . . . 99.989999999999995 110.336 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.271 12.2 p 3.52 78.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 128.475 2.71 . . . . 99.989999999999995 116.127 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -121.56 -67.61 0.95 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 112.597 -2.092 . . . . 99.989999999999995 116.284 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.71 95.76 1.37 Allowed Glycine 0 N--CA 1.479 1.56 0 N-CA-C 111.105 -0.798 . . . . 99.989999999999995 111.105 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 pt -121.58 159.28 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.526 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.65 151.57 29.41 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-N 114.132 -1.394 . . . . 99.989999999999995 112.214 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -45.49 -41.99 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.856 1.662 . . . . 99.989999999999995 112.892 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HA ' ' HG1' ' A' ' 73' ' ' THR . 3.9 mm? -59.49 -29.92 68.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.844 1.053 . . . . 99.989999999999995 113.844 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 62.97 149.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.123 2.169 . . . . 99.989999999999995 111.858 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.55 24.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.708 1.744 . . . . 99.989999999999995 115.708 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.9 p90 22.55 47.82 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 118.343 2.719 . . . . 99.989999999999995 118.343 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -160.12 -78.22 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.179 -1.828 . . . . 99.989999999999995 109.401 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -70.0 27.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 118.792 2.886 . . . . 99.989999999999995 118.792 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.78 -35.97 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.307 1.043 . . . . 99.989999999999995 111.698 172.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.26 -63.21 5.37 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 124.334 0.969 . . . . 99.989999999999995 113.398 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.77 121.64 0.01 OUTLIER Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.226 -1.487 . . . . 99.989999999999995 115.838 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.01 49.95 1.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.754 -1.723 . . . . 99.989999999999995 113.467 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -159.72 -154.04 0.38 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.502 1.921 . . . . 99.989999999999995 108.905 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -62.67 -0.87 0.7 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.732 2.123 . . . . 99.989999999999995 116.732 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -56.16 -61.61 2.27 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.352 1.061 . . . . 99.989999999999995 112.748 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.65 -36.31 24.31 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.619 1.34 . . . . 99.989999999999995 114.619 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.0 mmm -65.28 -52.3 55.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.598 1.159 . . . . 99.989999999999995 112.841 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.27 77.83 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.308 1.043 . . . . 99.989999999999995 112.668 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.81 -50.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.067 0.947 . . . . 99.989999999999995 110.177 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.97 -42.65 65.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.321 0.648 . . . . 99.989999999999995 112.566 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.46 -56.28 23.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.377 0.88 . . . . 99.989999999999995 113.377 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -65.68 -38.64 89.83 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.987 1.106 . . . . 99.989999999999995 113.987 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -66.55 -27.98 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.979 0.912 . . . . 99.989999999999995 111.951 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -71.14 -69.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.806 0.443 . . . . 99.989999999999995 111.222 166.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.23 2.678 . . . . 99.989999999999995 118.23 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.93 -44.01 3.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.999 0.92 . . . . 99.989999999999995 113.243 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.2 m-85 -82.62 -20.98 35.32 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.638 1.348 . . . . 99.989999999999995 114.638 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -46.67 0.62 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.658 2.783 . . . . 99.989999999999995 114.189 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.77 26.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 116.715 2.117 . . . . 99.989999999999995 116.715 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -6.72 76.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 120.29 3.441 . . . . 99.989999999999995 120.29 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -123.97 86.7 53.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 115.591 1.701 . . . . 99.989999999999995 115.591 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.24 150.8 84.64 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.17 2.58 . . . . 0.0 111.629 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 -48.73 0.35 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.605 1.962 . . . . 99.989999999999995 114.78 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -52.08 -69.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.616 1.566 . . . . 99.989999999999995 112.904 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.435 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -61.55 -20.46 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.344 1.239 . . . . 99.989999999999995 114.344 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 tp -93.44 -29.02 15.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.258 1.823 . . . . 99.989999999999995 114.633 -168.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -108.1 -40.33 5.24 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.607 1.163 . . . . 99.989999999999995 113.705 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.26 73.02 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.205 0.446 . . . . 99.989999999999995 112.205 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.0 pm0 -122.97 70.23 39.62 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 112.679 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.38 32.83 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.536 3.49 . . . . 0.0 115.097 -173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.45 ' HG1' ' HA ' ' A' ' 35' ' ' LEU . 8.6 t -139.03 137.51 36.35 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.856 1.262 . . . . 99.989999999999995 111.125 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.439 HD13 ' HE1' ' A' ' 23' ' ' TRP 0.306 3.2 mm -57.86 -27.94 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 115.085 1.513 . . . . 99.989999999999995 115.085 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -66.19 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.991 0.807 . . . . 99.989999999999995 110.169 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.5 78.5 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.097 1.147 . . . . 99.989999999999995 114.097 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.2 -44.39 88.09 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.503 0.557 . . . . 99.989999999999995 112.503 171.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.16 93.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.745 0.818 . . . . 99.989999999999995 112.653 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.3 mp0 -60.83 -46.28 91.16 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.157 1.169 . . . . 99.989999999999995 114.157 171.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -65.46 -26.97 68.18 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.322 1.971 . . . . 99.989999999999995 116.322 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.316 9.5 m -112.07 -75.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 115.192 1.553 . . . . 99.989999999999995 115.192 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 60.56 1.25 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.351 1.548 . . . . 99.989999999999995 113.428 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.4 m -161.69 -54.16 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.629 2.372 . . . . 99.989999999999995 109.05 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -106.03 -31.97 8.5 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.371 1.989 . . . . 99.989999999999995 116.371 173.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 127.353 2.261 . . . . 99.989999999999995 116.436 -178.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 111.18 0.067 . . . . 99.989999999999995 111.18 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.71 147.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.276 1.83 . . . . 99.989999999999995 113.465 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.43 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.557 -1.201 . . . . 99.989999999999995 112.556 -173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -118.25 -61.73 1.63 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.752 0.649 . . . . 99.989999999999995 112.752 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t 67.46 98.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 126.389 1.876 . . . . 99.989999999999995 111.553 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.58 78.86 38.06 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 115.529 -0.76 . . . . 99.989999999999995 112.018 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.56 145.68 77.16 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.665 2.244 . . . . 0.0 112.013 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.76 -87.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.604 -1.18 . . . . 99.989999999999995 111.046 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -105.26 -176.38 3.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.543 0.737 . . . . 99.989999999999995 111.646 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.49 -50.39 31.83 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.061 0.944 . . . . 99.989999999999995 113.119 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.91 -58.49 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.323 1.049 . . . . 99.989999999999995 110.504 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.28 -58.89 4.27 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.745 1.218 . . . . 99.989999999999995 113.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -67.97 -54.25 20.04 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.639 0.977 . . . . 99.989999999999995 113.639 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.89 -41.29 95.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.713 1.205 . . . . 99.989999999999995 113.291 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.95 -43.04 84.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 118.634 -0.698 . . . . 99.989999999999995 112.494 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.2 78.35 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.754 0.65 . . . . 99.989999999999995 112.754 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.92 -58.71 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.11 1.364 . . . . 99.989999999999995 111.452 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 2.6 pp -61.35 -36.13 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 112.781 0.66 . . . . 99.989999999999995 112.781 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -57.47 -60.74 3.19 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.485 0.714 . . . . 99.989999999999995 111.996 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.13 -26.8 65.03 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.822 1.786 . . . . 99.989999999999995 115.822 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -73.23 -70.48 0.36 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.808 1.243 . . . . 99.989999999999995 112.289 167.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.82 -39.91 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 125.162 1.385 . . . . 99.989999999999995 113.024 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 tt -61.06 -25.89 67.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 99.989999999999995 114.914 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.38 0.05 OUTLIER Glycine 0 N--CA 1.478 1.463 0 O-C-N 124.106 0.879 . . . . 99.989999999999995 111.38 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -20.7 88.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.39 2.676 . . . . 99.989999999999995 116.625 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -149.68 -51.82 0.15 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.015 -1.902 . . . . 99.989999999999995 113.006 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.02 124.14 2.59 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.804 0.69 . . . . 99.989999999999995 112.463 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.11 177.38 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.411 0.685 . . . . 99.989999999999995 110.884 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 150.88 17.27 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 114.563 -1.198 . . . . 99.989999999999995 112.762 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -28.23 -42.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.672 2.389 . . . . 99.989999999999995 114.463 164.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.428 ' O ' HG21 ' A' ' 73' ' ' THR . 6.4 mp -62.4 -34.17 76.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.991 1.716 . . . . 99.989999999999995 114.742 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.11 146.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.136 1.774 . . . . 99.989999999999995 113.171 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.45 25.92 0.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.479 1.289 . . . . 99.989999999999995 114.479 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.1 p90 21.1 49.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.446 2.758 . . . . 99.989999999999995 118.446 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -167.66 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.318 -1.31 . . . . 99.989999999999995 110.681 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.1 -14.49 17.08 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 118.987 2.958 . . . . 99.989999999999995 118.987 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -33.04 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 115.627 1.714 . . . . 99.989999999999995 115.627 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.47 12.57 15.98 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.743 0.652 . . . . 99.989999999999995 113.978 169.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 39.45 -155.68 0.03 OUTLIER Glycine 0 N--CA 1.48 1.574 0 C-N-CA 124.786 1.184 . . . . 99.989999999999995 114.759 -172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.39 52.14 1.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.332 -1.434 . . . . 99.989999999999995 110.7 171.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -171.49 -162.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.839 1.656 . . . . 99.989999999999995 112.02 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.82 -21.7 3.08 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 117.754 2.501 . . . . 99.989999999999995 117.754 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -52.58 -43.68 65.42 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.082 0.771 . . . . 99.989999999999995 113.082 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.17 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.676 0.991 . . . . 99.989999999999995 113.676 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.9 mtp -69.95 -45.65 66.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.763 1.225 . . . . 99.989999999999995 112.144 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.831 0.852 . . . . 99.989999999999995 112.536 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.7 t -67.27 -49.32 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 110.072 170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.3 -39.58 45.96 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.706 1.002 . . . . 99.989999999999995 113.706 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.9 -59.63 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.941 0.897 . . . . 99.989999999999995 112.339 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.52 -31.95 73.26 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.486 0.921 . . . . 99.989999999999995 113.486 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.671 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 76.1 t -62.24 -37.57 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.795 1.238 . . . . 99.989999999999995 112.748 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.4 -33.79 61.01 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.493 1.294 . . . . 99.989999999999995 114.493 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 -102.59 -37.65 7.86 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 118.357 2.725 . . . . 99.989999999999995 118.357 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -108.32 -35.35 6.55 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.777 0.831 . . . . 99.989999999999995 112.403 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.671 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.3 m-85 -80.12 -28.34 38.99 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.012 1.486 . . . . 99.989999999999995 115.012 173.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 68.25 -30.96 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.521 2.328 . . . . 99.989999999999995 115.18 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.59 -31.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 127.988 2.515 . . . . 99.989999999999995 115.785 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 66.87 141.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.326 1.85 . . . . 99.989999999999995 113.185 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.7 mt 65.22 154.75 0.12 Allowed Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 116.46 2.022 . . . . 99.989999999999995 116.46 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.51 -162.81 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.314 2.009 . . . . 0.0 111.476 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp 66.92 -51.15 0.47 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.712 2.005 . . . . 99.989999999999995 115.466 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -57.75 -85.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.779 1.632 . . . . 99.989999999999995 110.52 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.07 46.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.497 1.141 . . . . 99.989999999999995 113.885 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 mt -144.36 -50.34 0.29 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.508 -1.678 . . . . 99.989999999999995 114.839 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -109.84 -49.69 3.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 111.662 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.94 79.14 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.674 0.609 . . . . 99.989999999999995 111.563 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -116.9 87.28 21.65 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 115.598 -0.728 . . . . 99.989999999999995 109.73 167.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.98 -26.68 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.674 2.25 . . . . 0.0 114.653 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 44.0 p -80.5 138.0 36.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 99.989999999999995 109.97 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.255 0.4 OUTLIER -62.09 -23.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.993 -0.549 . . . . 99.989999999999995 111.913 172.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -59.6 -51.51 69.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.36 0.664 . . . . 99.989999999999995 111.818 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.59 95.02 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.057 0.391 . . . . 99.989999999999995 112.057 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 73' ' ' THR . 51.4 mt -57.97 -46.63 84.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.389 0.676 . . . . 99.989999999999995 112.254 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -45.33 85.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.609 1.164 . . . . 99.989999999999995 112.97 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.44 -31.91 71.56 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.07 1.507 . . . . 99.989999999999995 115.07 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -74.25 -22.36 59.36 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.236 1.939 . . . . 99.989999999999995 116.236 169.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.269 32.6 m -104.25 -73.97 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.793 1.034 . . . . 99.989999999999995 113.793 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.5 61.21 6.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 123.894 1.807 . . . . 99.989999999999995 111.196 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.4 m -161.17 -56.43 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.278 -2.237 . . . . 99.989999999999995 108.461 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.22 -30.87 6.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.785 2.143 . . . . 99.989999999999995 116.785 175.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.595 1.702 . . . . 99.989999999999995 115.595 -175.095 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 110.507 -0.183 . . . . 99.989999999999995 110.507 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.51 92.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.68 1.592 . . . . 99.989999999999995 113.786 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -98.97 -62.86 1.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.052 -1.886 . . . . 99.989999999999995 113.548 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -148.75 -60.57 0.23 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.857 1.263 . . . . 99.989999999999995 111.078 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 t 65.33 84.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.771 2.028 . . . . 99.989999999999995 112.598 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.65 85.02 61.4 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 115.003 -0.999 . . . . 99.989999999999995 110.988 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.97 143.68 61.28 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.779 2.319 . . . . 0.0 112.436 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -77.04 0.6 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.312 -1.313 . . . . 99.989999999999995 111.777 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -117.04 -172.85 2.29 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.563 1.145 . . . . 99.989999999999995 112.583 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.92 -63.29 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.71 1.204 . . . . 99.989999999999995 113.169 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.17 -47.17 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.401 1.081 . . . . 99.989999999999995 111.294 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.58 -63.54 1.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.72 1.208 . . . . 99.989999999999995 113.173 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 t -67.26 -45.44 76.63 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.278 0.844 . . . . 99.989999999999995 113.278 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.27 -54.11 50.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.003 1.321 . . . . 99.989999999999995 111.297 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.685 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.5 mm? -66.99 -36.81 82.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.64 0.978 . . . . 99.989999999999995 113.64 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.18 89.14 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.486 0.585 . . . . 99.989999999999995 112.437 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.36 -51.42 70.01 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.149 1.38 . . . . 99.989999999999995 111.278 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.85 -54.19 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.276 1.03 . . . . 99.989999999999995 110.517 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -55.29 -53.99 49.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.262 1.025 . . . . 99.989999999999995 113.51 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -61.51 -30.75 70.83 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.456 1.651 . . . . 99.989999999999995 115.456 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.75 -56.56 4.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.325 1.05 . . . . 99.989999999999995 111.93 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.0 -38.74 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 125.501 1.52 . . . . 99.989999999999995 113.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tt -59.81 -22.84 62.75 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.334 1.453 . . . . 99.989999999999995 113.585 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.85 74.74 0.3 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.079 -1.208 . . . . 99.989999999999995 110.079 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.272 13.0 p 0.78 81.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 128.32 2.648 . . . . 99.989999999999995 116.397 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 m -127.36 -80.32 0.59 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 112.579 -2.101 . . . . 99.989999999999995 115.17 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.88 102.37 0.67 Allowed Glycine 0 N--CA 1.479 1.523 0 N-CA-C 110.176 -1.17 . . . . 99.989999999999995 110.176 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 pt -125.05 166.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.355 0.872 . . . . 99.989999999999995 113.355 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.22 158.84 53.5 Favored Glycine 0 N--CA 1.477 1.397 0 CA-C-N 114.628 -1.169 . . . . 99.989999999999995 113.026 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mm -52.9 -42.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 114.179 -1.01 . . . . 99.989999999999995 111.75 164.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.16 9.23 0.33 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.555 1.687 . . . . 99.989999999999995 115.555 166.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 55.64 -137.47 1.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.677 1.591 . . . . 99.989999999999995 109.562 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.728 HD21 ' NE2' ' A' ' 40' ' ' GLN . 54.9 t30 -123.41 28.85 6.87 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.836 0.454 . . . . 99.989999999999995 110.276 156.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.281 53.2 p90 35.73 -0.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 1 N-CA-C 123.402 4.593 . . . . 99.989999999999995 123.402 -174.905 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -115.34 -74.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.922 1.689 . . . . 99.989999999999995 111.276 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.728 ' NE2' HD21 ' A' ' 37' ' ' ASN . 14.3 pt20 -67.71 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.839 2.903 . . . . 99.989999999999995 118.839 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -29.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.579 0.751 . . . . 99.989999999999995 112.434 171.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.51 -48.08 83.61 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 123.968 0.792 . . . . 99.989999999999995 113.349 170.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.93 99.32 0.01 OUTLIER Glycine 0 N--CA 1.478 1.46 0 O-C-N 125.1 1.118 . . . . 99.989999999999995 113.673 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -70.39 54.56 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.378 1.871 . . . . 99.989999999999995 114.747 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -165.3 -142.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.552 2.341 . . . . 99.989999999999995 108.078 -176.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.6 pt? -63.31 -18.36 63.54 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.319 1.6 . . . . 99.989999999999995 115.319 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.835 ' HZ3' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.56 -48.5 71.97 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.979 1.103 . . . . 99.989999999999995 113.979 -174.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.15 60.52 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.678 1.362 . . . . 99.989999999999995 114.678 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.5 mtm -69.94 -44.54 69.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.717 0.807 . . . . 99.989999999999995 112.952 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.83 79.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.472 0.709 . . . . 99.989999999999995 112.568 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -62.95 -50.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 109.865 170.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.46 -43.58 65.04 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.999 0.74 . . . . 99.989999999999995 112.999 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.37 46.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.277 1.031 . . . . 99.989999999999995 113.394 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -66.75 -37.06 83.87 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.867 1.062 . . . . 99.989999999999995 113.867 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 72.5 t -65.08 -25.22 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.373 1.069 . . . . 99.989999999999995 112.587 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.67 -54.59 5.27 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.331 0.863 . . . . 99.989999999999995 113.331 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -71.02 -37.7 72.61 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.961 2.208 . . . . 99.989999999999995 116.961 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -110.33 -31.43 7.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.933 1.293 . . . . 99.989999999999995 112.557 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.685 ' HH ' ' HG ' ' A' ' 19' ' ' LEU . 3.4 m-30 -102.84 -10.3 19.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.265 1.58 . . . . 99.989999999999995 115.265 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 62.05 -46.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 118.167 2.655 . . . . 99.989999999999995 118.167 -173.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 126.371 1.868 . . . . 99.989999999999995 115.81 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 52.54 28.23 5.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 120.428 3.492 . . . . 99.989999999999995 120.428 167.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.21 94.89 16.44 Favored Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 116.288 1.958 . . . . 99.989999999999995 116.288 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -66.13 151.01 84.76 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 123.709 2.94 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt 63.88 -44.95 0.26 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.745 2.018 . . . . 99.989999999999995 114.087 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -51.85 -69.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.984 1.714 . . . . 99.989999999999995 111.555 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.46 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 3.6 p -76.46 22.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.931 1.086 . . . . 99.989999999999995 113.931 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -130.94 -37.22 1.31 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 113.482 -169.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.31 -39.41 7.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.354 1.062 . . . . 99.989999999999995 113.797 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.42 90.22 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.525 0.565 . . . . 99.989999999999995 112.525 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.1 pm0 -124.87 73.12 63.91 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.53 1.132 . . . . 99.989999999999995 112.005 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -77.99 34.78 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.125 3.217 . . . . 0.0 114.754 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 t -142.02 131.95 24.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.847 1.659 . . . . 99.989999999999995 110.502 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.285 0.5 OUTLIER -63.8 -20.33 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.594 -1.184 . . . . 99.989999999999995 113.591 178.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.98 -56.63 19.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.17 0.588 . . . . 99.989999999999995 110.439 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.05 75.42 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.054 -0.975 . . . . 99.989999999999995 113.088 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.89 -45.51 90.05 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.076 0.769 . . . . 99.989999999999995 113.076 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.17 91.46 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 99.989999999999995 111.881 172.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -59.47 -45.08 92.67 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.42 0.688 . . . . 99.989999999999995 112.74 171.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.51 -28.63 67.99 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.165 2.283 . . . . 99.989999999999995 117.165 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.299 16.7 m -113.37 -68.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 114.992 1.478 . . . . 99.989999999999995 114.992 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 61.53 2.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 123.228 1.49 . . . . 99.989999999999995 112.203 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 99.7 m -164.81 -69.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.951 2.501 . . . . 99.989999999999995 108.084 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -29.08 13.7 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 116.125 1.898 . . . . 99.989999999999995 116.125 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 115.732 -2.08 . . . . 99.989999999999995 114.336 179.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 115.881 1.808 . . . . 99.989999999999995 115.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.07 119.1 1.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.692 1.197 . . . . 99.989999999999995 114.045 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -122.77 -80.07 0.62 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.793 -1.549 . . . . 99.989999999999995 112.75 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -135.38 -64.29 0.65 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.051 1.13 . . . . 99.989999999999995 114.051 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t 72.15 98.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.814 2.045 . . . . 99.989999999999995 112.394 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.18 82.99 10.42 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 114.316 -1.311 . . . . 99.989999999999995 110.432 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.05 147.52 61.16 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 122.923 2.416 . . . . 0.0 112.674 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.01 -82.78 0.58 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.451 -1.249 . . . . 99.989999999999995 111.007 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -108.47 -177.36 3.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.718 0.807 . . . . 99.989999999999995 111.833 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.99 50.39 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.49 0.922 . . . . 99.989999999999995 113.49 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.09 -59.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.761 1.224 . . . . 99.989999999999995 110.357 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -49.08 -59.57 3.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.981 1.312 . . . . 99.989999999999995 113.439 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.6 t -64.84 -56.37 13.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.085 0.954 . . . . 99.989999999999995 113.252 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -67.14 -40.86 86.82 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.01 0.745 . . . . 99.989999999999995 113.01 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.08 -40.64 94.92 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.244 -0.884 . . . . 99.989999999999995 112.913 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.83 84.6 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.937 0.718 . . . . 99.989999999999995 112.937 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.17 -53.14 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.581 1.152 . . . . 99.989999999999995 111.186 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.87 -50.96 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.327 1.051 . . . . 99.989999999999995 110.663 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -52.67 -60.11 3.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.32 1.048 . . . . 99.989999999999995 112.335 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -60.13 -31.36 69.99 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.852 1.797 . . . . 99.989999999999995 115.852 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -61.54 1.94 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.928 1.291 . . . . 99.989999999999995 111.865 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.21 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.28 1.032 . . . . 99.989999999999995 112.669 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 47' ' ' LYS . 34.9 tp -62.3 -32.7 73.47 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.535 1.309 . . . . 99.989999999999995 114.535 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.67 56.44 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 112.94 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.276 12.1 p -0.74 75.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 128.914 2.885 . . . . 99.989999999999995 116.955 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -138.77 -48.0 0.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.056 -1.884 . . . . 99.989999999999995 114.589 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.05 112.14 1.9 Allowed Glycine 0 N--CA 1.477 1.406 0 O-C-N 123.714 0.634 . . . . 99.989999999999995 113.381 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 pp -108.72 173.73 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.623 -0.789 . . . . 99.989999999999995 111.58 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.46 153.17 19.61 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 114.517 -1.219 . . . . 99.989999999999995 110.839 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -40.97 -47.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.995 1.318 . . . . 99.989999999999995 113.803 171.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.08 -21.07 63.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.775 1.768 . . . . 99.989999999999995 115.775 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 58.98 157.46 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.603 1.961 . . . . 99.989999999999995 113.324 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.95 8.92 3.29 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.319 1.229 . . . . 99.989999999999995 114.319 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.6 p90 39.61 22.5 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 121.057 3.725 . . . . 99.989999999999995 121.057 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -118.59 -85.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 111.776 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -59.5 -16.62 25.61 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 119.025 2.972 . . . . 99.989999999999995 119.025 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -33.34 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 114.45 1.278 . . . . 99.989999999999995 114.45 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.78 -53.08 0.6 Allowed Glycine 0 N--CA 1.476 1.326 0 CA-C-N 115.04 -0.982 . . . . 99.989999999999995 113.344 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.32 -144.88 18.82 Favored Glycine 0 N--CA 1.478 1.485 0 O-C-N 124.506 0.768 . . . . 99.989999999999995 112.333 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -139.48 41.85 2.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.979 1.371 . . . . 99.989999999999995 112.991 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.3 m -130.62 -154.46 0.63 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.103 -1.408 . . . . 99.989999999999995 111.048 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -49.94 -33.08 16.45 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.524 1.305 . . . . 99.989999999999995 114.524 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HZ3' ' HA ' ' A' ' 27' ' ' LEU . 7.9 mmtp -46.51 -73.04 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.398 1.479 . . . . 99.989999999999995 112.766 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.74 4.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.074 1.509 . . . . 99.989999999999995 115.074 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.26 -53.56 35.45 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.23 1.196 . . . . 99.989999999999995 114.23 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.97 91.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.909 0.884 . . . . 99.989999999999995 112.227 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 t -66.87 -40.26 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 118.177 -0.916 . . . . 99.989999999999995 110.995 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.34 -45.71 72.74 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.934 0.788 . . . . 99.989999999999995 111.67 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.87 76.14 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.758 -0.655 . . . . 99.989999999999995 112.387 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -54.56 -51.91 63.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.426 1.49 . . . . 99.989999999999995 112.446 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 60.2 t -65.68 -29.58 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.416 1.486 . . . . 99.989999999999995 112.56 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -68.1 -72.16 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.114 0.566 . . . . 99.989999999999995 111.28 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -64.5 -41.38 96.47 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.015 2.598 . . . . 99.989999999999995 118.015 -173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.35 -29.07 10.99 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.699 0.999 . . . . 99.989999999999995 113.699 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.3 m-85 -94.62 -22.58 18.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.219 1.192 . . . . 99.989999999999995 114.219 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 64.26 -33.78 0.15 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.664 2.468 . . . . 99.989999999999995 117.664 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -18.83 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.774 1.23 . . . . 99.989999999999995 114.168 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 47.76 39.01 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.824 3.268 . . . . 99.989999999999995 119.824 170.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -122.47 99.52 42.52 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 115.657 1.725 . . . . 99.989999999999995 115.657 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.6 160.76 41.64 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.3 2.666 . . . . 0.0 111.902 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 tt 66.09 -47.57 0.42 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.971 2.108 . . . . 99.989999999999995 114.852 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -56.75 -55.59 32.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 118.618 -0.706 . . . . 99.989999999999995 111.417 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.8 t -68.21 4.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.156 1.539 . . . . 99.989999999999995 115.156 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 mt -119.2 -29.66 5.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.194 1.553 . . . . 99.989999999999995 115.194 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -112.16 -38.06 4.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.52 1.304 . . . . 99.989999999999995 114.52 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.89 -44.78 30.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.406 0.682 . . . . 99.989999999999995 112.244 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -119.31 67.0 9.06 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.412 0.893 . . . . 99.989999999999995 113.412 168.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.06 26.16 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.057 3.172 . . . . 0.0 115.802 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 t -137.96 136.05 36.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.988 1.315 . . . . 99.989999999999995 110.714 -171.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.271 0.4 OUTLIER -62.31 -23.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.589 -0.732 . . . . 99.989999999999995 112.905 178.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -54.87 -62.81 1.41 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.373 1.069 . . . . 99.989999999999995 110.258 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.45 -35.25 80.34 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.875 -1.057 . . . . 99.989999999999995 113.34 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.54 -45.35 85.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.064 0.394 . . . . 99.989999999999995 112.064 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.33 85.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 112.834 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -63.19 -47.75 81.24 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.615 0.968 . . . . 99.989999999999995 113.615 170.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.93 -25.41 68.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.982 1.845 . . . . 99.989999999999995 115.982 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.272 5.2 m -101.13 -81.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.31 1.226 . . . . 99.989999999999995 114.31 168.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.43 65.72 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.52 1.629 . . . . 99.989999999999995 112.404 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.8 m -165.0 -50.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.155 2.582 . . . . 99.989999999999995 108.457 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.69 -30.7 5.72 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.256 2.317 . . . . 99.989999999999995 117.256 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 116.639 -1.648 . . . . 99.989999999999995 115.098 -174.096 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.881 0.697 . . . . 99.989999999999995 112.881 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.14 20.96 8.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 119.123 3.008 . . . . 99.989999999999995 119.123 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.94 -40.62 30.9 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.746 2.498 . . . . 99.989999999999995 117.746 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 t80 174.54 -68.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.089 0.956 . . . . 99.989999999999995 111.235 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 t 66.33 93.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 127.339 2.256 . . . . 99.989999999999995 112.222 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.72 82.59 59.77 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 115.332 -0.849 . . . . 99.989999999999995 111.361 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -68.66 150.45 74.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.894 2.396 . . . . 0.0 112.696 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 -81.04 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.413 -1.267 . . . . 99.989999999999995 110.932 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -113.95 -174.76 2.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 99.989999999999995 112.276 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.56 10.1 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.197 0.999 . . . . 99.989999999999995 113.24 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.26 -52.0 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.669 1.188 . . . . 99.989999999999995 110.954 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -51.02 -64.34 0.84 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.101 1.361 . . . . 99.989999999999995 113.495 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 t -66.91 -46.87 73.52 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.42 0.896 . . . . 99.989999999999995 113.42 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -60.76 -51.74 68.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.104 0.962 . . . . 99.989999999999995 111.053 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.98 -36.13 82.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.964 -1.017 . . . . 99.989999999999995 113.727 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.5 91.27 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.895 0.77 . . . . 99.989999999999995 112.587 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.07 -50.43 74.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.753 1.221 . . . . 99.989999999999995 111.344 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.4 mm -54.7 -52.17 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.088 0.955 . . . . 99.989999999999995 110.617 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.7 -54.83 41.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.346 1.058 . . . . 99.989999999999995 113.697 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.16 -28.27 66.44 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.469 1.655 . . . . 99.989999999999995 115.469 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -77.72 -61.53 1.96 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.794 1.638 . . . . 99.989999999999995 111.602 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.24 -39.62 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.517 1.927 . . . . 99.989999999999995 113.818 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.72 -24.22 61.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.385 1.474 . . . . 99.989999999999995 113.819 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.67 0.73 Allowed Glycine 0 N--CA 1.473 1.149 0 N-CA-C 108.358 -1.897 . . . . 99.989999999999995 108.358 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.25 13.1 p -22.52 95.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 127.404 2.282 . . . . 99.989999999999995 115.474 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 p -148.19 -58.8 0.24 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 112.608 -2.087 . . . . 99.989999999999995 114.505 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.69 95.58 0.88 Allowed Glycine 0 N--CA 1.48 1.594 0 O-C-N 123.824 0.702 . . . . 99.989999999999995 113.37 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 pt -107.57 166.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 121.441 0.639 . . . . 99.989999999999995 112.501 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.76 160.48 30.09 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.035 -1.439 . . . . 99.989999999999995 112.144 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -45.3 -51.34 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 125.319 1.448 . . . . 99.989999999999995 112.497 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.17 -27.66 69.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.412 1.485 . . . . 99.989999999999995 114.398 171.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 46.07 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.724 1.61 . . . . 99.989999999999995 114.26 -167.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -93.5 24.96 3.68 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.467 0.543 . . . . 99.989999999999995 112.467 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 34.15 43.07 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 118.744 2.868 . . . . 99.989999999999995 118.744 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -138.77 -82.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.426 -1.715 . . . . 99.989999999999995 110.426 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.39 36.77 0.06 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.912 2.56 . . . . 99.989999999999995 117.912 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.66 -42.46 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.407 0.521 . . . . 99.989999999999995 112.407 173.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.06 -48.45 59.81 Favored Glycine 0 N--CA 1.479 1.527 0 O-C-N 123.839 0.712 . . . . 99.989999999999995 114.457 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.33 115.13 0.01 OUTLIER Glycine 0 N--CA 1.478 1.454 0 O-C-N 125.171 1.159 . . . . 99.989999999999995 114.218 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -75.7 56.22 0.9 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 123.282 1.515 . . . . 99.989999999999995 112.725 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -169.73 -155.93 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.439 2.296 . . . . 99.989999999999995 109.438 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -53.98 -20.47 6.27 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.434 2.012 . . . . 99.989999999999995 116.434 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -55.42 -40.23 71.24 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.765 1.395 . . . . 99.989999999999995 114.765 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.06 -41.95 65.34 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.233 0.827 . . . . 99.989999999999995 113.233 170.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 mmt -68.53 -49.94 55.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.812 1.245 . . . . 99.989999999999995 112.367 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.87 81.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.183 0.993 . . . . 99.989999999999995 113.153 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 HG13 HD13 ' A' ' 68' ' ' LEU . 10.4 t -72.07 -42.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 118.756 -0.64 . . . . 99.989999999999995 110.725 173.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.79 63.18 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.597 0.592 . . . . 99.989999999999995 112.597 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -58.7 6.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.005 0.922 . . . . 99.989999999999995 112.895 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.92 -36.72 84.89 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.157 1.169 . . . . 99.989999999999995 114.157 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 89.0 t -68.59 -24.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.311 1.044 . . . . 99.989999999999995 112.791 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -80.54 -57.54 3.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.454 0.539 . . . . 99.989999999999995 112.454 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -69.72 -39.26 76.94 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.088 2.255 . . . . 99.989999999999995 117.088 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -103.5 -45.83 4.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.165 0.986 . . . . 99.989999999999995 111.802 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.3 m-85 -76.95 -28.6 55.26 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.963 1.468 . . . . 99.989999999999995 114.963 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 57.77 19.41 5.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.154 2.65 . . . . 99.989999999999995 118.154 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.16 -29.64 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.773 0.657 . . . . 99.989999999999995 112.773 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 45.98 73.88 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.927 1.691 . . . . 99.989999999999995 115.173 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -126.53 81.01 68.91 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.274 1.212 . . . . 99.989999999999995 114.274 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.81 148.51 91.9 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.097 2.531 . . . . 0.0 111.07 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp 64.44 -50.74 0.3 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.651 1.98 . . . . 99.989999999999995 113.958 -172.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -51.29 -60.21 3.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.011 1.324 . . . . 99.989999999999995 113.01 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -63.96 -13.68 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 115.19 1.552 . . . . 99.989999999999995 115.19 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD13 HG13 ' A' ' 51' ' ' VAL . 2.8 mm? -102.68 -25.22 13.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.774 1.768 . . . . 99.989999999999995 115.774 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -111.17 -38.03 5.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.932 1.086 . . . . 99.989999999999995 113.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.83 -42.47 40.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.194 0.598 . . . . 99.989999999999995 112.085 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.5 pm0 -120.9 67.64 15.32 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 113.751 1.019 . . . . 99.989999999999995 113.751 169.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.16 50.33 3.46 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.81 3.674 . . . . 0.0 115.111 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 t -161.38 137.74 8.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.754 1.221 . . . . 99.989999999999995 110.656 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.272 0.4 OUTLIER -63.87 -22.24 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 114.969 -1.014 . . . . 99.989999999999995 112.9 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -57.43 -61.38 2.53 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.963 0.905 . . . . 99.989999999999995 109.984 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.46 78.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.643 -1.162 . . . . 99.989999999999995 113.677 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.66 -47.42 82.33 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.655 0.382 . . . . 99.989999999999995 111.971 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.07 99.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.924 0.89 . . . . 99.989999999999995 111.905 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.03 -40.31 80.55 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.505 1.298 . . . . 99.989999999999995 114.505 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.06 -29.86 69.76 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.065 1.876 . . . . 99.989999999999995 116.065 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.289 15.7 m -113.76 -60.54 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 117.759 2.503 . . . . 99.989999999999995 117.759 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.35 36.89 0.25 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.083 1.753 . . . . 99.989999999999995 114.574 -173.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -124.02 -49.33 1.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.389 1.876 . . . . 99.989999999999995 108.925 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -32.6 5.91 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.43 2.011 . . . . 99.989999999999995 116.43 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 116.42 2.008 . . . . 99.989999999999995 116.42 -171.76 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 113.019 0.748 . . . . 99.989999999999995 113.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.097 1.759 . . . . 99.989999999999995 112.992 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -170.77 -118.9 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 112.814 -1.994 . . . . 99.989999999999995 107.344 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -50.77 -45.03 58.85 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.743 2.127 . . . . 99.989999999999995 116.743 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.304 9.2 p 2.43 56.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 120.776 3.621 . . . . 99.989999999999995 120.776 -170.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -113.98 102.64 55.0 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 115.312 -0.858 . . . . 99.989999999999995 111.536 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.28 -157.82 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.192 2.595 . . . . 0.0 112.559 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -159.07 -100.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.742 0.817 . . . . 99.989999999999995 109.123 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -76.3 167.54 21.67 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.908 1.283 . . . . 99.989999999999995 112.978 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.27 -48.06 24.84 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.132 1.16 . . . . 99.989999999999995 114.132 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.41 -60.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.325 1.05 . . . . 99.989999999999995 110.178 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' A' ' 74' ' ' ILE . 39.3 mt-10 -58.18 -45.34 87.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.365 1.246 . . . . 99.989999999999995 114.365 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -65.54 -55.81 15.74 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.621 0.768 . . . . 99.989999999999995 112.624 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.61 -43.61 98.53 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.432 1.093 . . . . 99.989999999999995 112.348 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.45 -46.52 85.84 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.033 0.753 . . . . 99.989999999999995 113.033 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.56 82.01 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.469 0.544 . . . . 99.989999999999995 112.469 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.7 -59.17 5.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.291 1.436 . . . . 99.989999999999995 111.498 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 pt -62.18 -35.75 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.021 0.749 . . . . 99.989999999999995 113.021 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.62 -59.09 5.51 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.598 -0.715 . . . . 99.989999999999995 112.424 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -61.25 -27.77 68.69 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.398 1.629 . . . . 99.989999999999995 115.398 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -64.3 0.89 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.582 1.153 . . . . 99.989999999999995 112.289 168.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.82 -37.68 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.921 1.689 . . . . 99.989999999999995 113.298 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.6 -23.58 59.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.337 1.455 . . . . 99.989999999999995 113.707 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.31 84.45 0.83 Allowed Glycine 0 N--CA 1.475 1.245 0 N-CA-C 108.444 -1.862 . . . . 99.989999999999995 108.444 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.266 13.9 p -16.16 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 127.77 2.428 . . . . 99.989999999999995 116.039 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.0 p -146.01 -74.11 0.22 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 112.81 -1.995 . . . . 99.989999999999995 115.0 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.04 111.14 0.91 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 114.736 0.654 . . . . 99.989999999999995 114.736 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 33' ' ' GLY . 11.1 pt -113.27 -82.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 114.985 1.476 . . . . 99.989999999999995 114.985 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' H ' HG13 ' A' ' 32' ' ' ILE . . . 120.95 -169.37 14.25 Favored Glycine 0 N--CA 1.479 1.535 0 C-N-CA 123.871 0.748 . . . . 99.989999999999995 112.753 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.71 -46.47 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 113.816 1.043 . . . . 99.989999999999995 113.816 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.61 -24.65 67.69 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.659 1.726 . . . . 99.989999999999995 115.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.39 -149.67 0.42 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.553 1.141 . . . . 99.989999999999995 109.014 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 39' ' ' PHE . 5.3 t-20 -115.43 13.02 16.42 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.635 0.606 . . . . 99.989999999999995 112.635 164.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.2 p90 41.23 14.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.852 2.908 . . . . 99.989999999999995 118.852 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 37' ' ' ASN . 79.5 t80 -135.77 -68.77 0.5 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.714 1.206 . . . . 99.989999999999995 112.417 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -68.53 32.21 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 118.326 2.713 . . . . 99.989999999999995 118.326 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.44 -37.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.386 1.074 . . . . 99.989999999999995 112.932 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.68 -44.96 14.03 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 115.765 -0.652 . . . . 99.989999999999995 113.343 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.46 -179.2 2.77 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 122.278 0.932 . . . . 99.989999999999995 113.286 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.82 56.57 1.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.67 1.224 . . . . 99.989999999999995 111.641 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -173.54 -159.4 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.199 1.8 . . . . 99.989999999999995 111.063 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.3 -20.69 4.55 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 117.116 2.265 . . . . 99.989999999999995 117.116 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -45.94 -59.8 2.62 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.356 1.062 . . . . 99.989999999999995 113.285 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.23 -37.77 56.14 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.795 1.405 . . . . 99.989999999999995 114.795 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.8 mmm -65.34 -50.05 67.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.431 1.092 . . . . 99.989999999999995 112.326 175.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.34 82.04 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.432 1.093 . . . . 99.989999999999995 112.573 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.98 -47.09 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 118.698 -0.667 . . . . 99.989999999999995 110.537 171.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.94 66.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 118.356 0.525 . . . . 99.989999999999995 112.402 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -56.1 26.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.129 0.972 . . . . 99.989999999999995 113.239 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.44 -37.99 89.46 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.932 1.086 . . . . 99.989999999999995 113.932 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.96 -37.36 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.951 0.9 . . . . 99.989999999999995 111.629 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -63.0 -44.2 96.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.057 0.762 . . . . 99.989999999999995 113.057 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -86.5 -44.44 11.96 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.125 2.269 . . . . 99.989999999999995 117.125 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.87 -28.99 13.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.01 1.324 . . . . 99.989999999999995 112.911 -173.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -97.99 -22.81 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.429 1.27 . . . . 99.989999999999995 114.429 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -48.56 0.41 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.568 2.747 . . . . 99.989999999999995 115.025 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.04 32.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.648 2.379 . . . . 99.989999999999995 116.897 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -10.08 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 119.718 3.229 . . . . 99.989999999999995 119.718 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -122.11 85.09 46.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.433 1.642 . . . . 99.989999999999995 115.433 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.22 150.13 87.85 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.779 2.319 . . . . 0.0 111.105 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.0 tp 66.05 -49.83 0.41 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.021 2.128 . . . . 99.989999999999995 114.623 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.38 -58.79 5.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.353 1.061 . . . . 99.989999999999995 113.014 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -16.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.378 1.251 . . . . 99.989999999999995 114.378 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -97.54 -25.39 15.17 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.854 1.798 . . . . 99.989999999999995 115.854 -174.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.08 -37.85 3.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.028 1.492 . . . . 99.989999999999995 115.028 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.91 -49.59 19.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.597 0.592 . . . . 99.989999999999995 112.597 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -128.72 52.7 9.56 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.912 2.189 . . . . 99.989999999999995 116.912 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -63.99 -23.59 67.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 116.214 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.5 p -68.03 132.6 47.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.348 0.659 . . . . 99.989999999999995 110.095 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 16' ' ' GLU 0.339 0.4 OUTLIER -61.27 -19.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 115.026 1.491 . . . . 99.989999999999995 115.026 -178.982 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -57.24 -63.84 1.09 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.864 0.866 . . . . 99.989999999999995 109.727 165.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.0 -37.93 89.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.996 -1.002 . . . . 99.989999999999995 113.332 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.9 mt -55.9 -46.72 78.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.139 0.576 . . . . 99.989999999999995 111.903 171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.82 -40.08 96.3 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.027 0.751 . . . . 99.989999999999995 113.027 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.46 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.5 mp0 -61.97 -43.39 98.95 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.708 1.003 . . . . 99.989999999999995 113.708 172.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.39 -25.37 67.99 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.756 1.761 . . . . 99.989999999999995 115.756 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.303 30.8 m -114.88 -65.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 116.852 2.167 . . . . 99.989999999999995 116.852 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' C ' ' HG1' ' A' ' 83' ' ' THR . . . -79.77 57.92 2.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 123.348 1.547 . . . . 99.989999999999995 111.545 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.2 m -165.65 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.86 2.464 . . . . 99.989999999999995 108.604 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.448 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -107.67 -30.9 8.32 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 116.857 2.169 . . . . 99.989999999999995 116.857 175.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 125.623 1.569 . . . . 99.989999999999995 115.072 176.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 110.675 -0.12 . . . . 99.989999999999995 110.675 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.2 -153.35 0.55 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.947 0.499 . . . . 99.989999999999995 109.976 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -160.32 -45.27 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.187 0.995 . . . . 99.989999999999995 111.049 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -63.98 40.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.565 2.432 . . . . 99.989999999999995 117.565 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.82 89.17 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.131 0.967 . . . . 99.989999999999995 112.309 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.18 87.29 4.73 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 113.983 -1.462 . . . . 99.989999999999995 111.516 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.39 161.05 47.43 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.385 2.724 . . . . 0.0 112.975 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -78.52 0.58 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.292 -1.322 . . . . 99.989999999999995 110.824 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -114.58 -173.71 2.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 99.989999999999995 112.54 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -59.31 3.56 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 99.989999999999995 113.166 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.23 -50.97 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.61 1.164 . . . . 99.989999999999995 110.932 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -51.48 -59.75 3.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.723 1.209 . . . . 99.989999999999995 113.318 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -69.04 -45.42 70.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.734 1.012 . . . . 99.989999999999995 113.734 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -57.33 -53.66 55.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.381 1.472 . . . . 99.989999999999995 110.977 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -38.92 92.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.299 0.851 . . . . 99.989999999999995 113.299 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.29 85.14 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.787 0.662 . . . . 99.989999999999995 112.787 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.82 -49.97 75.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.55 1.14 . . . . 99.989999999999995 111.456 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.78 -53.88 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.16 0.984 . . . . 99.989999999999995 110.632 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -55.45 -53.12 60.22 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.17 0.988 . . . . 99.989999999999995 113.192 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.72 -33.12 72.42 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.141 1.534 . . . . 99.989999999999995 115.141 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -70.29 -58.94 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.43 1.081 . . . . 99.989999999999995 113.097 169.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.01 -40.18 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.025 1.33 . . . . 99.989999999999995 113.326 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.96 -26.49 67.58 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.272 . . . . 99.989999999999995 113.986 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.55 73.47 0.12 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.489 -1.044 . . . . 99.989999999999995 110.489 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.278 12.7 p -2.12 80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.481 2.712 . . . . 99.989999999999995 116.933 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.4 m -134.14 -108.02 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.858 -1.974 . . . . 99.989999999999995 112.001 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.86 101.45 0.16 Allowed Glycine 0 N--CA 1.48 1.612 0 N-CA-C 111.244 -0.742 . . . . 99.989999999999995 111.244 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.79 -163.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 113.118 0.784 . . . . 99.989999999999995 113.118 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.09 161.4 23.53 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 110.548 -1.021 . . . . 99.989999999999995 110.548 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mm -55.54 -44.39 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.253 1.021 . . . . 99.989999999999995 111.777 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.3 tp -58.45 -29.61 66.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.606 1.162 . . . . 99.989999999999995 113.79 169.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 58.69 175.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.806 1.643 . . . . 99.989999999999995 112.389 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.61 1.61 45.29 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.257 0.836 . . . . 99.989999999999995 113.257 170.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.0 p90 49.8 0.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 120.086 3.365 . . . . 99.989999999999995 120.086 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -108.28 -84.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.913 1.285 . . . . 99.989999999999995 110.401 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -68.74 22.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.579 2.437 . . . . 99.989999999999995 117.579 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.56 -31.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.961 0.504 . . . . 99.989999999999995 111.418 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.71 -47.09 92.91 Favored Glycine 0 N--CA 1.479 1.53 0 O-C-N 124.152 0.908 . . . . 99.989999999999995 113.706 170.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.46 104.41 0.01 OUTLIER Glycine 0 N--CA 1.479 1.51 0 CA-C-N 114.361 -0.919 . . . . 99.989999999999995 115.279 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.88 58.13 0.64 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.738 1.615 . . . . 99.989999999999995 114.286 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 m -172.64 -154.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.25 2.22 . . . . 99.989999999999995 110.468 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.63 -18.27 1.69 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 116.776 2.139 . . . . 99.989999999999995 116.776 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 8.8 mptt -48.48 -47.5 38.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.343 1.057 . . . . 99.989999999999995 112.01 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.77 66.61 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.244 1.202 . . . . 99.989999999999995 114.244 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -71.66 -45.92 60.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.674 1.189 . . . . 99.989999999999995 112.74 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.78 78.22 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.743 0.817 . . . . 99.989999999999995 112.22 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.2 t -65.99 -48.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.267 1.027 . . . . 99.989999999999995 110.568 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.3 62.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.687 0.625 . . . . 99.989999999999995 112.687 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.36 -60.91 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.056 0.942 . . . . 99.989999999999995 112.937 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.7 -36.8 79.69 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.976 1.102 . . . . 99.989999999999995 113.976 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 88.3 t -68.11 -30.36 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 99.989999999999995 113.194 176.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -78.76 -55.31 5.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.113 0.565 . . . . 99.989999999999995 111.989 171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -76.35 -35.09 58.91 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.908 2.559 . . . . 99.989999999999995 117.908 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -111.27 -36.94 5.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.138 0.975 . . . . 99.989999999999995 112.84 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.8 m-85 -82.69 -28.73 30.39 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.297 1.221 . . . . 99.989999999999995 114.297 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 57.69 7.42 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 119.051 2.982 . . . . 99.989999999999995 119.051 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.31 -18.83 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 112.765 0.654 . . . . 99.989999999999995 112.765 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 50.38 58.58 5.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.017 1.858 . . . . 99.989999999999995 116.017 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.82 86.68 51.59 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 114.011 1.115 . . . . 99.989999999999995 114.011 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.21 151.1 86.81 Favored 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 123.098 2.532 . . . . 0.0 111.665 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 tp 67.75 -37.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.556 1.943 . . . . 99.989999999999995 115.26 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -55.37 -71.99 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.044 0.938 . . . . 99.989999999999995 111.213 173.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG12 HE22 ' A' ' 71' ' ' GLN . 22.5 m -76.47 58.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-O 123.162 1.458 . . . . 99.989999999999995 111.93 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.5 tp -168.35 -54.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.227 -1.806 . . . . 99.989999999999995 111.242 -171.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.7 -45.77 8.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.758 1.021 . . . . 99.989999999999995 113.758 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.74 88.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.979 0.511 . . . . 99.989999999999995 111.979 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.519 HE22 HG12 ' A' ' 67' ' ' VAL . 8.7 mp0 -115.2 81.09 7.78 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 115.647 -0.706 . . . . 99.989999999999995 110.074 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -82.08 36.92 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.113 2.542 . . . . 0.0 113.974 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -160.74 134.45 6.87 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.193 1.397 . . . . 99.989999999999995 110.728 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 0.5 OUTLIER -65.73 -22.92 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.283 -1.326 . . . . 99.989999999999995 113.842 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -59.52 -51.58 69.25 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.958 0.345 . . . . 99.989999999999995 110.973 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.03 83.97 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.058 0.762 . . . . 99.989999999999995 113.058 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.37 -44.3 88.79 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.685 0.994 . . . . 99.989999999999995 113.685 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.6 89.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.142 0.977 . . . . 99.989999999999995 112.159 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.29 -31.36 72.46 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.848 1.425 . . . . 99.989999999999995 114.848 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.22 -19.95 60.97 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.652 2.093 . . . . 99.989999999999995 116.652 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.275 14.0 m -114.87 -69.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.485 1.661 . . . . 99.989999999999995 115.485 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.75 61.25 4.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.656 1.693 . . . . 99.989999999999995 111.142 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.4 m -164.53 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.121 2.169 . . . . 99.989999999999995 108.286 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.466 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.52 -33.19 7.12 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.275 1.954 . . . . 99.989999999999995 116.275 176.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 116.947 2.203 . . . . 99.989999999999995 116.947 -177.277 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 113.438 0.903 . . . . 99.989999999999995 113.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.82 25.12 15.07 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 117.223 2.305 . . . . 99.989999999999995 117.223 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -46.67 -33.1 3.98 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.259 2.318 . . . . 99.989999999999995 117.259 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 t80 174.76 -70.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.843 1.657 . . . . 99.989999999999995 110.937 -173.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.73 88.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 126.904 2.081 . . . . 99.989999999999995 112.286 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.6 88.91 35.79 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.506 -0.77 . . . . 99.989999999999995 112.054 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.09 152.29 80.24 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 123.209 2.606 . . . . 0.0 113.167 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.33 -85.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.542 -1.208 . . . . 99.989999999999995 110.713 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -108.93 -176.85 3.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.181 0.593 . . . . 99.989999999999995 111.265 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -53.65 14.29 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 113.141 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.53 -52.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.947 0.899 . . . . 99.989999999999995 111.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -51.8 -59.62 4.1 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.297 1.039 . . . . 99.989999999999995 112.336 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -66.27 -50.36 63.99 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.433 0.901 . . . . 99.989999999999995 113.433 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -63.92 -46.94 82.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.753 1.221 . . . . 99.989999999999995 112.034 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.09 -37.64 84.33 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.495 0.924 . . . . 99.989999999999995 113.495 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.4 89.82 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.725 0.639 . . . . 99.989999999999995 112.725 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -59.77 -50.68 72.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.848 1.259 . . . . 99.989999999999995 111.419 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.52 -50.52 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.861 0.864 . . . . 99.989999999999995 110.298 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' A' ' 23' ' ' TRP . 5.5 m95 -57.01 -54.91 41.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.941 1.089 . . . . 99.989999999999995 113.941 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -58.0 -30.21 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.186 1.55 . . . . 99.989999999999995 115.186 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -74.96 -60.24 2.38 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.781 1.301 . . . . 99.989999999999995 111.862 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.13 -37.14 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.762 1.625 . . . . 99.989999999999995 113.195 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.65 -19.66 41.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.85 1.66 . . . . 99.989999999999995 114.38 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.04 69.23 0.4 Allowed Glycine 0 N--CA 1.476 1.321 0 N-CA-C 110.179 -1.168 . . . . 99.989999999999995 110.179 -177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.269 12.3 p 3.85 78.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 128.402 2.681 . . . . 99.989999999999995 115.611 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -121.18 -49.17 2.19 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 112.67 -2.059 . . . . 99.989999999999995 115.289 -168.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.1 84.42 1.72 Allowed Glycine 0 N--CA 1.48 1.628 0 O-C-N 123.748 0.655 . . . . 99.989999999999995 112.331 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 pt -113.67 153.86 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.251 0.834 . . . . 99.989999999999995 113.251 -170.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.25 158.44 52.16 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 113.496 -1.683 . . . . 99.989999999999995 113.27 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -45.45 -39.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.251 1.42 . . . . 99.989999999999995 112.261 166.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.6 tp -56.49 -31.77 64.36 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.92 1.688 . . . . 99.989999999999995 114.626 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 61.68 162.14 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.03 1.732 . . . . 99.989999999999995 111.627 -169.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 39' ' ' PHE . 59.7 t30 -68.04 4.25 1.29 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.543 0.942 . . . . 99.989999999999995 113.543 170.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.264 54.7 p90 48.96 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 119.767 3.247 . . . . 99.989999999999995 119.767 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 37' ' ' ASN . 90.7 t80 -109.11 -74.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.133 1.773 . . . . 99.989999999999995 112.558 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -73.08 33.58 0.07 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.567 2.432 . . . . 99.989999999999995 117.567 -175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.92 -37.4 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.192 0.812 . . . . 99.989999999999995 113.192 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.97 -30.48 4.8 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 115.319 -0.855 . . . . 99.989999999999995 113.274 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.43 -172.96 7.22 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-O 122.627 1.126 . . . . 99.989999999999995 113.849 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 53.9 0.88 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.911 -1.144 . . . . 99.989999999999995 111.862 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -173.49 -166.83 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.701 1.6 . . . . 99.989999999999995 112.39 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.64 -22.5 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 116.984 2.216 . . . . 99.989999999999995 116.984 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -42.34 -49.41 5.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.068 1.347 . . . . 99.989999999999995 112.07 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.57 71.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.795 1.238 . . . . 99.989999999999995 114.132 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -69.39 -45.7 68.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.215 1.006 . . . . 99.989999999999995 112.319 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.39 91.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.584 0.754 . . . . 99.989999999999995 111.889 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.96 -46.65 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.812 -0.631 . . . . 99.989999999999995 110.701 172.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.58 -42.52 64.59 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.147 1.165 . . . . 99.989999999999995 114.147 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -58.11 -48.26 80.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 99.989999999999995 112.28 174.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.38 -43.65 98.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 99.989999999999995 112.343 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.8 t -59.52 -34.58 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.153 1.381 . . . . 99.989999999999995 112.986 176.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -72.99 -39.55 65.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.924 1.083 . . . . 99.989999999999995 113.924 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.405 HH21 ' HB1' ' A' ' 53' ' ' ALA . 2.1 ptt180 -91.12 -53.31 4.42 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 116.882 2.179 . . . . 99.989999999999995 116.882 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.77 -29.01 22.65 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.457 1.503 . . . . 99.989999999999995 113.041 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 54.8 m-85 -103.23 -18.24 14.98 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.7 1.741 . . . . 99.989999999999995 115.7 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -38.95 0.13 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.811 2.444 . . . . 99.989999999999995 117.47 -174.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.29 -22.89 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 127.67 2.388 . . . . 99.989999999999995 115.476 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 59.74 152.33 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.862 2.465 . . . . 99.989999999999995 116.4 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt 65.9 150.26 0.12 Allowed Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 126.032 1.733 . . . . 99.989999999999995 115.47 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.1 172.93 10.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.036 1.824 . . . . 0.0 110.881 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 69' ' ' PHE . 8.0 tt 70.25 -40.28 0.46 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.188 1.795 . . . . 99.989999999999995 114.653 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -48.92 -92.36 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.054 2.141 . . . . 99.989999999999995 112.283 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 p -89.1 62.18 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 123.431 1.586 . . . . 99.989999999999995 109.304 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -157.51 -76.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 112.589 -2.096 . . . . 99.989999999999995 112.924 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.401 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 20.6 m-85 -77.82 -41.4 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.325 0.65 . . . . 99.989999999999995 112.508 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.22 73.18 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.599 0.963 . . . . 99.989999999999995 113.599 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.08 81.92 60.51 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 112.895 0.702 . . . . 99.989999999999995 112.895 166.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.22 30.56 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.641 2.894 . . . . 0.0 116.339 -172.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -139.93 131.85 27.7 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.397 1.479 . . . . 99.989999999999995 109.835 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.285 0.4 OUTLIER -63.64 -21.69 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.193 0.812 . . . . 99.989999999999995 113.193 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.24 -56.15 25.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.514 0.726 . . . . 99.989999999999995 110.495 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.07 73.55 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.134 0.79 . . . . 99.989999999999995 113.134 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -48.59 71.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.432 0.693 . . . . 99.989999999999995 112.533 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.96 96.54 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.284 0.846 . . . . 99.989999999999995 113.284 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -32.72 73.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.91 1.448 . . . . 99.989999999999995 114.91 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -71.64 -21.69 61.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.537 1.68 . . . . 99.989999999999995 115.537 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.281 29.8 m -110.27 -69.35 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.406 1.632 . . . . 99.989999999999995 115.406 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.41 56.12 3.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.599 1.666 . . . . 99.989999999999995 111.797 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 m -156.55 -61.41 0.1 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.882 -1.963 . . . . 99.989999999999995 108.843 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.54 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -102.27 -32.71 9.92 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.604 1.705 . . . . 99.989999999999995 115.604 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 116.201 1.926 . . . . 99.989999999999995 116.201 177.239 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 112.697 0.629 . . . . 99.989999999999995 112.697 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.116 -1.402 . . . . 99.989999999999995 112.827 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -102.03 -40.0 7.05 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.589 -1.187 . . . . 99.989999999999995 113.761 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -67.75 42.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.901 2.556 . . . . 99.989999999999995 117.901 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.62 90.35 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 122.018 0.913 . . . . 99.989999999999995 112.071 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.03 87.53 7.21 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 114.228 -1.351 . . . . 99.989999999999995 111.916 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.07 144.84 38.51 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.081 2.521 . . . . 0.0 113.223 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -75.55 0.47 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.046 -1.434 . . . . 99.989999999999995 111.467 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -116.58 -172.97 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.061 0.945 . . . . 99.989999999999995 112.486 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.06 57.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.157 0.983 . . . . 99.989999999999995 113.468 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -55.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.025 0.93 . . . . 99.989999999999995 110.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -51.12 -57.48 8.6 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.34 1.056 . . . . 99.989999999999995 113.597 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 t -65.1 -54.4 30.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.59 0.959 . . . . 99.989999999999995 113.59 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -60.96 -46.36 91.03 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.035 0.934 . . . . 99.989999999999995 111.705 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.6 mm? -64.86 -40.97 95.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 117.994 -1.003 . . . . 99.989999999999995 113.219 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.433 0.531 . . . . 99.989999999999995 112.433 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -59.64 -54.91 40.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.63 1.172 . . . . 99.989999999999995 111.545 170.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -52.83 -49.84 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.671 1.188 . . . . 99.989999999999995 110.593 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -53.71 -65.15 0.62 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.459 1.104 . . . . 99.989999999999995 111.907 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.45 -29.63 64.36 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.762 1.764 . . . . 99.989999999999995 115.762 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -72.63 -66.79 0.62 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.255 1.422 . . . . 99.989999999999995 111.919 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.31 -35.45 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.837 1.255 . . . . 99.989999999999995 113.342 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.51 -19.35 47.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.583 . . . . 99.989999999999995 114.089 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.37 71.9 0.2 Allowed Glycine 0 N--CA 1.476 1.364 0 C-N-CA 124.18 0.895 . . . . 99.989999999999995 111.099 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.7 p 0.65 82.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.502 2.721 . . . . 99.989999999999995 115.878 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 m -123.38 -81.62 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.193 -2.276 . . . . 99.989999999999995 114.863 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.21 96.95 0.57 Allowed Glycine 0 N--CA 1.478 1.457 0 N-CA-C 109.56 -1.416 . . . . 99.989999999999995 109.56 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 pt -124.37 -177.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 114.608 -0.796 . . . . 99.989999999999995 112.312 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.11 12.15 Favored Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.552 -1.204 . . . . 99.989999999999995 112.906 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -55.16 -45.27 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.092 1.357 . . . . 99.989999999999995 112.324 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.21 -18.27 57.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.851 1.661 . . . . 99.989999999999995 114.408 171.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.21 -163.95 0.23 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.162 1.785 . . . . 99.989999999999995 110.412 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' ND2' HE22 ' A' ' 40' ' ' GLN . 51.8 t30 -108.63 22.94 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.188 0.518 . . . . 99.989999999999995 110.967 165.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.6 p90 36.5 16.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 121.565 3.913 . . . . 99.989999999999995 121.565 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -119.83 -76.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.029 0.932 . . . . 99.989999999999995 111.642 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.455 HE22 ' ND2' ' A' ' 37' ' ' ASN . 17.3 pm0 -73.66 31.61 0.08 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.366 2.358 . . . . 99.989999999999995 117.366 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -38.12 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.338 0.655 . . . . 99.989999999999995 112.251 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.54 -55.08 27.39 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.193 0.933 . . . . 99.989999999999995 113.359 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.87 114.22 0.01 OUTLIER Glycine 0 N--CA 1.478 1.447 0 O-C-N 125.348 1.263 . . . . 99.989999999999995 114.867 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -78.66 59.76 2.57 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.917 1.341 . . . . 99.989999999999995 112.543 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -174.96 -157.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.816 2.446 . . . . 99.989999999999995 110.358 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.2 -17.58 2.98 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.869 2.174 . . . . 99.989999999999995 116.869 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -46.1 -52.65 11.7 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.229 1.011 . . . . 99.989999999999995 113.06 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.11 -38.43 62.62 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.371 1.248 . . . . 99.989999999999995 114.371 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -68.98 -48.55 62.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.454 1.102 . . . . 99.989999999999995 112.674 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.7 84.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.895 0.878 . . . . 99.989999999999995 112.47 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.9 -50.21 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.133 0.973 . . . . 99.989999999999995 110.099 171.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.6 63.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.522 0.729 . . . . 99.989999999999995 112.912 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.03 -57.17 13.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.896 0.878 . . . . 99.989999999999995 112.878 173.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.16 -36.93 84.41 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.422 1.268 . . . . 99.989999999999995 114.422 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 61.3 t -64.44 -29.52 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.298 1.039 . . . . 99.989999999999995 112.304 174.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -79.85 -67.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.8 0.44 . . . . 99.989999999999995 111.598 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.493 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -65.61 -35.98 82.38 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.217 2.303 . . . . 99.989999999999995 117.217 -171.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -107.68 -34.28 7.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.568 0.747 . . . . 99.989999999999995 112.938 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.479 ' HH ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m-30 -87.46 -25.73 23.6 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.799 1.407 . . . . 99.989999999999995 114.799 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 69.47 -43.61 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 129.049 2.94 . . . . 99.989999999999995 115.964 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.54 -21.25 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.531 2.419 . . . . 99.989999999999995 117.531 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 47.62 79.56 0.06 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.771 2.137 . . . . 99.989999999999995 116.771 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.69 83.71 29.18 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 114.082 1.142 . . . . 99.989999999999995 114.082 169.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -65.75 150.05 86.41 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.328 2.686 . . . . 0.0 111.952 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tt 65.65 -41.58 0.34 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.812 2.045 . . . . 99.989999999999995 114.546 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -51.1 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.935 1.694 . . . . 99.989999999999995 112.183 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.69 64.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.514 1.626 . . . . 99.989999999999995 110.049 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.7 tp -163.48 -63.69 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 111.977 -2.374 . . . . 99.989999999999995 111.219 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.94 -57.47 3.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.46 1.104 . . . . 99.989999999999995 112.706 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.89 71.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.282 0.633 . . . . 99.989999999999995 112.696 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -123.01 82.09 50.79 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.247 1.019 . . . . 99.989999999999995 111.099 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -82.76 31.89 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.376 2.717 . . . . 0.0 115.143 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 t -148.31 135.75 20.53 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.239 1.015 . . . . 99.989999999999995 111.307 -171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.279 0.4 OUTLIER -63.97 -23.54 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 114.775 -1.102 . . . . 99.989999999999995 113.467 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -52.94 -62.25 1.77 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.298 1.039 . . . . 99.989999999999995 110.485 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.37 80.51 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.821 -1.082 . . . . 99.989999999999995 113.912 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.25 -47.29 84.03 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.727 0.411 . . . . 99.989999999999995 110.934 173.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.03 92.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.41 1.084 . . . . 99.989999999999995 112.841 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -60.27 -36.63 78.24 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.623 1.342 . . . . 99.989999999999995 114.623 171.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -73.34 -39.84 64.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.457 1.651 . . . . 99.989999999999995 115.457 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.44 HG13 ' CD2' ' A' ' 59' ' ' TYR 0.251 26.2 m -105.95 -28.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 118.123 2.638 . . . . 99.989999999999995 118.123 -170.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.71 50.71 0.94 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.982 1.373 . . . . 99.989999999999995 109.834 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 90.6 m -162.27 -61.74 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.961 -1.472 . . . . 99.989999999999995 109.574 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.6 -33.18 7.1 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.502 1.668 . . . . 99.989999999999995 115.502 170.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 116.732 2.123 . . . . 99.989999999999995 116.732 171.131 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 115.401 1.63 . . . . 99.989999999999995 115.401 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.84 -135.04 0.06 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.331 1.452 . . . . 99.989999999999995 110.163 166.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -172.55 -66.74 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.569 1.547 . . . . 99.989999999999995 108.515 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -66.75 47.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.673 2.789 . . . . 99.989999999999995 117.117 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -96.13 87.24 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 122.346 1.069 . . . . 99.989999999999995 111.871 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 83.87 15.45 Favored Pre-proline 0 N--CA 1.477 0.893 0 CA-C-N 114.008 -1.451 . . . . 99.989999999999995 111.857 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -67.98 133.07 27.97 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.074 2.516 . . . . 99.989999999999995 113.401 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -78.49 -77.6 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.947 -1.479 . . . . 99.989999999999995 112.673 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.56 -174.46 2.57 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.339 1.055 . . . . 99.989999999999995 112.125 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -57.21 4.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.643 1.177 . . . . 99.989999999999995 113.388 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.81 -51.66 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.722 0.809 . . . . 99.989999999999995 111.813 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -52.06 -57.07 10.62 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.691 0.797 . . . . 99.989999999999995 112.504 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.2 -53.33 46.39 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.199 0.999 . . . . 99.989999999999995 113.501 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -55.6 -48.57 74.66 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 99.989999999999995 111.292 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.1 mm? -69.68 -44.21 70.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.156 -0.929 . . . . 99.989999999999995 113.28 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.44 78.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.297 0.48 . . . . 99.989999999999995 112.297 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.74 -59.64 5.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.306 1.442 . . . . 99.989999999999995 111.523 172.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 2.7 pp -61.12 -36.85 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.42 0.896 . . . . 99.989999999999995 113.42 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -59.75 -54.91 40.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.671 -0.68 . . . . 99.989999999999995 111.993 172.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.49 -29.85 69.33 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.229 1.566 . . . . 99.989999999999995 115.229 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -71.69 -66.84 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.682 1.593 . . . . 99.989999999999995 111.933 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.86 -34.3 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.219 1.808 . . . . 99.989999999999995 113.763 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.54 -24.82 49.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.598 1.159 . . . . 99.989999999999995 113.812 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.77 75.43 0.49 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 108.815 -1.714 . . . . 99.989999999999995 108.815 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.289 12.2 p -4.47 83.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 128.247 2.619 . . . . 99.989999999999995 116.208 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 m -116.7 -39.04 3.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.496 -2.138 . . . . 99.989999999999995 115.113 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.2 91.46 1.08 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.189 -1.164 . . . . 99.989999999999995 110.189 -169.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.09 -143.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.965 -0.618 . . . . 99.989999999999995 110.63 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.41 -150.58 5.65 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 122.747 1.193 . . . . 99.989999999999995 113.772 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.99 -61.12 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 111.685 -2.258 . . . . 99.989999999999995 108.757 170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.31 -29.77 66.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.157 1.383 . . . . 99.989999999999995 113.34 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 58.33 -148.24 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.882 1.273 . . . . 99.989999999999995 109.517 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -99.49 13.9 31.74 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.64 0.587 . . . . 99.989999999999995 111.351 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.26 35.5 p90 41.23 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 121.636 3.939 . . . . 99.989999999999995 121.636 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -96.05 -79.69 0.44 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.889 1.276 . . . . 99.989999999999995 112.816 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -74.33 35.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 117.522 2.415 . . . . 99.989999999999995 117.522 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -112.83 -35.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 113.997 -1.456 . . . . 99.989999999999995 111.61 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.27 -54.66 35.47 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 123.876 0.735 . . . . 99.989999999999995 112.546 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.39 97.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.122 -1.039 . . . . 99.989999999999995 115.399 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -74.41 63.55 1.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.17 1.388 . . . . 99.989999999999995 112.809 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -171.79 -153.03 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.838 2.455 . . . . 99.989999999999995 109.635 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.79 -22.57 3.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.21 1.93 . . . . 99.989999999999995 116.21 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mmpm? -46.43 -48.55 18.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.76 -1.114 . . . . 99.989999999999995 113.814 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.27 65.3 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.702 1.001 . . . . 99.989999999999995 113.702 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.95 -51.48 54.67 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.595 1.158 . . . . 99.989999999999995 112.606 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.15 92.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 99.989999999999995 112.664 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.1 -47.12 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.329 1.052 . . . . 99.989999999999995 110.007 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.58 -45.25 69.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.867 0.691 . . . . 99.989999999999995 112.867 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.73 75.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.447 0.699 . . . . 99.989999999999995 112.707 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -64.62 -39.26 93.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.095 0.958 . . . . 99.989999999999995 113.514 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 86.3 t -69.58 -30.13 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.989 1.315 . . . . 99.989999999999995 112.882 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -76.11 -40.18 53.49 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.597 0.592 . . . . 99.989999999999995 112.597 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -76.11 -91.23 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.664 1.186 . . . . 99.989999999999995 112.575 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.92 -30.09 67.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.929 1.692 . . . . 99.989999999999995 114.381 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.2 m-30 -98.23 -18.43 18.42 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.69 1.737 . . . . 99.989999999999995 115.69 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 57.69 -45.16 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.846 2.536 . . . . 99.989999999999995 117.846 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.31 -12.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.598 1.959 . . . . 99.989999999999995 115.208 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 48.41 44.88 20.65 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.913 3.301 . . . . 99.989999999999995 119.913 167.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -113.26 88.86 13.34 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 114.789 1.403 . . . . 99.989999999999995 114.789 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.87 152.8 80.51 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.427 2.752 . . . . 99.989999999999995 112.0 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tt 64.97 -43.73 0.33 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.705 2.002 . . . . 99.989999999999995 114.833 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.45 -69.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.563 1.145 . . . . 99.989999999999995 111.889 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.15 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 123.923 1.821 . . . . 99.989999999999995 111.224 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.1 tp -153.66 -78.06 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.863 -1.971 . . . . 99.989999999999995 110.53 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.32 -46.51 60.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.028 1.121 . . . . 99.989999999999995 114.028 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.82 -31.56 72.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.216 0.821 . . . . 99.989999999999995 113.216 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -124.71 75.65 64.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.876 0.871 . . . . 99.989999999999995 112.064 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.78 54.26 4.39 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.574 2.182 . . . . 99.989999999999995 113.396 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -169.16 131.34 1.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.161 1.384 . . . . 99.989999999999995 111.044 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.321 0.5 OUTLIER -62.88 -20.49 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 114.521 -1.218 . . . . 99.989999999999995 113.948 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -58.64 -52.8 64.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.564 0.746 . . . . 99.989999999999995 111.022 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -40.2 77.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.401 -0.818 . . . . 99.989999999999995 112.69 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.98 -48.51 79.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 99.989999999999995 112.582 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.0 96.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.01 0.924 . . . . 99.989999999999995 112.341 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -31.66 72.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.845 1.424 . . . . 99.989999999999995 114.845 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.71 -35.37 62.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.443 2.016 . . . . 99.989999999999995 116.443 169.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.27 -26.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 119.023 2.971 . . . . 99.989999999999995 119.023 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.3 22.42 12.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.405 1.082 . . . . 99.989999999999995 113.816 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -123.55 -59.39 1.54 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.191 -0.913 . . . . 99.989999999999995 110.499 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -98.13 -31.05 12.31 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.68 1.363 . . . . 99.989999999999995 114.68 172.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 115.527 -2.178 . . . . 99.989999999999995 115.763 173.48 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 114.405 1.261 . . . . 99.989999999999995 114.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.35 33.77 13.64 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 118.432 2.753 . . . . 99.989999999999995 118.432 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -45.91 -33.86 3.52 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 118.845 2.906 . . . . 99.989999999999995 118.845 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -177.54 -68.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.175 1.39 . . . . 99.989999999999995 111.306 -173.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t 61.2 78.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 126.588 1.955 . . . . 99.989999999999995 113.503 172.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 87.23 56.46 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 111.941 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 149.3 82.87 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.269 2.646 . . . . 0.0 113.054 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.05 -80.77 0.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.537 -1.211 . . . . 99.989999999999995 111.794 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -111.89 -174.87 2.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.431 1.092 . . . . 99.989999999999995 112.089 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.9 -61.94 1.63 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.588 1.155 . . . . 99.989999999999995 113.478 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.89 -48.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.238 1.015 . . . . 99.989999999999995 111.548 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -52.56 -58.05 8.03 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.36 1.064 . . . . 99.989999999999995 112.714 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -67.73 -48.77 65.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.001 0.92 . . . . 99.989999999999995 112.978 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -55.15 -53.57 54.32 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.391 1.476 . . . . 99.989999999999995 110.961 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.96 -45.62 88.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 118.082 -0.961 . . . . 99.989999999999995 113.3 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.81 79.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.52 0.563 . . . . 99.989999999999995 112.52 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.29 -61.99 2.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.602 1.561 . . . . 99.989999999999995 111.551 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 37.6 pt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 114.232 1.197 . . . . 99.989999999999995 114.232 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -59.22 -59.35 5.61 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 118.644 -0.693 . . . . 99.989999999999995 112.692 168.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -58.75 -32.16 69.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.504 1.298 . . . . 99.989999999999995 114.504 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -65.43 -68.39 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.519 1.528 . . . . 99.989999999999995 111.112 171.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.36 -37.05 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.724 1.61 . . . . 99.989999999999995 113.482 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.35 -21.0 61.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.034 1.124 . . . . 99.989999999999995 114.034 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.1 61.42 0.16 Allowed Glycine 0 N--CA 1.477 1.407 0 O-C-N 124.167 0.917 . . . . 99.989999999999995 112.265 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.259 9.2 p 19.49 66.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 127.874 2.469 . . . . 99.989999999999995 114.757 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -107.06 -61.77 1.5 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.563 -2.108 . . . . 99.989999999999995 114.577 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.94 89.42 1.72 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 115.692 -0.686 . . . . 99.989999999999995 111.557 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.3 pt -127.97 -153.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.366 -0.605 . . . . 99.989999999999995 109.366 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.69 -148.31 7.02 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 121.46 -0.4 . . . . 99.989999999999995 113.561 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' HA ' HG23 ' A' ' 74' ' ' ILE . 1.9 mp -47.86 -69.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 111.551 -2.324 . . . . 99.989999999999995 113.0 -172.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.49 -15.15 48.52 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.433 1.642 . . . . 99.989999999999995 115.433 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.99 -143.24 0.73 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.323 1.449 . . . . 99.989999999999995 108.861 -172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -112.14 18.15 18.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.342 0.867 . . . . 99.989999999999995 113.342 163.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.7 p90 39.72 15.85 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 119.252 3.056 . . . . 99.989999999999995 119.252 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -131.03 -82.18 0.53 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.518 1.527 . . . . 99.989999999999995 111.572 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.25 -40.52 11.61 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.698 2.851 . . . . 99.989999999999995 118.698 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -28.14 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 114.436 1.273 . . . . 99.989999999999995 114.436 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.42 65.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.543 1.068 . . . . 99.989999999999995 114.039 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.84 96.39 2.46 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 123.937 0.433 . . . . 99.989999999999995 113.768 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 1.22 1.62 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.908 1.448 . . . . 99.989999999999995 114.908 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m 177.03 -150.02 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.87 2.468 . . . . 99.989999999999995 109.715 -165.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -55.83 -7.12 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.627 2.825 . . . . 99.989999999999995 118.627 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.48 -31.57 6.56 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.611 1.337 . . . . 99.989999999999995 114.611 173.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.05 45.27 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.947 1.092 . . . . 99.989999999999995 113.947 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -65.26 -48.98 71.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.452 1.101 . . . . 99.989999999999995 111.722 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.64 90.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.031 0.932 . . . . 99.989999999999995 112.47 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.77 -52.22 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.595 0.758 . . . . 99.989999999999995 110.014 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.51 -39.87 71.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.03 0.932 . . . . 99.989999999999995 113.152 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.39 -50.51 72.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.54 0.736 . . . . 99.989999999999995 112.481 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.88 -44.92 96.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 99.989999999999995 112.98 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.63 -32.28 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.081 0.952 . . . . 99.989999999999995 112.495 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -68.89 -42.95 76.26 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.772 0.656 . . . . 99.989999999999995 112.772 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -82.45 -61.98 1.74 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.581 1.697 . . . . 99.989999999999995 115.581 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.28 -32.98 55.89 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.393 1.477 . . . . 99.989999999999995 113.327 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -101.59 -9.44 20.96 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.408 0.892 . . . . 99.989999999999995 113.408 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 62.53 -55.39 0.15 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.076 2.551 . . . . 99.989999999999995 115.413 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.15 4.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 126.462 1.905 . . . . 99.989999999999995 115.421 -166.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.285 15.0 pt-20 54.36 -38.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 121.545 3.905 . . . . 99.989999999999995 121.545 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -22.32 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 128.523 2.729 . . . . 99.989999999999995 118.201 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.21 147.37 78.67 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.026 2.484 . . . . 0.0 111.273 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 66.04 -38.58 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.584 1.954 . . . . 99.989999999999995 115.466 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -53.47 -73.84 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.36 1.064 . . . . 99.989999999999995 113.674 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.22 52.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 124.043 1.877 . . . . 99.989999999999995 111.618 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -154.31 -79.4 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 112.336 -2.211 . . . . 99.989999999999995 108.57 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.0 -43.8 98.36 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.33 1.233 . . . . 99.989999999999995 114.33 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.59 67.5 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.298 1.222 . . . . 99.989999999999995 114.298 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.92 71.16 7.18 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.917 0.887 . . . . 99.989999999999995 112.666 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.98 40.04 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.755 2.97 . . . . 0.0 114.921 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -147.9 131.26 16.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.321 1.848 . . . . 99.989999999999995 109.576 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' A' ' 34' ' ' ILE 0.285 0.5 OUTLIER -61.34 -21.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 114.56 -1.2 . . . . 99.989999999999995 113.865 -179.771 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.11 -60.87 2.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.583 1.153 . . . . 99.989999999999995 110.112 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -34.84 74.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.05 -0.977 . . . . 99.989999999999995 113.468 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.86 -47.24 85.6 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.696 0.628 . . . . 99.989999999999995 112.696 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.82 96.29 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.953 0.901 . . . . 99.989999999999995 112.378 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -55.92 -51.96 65.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 99.989999999999995 112.019 169.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.052 1.871 . . . . 99.989999999999995 116.052 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.309 6.6 m -108.41 -72.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 114.461 1.282 . . . . 99.989999999999995 114.461 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.42 64.46 3.51 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.371 1.557 . . . . 99.989999999999995 112.78 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 77.5 m -166.7 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.399 2.68 . . . . 99.989999999999995 108.702 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -110.19 -29.5 8.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.71 2.115 . . . . 99.989999999999995 116.71 176.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.517 -1.706 . . . . 99.989999999999995 115.424 -177.235 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 tpt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 122.882 1.325 . . . . 99.989999999999995 114.233 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.75 -146.44 16.35 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 109.428 -1.469 . . . . 99.989999999999995 109.428 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t 62.84 130.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 125.696 1.598 . . . . 99.989999999999995 112.233 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 t -104.13 -40.49 6.14 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.138 -1.392 . . . . 99.989999999999995 114.62 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -125.11 -166.11 1.49 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.681 0.792 . . . . 99.989999999999995 112.578 -172.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.86 25.05 4.93 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 118.286 2.698 . . . . 99.989999999999995 118.286 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -46.26 -36.04 5.81 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 117.858 2.54 . . . . 99.989999999999995 117.858 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.1 t80 177.2 -60.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.162 0.985 . . . . 99.989999999999995 111.699 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 57.33 79.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.139 2.176 . . . . 99.989999999999995 113.68 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.33 89.44 41.08 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.513 -0.767 . . . . 99.989999999999995 111.493 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.76 -152.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.596 2.864 . . . . 0.0 113.792 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.82 -83.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.666 0.786 . . . . 99.989999999999995 109.343 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -109.65 -175.19 2.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.487 1.115 . . . . 99.989999999999995 112.203 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.91 -58.24 5.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.435 1.094 . . . . 99.989999999999995 113.171 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.19 -49.87 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 111.307 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -50.6 -62.67 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.661 1.184 . . . . 99.989999999999995 113.068 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 t -67.98 -47.28 69.0 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.409 -0.814 . . . . 99.989999999999995 112.909 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -61.69 -47.06 87.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.83 0.852 . . . . 99.989999999999995 111.616 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.2 mm? -68.02 -36.58 80.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.685 1.365 . . . . 99.989999999999995 114.685 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.07 85.51 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.113 0.415 . . . . 99.989999999999995 111.649 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.62 -55.11 39.36 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.544 1.538 . . . . 99.989999999999995 111.829 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.7 mm -55.27 -51.04 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 110.892 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -55.98 -55.95 26.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 118.399 -0.81 . . . . 99.989999999999995 112.943 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -61.2 -28.04 68.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.844 1.794 . . . . 99.989999999999995 115.844 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -76.69 -61.15 2.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.324 1.05 . . . . 99.989999999999995 111.59 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.3 t -60.64 -40.69 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.602 1.561 . . . . 99.989999999999995 112.637 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -61.09 -19.3 61.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.984 1.313 . . . . 99.989999999999995 114.238 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.71 0.92 Allowed Glycine 0 N--CA 1.474 1.187 0 N-CA-C 108.735 -1.746 . . . . 99.989999999999995 108.735 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 p -13.83 90.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.422 2.289 . . . . 99.989999999999995 115.53 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 p -141.89 -69.37 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 112.816 -1.993 . . . . 99.989999999999995 114.501 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 126.99 94.72 0.89 Allowed Glycine 0 N--CA 1.48 1.617 0 O-C-N 123.943 0.777 . . . . 99.989999999999995 112.58 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 pt -101.74 -177.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 115.334 -0.433 . . . . 99.989999999999995 111.822 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.37 171.67 18.76 Favored Glycine 0 N--CA 1.477 1.368 0 CA-C-N 115.126 -0.943 . . . . 99.989999999999995 111.119 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.7 mm -57.33 -48.65 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.353 1.061 . . . . 99.989999999999995 111.884 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.2 -6.53 2.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.881 1.673 . . . . 99.989999999999995 114.399 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 54.46 -154.06 0.28 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.715 2.006 . . . . 99.989999999999995 110.059 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' PHE . 29.0 t-20 -101.24 13.74 34.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.258 -0.276 . . . . 99.989999999999995 111.311 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.256 50.1 p90 37.56 5.38 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 120.986 3.699 . . . . 99.989999999999995 120.986 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 37' ' ' ASN . 60.4 t80 -116.38 -79.25 0.59 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.768 1.227 . . . . 99.989999999999995 111.741 175.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -53.6 -31.55 47.41 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 118.588 2.811 . . . . 99.989999999999995 118.588 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -32.7 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.976 1.102 . . . . 99.989999999999995 113.976 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.93 -53.18 28.32 Favored Glycine 0 CA--C 1.538 1.488 0 O-C-N 124.076 0.86 . . . . 99.989999999999995 112.659 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.63 105.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.755 1.062 . . . . 99.989999999999995 115.755 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -75.08 53.88 0.64 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.498 1.519 . . . . 99.989999999999995 114.118 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.5 p -163.59 -146.92 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.629 1.972 . . . . 99.989999999999995 109.002 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -54.41 -25.24 23.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.431 1.271 . . . . 99.989999999999995 114.431 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -50.22 -55.38 15.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.338 1.055 . . . . 99.989999999999995 113.72 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 -42.79 38.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.012 1.115 . . . . 99.989999999999995 114.012 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.48 -53.02 39.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.46 1.104 . . . . 99.989999999999995 112.988 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.161 0.985 . . . . 99.989999999999995 112.889 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.1 t -66.27 -42.9 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.649 0.78 . . . . 99.989999999999995 110.18 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.05 -42.25 72.47 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.078 0.77 . . . . 99.989999999999995 113.078 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.67 81.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.801 0.667 . . . . 99.989999999999995 112.801 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -64.09 -46.92 82.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.643 1.177 . . . . 99.989999999999995 112.579 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 59.5 t -61.45 -28.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.167 1.387 . . . . 99.989999999999995 112.318 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.24 -77.92 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.625 0.77 . . . . 99.989999999999995 110.727 166.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -59.72 -37.87 80.1 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 118.45 2.759 . . . . 99.989999999999995 118.45 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.49 -30.51 9.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.553 0.946 . . . . 99.989999999999995 113.553 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' HH ' ' HG ' ' A' ' 19' ' ' LEU . 2.9 m-30 -93.92 -27.44 16.38 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.025 1.491 . . . . 99.989999999999995 115.025 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 61.73 1.91 0.66 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.842 2.457 . . . . 99.989999999999995 116.684 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.07 -12.44 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 112.502 0.556 . . . . 99.989999999999995 112.502 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.94 41.53 3.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 120.076 3.362 . . . . 99.989999999999995 120.076 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 63' ' ' LEU . 2.4 pt? -109.82 93.01 13.59 Favored Pre-proline 0 N--CA 1.482 1.138 0 N-CA-C 115.885 1.809 . . . . 99.989999999999995 115.885 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.35 149.67 84.84 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.493 2.795 . . . . 0.0 111.97 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 60.98 -46.87 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.251 2.22 . . . . 99.989999999999995 114.917 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -55.97 -65.47 0.59 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.722 1.209 . . . . 99.989999999999995 112.436 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -62.65 -25.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.721 1.008 . . . . 99.989999999999995 113.721 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.21 -41.6 66.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.951 1.7 . . . . 99.989999999999995 113.579 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -103.71 -39.54 6.64 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.673 1.36 . . . . 99.989999999999995 114.673 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.63 62.44 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.741 0.645 . . . . 99.989999999999995 112.741 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 11.3 mp0 -119.57 61.93 6.81 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.944 0.498 . . . . 99.989999999999995 111.654 171.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -79.87 38.17 0.72 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.175 3.25 . . . . 0.0 114.081 -172.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -157.15 131.72 8.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.142 2.177 . . . . 99.989999999999995 108.864 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.289 0.5 OUTLIER -62.37 -21.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.841 -1.072 . . . . 99.989999999999995 113.244 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.67 -53.62 56.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.343 0.657 . . . . 99.989999999999995 110.69 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.8 74.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.86 0.689 . . . . 99.989999999999995 112.86 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.35 -48.97 73.44 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.51 0.724 . . . . 99.989999999999995 112.579 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.35 93.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.003 0.921 . . . . 99.989999999999995 112.717 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.03 -26.93 68.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.518 1.673 . . . . 99.989999999999995 115.518 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -77.72 -27.03 50.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.278 1.955 . . . . 99.989999999999995 116.278 169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.35 -30.18 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 118.168 2.655 . . . . 99.989999999999995 118.168 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.42 56.13 0.8 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.477 1.608 . . . . 99.989999999999995 109.89 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 m -162.35 -65.55 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.495 -1.684 . . . . 99.989999999999995 108.988 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.53 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -101.53 -33.17 10.04 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.386 1.254 . . . . 99.989999999999995 114.386 171.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 114.823 1.416 . . . . 99.989999999999995 114.823 172.491 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ttt . . . . . 0 CA--C 1.553 1.088 0 N-CA-C 113.886 1.069 . . . . 99.989999999999995 113.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.453 ' H ' ' NE2' ' A' ' 7' ' ' GLN . . . -97.67 77.33 0.63 Allowed Glycine 0 N--CA 1.478 1.48 0 N-CA-C 110.151 -1.179 . . . . 99.989999999999995 110.151 -174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 171.43 -51.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 130.375 3.47 . . . . 99.989999999999995 110.768 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 t -176.09 -144.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.944 1.698 . . . . 99.989999999999995 108.91 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -57.05 -54.39 47.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.986 2.114 . . . . 99.989999999999995 111.481 173.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.76 -179.8 4.98 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.061 1.745 . . . . 99.989999999999995 114.508 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 2' ' ' GLY . 34.0 tt0 -168.58 -99.51 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.06 1.744 . . . . 99.989999999999995 108.903 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.43 -57.28 12.85 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.466 1.654 . . . . 99.989999999999995 115.466 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t 56.25 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 126.352 1.861 . . . . 99.989999999999995 113.897 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.08 98.24 33.53 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 115.618 -0.719 . . . . 99.989999999999995 111.23 168.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.75 -154.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.752 2.968 . . . . 0.0 113.994 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.73 -85.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.003 0.521 . . . . 99.989999999999995 110.202 -178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -107.9 -176.89 3.19 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.389 0.676 . . . . 99.989999999999995 111.481 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.15 -51.98 16.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.295 1.038 . . . . 99.989999999999995 113.071 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.37 -54.53 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.512 1.125 . . . . 99.989999999999995 111.46 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -49.93 -59.9 3.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.233 . . . . 99.989999999999995 112.255 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.1 m -65.17 -44.85 87.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.893 1.071 . . . . 99.989999999999995 113.893 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -57.98 -58.51 8.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.413 1.485 . . . . 99.989999999999995 110.539 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.81 -33.77 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.951 1.093 . . . . 99.989999999999995 113.951 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 -45.17 84.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.056 0.391 . . . . 99.989999999999995 112.056 170.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.1 -48.95 79.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.557 1.143 . . . . 99.989999999999995 111.763 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 mm -54.44 -54.77 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.099 0.96 . . . . 99.989999999999995 110.685 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -56.56 -53.32 58.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.882 0.873 . . . . 99.989999999999995 113.332 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -60.27 -30.12 69.24 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.076 1.88 . . . . 99.989999999999995 116.076 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -77.01 -63.72 1.3 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.972 1.42 . . . . 99.989999999999995 111.148 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.6 -43.45 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.498 1.519 . . . . 99.989999999999995 113.204 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 -14.98 62.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.234 1.939 . . . . 99.989999999999995 116.234 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.31 72.46 0.18 Allowed Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.552 1.157 . . . . 99.989999999999995 110.789 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.9 p -10.45 87.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 128.314 2.646 . . . . 99.989999999999995 116.968 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.9 m -139.19 -50.66 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.299 -1.773 . . . . 99.989999999999995 115.496 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 125.57 3.0 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.69 -0.964 . . . . 99.989999999999995 110.69 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -125.72 165.17 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 113.07 0.766 . . . . 99.989999999999995 113.07 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.34 162.4 14.41 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 113.867 -1.515 . . . . 99.989999999999995 111.295 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.97 -40.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.321 0.648 . . . . 99.989999999999995 111.734 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.2 -21.07 58.89 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.706 1.373 . . . . 99.989999999999995 114.706 167.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 56.96 -163.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.441 1.897 . . . . 99.989999999999995 111.788 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -101.58 1.11 37.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.576 -0.738 . . . . 99.989999999999995 112.295 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.307 53.5 p90 53.97 -38.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.298 2.703 . . . . 99.989999999999995 118.298 -171.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.09 -81.57 0.06 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.364 1.466 . . . . 99.989999999999995 112.252 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.19 21.98 0.07 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 117.76 2.504 . . . . 99.989999999999995 117.76 -173.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.23 -44.95 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 112.62 0.6 . . . . 99.989999999999995 112.62 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.22 -40.9 60.66 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.964 0.79 . . . . 99.989999999999995 113.642 170.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.69 116.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.671 1.029 . . . . 99.989999999999995 115.671 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.55 46.63 1.08 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.924 -1.638 . . . . 99.989999999999995 114.041 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.8 p -150.48 -150.51 0.35 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.848 1.659 . . . . 99.989999999999995 109.608 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -55.56 -18.65 7.9 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.577 1.325 . . . . 99.989999999999995 114.577 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -48.49 -51.14 28.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.055 0.942 . . . . 99.989999999999995 112.261 172.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.14 -47.03 62.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.597 1.332 . . . . 99.989999999999995 114.597 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 ptm -70.53 -41.6 72.32 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.628 1.344 . . . . 99.989999999999995 114.628 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.86 97.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.292 0.637 . . . . 99.989999999999995 112.483 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -66.08 -47.64 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.915 0.886 . . . . 99.989999999999995 109.7 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.81 -39.84 62.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.252 0.834 . . . . 99.989999999999995 113.252 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.89 -57.3 12.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.682 0.793 . . . . 99.989999999999995 112.775 173.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.32 -34.69 78.92 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.623 0.971 . . . . 99.989999999999995 113.623 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.638 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 92.0 t -64.7 -27.82 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.653 1.181 . . . . 99.989999999999995 112.908 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -77.13 -63.21 1.42 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.72 0.808 . . . . 99.989999999999995 112.166 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.2 ptt85 -70.92 -38.98 72.95 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 118.661 2.837 . . . . 99.989999999999995 118.661 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.22 -36.38 6.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.625 0.77 . . . . 99.989999999999995 112.745 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m-85 -84.81 -27.92 26.48 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.632 1.345 . . . . 99.989999999999995 114.632 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 65.69 -36.39 0.23 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.174 2.589 . . . . 99.989999999999995 116.661 -175.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 t -57.73 -23.45 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.311 1.444 . . . . 99.989999999999995 114.646 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 45.89 67.92 0.67 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.788 1.773 . . . . 99.989999999999995 115.788 171.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -136.96 87.4 19.16 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 115.425 1.639 . . . . 99.989999999999995 115.425 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.82 148.05 89.81 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.431 2.754 . . . . 0.0 112.096 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 tt 62.37 -43.96 0.18 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.403 2.281 . . . . 99.989999999999995 114.584 -172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.16 -68.76 0.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.248 1.419 . . . . 99.989999999999995 113.117 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.87 12.93 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 114.193 1.182 . . . . 99.989999999999995 114.193 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.7 -41.65 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 99.989999999999995 111.935 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -106.83 -45.87 4.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.027 1.331 . . . . 99.989999999999995 113.329 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.86 73.68 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.882 0.697 . . . . 99.989999999999995 112.882 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -120.24 65.53 11.1 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.846 0.684 . . . . 99.989999999999995 112.846 170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -80.24 27.55 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.571 2.847 . . . . 0.0 114.973 -170.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -139.68 136.31 34.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 110.568 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.278 0.4 OUTLIER -61.85 -19.77 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.217 -1.356 . . . . 99.989999999999995 113.752 175.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.63 -61.9 2.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 99.989999999999995 110.348 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.46 80.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.499 0.926 . . . . 99.989999999999995 113.499 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.3 mt -58.03 -46.55 85.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.146 0.578 . . . . 99.989999999999995 112.262 172.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.62 85.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.277 1.031 . . . . 99.989999999999995 112.755 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -62.3 -40.6 96.84 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.856 1.058 . . . . 99.989999999999995 113.856 170.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -66.81 -39.23 87.64 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.321 1.6 . . . . 99.989999999999995 115.321 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.0 m -99.59 -40.37 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 117.062 2.245 . . . . 99.989999999999995 117.062 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.87 50.9 0.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.174 1.464 . . . . 99.989999999999995 110.451 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 69.0 m -160.26 -55.11 0.06 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 113.664 -1.607 . . . . 99.989999999999995 109.553 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -35.02 5.79 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.145 1.905 . . . . 99.989999999999995 116.145 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 116.009 -1.948 . . . . 99.989999999999995 116.027 175.105 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 115.193 1.553 . . . . 99.989999999999995 115.193 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.77 140.36 5.97 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 113.432 -1.713 . . . . 99.989999999999995 108.837 -169.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.272 16.1 m -12.94 78.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 119.46 3.133 . . . . 99.989999999999995 119.46 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 t -86.32 -37.23 18.7 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.33 -1.759 . . . . 99.989999999999995 112.638 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -61.09 -174.56 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.808 -1.542 . . . . 99.989999999999995 112.365 164.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.43 -71.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.607 1.963 . . . . 99.989999999999995 111.903 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.306 4.8 pt20 46.38 -56.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 121.425 3.861 . . . . 99.989999999999995 121.425 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -175.99 -65.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.674 1.59 . . . . 99.989999999999995 111.471 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t 57.99 95.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 126.339 1.856 . . . . 99.989999999999995 112.888 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.85 81.58 19.39 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 112.775 0.658 . . . . 99.989999999999995 112.775 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -67.67 147.59 76.25 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 122.904 2.403 . . . . 99.989999999999995 112.473 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -80.31 0.59 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.526 -1.215 . . . . 99.989999999999995 111.475 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -113.86 -176.51 2.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.54 1.136 . . . . 99.989999999999995 112.335 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.25 19.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.253 1.021 . . . . 99.989999999999995 113.585 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.94 -54.22 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.161 0.984 . . . . 99.989999999999995 110.424 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -49.26 -59.62 3.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.678 1.191 . . . . 99.989999999999995 113.339 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -68.34 -51.12 48.0 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.791 1.034 . . . . 99.989999999999995 113.791 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.48 -40.68 96.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.976 . . . . 99.989999999999995 112.425 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.39 -43.86 84.71 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 118.42 -0.8 . . . . 99.989999999999995 112.69 172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.06 77.74 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.53 0.567 . . . . 99.989999999999995 112.53 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -57.2 -57.05 14.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.499 1.519 . . . . 99.989999999999995 111.721 170.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 2.5 pp -62.64 -36.99 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.059 0.763 . . . . 99.989999999999995 113.059 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -56.69 -58.11 9.51 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.057 0.943 . . . . 99.989999999999995 112.119 173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -59.85 -30.02 68.68 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.233 1.568 . . . . 99.989999999999995 115.233 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -71.48 -62.65 1.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.195 1.398 . . . . 99.989999999999995 112.033 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.9 -37.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 125.713 1.605 . . . . 99.989999999999995 113.251 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.86 -23.16 51.65 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.006 1.323 . . . . 99.989999999999995 113.488 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.58 73.24 0.39 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.938 -1.265 . . . . 99.989999999999995 109.938 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.6 p 1.62 79.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 128.244 2.618 . . . . 99.989999999999995 116.304 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -123.52 -47.31 1.98 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 117.311 2.337 . . . . 99.989999999999995 117.311 -172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.14 91.9 2.23 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 111.349 -0.701 . . . . 99.989999999999995 111.349 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.5 pt -119.96 167.17 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 120.727 0.299 . . . . 99.989999999999995 111.117 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.73 168.97 24.09 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 123.116 1.398 . . . . 99.989999999999995 113.901 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.7 mm -48.68 -36.6 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 111.833 -2.184 . . . . 99.989999999999995 112.804 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.12 -20.11 64.88 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.57 1.548 . . . . 99.989999999999995 114.307 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 58.77 -156.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.721 1.608 . . . . 99.989999999999995 109.865 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -119.1 13.38 12.92 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.499 0.926 . . . . 99.989999999999995 113.499 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 36.87 34.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.889 2.181 . . . . 99.989999999999995 116.889 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -152.49 -81.42 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.769 -1.559 . . . . 99.989999999999995 109.775 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -70.94 29.91 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.053 2.612 . . . . 99.989999999999995 118.053 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.82 -40.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 112.766 0.654 . . . . 99.989999999999995 112.766 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.34 -40.3 97.73 Favored Glycine 0 N--CA 1.48 1.603 0 O-C-N 123.813 0.696 . . . . 99.989999999999995 113.279 166.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.69 149.64 0.11 Allowed Glycine 0 N--CA 1.477 1.4 0 O-C-N 125.101 1.118 . . . . 99.989999999999995 114.022 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -93.05 45.95 1.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 113.627 -1.286 . . . . 99.989999999999995 112.189 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -174.94 -159.76 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.28 1.832 . . . . 99.989999999999995 111.38 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -58.04 -5.44 0.45 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.132 2.641 . . . . 99.989999999999995 118.132 -178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -52.63 -51.97 57.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.066 0.947 . . . . 99.989999999999995 110.901 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.74 60.93 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.965 1.469 . . . . 99.989999999999995 114.965 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.0 mmt -68.74 -47.41 66.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.967 0.907 . . . . 99.989999999999995 112.896 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.99 80.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.497 0.719 . . . . 99.989999999999995 111.835 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.87 -47.81 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.603 -0.726 . . . . 99.989999999999995 111.024 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.37 -42.82 64.27 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.803 0.729 . . . . 99.989999999999995 112.225 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -60.48 -52.18 66.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.951 1.093 . . . . 99.989999999999995 113.951 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -65.01 -38.94 92.59 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.816 1.043 . . . . 99.989999999999995 113.816 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.56 -28.64 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.498 1.119 . . . . 99.989999999999995 112.203 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -66.51 -59.25 3.82 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.209 -0.424 . . . . 99.989999999999995 111.327 167.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 HH21 ' HB1' ' A' ' 53' ' ' ALA . 11.6 ptp180 -71.84 -46.46 57.98 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.655 2.465 . . . . 99.989999999999995 117.655 -173.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -100.41 -30.69 11.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.632 1.573 . . . . 99.989999999999995 112.609 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -94.65 -30.83 14.12 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.211 1.189 . . . . 99.989999999999995 114.211 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.9 12.72 2.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.275 2.23 . . . . 99.989999999999995 115.998 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -116.39 12.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 121.172 0.511 . . . . 99.989999999999995 111.867 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 6.99 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 119.846 3.276 . . . . 99.989999999999995 119.846 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -121.31 87.18 44.38 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 114.364 1.246 . . . . 99.989999999999995 114.364 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.65 154.78 72.29 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 123.02 2.48 . . . . 99.989999999999995 111.214 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt 66.53 -44.45 0.42 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.639 1.976 . . . . 99.989999999999995 114.332 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.59 -61.11 2.52 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.406 0.682 . . . . 99.989999999999995 112.776 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.57 -8.93 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 116.591 2.071 . . . . 99.989999999999995 116.591 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.72 -24.49 12.93 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.306 1.443 . . . . 99.989999999999995 114.871 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -117.91 -40.92 2.94 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.261 1.208 . . . . 99.989999999999995 114.261 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.41 -49.12 14.09 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.609 0.764 . . . . 99.989999999999995 112.801 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -121.43 59.18 8.86 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 115.108 1.521 . . . . 99.989999999999995 115.108 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.35 19.18 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.335 3.357 . . . . 99.989999999999995 116.777 -170.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.7 p -120.86 137.36 54.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.869 -1.16 . . . . 99.989999999999995 107.869 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.333 0.5 OUTLIER -63.19 -20.99 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.719 1.007 . . . . 99.989999999999995 113.719 178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -52.55 -66.33 0.4 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.759 1.224 . . . . 99.989999999999995 109.567 165.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.98 85.79 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.165 -0.925 . . . . 99.989999999999995 113.173 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.5 mt -58.18 -44.75 88.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.313 0.645 . . . . 99.989999999999995 112.648 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.31 98.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.5 0.72 . . . . 99.989999999999995 112.34 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.35 -39.89 94.61 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.128 1.159 . . . . 99.989999999999995 114.128 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -71.44 -29.84 65.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.658 2.096 . . . . 99.989999999999995 116.658 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.275 33.4 m -116.83 -41.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.057 2.614 . . . . 99.989999999999995 118.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.408 ' C ' ' HG1' ' A' ' 83' ' ' THR . . . -99.62 57.27 1.01 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 123.335 1.54 . . . . 99.989999999999995 109.476 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 82' ' ' ALA . 92.1 m -165.46 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.128 -1.851 . . . . 99.989999999999995 109.205 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.508 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.2 -31.16 8.01 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.129 1.9 . . . . 99.989999999999995 116.129 174.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.969 1.47 . . . . 99.989999999999995 114.969 176.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 116.876 2.176 . . . . 99.989999999999995 116.876 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.11 -151.73 21.93 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 110.051 -1.22 . . . . 99.989999999999995 110.051 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 p -22.67 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 127.231 2.213 . . . . 99.989999999999995 116.444 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -115.64 -25.49 7.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.891 -1.959 . . . . 99.989999999999995 114.675 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.06 178.49 5.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.421 -0.809 . . . . 99.989999999999995 112.371 -170.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.11 72.01 0.3 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.243 1.817 . . . . 99.989999999999995 115.187 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -78.7 -75.43 0.23 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.381 -1.736 . . . . 99.989999999999995 112.946 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -121.54 -44.58 2.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.926 1.824 . . . . 99.989999999999995 115.926 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 t 48.94 82.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.444 1.898 . . . . 99.989999999999995 114.057 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.36 88.47 54.27 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 115.694 -0.684 . . . . 99.989999999999995 111.865 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.48 149.97 75.07 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 122.988 2.459 . . . . 0.0 112.642 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.35 -84.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.72 -1.127 . . . . 99.989999999999995 110.843 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -109.9 -178.02 3.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.606 0.762 . . . . 99.989999999999995 111.404 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.06 -45.54 43.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.849 1.055 . . . . 99.989999999999995 113.849 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.87 -58.79 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.06 0.944 . . . . 99.989999999999995 110.392 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 74' ' ' ILE . 52.5 mm-40 -51.08 -56.03 14.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.261 1.024 . . . . 99.989999999999995 112.604 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.84 -57.85 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.164 0.986 . . . . 99.989999999999995 113.537 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -66.51 -36.55 82.98 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.21 0.819 . . . . 99.989999999999995 113.21 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.83 -45.94 76.68 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 118.763 -0.637 . . . . 99.989999999999995 112.601 171.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.71 78.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.561 0.578 . . . . 99.989999999999995 112.561 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -56.57 -58.8 6.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.474 1.51 . . . . 99.989999999999995 111.229 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.268 2.6 pp -60.89 -38.39 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 118.319 -0.848 . . . . 99.989999999999995 112.81 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -55.85 -59.08 5.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.505 0.722 . . . . 99.989999999999995 112.266 172.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.43 -30.29 71.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.507 1.669 . . . . 99.989999999999995 115.507 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -75.9 -58.19 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.02 0.928 . . . . 99.989999999999995 112.335 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.09 -35.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.963 1.305 . . . . 99.989999999999995 112.557 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.33 -21.34 59.62 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.097 1.147 . . . . 99.989999999999995 114.097 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.51 72.1 0.29 Allowed Glycine 0 N--CA 1.476 1.333 0 N-CA-C 110.129 -1.188 . . . . 99.989999999999995 110.129 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.4 p 0.91 80.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 128.484 2.714 . . . . 99.989999999999995 116.187 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 m -119.74 -70.44 0.79 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.594 -2.094 . . . . 99.989999999999995 115.098 -172.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.75 101.98 1.51 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 110.975 -0.85 . . . . 99.989999999999995 110.975 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.6 pt -125.05 167.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.997 1.11 . . . . 99.989999999999995 113.997 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.37 157.91 53.48 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.283 -1.326 . . . . 99.989999999999995 112.911 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -57.01 -40.99 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.727 -0.737 . . . . 99.989999999999995 112.273 164.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.61 13.52 0.09 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.062 1.504 . . . . 99.989999999999995 115.062 162.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 50.76 -140.48 0.84 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.143 1.777 . . . . 99.989999999999995 110.348 -176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -115.77 22.67 12.89 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 111.05 154.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.255 53.1 p90 42.11 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 1 N-CA-C 122.135 4.124 . . . . 99.989999999999995 122.135 -178.523 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -112.8 -84.02 0.59 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.065 1.346 . . . . 99.989999999999995 112.335 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -48.24 -31.84 6.41 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 118.628 2.825 . . . . 99.989999999999995 118.628 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.42 -34.31 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.695 1.739 . . . . 99.989999999999995 115.695 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.97 75.2 Favored Glycine 0 N--CA 1.478 1.447 0 O-C-N 123.9 0.75 . . . . 99.989999999999995 113.029 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.98 127.08 0.01 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 117.319 1.688 . . . . 99.989999999999995 117.319 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 53.38 2.63 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.516 -2.342 . . . . 99.989999999999995 112.555 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -169.89 -152.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.052 1.741 . . . . 99.989999999999995 110.369 -174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.32 -22.13 2.64 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.333 1.975 . . . . 99.989999999999995 116.333 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.8 mptt -48.19 -62.1 1.65 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.917 1.287 . . . . 99.989999999999995 111.818 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.23 -45.66 44.89 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.445 1.646 . . . . 99.989999999999995 115.445 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 ptm -69.81 -41.34 75.14 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.082 1.512 . . . . 99.989999999999995 115.082 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.09 86.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.159 0.584 . . . . 99.989999999999995 112.06 171.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG12 HD12 ' A' ' 68' ' ' LEU . 6.0 t -67.82 -43.75 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.806 -0.634 . . . . 99.989999999999995 110.576 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.39 -42.58 64.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.552 0.615 . . . . 99.989999999999995 112.385 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.73 68.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.883 1.068 . . . . 99.989999999999995 113.883 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -66.68 -38.58 87.09 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.094 1.146 . . . . 99.989999999999995 114.094 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.83 -27.31 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.657 1.183 . . . . 99.989999999999995 112.254 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -70.34 -61.46 1.76 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.385 0.274 . . . . 99.989999999999995 111.445 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.38 -42.05 93.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.22 2.304 . . . . 99.989999999999995 117.22 -173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -107.15 -32.74 7.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.868 1.267 . . . . 99.989999999999995 113.076 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -94.69 -20.58 19.42 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.407 1.262 . . . . 99.989999999999995 114.407 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 61.96 -47.69 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.17 2.285 . . . . 99.989999999999995 117.17 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.68 28.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 N-CA-C 116.598 2.073 . . . . 99.989999999999995 116.598 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -9.9 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.457 3.132 . . . . 99.989999999999995 119.457 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -123.44 82.69 52.97 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 115.411 1.634 . . . . 99.989999999999995 115.411 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.11 148.39 85.24 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 123.401 2.734 . . . . 0.0 111.52 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.0 tt 63.31 -47.84 0.23 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.731 2.012 . . . . 99.989999999999995 113.563 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -46.24 -66.82 0.35 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.068 1.747 . . . . 99.989999999999995 112.207 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.436 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -68.27 -4.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 115.376 1.621 . . . . 99.989999999999995 115.376 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD12 HG12 ' A' ' 51' ' ' VAL . 3.1 mm? -107.86 -31.45 8.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.235 1.569 . . . . 99.989999999999995 115.235 -175.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -107.8 -37.27 6.17 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.649 0.981 . . . . 99.989999999999995 113.649 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.78 -44.17 56.77 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.55 0.34 . . . . 99.989999999999995 111.856 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.1 pm0 -123.21 71.83 45.69 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 113.992 1.108 . . . . 99.989999999999995 113.992 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.57 38.33 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.567 3.511 . . . . 0.0 115.924 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 t -144.44 133.55 22.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.569 1.548 . . . . 99.989999999999995 110.59 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 16' ' ' GLU 0.277 0.4 OUTLIER -63.91 -23.11 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 114.878 -1.056 . . . . 99.989999999999995 113.544 178.878 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.59 -61.96 2.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.85 0.86 . . . . 99.989999999999995 110.131 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.6 76.23 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.81 -1.086 . . . . 99.989999999999995 113.707 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.3 mt -56.09 -47.46 77.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.79 0.436 . . . . 99.989999999999995 112.154 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.55 94.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.523 0.729 . . . . 99.989999999999995 112.866 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -61.03 -43.51 98.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.146 1.165 . . . . 99.989999999999995 114.146 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.15 -26.49 67.45 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.296 1.962 . . . . 99.989999999999995 116.296 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.329 7.2 m -114.98 -73.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.29 1.959 . . . . 99.989999999999995 116.29 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.81 64.48 0.67 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 123.471 1.605 . . . . 99.989999999999995 112.563 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 88.4 m -169.4 -53.53 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 129.075 2.95 . . . . 99.989999999999995 108.622 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.97 -28.91 6.5 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 117.708 2.484 . . . . 99.989999999999995 117.708 175.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.465 2.024 . . . . 99.989999999999995 116.465 -175.274 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 116.93 2.196 . . . . 99.989999999999995 116.93 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.95 -133.1 40.25 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 111.287 -0.725 . . . . 99.989999999999995 111.287 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.26 79.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 122.631 1.205 . . . . 99.989999999999995 113.223 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.7 t -95.88 -40.15 9.45 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.836 -1.984 . . . . 99.989999999999995 112.585 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 6' ' ' ALA . 7.9 pm0 -63.18 -76.32 0.07 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.784 1.634 . . . . 99.989999999999995 113.062 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -72.15 172.15 10.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.721 1.208 . . . . 99.989999999999995 112.957 164.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -169.54 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.739 1.616 . . . . 99.989999999999995 107.422 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -60.92 -64.03 1.1 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.286 1.587 . . . . 99.989999999999995 115.286 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t 57.55 82.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 126.49 1.916 . . . . 99.989999999999995 113.456 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.01 91.6 49.06 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-N 115.844 -0.616 . . . . 99.989999999999995 112.063 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.38 143.21 47.2 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.121 2.547 . . . . 0.0 113.696 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -106.02 -81.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 114.475 -1.239 . . . . 99.989999999999995 111.911 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -116.44 -174.36 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.932 0.716 . . . . 99.989999999999995 112.932 -170.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.91 -57.01 6.25 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 117.393 -1.289 . . . . 99.989999999999995 113.099 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.6 -52.41 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.323 1.049 . . . . 99.989999999999995 111.023 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -55.08 -60.32 3.53 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.661 0.986 . . . . 99.989999999999995 113.661 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 t -64.33 -43.68 93.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.003 0.815 . . . . 99.989999999999995 113.197 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -57.74 -57.03 14.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 99.989999999999995 110.659 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.35 -38.71 92.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.41 0.893 . . . . 99.989999999999995 113.41 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.99 90.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.734 0.642 . . . . 99.989999999999995 112.734 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.73 -50.82 71.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.734 1.214 . . . . 99.989999999999995 111.573 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -54.82 -54.24 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.962 0.905 . . . . 99.989999999999995 110.357 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -56.2 -52.45 64.36 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.312 -0.852 . . . . 99.989999999999995 113.015 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -60.75 -30.26 69.89 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.788 1.773 . . . . 99.989999999999995 115.788 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -74.26 -62.47 1.5 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.096 1.358 . . . . 99.989999999999995 111.065 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.2 -45.76 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.785 1.634 . . . . 99.989999999999995 113.412 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 tt -56.14 -25.61 46.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.086 1.754 . . . . 99.989999999999995 113.87 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.89 81.5 0.33 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.992 -1.643 . . . . 99.989999999999995 108.992 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 13.1 p -17.02 92.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.959 2.504 . . . . 99.989999999999995 116.197 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 p -149.86 -49.0 0.14 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 113.139 -1.846 . . . . 99.989999999999995 115.933 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.36 119.01 2.32 Favored Glycine 0 N--CA 1.481 1.664 0 O-C-N 123.695 0.622 . . . . 99.989999999999995 111.758 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.66 158.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 113.17 0.804 . . . . 99.989999999999995 113.17 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.17 152.23 24.32 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 113.758 -1.564 . . . . 99.989999999999995 112.695 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm -50.02 -40.32 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.318 1.047 . . . . 99.989999999999995 112.445 168.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -50.46 -34.4 24.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.583 1.553 . . . . 99.989999999999995 113.786 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.17 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.631 1.972 . . . . 99.989999999999995 113.356 -168.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.796 ' ND2' HE21 ' A' ' 40' ' ' GLN . 26.5 t-20 -57.17 -22.04 37.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.456 -1.247 . . . . 99.989999999999995 113.562 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.282 38.0 p90 60.42 -7.47 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 117.959 2.577 . . . . 99.989999999999995 117.959 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.8 -71.97 0.74 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.424 1.09 . . . . 99.989999999999995 112.261 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.796 HE21 ' ND2' ' A' ' 37' ' ' ASN . 25.8 pt20 -72.69 11.79 0.59 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.311 1.967 . . . . 99.989999999999995 116.311 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -51.48 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.915 0.709 . . . . 99.989999999999995 112.915 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.01 14.85 4.32 Favored Glycine 0 CA--C 1.541 1.709 0 O-C-N 124.288 0.993 . . . . 99.989999999999995 114.559 167.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.97 62.31 4.39 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.65 -0.58 . . . . 99.989999999999995 111.65 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -125.18 -130.22 0.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.747 -1.226 . . . . 99.989999999999995 108.473 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 p -110.01 -86.42 0.53 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.771 0.828 . . . . 99.989999999999995 111.273 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.89 -18.95 37.8 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.776 1.769 . . . . 99.989999999999995 115.776 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -56.1 -36.35 68.07 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.71 1.374 . . . . 99.989999999999995 114.71 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.97 74.15 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.278 0.473 . . . . 99.989999999999995 112.278 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.59 -48.2 67.51 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.906 1.282 . . . . 99.989999999999995 112.483 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.59 85.76 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.357 0.873 . . . . 99.989999999999995 113.357 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.26 -49.52 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.176 0.99 . . . . 99.989999999999995 110.225 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.52 -41.36 66.29 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.304 0.853 . . . . 99.989999999999995 113.304 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -54.52 43.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.363 1.065 . . . . 99.989999999999995 112.367 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.86 -43.63 90.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.338 1.055 . . . . 99.989999999999995 112.896 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 48.2 t -68.1 -25.58 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.81 1.244 . . . . 99.989999999999995 113.353 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -85.2 -27.01 26.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.26 1.207 . . . . 99.989999999999995 114.26 172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -97.64 -56.19 2.59 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 116.376 1.991 . . . . 99.989999999999995 116.376 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.25 -32.17 17.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.642 1.177 . . . . 99.989999999999995 112.315 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.3 m-85 -85.72 -33.18 21.55 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.897 1.073 . . . . 99.989999999999995 113.897 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 58.02 3.65 0.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.662 2.467 . . . . 99.989999999999995 117.662 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.16 10.99 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.021 1.489 . . . . 99.989999999999995 115.021 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 15.47 81.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 118.151 2.648 . . . . 99.989999999999995 118.151 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.4 pt? -128.39 77.59 76.89 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.626 1.343 . . . . 99.989999999999995 114.626 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.57 145.95 88.2 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 123.361 2.707 . . . . 0.0 111.987 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.281 3.0 pp 58.75 -39.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.843 2.457 . . . . 99.989999999999995 115.861 -170.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.8 -65.6 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.065 2.146 . . . . 99.989999999999995 110.517 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.541 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 3.0 p -61.94 -22.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 114.846 1.424 . . . . 99.989999999999995 114.846 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 tp -95.4 -26.88 15.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.803 1.641 . . . . 99.989999999999995 115.123 -166.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -114.88 -38.96 3.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.386 1.074 . . . . 99.989999999999995 113.603 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.35 49.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.6 0.592 . . . . 99.989999999999995 112.6 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -121.56 59.45 9.52 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 114.309 1.226 . . . . 99.989999999999995 114.309 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -75.63 24.32 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.953 3.769 . . . . 0.0 116.68 -168.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 t -126.0 138.85 53.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 99.989999999999995 110.159 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.258 0.4 OUTLIER -60.64 -27.39 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.357 0.873 . . . . 99.989999999999995 113.357 -178.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -55.16 -55.37 31.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.386 0.675 . . . . 99.989999999999995 110.855 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.19 75.88 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 99.989999999999995 113.422 175.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.1 mt -55.2 -46.34 75.9 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.535 0.734 . . . . 99.989999999999995 112.173 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.51 85.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.179 0.992 . . . . 99.989999999999995 112.317 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.79 -32.75 74.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.145 1.535 . . . . 99.989999999999995 115.145 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -69.47 -16.08 63.4 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.986 1.847 . . . . 99.989999999999995 115.986 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.274 15.6 m -117.72 -71.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.235 1.569 . . . . 99.989999999999995 115.235 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 61.11 3.16 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.797 1.761 . . . . 99.989999999999995 111.622 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.1 m -165.44 -57.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.616 2.367 . . . . 99.989999999999995 108.338 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.77 -27.88 7.98 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.962 2.208 . . . . 99.989999999999995 116.962 177.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.575 -1.679 . . . . 99.989999999999995 115.149 -174.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 116.044 1.868 . . . . 99.989999999999995 116.044 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.41 165.52 11.81 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.617 -1.174 . . . . 99.989999999999995 110.309 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t 69.13 140.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.268 1.427 . . . . 99.989999999999995 112.595 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.557 ' HG1' ' ND2' ' A' ' 37' ' ' ASN . 2.4 t -115.58 -45.31 2.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.353 -1.749 . . . . 99.989999999999995 112.784 174.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -59.75 179.54 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.028 1.331 . . . . 99.989999999999995 114.121 168.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.61 21.03 5.39 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.488 2.773 . . . . 99.989999999999995 118.488 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -38.76 -35.74 0.22 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 119.373 3.101 . . . . 99.989999999999995 119.373 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.8 t80 176.96 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.072 1.349 . . . . 99.989999999999995 110.697 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 t 65.72 93.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 127.092 2.157 . . . . 99.989999999999995 112.785 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.68 82.15 67.8 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 115.651 -0.704 . . . . 99.989999999999995 111.784 169.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 137.38 32.56 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.602 2.201 . . . . 0.0 112.539 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -76.37 0.55 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.185 -1.37 . . . . 99.989999999999995 111.612 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -118.84 -176.49 3.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.618 1.167 . . . . 99.989999999999995 112.582 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.11 54.25 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 99.989999999999995 113.889 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -57.08 -56.22 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.346 1.058 . . . . 99.989999999999995 110.022 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -48.96 -56.38 9.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 113.555 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 t -67.42 -55.04 15.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.158 0.983 . . . . 99.989999999999995 113.561 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -64.18 -38.67 91.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.854 0.862 . . . . 99.989999999999995 112.889 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.24 -45.83 83.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 118.473 -0.775 . . . . 99.989999999999995 112.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.75 76.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 112.693 0.627 . . . . 99.989999999999995 112.693 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -57.92 -58.88 6.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.211 1.404 . . . . 99.989999999999995 111.677 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 pp -61.5 -38.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.685 0.624 . . . . 99.989999999999995 112.685 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.06 -57.39 12.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 99.989999999999995 112.161 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.18 -31.55 71.3 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.569 1.322 . . . . 99.989999999999995 114.569 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -69.38 -62.0 1.56 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.752 1.282 . . . . 99.989999999999995 111.927 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.6 -37.88 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.576 1.551 . . . . 99.989999999999995 113.193 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.69 -25.5 60.39 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.377 1.071 . . . . 99.989999999999995 113.623 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.4 62.19 0.14 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.155 0.909 . . . . 99.989999999999995 111.587 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.262 10.3 p 16.67 67.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 127.888 2.475 . . . . 99.989999999999995 114.997 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 m -109.9 -49.86 3.04 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 112.372 -2.194 . . . . 99.989999999999995 116.667 -167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 92.07 2.21 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 111.216 -0.754 . . . . 99.989999999999995 111.216 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.66 159.23 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.978 1.103 . . . . 99.989999999999995 113.978 -170.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.24 153.3 41.15 Favored Glycine 0 N--CA 1.475 1.285 0 CA-C-N 113.889 -1.505 . . . . 99.989999999999995 113.34 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 mm -48.56 -40.99 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.753 1.221 . . . . 99.989999999999995 113.121 167.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.13 -14.09 33.51 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.705 1.602 . . . . 99.989999999999995 114.753 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.04 -158.8 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.097 2.159 . . . . 99.989999999999995 110.455 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' HG1' ' A' ' 4' ' ' THR . 22.8 t-20 -111.25 17.92 19.79 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.045 0.387 . . . . 99.989999999999995 112.045 171.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.3 p90 40.51 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 119.889 3.292 . . . . 99.989999999999995 119.889 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 37' ' ' ASN . 88.9 t80 -124.27 -85.91 0.64 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 99.989999999999995 111.605 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -71.81 33.22 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 119.441 3.126 . . . . 99.989999999999995 119.441 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.02 -40.26 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 115.731 -0.668 . . . . 99.989999999999995 111.948 172.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.64 -64.26 4.26 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.918 0.761 . . . . 99.989999999999995 112.966 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.55 100.05 0.14 Allowed Glycine 0 N--CA 1.476 1.361 0 CA-C-N 114.471 -0.865 . . . . 99.989999999999995 113.49 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.22 -36.91 85.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.34 0.656 . . . . 99.989999999999995 112.459 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -151.12 -90.4 0.06 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.398 1.479 . . . . 99.989999999999995 108.932 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.8 pt? -93.92 -11.0 31.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.837 2.162 . . . . 99.989999999999995 116.837 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -42.29 -37.21 1.45 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 116.336 1.976 . . . . 99.989999999999995 116.336 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.21 -38.69 41.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.136 1.161 . . . . 99.989999999999995 114.136 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 79.3 mtm -71.49 -45.37 62.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.294 0.85 . . . . 99.989999999999995 113.294 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.04 88.35 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.667 0.787 . . . . 99.989999999999995 112.385 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.27 -42.59 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.808 -0.633 . . . . 99.989999999999995 110.699 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -38.42 63.81 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.422 0.555 . . . . 99.989999999999995 112.406 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.56 -58.16 8.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.721 0.808 . . . . 99.989999999999995 112.525 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -63.55 -37.48 87.49 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.985 1.106 . . . . 99.989999999999995 113.985 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 94.3 t -66.03 -24.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.671 1.188 . . . . 99.989999999999995 112.93 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -87.18 -58.35 2.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.238 0.615 . . . . 99.989999999999995 112.272 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -68.78 -37.91 79.65 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 116.77 2.137 . . . . 99.989999999999995 116.77 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -106.64 -46.62 3.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.367 1.067 . . . . 99.989999999999995 111.759 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-85 -75.76 -32.49 59.98 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.653 1.353 . . . . 99.989999999999995 114.653 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . 0.25 94.6 mt-30 66.97 -31.49 0.17 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.753 2.501 . . . . 99.989999999999995 117.753 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.49 -30.3 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.176 1.39 . . . . 99.989999999999995 113.47 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 47.61 79.19 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.181 1.792 . . . . 99.989999999999995 115.368 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.19 83.32 12.45 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 115.827 1.788 . . . . 99.989999999999995 115.827 174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -63.87 152.82 79.01 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.132 2.555 . . . . 0.0 110.939 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 64' ' ' PRO 0.303 3.7 pp 60.65 -41.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.7 2.4 . . . . 99.989999999999995 116.724 -172.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -56.83 -67.01 0.35 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.89 1.276 . . . . 99.989999999999995 111.897 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.13 13.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.053 1.131 . . . . 99.989999999999995 114.053 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.3 mt -123.85 -35.54 2.85 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.789 2.144 . . . . 99.989999999999995 116.789 -170.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.89 -48.26 3.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.68 1.192 . . . . 99.989999999999995 110.979 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.42 76.02 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.784 0.661 . . . . 99.989999999999995 112.784 170.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -121.33 55.8 5.43 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.836 1.421 . . . . 99.989999999999995 114.836 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -76.32 24.54 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.387 3.391 . . . . 0.0 116.58 -167.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -132.94 141.11 48.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.092 1.357 . . . . 99.989999999999995 110.169 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER -62.99 -22.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 115.246 -0.888 . . . . 99.989999999999995 113.092 178.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -57.82 -52.0 67.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 110.793 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.43 74.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.211 1.005 . . . . 99.989999999999995 113.403 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.7 mt -56.02 -47.67 77.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.274 0.63 . . . . 99.989999999999995 111.897 172.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.33 98.73 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 99.989999999999995 112.705 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -54.59 -44.95 73.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.221 1.008 . . . . 99.989999999999995 112.796 171.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -71.31 -22.54 61.92 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.171 2.286 . . . . 99.989999999999995 117.171 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.28 11.6 m -108.42 -70.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.174 1.546 . . . . 99.989999999999995 115.174 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.18 60.0 3.52 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.416 1.579 . . . . 99.989999999999995 111.748 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 98.8 m -166.37 -60.56 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 128.202 2.601 . . . . 99.989999999999995 108.384 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -27.61 7.62 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.837 2.532 . . . . 99.989999999999995 117.837 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 116.226 1.936 . . . . 99.989999999999995 116.226 -174.641 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 115.865 1.802 . . . . 99.989999999999995 115.865 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.78 -83.04 1.63 Allowed Glycine 0 N--CA 1.477 1.379 0 CA-C-N 115.118 -0.946 . . . . 99.989999999999995 111.914 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 m -1.22 87.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 118.371 2.73 . . . . 99.989999999999995 118.371 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.5 -71.85 0.47 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 113.29 -1.777 . . . . 99.989999999999995 112.749 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.02 171.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.313 1.845 . . . . 99.989999999999995 114.978 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.94 35.13 11.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.893 2.077 . . . . 99.989999999999995 116.375 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -42.25 -46.73 4.58 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.632 2.086 . . . . 99.989999999999995 116.632 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.6 t80 172.88 -59.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.775 1.23 . . . . 99.989999999999995 112.463 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.319 5.4 p 56.56 98.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.864 2.465 . . . . 99.989999999999995 116.199 -175.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.21 84.81 34.92 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 114.736 -1.12 . . . . 99.989999999999995 111.982 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.08 153.15 78.6 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.151 2.567 . . . . 0.0 112.744 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.23 -82.41 0.57 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.581 -1.19 . . . . 99.989999999999995 110.938 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -113.2 -177.39 3.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.758 1.223 . . . . 99.989999999999995 112.034 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -55.74 10.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.411 1.084 . . . . 99.989999999999995 113.444 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.27 -51.29 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.232 1.013 . . . . 99.989999999999995 111.089 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 74' ' ' ILE . 43.2 mm-40 -50.93 -58.73 5.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.345 1.058 . . . . 99.989999999999995 112.581 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -67.94 -50.35 56.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.309 -0.86 . . . . 99.989999999999995 113.257 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -57.75 -50.38 73.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.194 1.397 . . . . 99.989999999999995 112.066 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.5 mm? -66.45 -43.79 84.6 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.43 -0.795 . . . . 99.989999999999995 112.747 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.96 83.82 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.689 0.626 . . . . 99.989999999999995 112.689 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -57.02 -60.28 3.82 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.745 1.618 . . . . 99.989999999999995 110.673 171.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 2.6 pp -60.51 -36.75 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 113.338 0.866 . . . . 99.989999999999995 113.338 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.95 -63.91 1.0 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.802 0.841 . . . . 99.989999999999995 111.552 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HB2' ' H ' ' A' ' 31' ' ' GLY . 17.9 pt-20 -61.44 -33.97 74.63 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.088 1.514 . . . . 99.989999999999995 115.088 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -67.71 -63.29 1.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.137 1.375 . . . . 99.989999999999995 111.717 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.29 -30.03 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.038 1.335 . . . . 99.989999999999995 112.469 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.88 -34.8 70.17 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.748 1.018 . . . . 99.989999999999995 113.748 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.24 61.96 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 111.557 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.255 7.4 p 17.7 62.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 128.615 2.766 . . . . 99.989999999999995 115.272 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -102.91 -47.36 4.4 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.121 -1.854 . . . . 99.989999999999995 115.473 -165.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' A' ' 24' ' ' GLU . . . 92.55 105.22 1.59 Allowed Glycine 0 N--CA 1.48 1.6 0 N-CA-C 110.698 -0.961 . . . . 99.989999999999995 110.698 -174.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 18.3 pt -120.28 -151.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 112.468 0.544 . . . . 99.989999999999995 112.468 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.89 160.41 18.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.602 -0.599 . . . . 99.989999999999995 111.602 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.18 -40.48 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.144 0.794 . . . . 99.989999999999995 113.144 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD22 ' HG1' ' A' ' 73' ' ' THR . 63.5 mt -67.96 -0.69 4.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.612 1.708 . . . . 99.989999999999995 115.612 170.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.95 -145.58 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.287 1.835 . . . . 99.989999999999995 111.6 -174.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -139.76 42.05 1.99 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.773 0.429 . . . . 99.989999999999995 111.835 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -6.01 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.427 2.291 . . . . 99.989999999999995 117.027 -169.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.4 t80 173.67 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 112.597 -2.092 . . . . 99.989999999999995 108.814 -171.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -70.83 19.33 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.285 3.068 . . . . 99.989999999999995 119.285 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -104.22 -40.55 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 112.831 0.678 . . . . 99.989999999999995 112.831 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.23 63.39 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.715 -0.675 . . . . 99.989999999999995 113.85 166.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.99 -162.71 26.55 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.445 -0.878 . . . . 99.989999999999995 111.413 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.594 ' HE2' ' HG ' ' A' ' 46' ' ' LEU . 9.6 p80 -70.8 -44.23 67.03 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.682 0.993 . . . . 99.989999999999995 113.682 175.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.5 p -174.83 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.317 1.969 . . . . 99.989999999999995 116.317 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.594 ' HG ' ' HE2' ' A' ' 44' ' ' HIS . 4.2 pp -61.2 -36.76 80.78 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.315 1.228 . . . . 99.989999999999995 114.315 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -58.87 -49.89 76.05 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 118.404 -0.808 . . . . 99.989999999999995 112.822 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -37.64 57.14 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.208 1.188 . . . . 99.989999999999995 114.208 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -63.12 -50.72 69.36 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.668 0.988 . . . . 99.989999999999995 113.668 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.548 0.739 . . . . 99.989999999999995 112.492 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 -50.49 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.746 1.218 . . . . 99.989999999999995 110.077 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.56 -42.9 67.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.221 0.608 . . . . 99.989999999999995 112.531 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB2' HH21 ' A' ' 57' ' ' ARG . . . -61.2 -51.51 68.7 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.2 1.185 . . . . 99.989999999999995 114.2 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -66.98 -38.6 86.35 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.477 1.288 . . . . 99.989999999999995 114.477 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 93.3 t -66.38 -30.01 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.088 . . . . 99.989999999999995 111.816 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -69.29 -68.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.827 0.451 . . . . 99.989999999999995 111.285 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.496 HH21 ' HB2' ' A' ' 53' ' ' ALA . 10.9 ptp180 -59.38 -42.52 91.88 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.744 2.128 . . . . 99.989999999999995 116.744 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.55 -38.93 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.16 0.8 . . . . 99.989999999999995 113.16 -170.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -78.02 -25.04 47.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.257 1.206 . . . . 99.989999999999995 114.257 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 69.92 -44.84 0.57 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.639 2.776 . . . . 99.989999999999995 114.998 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.03 27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 126.663 1.985 . . . . 99.989999999999995 116.14 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -8.93 77.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 120.335 3.457 . . . . 99.989999999999995 120.335 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -125.72 91.46 48.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 114.905 1.446 . . . . 99.989999999999995 114.905 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.42 152.03 81.83 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.986 2.457 . . . . 0.0 111.891 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tt 65.15 -42.29 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.068 2.147 . . . . 99.989999999999995 116.051 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -54.1 -71.69 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.328 0.862 . . . . 99.989999999999995 113.328 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.255 4.0 p -84.63 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 123.819 1.771 . . . . 99.989999999999995 110.464 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.6 tp -162.5 -49.76 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.765 -2.016 . . . . 99.989999999999995 112.402 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.63 -62.59 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.527 1.131 . . . . 99.989999999999995 111.566 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.31 78.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.307 0.643 . . . . 99.989999999999995 112.624 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -120.9 83.2 36.71 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 111.201 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -85.62 26.78 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.223 2.615 . . . . 0.0 114.776 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.405 ' HG1' HD22 ' A' ' 35' ' ' LEU . 2.8 t -136.21 136.08 39.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.033 0.533 . . . . 99.989999999999995 111.404 -171.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 16' ' ' GLU 0.264 0.4 OUTLIER -62.73 -22.34 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.701 -1.136 . . . . 99.989999999999995 112.911 177.268 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -58.52 -57.56 12.4 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.184 0.594 . . . . 99.989999999999995 110.097 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.51 81.07 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.906 1.076 . . . . 99.989999999999995 113.906 174.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.24 -46.12 89.33 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.585 0.354 . . . . 99.989999999999995 110.876 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.87 85.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.065 0.946 . . . . 99.989999999999995 112.844 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.521 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -59.39 -39.93 84.97 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.065 1.135 . . . . 99.989999999999995 114.065 169.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.81 -38.35 79.86 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.506 1.669 . . . . 99.989999999999995 115.506 172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.314 28.1 m -106.59 -57.18 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 117.115 2.265 . . . . 99.989999999999995 117.115 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' C ' ' HG1' ' A' ' 83' ' ' THR . . . -85.38 49.27 1.72 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 122.963 1.364 . . . . 99.989999999999995 111.369 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 86.5 m -161.38 -65.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.556 1.942 . . . . 99.989999999999995 109.212 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 -30.04 8.64 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 117.198 2.295 . . . . 99.989999999999995 117.198 174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.592 1.701 . . . . 99.989999999999995 115.592 174.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 114.579 1.326 . . . . 99.989999999999995 114.579 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.0 118.62 4.05 Favored Glycine 0 N--CA 1.478 1.454 0 CA-C-N 115.062 -0.972 . . . . 99.989999999999995 110.845 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.22 92.81 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.645 0.736 . . . . 99.989999999999995 110.861 -173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 t -64.66 -34.35 78.08 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.784 -1.553 . . . . 99.989999999999995 113.178 170.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.0 -168.93 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.511 -1.677 . . . . 99.989999999999995 111.884 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.0 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.831 2.052 . . . . 99.989999999999995 111.423 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.314 5.1 pt20 46.82 -45.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 120.856 3.651 . . . . 99.989999999999995 120.856 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -175.32 -67.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.935 1.694 . . . . 99.989999999999995 111.757 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.15 84.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 126.573 1.949 . . . . 99.989999999999995 112.406 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 88.93 30.19 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 115.131 -0.94 . . . . 99.989999999999995 111.005 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.64 146.96 75.14 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.875 2.384 . . . . 0.0 112.17 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 -79.85 0.5 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.376 -1.284 . . . . 99.989999999999995 110.297 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -116.51 178.23 4.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.046 0.938 . . . . 99.989999999999995 111.304 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.24 37.06 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.84 1.052 . . . . 99.989999999999995 113.84 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.88 -60.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.879 1.272 . . . . 99.989999999999995 110.586 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -53.08 -49.85 65.57 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.136 0.974 . . . . 99.989999999999995 112.941 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -61.68 -55.6 28.67 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.071 0.949 . . . . 99.989999999999995 113.165 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.24 -44.12 97.77 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.053 0.941 . . . . 99.989999999999995 112.242 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.63 -47.55 80.88 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.278 0.844 . . . . 99.989999999999995 113.278 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.17 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.124 0.416 . . . . 99.989999999999995 112.124 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -57.84 -58.08 9.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.92 1.288 . . . . 99.989999999999995 111.942 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 pt -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.043 0.757 . . . . 99.989999999999995 113.043 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -59.4 -46.55 88.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.907 1.077 . . . . 99.989999999999995 113.907 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.8 -26.83 67.87 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.055 1.502 . . . . 99.989999999999995 115.055 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -46.42 20.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.314 1.045 . . . . 99.989999999999995 111.42 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.48 -42.4 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.683 1.593 . . . . 99.989999999999995 112.173 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.77 -25.14 39.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.713 1.205 . . . . 99.989999999999995 114.096 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.63 87.13 1.46 Allowed Glycine 0 CA--C 1.531 1.074 0 N-CA-C 106.804 -2.518 . . . . 99.989999999999995 106.804 -166.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -18.15 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 127.288 2.235 . . . . 99.989999999999995 115.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 p -140.96 -52.44 0.47 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 112.77 -2.014 . . . . 99.989999999999995 114.873 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 98.22 2.06 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 115.515 -0.766 . . . . 99.989999999999995 112.736 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.52 146.63 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.532 0.682 . . . . 99.989999999999995 111.732 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.22 164.27 47.61 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 113.732 -1.577 . . . . 99.989999999999995 112.758 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -50.42 -34.57 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 113.36 -1.42 . . . . 99.989999999999995 112.598 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.87 -23.89 67.37 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.846 1.424 . . . . 99.989999999999995 114.846 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.23 -175.3 0.15 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.247 1.819 . . . . 99.989999999999995 111.323 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -96.06 14.15 24.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.925 1.083 . . . . 99.989999999999995 113.925 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 p90 32.36 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.291 2.33 . . . . 99.989999999999995 117.291 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -162.58 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.458 -1.701 . . . . 99.989999999999995 109.83 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.06 43.17 0.35 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.982 2.216 . . . . 99.989999999999995 116.982 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 -43.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.803 -1.09 . . . . 99.989999999999995 111.128 170.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.32 -51.43 43.51 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.521 -0.763 . . . . 99.989999999999995 114.214 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -174.23 102.14 0.17 Allowed Glycine 0 N--CA 1.476 1.331 0 O-C-N 124.526 0.78 . . . . 99.989999999999995 114.857 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -29.12 70.32 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.394 -0.903 . . . . 99.989999999999995 112.09 156.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.2 p 174.19 -93.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 130.723 3.609 . . . . 99.989999999999995 108.14 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -26.64 68.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.941 2.2 . . . . 99.989999999999995 116.941 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -39.5 -38.72 0.61 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.202 1.927 . . . . 99.989999999999995 116.202 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 -55.04 18.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.065 0.765 . . . . 99.989999999999995 113.065 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ptm -70.96 -41.19 71.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.277 1.214 . . . . 99.989999999999995 114.277 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.94 92.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.782 . . . . 99.989999999999995 112.989 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.8 -39.73 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 118.442 -0.789 . . . . 99.989999999999995 110.262 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.69 68.95 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.846 1.054 . . . . 99.989999999999995 113.846 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.37 -43.78 79.51 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.518 0.727 . . . . 99.989999999999995 112.871 173.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.37 -43.22 74.0 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.813 1.245 . . . . 99.989999999999995 112.372 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 57.0 t -58.41 -31.3 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.41 1.084 . . . . 99.989999999999995 111.33 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.49 -80.06 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.504 0.722 . . . . 99.989999999999995 111.378 165.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.9 -31.49 66.81 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 117.265 2.321 . . . . 99.989999999999995 117.265 -168.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -109.15 -37.41 5.8 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.148 0.979 . . . . 99.989999999999995 112.983 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.558 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 4.1 m-30 -94.72 -18.8 20.95 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.314 1.968 . . . . 99.989999999999995 116.314 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 68.63 -39.03 0.4 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.239 2.616 . . . . 99.989999999999995 115.722 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.84 -23.49 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 125.072 1.349 . . . . 99.989999999999995 113.712 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 50.57 23.22 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 121.271 3.804 . . . . 99.989999999999995 121.271 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.1 104.93 51.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.034 1.864 . . . . 99.989999999999995 116.034 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.73 152.63 79.66 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 123.509 2.806 . . . . 0.0 112.132 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt 63.81 -56.65 0.21 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.7 2.0 . . . . 99.989999999999995 114.241 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.12 -64.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.431 1.493 . . . . 99.989999999999995 113.082 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 4.7 p -60.94 -29.57 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 114.562 1.319 . . . . 99.989999999999995 114.562 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.51 -24.24 34.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.006 1.854 . . . . 99.989999999999995 116.006 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -109.33 -37.51 5.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.948 1.462 . . . . 99.989999999999995 114.948 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.75 77.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.726 0.41 . . . . 99.989999999999995 111.655 173.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.4 pm0 -123.62 73.06 52.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 115.651 -0.704 . . . . 99.989999999999995 112.063 168.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.71 24.63 0.37 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.62 3.547 . . . . 0.0 117.158 -170.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t -135.2 137.0 42.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.105 1.362 . . . . 99.989999999999995 110.697 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -26.3 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.657 -1.156 . . . . 99.989999999999995 112.56 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -58.61 -50.03 75.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.844 0.458 . . . . 99.989999999999995 110.962 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.91 68.48 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.03 0.752 . . . . 99.989999999999995 113.03 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.32 -43.16 78.71 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.955 0.902 . . . . 99.989999999999995 113.201 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.7 79.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 99.989999999999995 112.42 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.61 -37.41 84.82 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.195 1.183 . . . . 99.989999999999995 114.195 174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -60.91 -17.85 53.33 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.734 1.753 . . . . 99.989999999999995 115.734 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.267 16.5 m -110.75 -73.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.901 1.075 . . . . 99.989999999999995 113.901 170.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.92 74.54 6.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.392 1.568 . . . . 99.989999999999995 111.353 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.0 m -173.27 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 129.409 3.084 . . . . 99.989999999999995 107.341 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.69 -30.18 6.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.09 2.255 . . . . 99.989999999999995 117.09 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 116.148 1.907 . . . . 99.989999999999995 116.148 -177.388 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.421 1.267 . . . . 99.989999999999995 114.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.96 89.01 0.23 Allowed Glycine 0 N--CA 1.479 1.56 0 CA-C-N 114.42 -1.264 . . . . 99.989999999999995 113.255 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.61 138.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.783 0.801 . . . . 99.989999999999995 111.993 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -133.96 -56.85 0.87 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 113.358 -1.747 . . . . 99.989999999999995 111.686 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.18 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.817 1.647 . . . . 99.989999999999995 114.704 166.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.91 20.39 8.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.264 2.32 . . . . 99.989999999999995 117.264 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.43 -28.11 0.83 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 120.19 3.404 . . . . 99.989999999999995 120.19 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 t80 176.2 -70.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.326 1.45 . . . . 99.989999999999995 110.921 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 62.75 85.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 126.926 2.09 . . . . 99.989999999999995 113.009 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.11 90.61 48.93 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 115.418 -0.81 . . . . 99.989999999999995 112.563 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.71 156.72 44.28 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 123.341 2.694 . . . . 0.0 113.466 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.3 -83.35 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.558 -1.201 . . . . 99.989999999999995 112.056 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.86 -171.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.677 0.791 . . . . 99.989999999999995 112.457 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.79 -50.8 55.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.198 0.999 . . . . 99.989999999999995 113.467 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.7 -53.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.11 0.964 . . . . 99.989999999999995 110.235 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.72 -62.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 113.176 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -64.58 -51.45 62.71 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.881 1.067 . . . . 99.989999999999995 113.881 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -63.6 -45.73 89.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.584 0.754 . . . . 99.989999999999995 112.197 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.0 -39.3 90.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.431 0.9 . . . . 99.989999999999995 113.431 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.87 85.34 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.209 0.459 . . . . 99.989999999999995 112.054 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -57.33 -53.72 54.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.7 1.2 . . . . 99.989999999999995 111.068 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.2 mm -53.67 -53.46 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.34 1.056 . . . . 99.989999999999995 110.638 176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.439 ' HE1' HD13 ' A' ' 74' ' ' ILE . 21.3 m95 -54.28 -60.4 3.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.266 1.027 . . . . 99.989999999999995 112.779 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -58.66 -31.98 68.67 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.221 1.563 . . . . 99.989999999999995 115.221 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -69.87 -63.81 1.01 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 99.989999999999995 111.376 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.85 -36.45 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.149 1.38 . . . . 99.989999999999995 112.801 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.4 tt -56.92 -24.5 52.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.666 1.586 . . . . 99.989999999999995 113.956 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.19 71.29 0.24 Allowed Glycine 0 N--CA 1.476 1.314 0 N-CA-C 110.336 -1.106 . . . . 99.989999999999995 110.336 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.271 12.2 p 3.52 78.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 128.475 2.71 . . . . 99.989999999999995 116.127 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.4 m -121.56 -67.61 0.95 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 112.597 -2.092 . . . . 99.989999999999995 116.284 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.71 95.76 1.37 Allowed Glycine 0 N--CA 1.479 1.56 0 N-CA-C 111.105 -0.798 . . . . 99.989999999999995 111.105 -175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 pt -121.58 159.28 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.526 -173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.65 151.57 29.41 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-N 114.132 -1.394 . . . . 99.989999999999995 112.214 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -45.49 -41.99 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.856 1.662 . . . . 99.989999999999995 112.892 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HA ' ' HG1' ' A' ' 73' ' ' THR . 3.9 mm? -59.49 -29.92 68.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.844 1.053 . . . . 99.989999999999995 113.844 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 62.97 149.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.123 2.169 . . . . 99.989999999999995 111.858 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.55 24.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.708 1.744 . . . . 99.989999999999995 115.708 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.9 p90 22.55 47.82 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 118.343 2.719 . . . . 99.989999999999995 118.343 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -160.12 -78.22 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.179 -1.828 . . . . 99.989999999999995 109.401 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -70.0 27.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 118.792 2.886 . . . . 99.989999999999995 118.792 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.78 -35.97 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.307 1.043 . . . . 99.989999999999995 111.698 172.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.26 -63.21 5.37 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 124.334 0.969 . . . . 99.989999999999995 113.398 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.77 121.64 0.01 OUTLIER Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.226 -1.487 . . . . 99.989999999999995 115.838 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.01 49.95 1.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.754 -1.723 . . . . 99.989999999999995 113.467 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -159.72 -154.04 0.38 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.502 1.921 . . . . 99.989999999999995 108.905 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -62.67 -0.87 0.7 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.732 2.123 . . . . 99.989999999999995 116.732 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -56.16 -61.61 2.27 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.352 1.061 . . . . 99.989999999999995 112.748 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.65 -36.31 24.31 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.619 1.34 . . . . 99.989999999999995 114.619 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.0 mmm -65.28 -52.3 55.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.598 1.159 . . . . 99.989999999999995 112.841 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.27 77.83 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.308 1.043 . . . . 99.989999999999995 112.668 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.81 -50.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.067 0.947 . . . . 99.989999999999995 110.177 171.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.97 -42.65 65.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.321 0.648 . . . . 99.989999999999995 112.566 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.46 -56.28 23.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.377 0.88 . . . . 99.989999999999995 113.377 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -65.68 -38.64 89.83 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.987 1.106 . . . . 99.989999999999995 113.987 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -66.55 -27.98 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.979 0.912 . . . . 99.989999999999995 111.951 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -71.14 -69.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.806 0.443 . . . . 99.989999999999995 111.222 166.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.23 2.678 . . . . 99.989999999999995 118.23 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.93 -44.01 3.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.999 0.92 . . . . 99.989999999999995 113.243 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.2 m-85 -82.62 -20.98 35.32 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.638 1.348 . . . . 99.989999999999995 114.638 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -46.67 0.62 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.658 2.783 . . . . 99.989999999999995 114.189 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.77 26.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 116.715 2.117 . . . . 99.989999999999995 116.715 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -6.72 76.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 120.29 3.441 . . . . 99.989999999999995 120.29 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -123.97 86.7 53.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 115.591 1.701 . . . . 99.989999999999995 115.591 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.24 150.8 84.64 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.17 2.58 . . . . 0.0 111.629 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 -48.73 0.35 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.605 1.962 . . . . 99.989999999999995 114.78 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -52.08 -69.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.616 1.566 . . . . 99.989999999999995 112.904 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.435 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -61.55 -20.46 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.344 1.239 . . . . 99.989999999999995 114.344 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 tp -93.44 -29.02 15.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.258 1.823 . . . . 99.989999999999995 114.633 -168.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -108.1 -40.33 5.24 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.607 1.163 . . . . 99.989999999999995 113.705 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.26 73.02 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.205 0.446 . . . . 99.989999999999995 112.205 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.0 pm0 -122.97 70.23 39.62 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 112.679 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.38 32.83 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.536 3.49 . . . . 0.0 115.097 -173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.45 ' HG1' ' HA ' ' A' ' 35' ' ' LEU . 8.6 t -139.03 137.51 36.35 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.856 1.262 . . . . 99.989999999999995 111.125 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.439 HD13 ' HE1' ' A' ' 23' ' ' TRP 0.306 3.2 mm -57.86 -27.94 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 115.085 1.513 . . . . 99.989999999999995 115.085 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -66.19 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.991 0.807 . . . . 99.989999999999995 110.169 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.5 78.5 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.097 1.147 . . . . 99.989999999999995 114.097 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.2 -44.39 88.09 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.503 0.557 . . . . 99.989999999999995 112.503 171.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.16 93.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.745 0.818 . . . . 99.989999999999995 112.653 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.454 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.3 mp0 -60.83 -46.28 91.16 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.157 1.169 . . . . 99.989999999999995 114.157 171.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -65.46 -26.97 68.18 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.322 1.971 . . . . 99.989999999999995 116.322 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.316 9.5 m -112.07 -75.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 115.192 1.553 . . . . 99.989999999999995 115.192 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 60.56 1.25 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.351 1.548 . . . . 99.989999999999995 113.428 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.4 m -161.69 -54.16 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.629 2.372 . . . . 99.989999999999995 109.05 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -106.03 -31.97 8.5 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.371 1.989 . . . . 99.989999999999995 116.371 173.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 127.353 2.261 . . . . 99.989999999999995 116.436 -178.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 116.505 2.039 . . . . 99.989999999999995 116.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.01 79.83 0.21 Allowed Glycine 0 N--CA 1.478 1.49 0 CA-C-N 114.409 -1.269 . . . . 99.989999999999995 113.708 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.81 129.64 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.453 -0.873 . . . . 99.989999999999995 110.424 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.9 t -125.46 -30.36 3.12 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.635 -1.62 . . . . 99.989999999999995 114.571 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -68.35 161.44 27.44 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.721 0.809 . . . . 99.989999999999995 111.18 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.71 147.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.276 1.83 . . . . 99.989999999999995 113.465 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.43 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.557 -1.201 . . . . 99.989999999999995 112.556 -173.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -118.25 -61.73 1.63 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.752 0.649 . . . . 99.989999999999995 112.752 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t 67.46 98.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 126.389 1.876 . . . . 99.989999999999995 111.553 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.58 78.86 38.06 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 115.529 -0.76 . . . . 99.989999999999995 112.018 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.56 145.68 77.16 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.665 2.244 . . . . 0.0 112.013 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.76 -87.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.604 -1.18 . . . . 99.989999999999995 111.046 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -105.26 -176.38 3.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.543 0.737 . . . . 99.989999999999995 111.646 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.49 -50.39 31.83 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.061 0.944 . . . . 99.989999999999995 113.119 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.91 -58.49 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.323 1.049 . . . . 99.989999999999995 110.504 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -49.28 -58.89 4.27 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.745 1.218 . . . . 99.989999999999995 113.277 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -67.97 -54.25 20.04 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.639 0.977 . . . . 99.989999999999995 113.639 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -64.89 -41.29 95.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.713 1.205 . . . . 99.989999999999995 113.291 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.95 -43.04 84.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 118.634 -0.698 . . . . 99.989999999999995 112.494 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.2 78.35 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.754 0.65 . . . . 99.989999999999995 112.754 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.92 -58.71 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.11 1.364 . . . . 99.989999999999995 111.452 171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 2.6 pp -61.35 -36.13 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 112.781 0.66 . . . . 99.989999999999995 112.781 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -57.47 -60.74 3.19 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.485 0.714 . . . . 99.989999999999995 111.996 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -59.13 -26.8 65.03 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.822 1.786 . . . . 99.989999999999995 115.822 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -73.23 -70.48 0.36 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.808 1.243 . . . . 99.989999999999995 112.289 167.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.82 -39.91 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 125.162 1.385 . . . . 99.989999999999995 113.024 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 tt -61.06 -25.89 67.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 99.989999999999995 114.914 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.38 0.05 OUTLIER Glycine 0 N--CA 1.478 1.463 0 O-C-N 124.106 0.879 . . . . 99.989999999999995 111.38 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -20.7 88.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.39 2.676 . . . . 99.989999999999995 116.625 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -149.68 -51.82 0.15 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.015 -1.902 . . . . 99.989999999999995 113.006 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.02 124.14 2.59 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.804 0.69 . . . . 99.989999999999995 112.463 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 pt -134.11 177.38 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.411 0.685 . . . . 99.989999999999995 110.884 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 150.88 17.27 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 114.563 -1.198 . . . . 99.989999999999995 112.762 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -28.23 -42.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.672 2.389 . . . . 99.989999999999995 114.463 164.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.428 ' O ' HG21 ' A' ' 73' ' ' THR . 6.4 mp -62.4 -34.17 76.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.991 1.716 . . . . 99.989999999999995 114.742 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.11 146.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.136 1.774 . . . . 99.989999999999995 113.171 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.45 25.92 0.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.479 1.289 . . . . 99.989999999999995 114.479 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.1 p90 21.1 49.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.446 2.758 . . . . 99.989999999999995 118.446 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -167.66 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.318 -1.31 . . . . 99.989999999999995 110.681 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.1 -14.49 17.08 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 118.987 2.958 . . . . 99.989999999999995 118.987 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -33.04 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 115.627 1.714 . . . . 99.989999999999995 115.627 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.47 12.57 15.98 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.743 0.652 . . . . 99.989999999999995 113.978 169.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 39.45 -155.68 0.03 OUTLIER Glycine 0 N--CA 1.48 1.574 0 C-N-CA 124.786 1.184 . . . . 99.989999999999995 114.759 -172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.39 52.14 1.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.332 -1.434 . . . . 99.989999999999995 110.7 171.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -171.49 -162.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.839 1.656 . . . . 99.989999999999995 112.02 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.82 -21.7 3.08 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 117.754 2.501 . . . . 99.989999999999995 117.754 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -52.58 -43.68 65.42 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.082 0.771 . . . . 99.989999999999995 113.082 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.17 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.676 0.991 . . . . 99.989999999999995 113.676 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.9 mtp -69.95 -45.65 66.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.763 1.225 . . . . 99.989999999999995 112.144 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.831 0.852 . . . . 99.989999999999995 112.536 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 20.7 t -67.27 -49.32 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 110.072 170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.3 -39.58 45.96 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.706 1.002 . . . . 99.989999999999995 113.706 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.9 -59.63 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.941 0.897 . . . . 99.989999999999995 112.339 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -63.52 -31.95 73.26 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.486 0.921 . . . . 99.989999999999995 113.486 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.671 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 76.1 t -62.24 -37.57 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.795 1.238 . . . . 99.989999999999995 112.748 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.4 -33.79 61.01 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.493 1.294 . . . . 99.989999999999995 114.493 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 -102.59 -37.65 7.86 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 118.357 2.725 . . . . 99.989999999999995 118.357 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -108.32 -35.35 6.55 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.777 0.831 . . . . 99.989999999999995 112.403 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.671 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.3 m-85 -80.12 -28.34 38.99 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.012 1.486 . . . . 99.989999999999995 115.012 173.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 68.25 -30.96 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.521 2.328 . . . . 99.989999999999995 115.18 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.59 -31.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 127.988 2.515 . . . . 99.989999999999995 115.785 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 66.87 141.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.326 1.85 . . . . 99.989999999999995 113.185 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.7 mt 65.22 154.75 0.12 Allowed Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 116.46 2.022 . . . . 99.989999999999995 116.46 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.51 -162.81 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.314 2.009 . . . . 0.0 111.476 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp 66.92 -51.15 0.47 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.712 2.005 . . . . 99.989999999999995 115.466 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -57.75 -85.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.779 1.632 . . . . 99.989999999999995 110.52 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.07 46.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.497 1.141 . . . . 99.989999999999995 113.885 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.3 mt -144.36 -50.34 0.29 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.508 -1.678 . . . . 99.989999999999995 114.839 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -109.84 -49.69 3.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 111.662 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.94 79.14 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.674 0.609 . . . . 99.989999999999995 111.563 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -116.9 87.28 21.65 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 115.598 -0.728 . . . . 99.989999999999995 109.73 167.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.98 -26.68 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.674 2.25 . . . . 0.0 114.653 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 44.0 p -80.5 138.0 36.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 99.989999999999995 109.97 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.255 0.4 OUTLIER -62.09 -23.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.993 -0.549 . . . . 99.989999999999995 111.913 172.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -59.6 -51.51 69.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.36 0.664 . . . . 99.989999999999995 111.818 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.59 95.02 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.057 0.391 . . . . 99.989999999999995 112.057 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 73' ' ' THR . 51.4 mt -57.97 -46.63 84.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.389 0.676 . . . . 99.989999999999995 112.254 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -45.33 85.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.609 1.164 . . . . 99.989999999999995 112.97 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.44 -31.91 71.56 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.07 1.507 . . . . 99.989999999999995 115.07 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -74.25 -22.36 59.36 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.236 1.939 . . . . 99.989999999999995 116.236 169.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.269 32.6 m -104.25 -73.97 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.793 1.034 . . . . 99.989999999999995 113.793 176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.5 61.21 6.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 123.894 1.807 . . . . 99.989999999999995 111.196 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.4 m -161.17 -56.43 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.278 -2.237 . . . . 99.989999999999995 108.461 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.22 -30.87 6.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.785 2.143 . . . . 99.989999999999995 116.785 175.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.595 1.702 . . . . 99.989999999999995 115.595 -175.095 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 116.02 1.859 . . . . 99.989999999999995 116.02 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.32 -168.92 16.33 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 114.578 -1.192 . . . . 99.989999999999995 111.874 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.37 139.22 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 114.308 -0.946 . . . . 99.989999999999995 111.289 -174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -96.07 -15.38 22.24 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.372 1.082 . . . . 99.989999999999995 113.886 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -106.88 173.55 6.27 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.029 1.331 . . . . 99.989999999999995 110.507 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.51 92.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.68 1.592 . . . . 99.989999999999995 113.786 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -98.97 -62.86 1.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.052 -1.886 . . . . 99.989999999999995 113.548 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -148.75 -60.57 0.23 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.857 1.263 . . . . 99.989999999999995 111.078 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 t 65.33 84.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.771 2.028 . . . . 99.989999999999995 112.598 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.65 85.02 61.4 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 115.003 -0.999 . . . . 99.989999999999995 110.988 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.97 143.68 61.28 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.779 2.319 . . . . 0.0 112.436 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -77.04 0.6 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.312 -1.313 . . . . 99.989999999999995 111.777 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -117.04 -172.85 2.29 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.563 1.145 . . . . 99.989999999999995 112.583 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.92 -63.29 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.71 1.204 . . . . 99.989999999999995 113.169 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.17 -47.17 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.401 1.081 . . . . 99.989999999999995 111.294 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.58 -63.54 1.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.72 1.208 . . . . 99.989999999999995 113.173 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 t -67.26 -45.44 76.63 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.278 0.844 . . . . 99.989999999999995 113.278 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.27 -54.11 50.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.003 1.321 . . . . 99.989999999999995 111.297 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.685 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.5 mm? -66.99 -36.81 82.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.64 0.978 . . . . 99.989999999999995 113.64 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.18 89.14 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.486 0.585 . . . . 99.989999999999995 112.437 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.36 -51.42 70.01 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.149 1.38 . . . . 99.989999999999995 111.278 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.85 -54.19 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.276 1.03 . . . . 99.989999999999995 110.517 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -55.29 -53.99 49.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.262 1.025 . . . . 99.989999999999995 113.51 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -61.51 -30.75 70.83 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.456 1.651 . . . . 99.989999999999995 115.456 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.75 -56.56 4.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.325 1.05 . . . . 99.989999999999995 111.93 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.0 -38.74 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 125.501 1.52 . . . . 99.989999999999995 113.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tt -59.81 -22.84 62.75 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.334 1.453 . . . . 99.989999999999995 113.585 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.85 74.74 0.3 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.079 -1.208 . . . . 99.989999999999995 110.079 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.272 13.0 p 0.78 81.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 128.32 2.648 . . . . 99.989999999999995 116.397 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 m -127.36 -80.32 0.59 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 112.579 -2.101 . . . . 99.989999999999995 115.17 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.88 102.37 0.67 Allowed Glycine 0 N--CA 1.479 1.523 0 N-CA-C 110.176 -1.17 . . . . 99.989999999999995 110.176 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.3 pt -125.05 166.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.355 0.872 . . . . 99.989999999999995 113.355 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.22 158.84 53.5 Favored Glycine 0 N--CA 1.477 1.397 0 CA-C-N 114.628 -1.169 . . . . 99.989999999999995 113.026 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.5 mm -52.9 -42.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 114.179 -1.01 . . . . 99.989999999999995 111.75 164.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.16 9.23 0.33 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.555 1.687 . . . . 99.989999999999995 115.555 166.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 55.64 -137.47 1.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.677 1.591 . . . . 99.989999999999995 109.562 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.728 HD21 ' NE2' ' A' ' 40' ' ' GLN . 54.9 t30 -123.41 28.85 6.87 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.836 0.454 . . . . 99.989999999999995 110.276 156.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.281 53.2 p90 35.73 -0.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 1 N-CA-C 123.402 4.593 . . . . 99.989999999999995 123.402 -174.905 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -115.34 -74.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.922 1.689 . . . . 99.989999999999995 111.276 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.728 ' NE2' HD21 ' A' ' 37' ' ' ASN . 14.3 pt20 -67.71 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.839 2.903 . . . . 99.989999999999995 118.839 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.44 -29.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.579 0.751 . . . . 99.989999999999995 112.434 171.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.51 -48.08 83.61 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 123.968 0.792 . . . . 99.989999999999995 113.349 170.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.93 99.32 0.01 OUTLIER Glycine 0 N--CA 1.478 1.46 0 O-C-N 125.1 1.118 . . . . 99.989999999999995 113.673 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -70.39 54.56 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.378 1.871 . . . . 99.989999999999995 114.747 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -165.3 -142.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.552 2.341 . . . . 99.989999999999995 108.078 -176.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.6 pt? -63.31 -18.36 63.54 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.319 1.6 . . . . 99.989999999999995 115.319 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.835 ' HZ3' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.56 -48.5 71.97 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.979 1.103 . . . . 99.989999999999995 113.979 -174.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.15 60.52 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.678 1.362 . . . . 99.989999999999995 114.678 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.5 mtm -69.94 -44.54 69.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.717 0.807 . . . . 99.989999999999995 112.952 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.83 79.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.472 0.709 . . . . 99.989999999999995 112.568 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -62.95 -50.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 109.865 170.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.46 -43.58 65.04 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.999 0.74 . . . . 99.989999999999995 112.999 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.37 46.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.277 1.031 . . . . 99.989999999999995 113.394 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -66.75 -37.06 83.87 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.867 1.062 . . . . 99.989999999999995 113.867 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 72.5 t -65.08 -25.22 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.373 1.069 . . . . 99.989999999999995 112.587 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.67 -54.59 5.27 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.331 0.863 . . . . 99.989999999999995 113.331 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -71.02 -37.7 72.61 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.961 2.208 . . . . 99.989999999999995 116.961 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -110.33 -31.43 7.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.933 1.293 . . . . 99.989999999999995 112.557 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.685 ' HH ' ' HG ' ' A' ' 19' ' ' LEU . 3.4 m-30 -102.84 -10.3 19.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.265 1.58 . . . . 99.989999999999995 115.265 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 62.05 -46.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 118.167 2.655 . . . . 99.989999999999995 118.167 -173.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 126.371 1.868 . . . . 99.989999999999995 115.81 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 52.54 28.23 5.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 120.428 3.492 . . . . 99.989999999999995 120.428 167.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.21 94.89 16.44 Favored Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 116.288 1.958 . . . . 99.989999999999995 116.288 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -66.13 151.01 84.76 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 123.709 2.94 . . . . 0.0 111.889 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.0 tt 63.88 -44.95 0.26 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.745 2.018 . . . . 99.989999999999995 114.087 -175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -51.85 -69.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.984 1.714 . . . . 99.989999999999995 111.555 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.46 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 3.6 p -76.46 22.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.931 1.086 . . . . 99.989999999999995 113.931 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.9 tp -130.94 -37.22 1.31 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 113.482 -169.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.31 -39.41 7.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.354 1.062 . . . . 99.989999999999995 113.797 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.42 90.22 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.525 0.565 . . . . 99.989999999999995 112.525 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.1 pm0 -124.87 73.12 63.91 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.53 1.132 . . . . 99.989999999999995 112.005 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -77.99 34.78 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.125 3.217 . . . . 0.0 114.754 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 t -142.02 131.95 24.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.847 1.659 . . . . 99.989999999999995 110.502 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.285 0.5 OUTLIER -63.8 -20.33 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.594 -1.184 . . . . 99.989999999999995 113.591 178.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.98 -56.63 19.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.17 0.588 . . . . 99.989999999999995 110.439 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.05 75.42 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.054 -0.975 . . . . 99.989999999999995 113.088 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.89 -45.51 90.05 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.076 0.769 . . . . 99.989999999999995 113.076 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.17 91.46 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 99.989999999999995 111.881 172.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -59.47 -45.08 92.67 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.42 0.688 . . . . 99.989999999999995 112.74 171.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.51 -28.63 67.99 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.165 2.283 . . . . 99.989999999999995 117.165 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.299 16.7 m -113.37 -68.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 114.992 1.478 . . . . 99.989999999999995 114.992 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 61.53 2.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 123.228 1.49 . . . . 99.989999999999995 112.203 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 99.7 m -164.81 -69.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.951 2.501 . . . . 99.989999999999995 108.084 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -29.08 13.7 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 116.125 1.898 . . . . 99.989999999999995 116.125 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 115.732 -2.08 . . . . 99.989999999999995 114.336 179.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 115.03 1.493 . . . . 99.989999999999995 115.03 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.89 -151.71 22.19 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.815 -1.084 . . . . 99.989999999999995 111.56 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.1 p -157.22 149.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 109.649 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 t -55.2 -38.1 67.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 117.246 2.313 . . . . 99.989999999999995 117.246 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -132.08 -73.01 0.52 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.881 1.808 . . . . 99.989999999999995 115.881 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.07 119.1 1.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.692 1.197 . . . . 99.989999999999995 114.045 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -122.77 -80.07 0.62 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.793 -1.549 . . . . 99.989999999999995 112.75 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -135.38 -64.29 0.65 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.051 1.13 . . . . 99.989999999999995 114.051 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t 72.15 98.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.814 2.045 . . . . 99.989999999999995 112.394 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.18 82.99 10.42 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 114.316 -1.311 . . . . 99.989999999999995 110.432 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.05 147.52 61.16 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 122.923 2.416 . . . . 0.0 112.674 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.01 -82.78 0.58 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.451 -1.249 . . . . 99.989999999999995 111.007 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -108.47 -177.36 3.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.718 0.807 . . . . 99.989999999999995 111.833 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.99 50.39 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.49 0.922 . . . . 99.989999999999995 113.49 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.09 -59.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.761 1.224 . . . . 99.989999999999995 110.357 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -49.08 -59.57 3.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.981 1.312 . . . . 99.989999999999995 113.439 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.6 t -64.84 -56.37 13.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.085 0.954 . . . . 99.989999999999995 113.252 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -67.14 -40.86 86.82 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.01 0.745 . . . . 99.989999999999995 113.01 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.08 -40.64 94.92 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.244 -0.884 . . . . 99.989999999999995 112.913 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.83 84.6 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.937 0.718 . . . . 99.989999999999995 112.937 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.17 -53.14 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.581 1.152 . . . . 99.989999999999995 111.186 170.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.87 -50.96 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.327 1.051 . . . . 99.989999999999995 110.663 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -52.67 -60.11 3.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.32 1.048 . . . . 99.989999999999995 112.335 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -60.13 -31.36 69.99 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.852 1.797 . . . . 99.989999999999995 115.852 -177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -61.54 1.94 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.928 1.291 . . . . 99.989999999999995 111.865 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.21 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.28 1.032 . . . . 99.989999999999995 112.669 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.541 ' HA ' ' HZ3' ' A' ' 47' ' ' LYS . 34.9 tp -62.3 -32.7 73.47 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.535 1.309 . . . . 99.989999999999995 114.535 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.67 56.44 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 112.94 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.276 12.1 p -0.74 75.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 128.914 2.885 . . . . 99.989999999999995 116.955 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 56.3 m -138.77 -48.0 0.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.056 -1.884 . . . . 99.989999999999995 114.589 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.05 112.14 1.9 Allowed Glycine 0 N--CA 1.477 1.406 0 O-C-N 123.714 0.634 . . . . 99.989999999999995 113.381 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 pp -108.72 173.73 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.623 -0.789 . . . . 99.989999999999995 111.58 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.46 153.17 19.61 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 114.517 -1.219 . . . . 99.989999999999995 110.839 174.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mm -40.97 -47.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.995 1.318 . . . . 99.989999999999995 113.803 171.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.08 -21.07 63.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.775 1.768 . . . . 99.989999999999995 115.775 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 58.98 157.46 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.603 1.961 . . . . 99.989999999999995 113.324 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.95 8.92 3.29 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.319 1.229 . . . . 99.989999999999995 114.319 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.6 p90 39.61 22.5 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 121.057 3.725 . . . . 99.989999999999995 121.057 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -118.59 -85.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 111.776 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -59.5 -16.62 25.61 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 119.025 2.972 . . . . 99.989999999999995 119.025 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -33.34 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 114.45 1.278 . . . . 99.989999999999995 114.45 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.78 -53.08 0.6 Allowed Glycine 0 N--CA 1.476 1.326 0 CA-C-N 115.04 -0.982 . . . . 99.989999999999995 113.344 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.32 -144.88 18.82 Favored Glycine 0 N--CA 1.478 1.485 0 O-C-N 124.506 0.768 . . . . 99.989999999999995 112.333 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -139.48 41.85 2.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.979 1.371 . . . . 99.989999999999995 112.991 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.3 m -130.62 -154.46 0.63 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.103 -1.408 . . . . 99.989999999999995 111.048 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -49.94 -33.08 16.45 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.524 1.305 . . . . 99.989999999999995 114.524 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HZ3' ' HA ' ' A' ' 27' ' ' LEU . 7.9 mmtp -46.51 -73.04 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.398 1.479 . . . . 99.989999999999995 112.766 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.74 4.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.074 1.509 . . . . 99.989999999999995 115.074 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.26 -53.56 35.45 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.23 1.196 . . . . 99.989999999999995 114.23 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.97 91.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.909 0.884 . . . . 99.989999999999995 112.227 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 t -66.87 -40.26 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 118.177 -0.916 . . . . 99.989999999999995 110.995 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.34 -45.71 72.74 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.934 0.788 . . . . 99.989999999999995 111.67 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.87 76.14 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.758 -0.655 . . . . 99.989999999999995 112.387 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -54.56 -51.91 63.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.426 1.49 . . . . 99.989999999999995 112.446 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 60.2 t -65.68 -29.58 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.416 1.486 . . . . 99.989999999999995 112.56 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -68.1 -72.16 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.114 0.566 . . . . 99.989999999999995 111.28 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -64.5 -41.38 96.47 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.015 2.598 . . . . 99.989999999999995 118.015 -173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.35 -29.07 10.99 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.699 0.999 . . . . 99.989999999999995 113.699 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.3 m-85 -94.62 -22.58 18.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.219 1.192 . . . . 99.989999999999995 114.219 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 64.26 -33.78 0.15 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.664 2.468 . . . . 99.989999999999995 117.664 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -18.83 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.774 1.23 . . . . 99.989999999999995 114.168 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 47.76 39.01 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.824 3.268 . . . . 99.989999999999995 119.824 170.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -122.47 99.52 42.52 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 115.657 1.725 . . . . 99.989999999999995 115.657 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -65.6 160.76 41.64 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.3 2.666 . . . . 0.0 111.902 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 tt 66.09 -47.57 0.42 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.971 2.108 . . . . 99.989999999999995 114.852 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -56.75 -55.59 32.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 118.618 -0.706 . . . . 99.989999999999995 111.417 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.8 t -68.21 4.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.156 1.539 . . . . 99.989999999999995 115.156 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 mt -119.2 -29.66 5.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.194 1.553 . . . . 99.989999999999995 115.194 -178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -112.16 -38.06 4.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.52 1.304 . . . . 99.989999999999995 114.52 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.89 -44.78 30.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.406 0.682 . . . . 99.989999999999995 112.244 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -119.31 67.0 9.06 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.412 0.893 . . . . 99.989999999999995 113.412 168.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.06 26.16 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.057 3.172 . . . . 0.0 115.802 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 t -137.96 136.05 36.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.988 1.315 . . . . 99.989999999999995 110.714 -171.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.271 0.4 OUTLIER -62.31 -23.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.589 -0.732 . . . . 99.989999999999995 112.905 178.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -54.87 -62.81 1.41 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.373 1.069 . . . . 99.989999999999995 110.258 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.45 -35.25 80.34 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.875 -1.057 . . . . 99.989999999999995 113.34 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.54 -45.35 85.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.064 0.394 . . . . 99.989999999999995 112.064 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.33 85.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 112.834 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -63.19 -47.75 81.24 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.615 0.968 . . . . 99.989999999999995 113.615 170.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.93 -25.41 68.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.982 1.845 . . . . 99.989999999999995 115.982 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.272 5.2 m -101.13 -81.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.31 1.226 . . . . 99.989999999999995 114.31 168.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.43 65.72 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.52 1.629 . . . . 99.989999999999995 112.404 -173.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.8 m -165.0 -50.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.155 2.582 . . . . 99.989999999999995 108.457 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.69 -30.7 5.72 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.256 2.317 . . . . 99.989999999999995 117.256 174.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 116.639 -1.648 . . . . 99.989999999999995 115.098 -174.096 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 115.092 1.515 . . . . 99.989999999999995 115.092 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.09 -149.72 44.71 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 115.466 -0.788 . . . . 99.989999999999995 111.523 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -156.02 164.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.845 1.258 . . . . 99.989999999999995 111.765 -174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 t -52.1 -31.27 29.91 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.649 1.722 . . . . 99.989999999999995 115.649 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -152.39 -169.71 3.43 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.718 0.807 . . . . 99.989999999999995 112.881 -172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.14 20.96 8.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 119.123 3.008 . . . . 99.989999999999995 119.123 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.94 -40.62 30.9 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.746 2.498 . . . . 99.989999999999995 117.746 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 t80 174.54 -68.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.089 0.956 . . . . 99.989999999999995 111.235 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 t 66.33 93.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 127.339 2.256 . . . . 99.989999999999995 112.222 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.72 82.59 59.77 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 115.332 -0.849 . . . . 99.989999999999995 111.361 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -68.66 150.45 74.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.894 2.396 . . . . 0.0 112.696 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 -81.04 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.413 -1.267 . . . . 99.989999999999995 110.932 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -113.95 -174.76 2.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 99.989999999999995 112.276 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.56 10.1 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.197 0.999 . . . . 99.989999999999995 113.24 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.26 -52.0 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.669 1.188 . . . . 99.989999999999995 110.954 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -51.02 -64.34 0.84 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.101 1.361 . . . . 99.989999999999995 113.495 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 t -66.91 -46.87 73.52 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.42 0.896 . . . . 99.989999999999995 113.42 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -60.76 -51.74 68.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.104 0.962 . . . . 99.989999999999995 111.053 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.98 -36.13 82.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.964 -1.017 . . . . 99.989999999999995 113.727 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.5 91.27 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.895 0.77 . . . . 99.989999999999995 112.587 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.07 -50.43 74.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.753 1.221 . . . . 99.989999999999995 111.344 170.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.4 mm -54.7 -52.17 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.088 0.955 . . . . 99.989999999999995 110.617 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -56.7 -54.83 41.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.346 1.058 . . . . 99.989999999999995 113.697 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.16 -28.27 66.44 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.469 1.655 . . . . 99.989999999999995 115.469 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -77.72 -61.53 1.96 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.794 1.638 . . . . 99.989999999999995 111.602 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.24 -39.62 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.517 1.927 . . . . 99.989999999999995 113.818 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.72 -24.22 61.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.385 1.474 . . . . 99.989999999999995 113.819 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.67 0.73 Allowed Glycine 0 N--CA 1.473 1.149 0 N-CA-C 108.358 -1.897 . . . . 99.989999999999995 108.358 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.25 13.1 p -22.52 95.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 127.404 2.282 . . . . 99.989999999999995 115.474 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.1 p -148.19 -58.8 0.24 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 112.608 -2.087 . . . . 99.989999999999995 114.505 -173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.69 95.58 0.88 Allowed Glycine 0 N--CA 1.48 1.594 0 O-C-N 123.824 0.702 . . . . 99.989999999999995 113.37 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 pt -107.57 166.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 121.441 0.639 . . . . 99.989999999999995 112.501 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.76 160.48 30.09 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.035 -1.439 . . . . 99.989999999999995 112.144 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -45.3 -51.34 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 125.319 1.448 . . . . 99.989999999999995 112.497 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.17 -27.66 69.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.412 1.485 . . . . 99.989999999999995 114.398 171.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 46.07 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.724 1.61 . . . . 99.989999999999995 114.26 -167.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -93.5 24.96 3.68 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.467 0.543 . . . . 99.989999999999995 112.467 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 34.15 43.07 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 118.744 2.868 . . . . 99.989999999999995 118.744 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -138.77 -82.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.426 -1.715 . . . . 99.989999999999995 110.426 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.39 36.77 0.06 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.912 2.56 . . . . 99.989999999999995 117.912 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.66 -42.46 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.407 0.521 . . . . 99.989999999999995 112.407 173.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.06 -48.45 59.81 Favored Glycine 0 N--CA 1.479 1.527 0 O-C-N 123.839 0.712 . . . . 99.989999999999995 114.457 171.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.33 115.13 0.01 OUTLIER Glycine 0 N--CA 1.478 1.454 0 O-C-N 125.171 1.159 . . . . 99.989999999999995 114.218 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -75.7 56.22 0.9 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 123.282 1.515 . . . . 99.989999999999995 112.725 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -169.73 -155.93 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.439 2.296 . . . . 99.989999999999995 109.438 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -53.98 -20.47 6.27 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.434 2.012 . . . . 99.989999999999995 116.434 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -55.42 -40.23 71.24 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.765 1.395 . . . . 99.989999999999995 114.765 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.06 -41.95 65.34 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.233 0.827 . . . . 99.989999999999995 113.233 170.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 mmt -68.53 -49.94 55.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.812 1.245 . . . . 99.989999999999995 112.367 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.87 81.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.183 0.993 . . . . 99.989999999999995 113.153 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 HG13 HD13 ' A' ' 68' ' ' LEU . 10.4 t -72.07 -42.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 118.756 -0.64 . . . . 99.989999999999995 110.725 173.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.65 -40.79 63.18 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.597 0.592 . . . . 99.989999999999995 112.597 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -58.7 6.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.005 0.922 . . . . 99.989999999999995 112.895 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -63.92 -36.72 84.89 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.157 1.169 . . . . 99.989999999999995 114.157 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 89.0 t -68.59 -24.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.311 1.044 . . . . 99.989999999999995 112.791 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -80.54 -57.54 3.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.454 0.539 . . . . 99.989999999999995 112.454 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -69.72 -39.26 76.94 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.088 2.255 . . . . 99.989999999999995 117.088 -174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -103.5 -45.83 4.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.165 0.986 . . . . 99.989999999999995 111.802 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.3 m-85 -76.95 -28.6 55.26 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.963 1.468 . . . . 99.989999999999995 114.963 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 57.77 19.41 5.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.154 2.65 . . . . 99.989999999999995 118.154 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.16 -29.64 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.773 0.657 . . . . 99.989999999999995 112.773 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 45.98 73.88 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.927 1.691 . . . . 99.989999999999995 115.173 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -126.53 81.01 68.91 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.274 1.212 . . . . 99.989999999999995 114.274 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -63.81 148.51 91.9 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.097 2.531 . . . . 0.0 111.07 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp 64.44 -50.74 0.3 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.651 1.98 . . . . 99.989999999999995 113.958 -172.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -51.29 -60.21 3.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.011 1.324 . . . . 99.989999999999995 113.01 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -63.96 -13.68 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 115.19 1.552 . . . . 99.989999999999995 115.19 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD13 HG13 ' A' ' 51' ' ' VAL . 2.8 mm? -102.68 -25.22 13.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.774 1.768 . . . . 99.989999999999995 115.774 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -111.17 -38.03 5.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.932 1.086 . . . . 99.989999999999995 113.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.83 -42.47 40.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.194 0.598 . . . . 99.989999999999995 112.085 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.5 pm0 -120.9 67.64 15.32 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 113.751 1.019 . . . . 99.989999999999995 113.751 169.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.16 50.33 3.46 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.81 3.674 . . . . 0.0 115.111 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 t -161.38 137.74 8.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.754 1.221 . . . . 99.989999999999995 110.656 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.272 0.4 OUTLIER -63.87 -22.24 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 114.969 -1.014 . . . . 99.989999999999995 112.9 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -57.43 -61.38 2.53 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.963 0.905 . . . . 99.989999999999995 109.984 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.46 78.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.643 -1.162 . . . . 99.989999999999995 113.677 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.66 -47.42 82.33 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.655 0.382 . . . . 99.989999999999995 111.971 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.07 99.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.924 0.89 . . . . 99.989999999999995 111.905 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.03 -40.31 80.55 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.505 1.298 . . . . 99.989999999999995 114.505 172.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.06 -29.86 69.76 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.065 1.876 . . . . 99.989999999999995 116.065 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.289 15.7 m -113.76 -60.54 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 117.759 2.503 . . . . 99.989999999999995 117.759 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.35 36.89 0.25 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.083 1.753 . . . . 99.989999999999995 114.574 -173.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -124.02 -49.33 1.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.389 1.876 . . . . 99.989999999999995 108.925 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -32.6 5.91 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.43 2.011 . . . . 99.989999999999995 116.43 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 116.42 2.008 . . . . 99.989999999999995 116.42 -171.76 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 99.989999999999995 113.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.25 -83.25 1.26 Allowed Glycine 0 N--CA 1.476 1.314 0 CA-C-N 114.091 -1.413 . . . . 99.989999999999995 109.797 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.02 144.06 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.656 -0.772 . . . . 99.989999999999995 112.661 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -125.04 -55.83 1.57 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.897 -1.501 . . . . 99.989999999999995 111.359 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -57.02 174.75 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.699 1.2 . . . . 99.989999999999995 113.019 164.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.097 1.759 . . . . 99.989999999999995 112.992 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -170.77 -118.9 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 112.814 -1.994 . . . . 99.989999999999995 107.344 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -50.77 -45.03 58.85 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.743 2.127 . . . . 99.989999999999995 116.743 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.304 9.2 p 2.43 56.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 120.776 3.621 . . . . 99.989999999999995 120.776 -170.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -113.98 102.64 55.0 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 115.312 -0.858 . . . . 99.989999999999995 111.536 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.28 -157.82 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.192 2.595 . . . . 0.0 112.559 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -159.07 -100.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.742 0.817 . . . . 99.989999999999995 109.123 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -76.3 167.54 21.67 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.908 1.283 . . . . 99.989999999999995 112.978 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.27 -48.06 24.84 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.132 1.16 . . . . 99.989999999999995 114.132 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.41 -60.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.325 1.05 . . . . 99.989999999999995 110.178 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' A' ' 74' ' ' ILE . 39.3 mt-10 -58.18 -45.34 87.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.365 1.246 . . . . 99.989999999999995 114.365 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -65.54 -55.81 15.74 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.621 0.768 . . . . 99.989999999999995 112.624 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.61 -43.61 98.53 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.432 1.093 . . . . 99.989999999999995 112.348 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.45 -46.52 85.84 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.033 0.753 . . . . 99.989999999999995 113.033 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.56 82.01 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.469 0.544 . . . . 99.989999999999995 112.469 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.7 -59.17 5.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.291 1.436 . . . . 99.989999999999995 111.498 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 pt -62.18 -35.75 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.021 0.749 . . . . 99.989999999999995 113.021 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -56.62 -59.09 5.51 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.598 -0.715 . . . . 99.989999999999995 112.424 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -61.25 -27.77 68.69 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.398 1.629 . . . . 99.989999999999995 115.398 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -64.3 0.89 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.582 1.153 . . . . 99.989999999999995 112.289 168.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.82 -37.68 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.921 1.689 . . . . 99.989999999999995 113.298 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.6 -23.58 59.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.337 1.455 . . . . 99.989999999999995 113.707 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.31 84.45 0.83 Allowed Glycine 0 N--CA 1.475 1.245 0 N-CA-C 108.444 -1.862 . . . . 99.989999999999995 108.444 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.266 13.9 p -16.16 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 127.77 2.428 . . . . 99.989999999999995 116.039 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.0 p -146.01 -74.11 0.22 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 112.81 -1.995 . . . . 99.989999999999995 115.0 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.04 111.14 0.91 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 114.736 0.654 . . . . 99.989999999999995 114.736 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 33' ' ' GLY . 11.1 pt -113.27 -82.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 114.985 1.476 . . . . 99.989999999999995 114.985 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' H ' HG13 ' A' ' 32' ' ' ILE . . . 120.95 -169.37 14.25 Favored Glycine 0 N--CA 1.479 1.535 0 C-N-CA 123.871 0.748 . . . . 99.989999999999995 112.753 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.71 -46.47 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 113.816 1.043 . . . . 99.989999999999995 113.816 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.61 -24.65 67.69 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.659 1.726 . . . . 99.989999999999995 115.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.39 -149.67 0.42 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.553 1.141 . . . . 99.989999999999995 109.014 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 39' ' ' PHE . 5.3 t-20 -115.43 13.02 16.42 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.635 0.606 . . . . 99.989999999999995 112.635 164.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.2 p90 41.23 14.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.852 2.908 . . . . 99.989999999999995 118.852 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 37' ' ' ASN . 79.5 t80 -135.77 -68.77 0.5 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.714 1.206 . . . . 99.989999999999995 112.417 177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -68.53 32.21 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 118.326 2.713 . . . . 99.989999999999995 118.326 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.44 -37.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.386 1.074 . . . . 99.989999999999995 112.932 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.68 -44.96 14.03 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 115.765 -0.652 . . . . 99.989999999999995 113.343 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.46 -179.2 2.77 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 122.278 0.932 . . . . 99.989999999999995 113.286 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.82 56.57 1.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.67 1.224 . . . . 99.989999999999995 111.641 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -173.54 -159.4 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.199 1.8 . . . . 99.989999999999995 111.063 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.3 -20.69 4.55 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 117.116 2.265 . . . . 99.989999999999995 117.116 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -45.94 -59.8 2.62 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.356 1.062 . . . . 99.989999999999995 113.285 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.23 -37.77 56.14 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.795 1.405 . . . . 99.989999999999995 114.795 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.8 mmm -65.34 -50.05 67.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.431 1.092 . . . . 99.989999999999995 112.326 175.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.34 82.04 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.432 1.093 . . . . 99.989999999999995 112.573 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.98 -47.09 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 118.698 -0.667 . . . . 99.989999999999995 110.537 171.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.94 66.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 118.356 0.525 . . . . 99.989999999999995 112.402 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -56.1 26.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.129 0.972 . . . . 99.989999999999995 113.239 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.44 -37.99 89.46 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.932 1.086 . . . . 99.989999999999995 113.932 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.96 -37.36 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.951 0.9 . . . . 99.989999999999995 111.629 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -63.0 -44.2 96.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.057 0.762 . . . . 99.989999999999995 113.057 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -86.5 -44.44 11.96 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.125 2.269 . . . . 99.989999999999995 117.125 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.87 -28.99 13.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.01 1.324 . . . . 99.989999999999995 112.911 -173.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -97.99 -22.81 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.429 1.27 . . . . 99.989999999999995 114.429 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -48.56 0.41 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.568 2.747 . . . . 99.989999999999995 115.025 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.04 32.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.648 2.379 . . . . 99.989999999999995 116.897 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -10.08 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 119.718 3.229 . . . . 99.989999999999995 119.718 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -122.11 85.09 46.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.433 1.642 . . . . 99.989999999999995 115.433 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.22 150.13 87.85 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.779 2.319 . . . . 0.0 111.105 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.0 tp 66.05 -49.83 0.41 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.021 2.128 . . . . 99.989999999999995 114.623 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.38 -58.79 5.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.353 1.061 . . . . 99.989999999999995 113.014 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -16.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.378 1.251 . . . . 99.989999999999995 114.378 178.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.5 mt -97.54 -25.39 15.17 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.854 1.798 . . . . 99.989999999999995 115.854 -174.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.08 -37.85 3.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.028 1.492 . . . . 99.989999999999995 115.028 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.91 -49.59 19.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.597 0.592 . . . . 99.989999999999995 112.597 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -128.72 52.7 9.56 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.912 2.189 . . . . 99.989999999999995 116.912 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -63.99 -23.59 67.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 116.214 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.5 p -68.03 132.6 47.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.348 0.659 . . . . 99.989999999999995 110.095 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 16' ' ' GLU 0.339 0.4 OUTLIER -61.27 -19.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 115.026 1.491 . . . . 99.989999999999995 115.026 -178.982 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -57.24 -63.84 1.09 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.864 0.866 . . . . 99.989999999999995 109.727 165.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.0 -37.93 89.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.996 -1.002 . . . . 99.989999999999995 113.332 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.9 mt -55.9 -46.72 78.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.139 0.576 . . . . 99.989999999999995 111.903 171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.82 -40.08 96.3 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.027 0.751 . . . . 99.989999999999995 113.027 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.5 mp0 -61.97 -43.39 98.95 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.708 1.003 . . . . 99.989999999999995 113.708 172.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.39 -25.37 67.99 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.756 1.761 . . . . 99.989999999999995 115.756 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.303 30.8 m -114.88 -65.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 116.852 2.167 . . . . 99.989999999999995 116.852 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' C ' ' HG1' ' A' ' 83' ' ' THR . . . -79.77 57.92 2.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 123.348 1.547 . . . . 99.989999999999995 111.545 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.2 m -165.65 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.86 2.464 . . . . 99.989999999999995 108.604 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.448 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -107.67 -30.9 8.32 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 116.857 2.169 . . . . 99.989999999999995 116.857 175.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 125.623 1.569 . . . . 99.989999999999995 115.072 176.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 116.519 2.044 . . . . 99.989999999999995 116.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.68 144.39 31.39 Favored Glycine 0 N--CA 1.478 1.446 0 CA-C-N 114.32 -1.309 . . . . 99.989999999999995 112.007 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.16 126.41 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.451 -0.875 . . . . 99.989999999999995 109.085 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 t -161.78 -72.47 0.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.321 -1.309 . . . . 99.989999999999995 111.603 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -119.79 -159.97 0.8 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.402 -0.817 . . . . 99.989999999999995 110.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.2 -153.35 0.55 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.947 0.499 . . . . 99.989999999999995 109.976 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -160.32 -45.27 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.187 0.995 . . . . 99.989999999999995 111.049 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -63.98 40.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.565 2.432 . . . . 99.989999999999995 117.565 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.82 89.17 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.131 0.967 . . . . 99.989999999999995 112.309 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.18 87.29 4.73 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 113.983 -1.462 . . . . 99.989999999999995 111.516 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.39 161.05 47.43 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.385 2.724 . . . . 0.0 112.975 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -78.52 0.58 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.292 -1.322 . . . . 99.989999999999995 110.824 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -114.58 -173.71 2.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 99.989999999999995 112.54 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -59.31 3.56 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 99.989999999999995 113.166 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.23 -50.97 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.61 1.164 . . . . 99.989999999999995 110.932 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -51.48 -59.75 3.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.723 1.209 . . . . 99.989999999999995 113.318 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -69.04 -45.42 70.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.734 1.012 . . . . 99.989999999999995 113.734 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -57.33 -53.66 55.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.381 1.472 . . . . 99.989999999999995 110.977 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -38.92 92.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.299 0.851 . . . . 99.989999999999995 113.299 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.29 85.14 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.787 0.662 . . . . 99.989999999999995 112.787 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.82 -49.97 75.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.55 1.14 . . . . 99.989999999999995 111.456 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.78 -53.88 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.16 0.984 . . . . 99.989999999999995 110.632 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -55.45 -53.12 60.22 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.17 0.988 . . . . 99.989999999999995 113.192 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.72 -33.12 72.42 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.141 1.534 . . . . 99.989999999999995 115.141 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -70.29 -58.94 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.43 1.081 . . . . 99.989999999999995 113.097 169.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.01 -40.18 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.025 1.33 . . . . 99.989999999999995 113.326 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.9 tt -60.96 -26.49 67.58 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.272 . . . . 99.989999999999995 113.986 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.55 73.47 0.12 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.489 -1.044 . . . . 99.989999999999995 110.489 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.278 12.7 p -2.12 80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.481 2.712 . . . . 99.989999999999995 116.933 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.4 m -134.14 -108.02 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.858 -1.974 . . . . 99.989999999999995 112.001 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.86 101.45 0.16 Allowed Glycine 0 N--CA 1.48 1.612 0 N-CA-C 111.244 -0.742 . . . . 99.989999999999995 111.244 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.79 -163.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 113.118 0.784 . . . . 99.989999999999995 113.118 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -131.09 161.4 23.53 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 110.548 -1.021 . . . . 99.989999999999995 110.548 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mm -55.54 -44.39 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.253 1.021 . . . . 99.989999999999995 111.777 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.3 tp -58.45 -29.61 66.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.606 1.162 . . . . 99.989999999999995 113.79 169.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 58.69 175.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.806 1.643 . . . . 99.989999999999995 112.389 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.61 1.61 45.29 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.257 0.836 . . . . 99.989999999999995 113.257 170.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.0 p90 49.8 0.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 120.086 3.365 . . . . 99.989999999999995 120.086 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -108.28 -84.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.913 1.285 . . . . 99.989999999999995 110.401 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -68.74 22.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.579 2.437 . . . . 99.989999999999995 117.579 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pp -98.56 -31.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.961 0.504 . . . . 99.989999999999995 111.418 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.71 -47.09 92.91 Favored Glycine 0 N--CA 1.479 1.53 0 O-C-N 124.152 0.908 . . . . 99.989999999999995 113.706 170.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.46 104.41 0.01 OUTLIER Glycine 0 N--CA 1.479 1.51 0 CA-C-N 114.361 -0.919 . . . . 99.989999999999995 115.279 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.88 58.13 0.64 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.738 1.615 . . . . 99.989999999999995 114.286 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 m -172.64 -154.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.25 2.22 . . . . 99.989999999999995 110.468 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.63 -18.27 1.69 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 116.776 2.139 . . . . 99.989999999999995 116.776 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 8.8 mptt -48.48 -47.5 38.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.343 1.057 . . . . 99.989999999999995 112.01 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.77 66.61 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.244 1.202 . . . . 99.989999999999995 114.244 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -71.66 -45.92 60.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.674 1.189 . . . . 99.989999999999995 112.74 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.78 78.22 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.743 0.817 . . . . 99.989999999999995 112.22 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.2 t -65.99 -48.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.267 1.027 . . . . 99.989999999999995 110.568 170.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.3 62.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.687 0.625 . . . . 99.989999999999995 112.687 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.36 -60.91 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.056 0.942 . . . . 99.989999999999995 112.937 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.7 -36.8 79.69 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.976 1.102 . . . . 99.989999999999995 113.976 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 88.3 t -68.11 -30.36 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 99.989999999999995 113.194 176.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -78.76 -55.31 5.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.113 0.565 . . . . 99.989999999999995 111.989 171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -76.35 -35.09 58.91 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.908 2.559 . . . . 99.989999999999995 117.908 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -111.27 -36.94 5.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.138 0.975 . . . . 99.989999999999995 112.84 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.8 m-85 -82.69 -28.73 30.39 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.297 1.221 . . . . 99.989999999999995 114.297 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 57.69 7.42 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 119.051 2.982 . . . . 99.989999999999995 119.051 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.31 -18.83 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 112.765 0.654 . . . . 99.989999999999995 112.765 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 50.38 58.58 5.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.017 1.858 . . . . 99.989999999999995 116.017 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.82 86.68 51.59 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 114.011 1.115 . . . . 99.989999999999995 114.011 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.21 151.1 86.81 Favored 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 123.098 2.532 . . . . 0.0 111.665 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 tp 67.75 -37.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.556 1.943 . . . . 99.989999999999995 115.26 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -55.37 -71.99 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.044 0.938 . . . . 99.989999999999995 111.213 173.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG12 HE22 ' A' ' 71' ' ' GLN . 22.5 m -76.47 58.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-O 123.162 1.458 . . . . 99.989999999999995 111.93 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.5 tp -168.35 -54.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.227 -1.806 . . . . 99.989999999999995 111.242 -171.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.7 -45.77 8.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.758 1.021 . . . . 99.989999999999995 113.758 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.74 88.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.979 0.511 . . . . 99.989999999999995 111.979 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.519 HE22 HG12 ' A' ' 67' ' ' VAL . 8.7 mp0 -115.2 81.09 7.78 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 115.647 -0.706 . . . . 99.989999999999995 110.074 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -82.08 36.92 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.113 2.542 . . . . 0.0 113.974 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -160.74 134.45 6.87 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.193 1.397 . . . . 99.989999999999995 110.728 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.273 0.5 OUTLIER -65.73 -22.92 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.283 -1.326 . . . . 99.989999999999995 113.842 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -59.52 -51.58 69.25 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.958 0.345 . . . . 99.989999999999995 110.973 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.03 83.97 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.058 0.762 . . . . 99.989999999999995 113.058 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.37 -44.3 88.79 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.685 0.994 . . . . 99.989999999999995 113.685 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.6 89.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.142 0.977 . . . . 99.989999999999995 112.159 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.29 -31.36 72.46 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.848 1.425 . . . . 99.989999999999995 114.848 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.22 -19.95 60.97 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.652 2.093 . . . . 99.989999999999995 116.652 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.275 14.0 m -114.87 -69.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.485 1.661 . . . . 99.989999999999995 115.485 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.75 61.25 4.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.656 1.693 . . . . 99.989999999999995 111.142 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.4 m -164.53 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.121 2.169 . . . . 99.989999999999995 108.286 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.466 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.52 -33.19 7.12 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.275 1.954 . . . . 99.989999999999995 116.275 176.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 116.947 2.203 . . . . 99.989999999999995 116.947 -177.277 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 115.979 1.844 . . . . 99.989999999999995 115.979 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.7 -72.4 0.48 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-N 114.234 -1.348 . . . . 99.989999999999995 112.438 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.61 133.98 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 115.033 1.494 . . . . 99.989999999999995 115.033 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 t -59.93 -37.39 79.38 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.573 -1.649 . . . . 99.989999999999995 113.511 165.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -69.9 166.74 18.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.393 1.077 . . . . 99.989999999999995 113.438 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.82 25.12 15.07 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 117.223 2.305 . . . . 99.989999999999995 117.223 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -46.67 -33.1 3.98 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.259 2.318 . . . . 99.989999999999995 117.259 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 t80 174.76 -70.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.843 1.657 . . . . 99.989999999999995 110.937 -173.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t 62.73 88.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 126.904 2.081 . . . . 99.989999999999995 112.286 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.6 88.91 35.79 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.506 -0.77 . . . . 99.989999999999995 112.054 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.09 152.29 80.24 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 123.209 2.606 . . . . 0.0 113.167 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.33 -85.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.542 -1.208 . . . . 99.989999999999995 110.713 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -108.93 -176.85 3.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.181 0.593 . . . . 99.989999999999995 111.265 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -53.65 14.29 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 113.141 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.53 -52.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.947 0.899 . . . . 99.989999999999995 111.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -51.8 -59.62 4.1 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.297 1.039 . . . . 99.989999999999995 112.336 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -66.27 -50.36 63.99 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.433 0.901 . . . . 99.989999999999995 113.433 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -63.92 -46.94 82.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.753 1.221 . . . . 99.989999999999995 112.034 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.09 -37.64 84.33 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.495 0.924 . . . . 99.989999999999995 113.495 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.4 89.82 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.725 0.639 . . . . 99.989999999999995 112.725 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -59.77 -50.68 72.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.848 1.259 . . . . 99.989999999999995 111.419 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.52 -50.52 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.861 0.864 . . . . 99.989999999999995 110.298 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' A' ' 23' ' ' TRP . 5.5 m95 -57.01 -54.91 41.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.941 1.089 . . . . 99.989999999999995 113.941 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -58.0 -30.21 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.186 1.55 . . . . 99.989999999999995 115.186 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -74.96 -60.24 2.38 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.781 1.301 . . . . 99.989999999999995 111.862 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.13 -37.14 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.762 1.625 . . . . 99.989999999999995 113.195 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.65 -19.66 41.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.85 1.66 . . . . 99.989999999999995 114.38 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.04 69.23 0.4 Allowed Glycine 0 N--CA 1.476 1.321 0 N-CA-C 110.179 -1.168 . . . . 99.989999999999995 110.179 -177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.269 12.3 p 3.85 78.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 128.402 2.681 . . . . 99.989999999999995 115.611 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -121.18 -49.17 2.19 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 112.67 -2.059 . . . . 99.989999999999995 115.289 -168.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.1 84.42 1.72 Allowed Glycine 0 N--CA 1.48 1.628 0 O-C-N 123.748 0.655 . . . . 99.989999999999995 112.331 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.4 pt -113.67 153.86 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.251 0.834 . . . . 99.989999999999995 113.251 -170.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.25 158.44 52.16 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 113.496 -1.683 . . . . 99.989999999999995 113.27 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.9 mm -45.45 -39.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.251 1.42 . . . . 99.989999999999995 112.261 166.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.6 tp -56.49 -31.77 64.36 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.92 1.688 . . . . 99.989999999999995 114.626 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 61.68 162.14 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.03 1.732 . . . . 99.989999999999995 111.627 -169.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 39' ' ' PHE . 59.7 t30 -68.04 4.25 1.29 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.543 0.942 . . . . 99.989999999999995 113.543 170.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.264 54.7 p90 48.96 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 119.767 3.247 . . . . 99.989999999999995 119.767 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 37' ' ' ASN . 90.7 t80 -109.11 -74.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.133 1.773 . . . . 99.989999999999995 112.558 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -73.08 33.58 0.07 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.567 2.432 . . . . 99.989999999999995 117.567 -175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.92 -37.4 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.192 0.812 . . . . 99.989999999999995 113.192 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.97 -30.48 4.8 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 115.319 -0.855 . . . . 99.989999999999995 113.274 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.43 -172.96 7.22 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-O 122.627 1.126 . . . . 99.989999999999995 113.849 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 53.9 0.88 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.911 -1.144 . . . . 99.989999999999995 111.862 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 m -173.49 -166.83 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.701 1.6 . . . . 99.989999999999995 112.39 -173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.64 -22.5 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 116.984 2.216 . . . . 99.989999999999995 116.984 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -42.34 -49.41 5.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.068 1.347 . . . . 99.989999999999995 112.07 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.57 71.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.795 1.238 . . . . 99.989999999999995 114.132 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -69.39 -45.7 68.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.215 1.006 . . . . 99.989999999999995 112.319 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.39 91.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.584 0.754 . . . . 99.989999999999995 111.889 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.96 -46.65 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.812 -0.631 . . . . 99.989999999999995 110.701 172.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.58 -42.52 64.59 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.147 1.165 . . . . 99.989999999999995 114.147 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -58.11 -48.26 80.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 99.989999999999995 112.28 174.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.38 -43.65 98.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 99.989999999999995 112.343 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.8 t -59.52 -34.58 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.153 1.381 . . . . 99.989999999999995 112.986 176.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -72.99 -39.55 65.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.924 1.083 . . . . 99.989999999999995 113.924 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.405 HH21 ' HB1' ' A' ' 53' ' ' ALA . 2.1 ptt180 -91.12 -53.31 4.42 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 116.882 2.179 . . . . 99.989999999999995 116.882 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.77 -29.01 22.65 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.457 1.503 . . . . 99.989999999999995 113.041 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 54.8 m-85 -103.23 -18.24 14.98 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.7 1.741 . . . . 99.989999999999995 115.7 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -38.95 0.13 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.811 2.444 . . . . 99.989999999999995 117.47 -174.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.29 -22.89 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 127.67 2.388 . . . . 99.989999999999995 115.476 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 59.74 152.33 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.862 2.465 . . . . 99.989999999999995 116.4 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt 65.9 150.26 0.12 Allowed Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 126.032 1.733 . . . . 99.989999999999995 115.47 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.1 172.93 10.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.036 1.824 . . . . 0.0 110.881 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 69' ' ' PHE . 8.0 tt 70.25 -40.28 0.46 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.188 1.795 . . . . 99.989999999999995 114.653 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -48.92 -92.36 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.054 2.141 . . . . 99.989999999999995 112.283 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 p -89.1 62.18 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 123.431 1.586 . . . . 99.989999999999995 109.304 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -157.51 -76.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 112.589 -2.096 . . . . 99.989999999999995 112.924 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.401 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 20.6 m-85 -77.82 -41.4 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.325 0.65 . . . . 99.989999999999995 112.508 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.22 73.18 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.599 0.963 . . . . 99.989999999999995 113.599 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.08 81.92 60.51 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 112.895 0.702 . . . . 99.989999999999995 112.895 166.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.22 30.56 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.641 2.894 . . . . 0.0 116.339 -172.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -139.93 131.85 27.7 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.397 1.479 . . . . 99.989999999999995 109.835 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.285 0.4 OUTLIER -63.64 -21.69 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.193 0.812 . . . . 99.989999999999995 113.193 -179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -57.24 -56.15 25.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.514 0.726 . . . . 99.989999999999995 110.495 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.07 73.55 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.134 0.79 . . . . 99.989999999999995 113.134 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.9 mt -54.4 -48.59 71.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.432 0.693 . . . . 99.989999999999995 112.533 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.96 96.54 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.284 0.846 . . . . 99.989999999999995 113.284 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -32.72 73.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.91 1.448 . . . . 99.989999999999995 114.91 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -71.64 -21.69 61.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.537 1.68 . . . . 99.989999999999995 115.537 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.281 29.8 m -110.27 -69.35 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.406 1.632 . . . . 99.989999999999995 115.406 177.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.41 56.12 3.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.599 1.666 . . . . 99.989999999999995 111.797 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 m -156.55 -61.41 0.1 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.882 -1.963 . . . . 99.989999999999995 108.843 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.54 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -102.27 -32.71 9.92 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.604 1.705 . . . . 99.989999999999995 115.604 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 116.201 1.926 . . . . 99.989999999999995 116.201 177.239 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 mtt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 116.192 1.923 . . . . 99.989999999999995 116.192 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.77 149.67 48.9 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 114.772 -1.103 . . . . 99.989999999999995 111.848 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.67 143.56 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.256 -1.016 . . . . 99.989999999999995 108.256 -174.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 t -57.43 -33.51 67.97 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.875 1.065 . . . . 99.989999999999995 113.875 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.98 151.14 37.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.056 1.342 . . . . 99.989999999999995 112.697 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.116 -1.402 . . . . 99.989999999999995 112.827 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -102.03 -40.0 7.05 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.589 -1.187 . . . . 99.989999999999995 113.761 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -67.75 42.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.901 2.556 . . . . 99.989999999999995 117.901 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.62 90.35 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 122.018 0.913 . . . . 99.989999999999995 112.071 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.03 87.53 7.21 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 114.228 -1.351 . . . . 99.989999999999995 111.916 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.07 144.84 38.51 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.081 2.521 . . . . 0.0 113.223 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -75.55 0.47 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.046 -1.434 . . . . 99.989999999999995 111.467 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -116.58 -172.97 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.061 0.945 . . . . 99.989999999999995 112.486 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.06 57.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.157 0.983 . . . . 99.989999999999995 113.468 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -55.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.025 0.93 . . . . 99.989999999999995 110.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -51.12 -57.48 8.6 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.34 1.056 . . . . 99.989999999999995 113.597 176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 t -65.1 -54.4 30.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.59 0.959 . . . . 99.989999999999995 113.59 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -60.96 -46.36 91.03 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.035 0.934 . . . . 99.989999999999995 111.705 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.6 mm? -64.86 -40.97 95.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 117.994 -1.003 . . . . 99.989999999999995 113.219 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.433 0.531 . . . . 99.989999999999995 112.433 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -59.64 -54.91 40.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.63 1.172 . . . . 99.989999999999995 111.545 170.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -52.83 -49.84 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.671 1.188 . . . . 99.989999999999995 110.593 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -53.71 -65.15 0.62 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.459 1.104 . . . . 99.989999999999995 111.907 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -57.45 -29.63 64.36 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.762 1.764 . . . . 99.989999999999995 115.762 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -72.63 -66.79 0.62 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.255 1.422 . . . . 99.989999999999995 111.919 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.31 -35.45 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.837 1.255 . . . . 99.989999999999995 113.342 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.51 -19.35 47.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.583 . . . . 99.989999999999995 114.089 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.37 71.9 0.2 Allowed Glycine 0 N--CA 1.476 1.364 0 C-N-CA 124.18 0.895 . . . . 99.989999999999995 111.099 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.7 p 0.65 82.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.502 2.721 . . . . 99.989999999999995 115.878 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 m -123.38 -81.62 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.193 -2.276 . . . . 99.989999999999995 114.863 -171.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.21 96.95 0.57 Allowed Glycine 0 N--CA 1.478 1.457 0 N-CA-C 109.56 -1.416 . . . . 99.989999999999995 109.56 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 pt -124.37 -177.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 114.608 -0.796 . . . . 99.989999999999995 112.312 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.41 166.11 12.15 Favored Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.552 -1.204 . . . . 99.989999999999995 112.906 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.3 mm -55.16 -45.27 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.092 1.357 . . . . 99.989999999999995 112.324 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.3 tp -61.21 -18.27 57.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.851 1.661 . . . . 99.989999999999995 114.408 171.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.21 -163.95 0.23 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.162 1.785 . . . . 99.989999999999995 110.412 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' ND2' HE22 ' A' ' 40' ' ' GLN . 51.8 t30 -108.63 22.94 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.188 0.518 . . . . 99.989999999999995 110.967 165.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.6 p90 36.5 16.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 121.565 3.913 . . . . 99.989999999999995 121.565 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -119.83 -76.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.029 0.932 . . . . 99.989999999999995 111.642 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.455 HE22 ' ND2' ' A' ' 37' ' ' ASN . 17.3 pm0 -73.66 31.61 0.08 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.366 2.358 . . . . 99.989999999999995 117.366 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -38.12 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.338 0.655 . . . . 99.989999999999995 112.251 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.54 -55.08 27.39 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.193 0.933 . . . . 99.989999999999995 113.359 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.87 114.22 0.01 OUTLIER Glycine 0 N--CA 1.478 1.447 0 O-C-N 125.348 1.263 . . . . 99.989999999999995 114.867 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -78.66 59.76 2.57 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.917 1.341 . . . . 99.989999999999995 112.543 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -174.96 -157.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.816 2.446 . . . . 99.989999999999995 110.358 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -54.2 -17.58 2.98 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.869 2.174 . . . . 99.989999999999995 116.869 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -46.1 -52.65 11.7 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.229 1.011 . . . . 99.989999999999995 113.06 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.11 -38.43 62.62 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.371 1.248 . . . . 99.989999999999995 114.371 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -68.98 -48.55 62.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.454 1.102 . . . . 99.989999999999995 112.674 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.7 84.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.895 0.878 . . . . 99.989999999999995 112.47 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -63.9 -50.21 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.133 0.973 . . . . 99.989999999999995 110.099 171.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.6 63.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.522 0.729 . . . . 99.989999999999995 112.912 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.03 -57.17 13.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.896 0.878 . . . . 99.989999999999995 112.878 173.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -66.16 -36.93 84.41 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.422 1.268 . . . . 99.989999999999995 114.422 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.434 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 61.3 t -64.44 -29.52 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.298 1.039 . . . . 99.989999999999995 112.304 174.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -79.85 -67.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.8 0.44 . . . . 99.989999999999995 111.598 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.493 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -65.61 -35.98 82.38 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.217 2.303 . . . . 99.989999999999995 117.217 -171.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -107.68 -34.28 7.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.568 0.747 . . . . 99.989999999999995 112.938 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.479 ' HH ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 m-30 -87.46 -25.73 23.6 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.799 1.407 . . . . 99.989999999999995 114.799 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 69.47 -43.61 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 129.049 2.94 . . . . 99.989999999999995 115.964 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.54 -21.25 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.531 2.419 . . . . 99.989999999999995 117.531 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 47.62 79.56 0.06 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.771 2.137 . . . . 99.989999999999995 116.771 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.69 83.71 29.18 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 114.082 1.142 . . . . 99.989999999999995 114.082 169.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -65.75 150.05 86.41 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.328 2.686 . . . . 0.0 111.952 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.2 tt 65.65 -41.58 0.34 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.812 2.045 . . . . 99.989999999999995 114.546 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -51.1 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.935 1.694 . . . . 99.989999999999995 112.183 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.69 64.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.514 1.626 . . . . 99.989999999999995 110.049 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.7 tp -163.48 -63.69 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 111.977 -2.374 . . . . 99.989999999999995 111.219 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -79.94 -57.47 3.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.46 1.104 . . . . 99.989999999999995 112.706 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.89 71.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.282 0.633 . . . . 99.989999999999995 112.696 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -123.01 82.09 50.79 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.247 1.019 . . . . 99.989999999999995 111.099 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -82.76 31.89 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.376 2.717 . . . . 0.0 115.143 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 t -148.31 135.75 20.53 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.239 1.015 . . . . 99.989999999999995 111.307 -171.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.279 0.4 OUTLIER -63.97 -23.54 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 114.775 -1.102 . . . . 99.989999999999995 113.467 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -52.94 -62.25 1.77 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.298 1.039 . . . . 99.989999999999995 110.485 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.37 80.51 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.821 -1.082 . . . . 99.989999999999995 113.912 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.25 -47.29 84.03 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.727 0.411 . . . . 99.989999999999995 110.934 173.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.03 92.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.41 1.084 . . . . 99.989999999999995 112.841 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -60.27 -36.63 78.24 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.623 1.342 . . . . 99.989999999999995 114.623 171.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -73.34 -39.84 64.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.457 1.651 . . . . 99.989999999999995 115.457 171.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.44 HG13 ' CD2' ' A' ' 59' ' ' TYR 0.251 26.2 m -105.95 -28.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 118.123 2.638 . . . . 99.989999999999995 118.123 -170.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.71 50.71 0.94 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.982 1.373 . . . . 99.989999999999995 109.834 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 90.6 m -162.27 -61.74 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.961 -1.472 . . . . 99.989999999999995 109.574 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.445 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.6 -33.18 7.1 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.502 1.668 . . . . 99.989999999999995 115.502 170.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 116.732 2.123 . . . . 99.989999999999995 116.732 171.131 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 114.506 1.298 . . . . 99.989999999999995 114.506 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.25 -178.57 39.52 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 115.283 -0.871 . . . . 99.989999999999995 111.914 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.04 146.44 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.583 0.753 . . . . 99.989999999999995 112.285 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.9 t -54.45 -46.17 73.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.167 1.914 . . . . 99.989999999999995 116.167 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 39.76 -153.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.401 1.63 . . . . 99.989999999999995 115.401 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.84 -135.04 0.06 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.331 1.452 . . . . 99.989999999999995 110.163 166.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -172.55 -66.74 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.569 1.547 . . . . 99.989999999999995 108.515 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -66.75 47.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.673 2.789 . . . . 99.989999999999995 117.117 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -96.13 87.24 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 122.346 1.069 . . . . 99.989999999999995 111.871 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 83.87 15.45 Favored Pre-proline 0 N--CA 1.477 0.893 0 CA-C-N 114.008 -1.451 . . . . 99.989999999999995 111.857 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -67.98 133.07 27.97 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.074 2.516 . . . . 99.989999999999995 113.401 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -78.49 -77.6 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.947 -1.479 . . . . 99.989999999999995 112.673 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.56 -174.46 2.57 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.339 1.055 . . . . 99.989999999999995 112.125 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -57.21 4.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.643 1.177 . . . . 99.989999999999995 113.388 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.81 -51.66 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.722 0.809 . . . . 99.989999999999995 111.813 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -52.06 -57.07 10.62 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.691 0.797 . . . . 99.989999999999995 112.504 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.2 -53.33 46.39 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.199 0.999 . . . . 99.989999999999995 113.501 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -55.6 -48.57 74.66 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 99.989999999999995 111.292 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.46 ' HG ' ' HH ' ' A' ' 59' ' ' TYR . 4.1 mm? -69.68 -44.21 70.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.156 -0.929 . . . . 99.989999999999995 113.28 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.44 78.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.297 0.48 . . . . 99.989999999999995 112.297 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -59.74 -59.64 5.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.306 1.442 . . . . 99.989999999999995 111.523 172.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 2.7 pp -61.12 -36.85 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.42 0.896 . . . . 99.989999999999995 113.42 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -59.75 -54.91 40.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.671 -0.68 . . . . 99.989999999999995 111.993 172.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.49 -29.85 69.33 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.229 1.566 . . . . 99.989999999999995 115.229 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -71.69 -66.84 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.682 1.593 . . . . 99.989999999999995 111.933 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.86 -34.3 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.219 1.808 . . . . 99.989999999999995 113.763 -172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.54 -24.82 49.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.598 1.159 . . . . 99.989999999999995 113.812 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.77 75.43 0.49 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 108.815 -1.714 . . . . 99.989999999999995 108.815 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.289 12.2 p -4.47 83.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 128.247 2.619 . . . . 99.989999999999995 116.208 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 m -116.7 -39.04 3.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.496 -2.138 . . . . 99.989999999999995 115.113 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.2 91.46 1.08 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.189 -1.164 . . . . 99.989999999999995 110.189 -169.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.09 -143.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.965 -0.618 . . . . 99.989999999999995 110.63 -174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.41 -150.58 5.65 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 122.747 1.193 . . . . 99.989999999999995 113.772 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.3 mt -93.99 -61.12 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 111.685 -2.258 . . . . 99.989999999999995 108.757 170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.31 -29.77 66.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.157 1.383 . . . . 99.989999999999995 113.34 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 58.33 -148.24 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.882 1.273 . . . . 99.989999999999995 109.517 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -99.49 13.9 31.74 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.64 0.587 . . . . 99.989999999999995 111.351 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.26 35.5 p90 41.23 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 121.636 3.939 . . . . 99.989999999999995 121.636 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -96.05 -79.69 0.44 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.889 1.276 . . . . 99.989999999999995 112.816 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -74.33 35.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 117.522 2.415 . . . . 99.989999999999995 117.522 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -112.83 -35.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 113.997 -1.456 . . . . 99.989999999999995 111.61 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.27 -54.66 35.47 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 123.876 0.735 . . . . 99.989999999999995 112.546 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.39 97.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.122 -1.039 . . . . 99.989999999999995 115.399 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -74.41 63.55 1.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.17 1.388 . . . . 99.989999999999995 112.809 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -171.79 -153.03 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.838 2.455 . . . . 99.989999999999995 109.635 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -51.79 -22.57 3.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.21 1.93 . . . . 99.989999999999995 116.21 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mmpm? -46.43 -48.55 18.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.76 -1.114 . . . . 99.989999999999995 113.814 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.27 65.3 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.702 1.001 . . . . 99.989999999999995 113.702 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.95 -51.48 54.67 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.595 1.158 . . . . 99.989999999999995 112.606 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.15 92.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 99.989999999999995 112.664 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.1 -47.12 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.329 1.052 . . . . 99.989999999999995 110.007 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.58 -45.25 69.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.867 0.691 . . . . 99.989999999999995 112.867 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.73 75.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.447 0.699 . . . . 99.989999999999995 112.707 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -64.62 -39.26 93.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.095 0.958 . . . . 99.989999999999995 113.514 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 86.3 t -69.58 -30.13 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.989 1.315 . . . . 99.989999999999995 112.882 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -76.11 -40.18 53.49 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.597 0.592 . . . . 99.989999999999995 112.597 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -76.11 -91.23 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.664 1.186 . . . . 99.989999999999995 112.575 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.92 -30.09 67.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.929 1.692 . . . . 99.989999999999995 114.381 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.2 m-30 -98.23 -18.43 18.42 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.69 1.737 . . . . 99.989999999999995 115.69 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 57.69 -45.16 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.846 2.536 . . . . 99.989999999999995 117.846 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.31 -12.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.598 1.959 . . . . 99.989999999999995 115.208 -171.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 48.41 44.88 20.65 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.913 3.301 . . . . 99.989999999999995 119.913 167.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -113.26 88.86 13.34 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 114.789 1.403 . . . . 99.989999999999995 114.789 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.87 152.8 80.51 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.427 2.752 . . . . 99.989999999999995 112.0 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tt 64.97 -43.73 0.33 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.705 2.002 . . . . 99.989999999999995 114.833 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.45 -69.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.563 1.145 . . . . 99.989999999999995 111.889 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.15 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 123.923 1.821 . . . . 99.989999999999995 111.224 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.1 tp -153.66 -78.06 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.863 -1.971 . . . . 99.989999999999995 110.53 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.32 -46.51 60.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.028 1.121 . . . . 99.989999999999995 114.028 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.82 -31.56 72.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.216 0.821 . . . . 99.989999999999995 113.216 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -124.71 75.65 64.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.876 0.871 . . . . 99.989999999999995 112.064 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.78 54.26 4.39 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.574 2.182 . . . . 99.989999999999995 113.396 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -169.16 131.34 1.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.161 1.384 . . . . 99.989999999999995 111.044 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.321 0.5 OUTLIER -62.88 -20.49 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 114.521 -1.218 . . . . 99.989999999999995 113.948 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -58.64 -52.8 64.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.564 0.746 . . . . 99.989999999999995 111.022 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -40.2 77.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.401 -0.818 . . . . 99.989999999999995 112.69 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.98 -48.51 79.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 99.989999999999995 112.582 176.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.0 96.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.01 0.924 . . . . 99.989999999999995 112.341 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.1 -31.66 72.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.845 1.424 . . . . 99.989999999999995 114.845 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.71 -35.37 62.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.443 2.016 . . . . 99.989999999999995 116.443 169.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.27 -26.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 119.023 2.971 . . . . 99.989999999999995 119.023 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.3 22.42 12.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.405 1.082 . . . . 99.989999999999995 113.816 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.4 m -123.55 -59.39 1.54 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.191 -0.913 . . . . 99.989999999999995 110.499 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.486 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -98.13 -31.05 12.31 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.68 1.363 . . . . 99.989999999999995 114.68 172.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 115.527 -2.178 . . . . 99.989999999999995 115.763 173.48 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 115.979 1.844 . . . . 99.989999999999995 115.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.54 -149.97 13.2 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.518 -1.219 . . . . 99.989999999999995 111.556 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.32 141.02 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.196 0.813 . . . . 99.989999999999995 113.196 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 t -64.11 -40.76 96.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.307 -1.315 . . . . 99.989999999999995 112.163 169.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.67 175.84 6.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.077 1.351 . . . . 99.989999999999995 114.405 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.35 33.77 13.64 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 118.432 2.753 . . . . 99.989999999999995 118.432 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -45.91 -33.86 3.52 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 118.845 2.906 . . . . 99.989999999999995 118.845 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -177.54 -68.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.175 1.39 . . . . 99.989999999999995 111.306 -173.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t 61.2 78.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 126.588 1.955 . . . . 99.989999999999995 113.503 172.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 87.23 56.46 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 111.941 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 149.3 82.87 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.269 2.646 . . . . 0.0 113.054 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.05 -80.77 0.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.537 -1.211 . . . . 99.989999999999995 111.794 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -111.89 -174.87 2.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.431 1.092 . . . . 99.989999999999995 112.089 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.9 -61.94 1.63 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.588 1.155 . . . . 99.989999999999995 113.478 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.89 -48.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.238 1.015 . . . . 99.989999999999995 111.548 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -52.56 -58.05 8.03 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.36 1.064 . . . . 99.989999999999995 112.714 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -67.73 -48.77 65.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.001 0.92 . . . . 99.989999999999995 112.978 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -55.15 -53.57 54.32 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.391 1.476 . . . . 99.989999999999995 110.961 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.96 -45.62 88.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 118.082 -0.961 . . . . 99.989999999999995 113.3 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.81 79.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.52 0.563 . . . . 99.989999999999995 112.52 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.29 -61.99 2.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.602 1.561 . . . . 99.989999999999995 111.551 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 37.6 pt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 114.232 1.197 . . . . 99.989999999999995 114.232 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -59.22 -59.35 5.61 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 118.644 -0.693 . . . . 99.989999999999995 112.692 168.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -58.75 -32.16 69.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.504 1.298 . . . . 99.989999999999995 114.504 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -65.43 -68.39 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.519 1.528 . . . . 99.989999999999995 111.112 171.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.36 -37.05 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.724 1.61 . . . . 99.989999999999995 113.482 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.35 -21.0 61.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.034 1.124 . . . . 99.989999999999995 114.034 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.1 61.42 0.16 Allowed Glycine 0 N--CA 1.477 1.407 0 O-C-N 124.167 0.917 . . . . 99.989999999999995 112.265 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.259 9.2 p 19.49 66.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 127.874 2.469 . . . . 99.989999999999995 114.757 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -107.06 -61.77 1.5 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.563 -2.108 . . . . 99.989999999999995 114.577 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.94 89.42 1.72 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 115.692 -0.686 . . . . 99.989999999999995 111.557 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.3 pt -127.97 -153.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.366 -0.605 . . . . 99.989999999999995 109.366 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.69 -148.31 7.02 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 121.46 -0.4 . . . . 99.989999999999995 113.561 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' HA ' HG23 ' A' ' 74' ' ' ILE . 1.9 mp -47.86 -69.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 111.551 -2.324 . . . . 99.989999999999995 113.0 -172.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.49 -15.15 48.52 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.433 1.642 . . . . 99.989999999999995 115.433 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.99 -143.24 0.73 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.323 1.449 . . . . 99.989999999999995 108.861 -172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -112.14 18.15 18.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.342 0.867 . . . . 99.989999999999995 113.342 163.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.7 p90 39.72 15.85 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 119.252 3.056 . . . . 99.989999999999995 119.252 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -131.03 -82.18 0.53 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.518 1.527 . . . . 99.989999999999995 111.572 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.25 -40.52 11.61 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.698 2.851 . . . . 99.989999999999995 118.698 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -28.14 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 114.436 1.273 . . . . 99.989999999999995 114.436 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.42 65.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.543 1.068 . . . . 99.989999999999995 114.039 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.84 96.39 2.46 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 123.937 0.433 . . . . 99.989999999999995 113.768 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 1.22 1.62 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.908 1.448 . . . . 99.989999999999995 114.908 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m 177.03 -150.02 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.87 2.468 . . . . 99.989999999999995 109.715 -165.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -55.83 -7.12 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.627 2.825 . . . . 99.989999999999995 118.627 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.48 -31.57 6.56 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.611 1.337 . . . . 99.989999999999995 114.611 173.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.05 45.27 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.947 1.092 . . . . 99.989999999999995 113.947 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -65.26 -48.98 71.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.452 1.101 . . . . 99.989999999999995 111.722 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.64 90.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.031 0.932 . . . . 99.989999999999995 112.47 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.77 -52.22 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.595 0.758 . . . . 99.989999999999995 110.014 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.51 -39.87 71.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.03 0.932 . . . . 99.989999999999995 113.152 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.39 -50.51 72.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.54 0.736 . . . . 99.989999999999995 112.481 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.88 -44.92 96.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 99.989999999999995 112.98 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.63 -32.28 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.081 0.952 . . . . 99.989999999999995 112.495 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -68.89 -42.95 76.26 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.772 0.656 . . . . 99.989999999999995 112.772 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -82.45 -61.98 1.74 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.581 1.697 . . . . 99.989999999999995 115.581 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.28 -32.98 55.89 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.393 1.477 . . . . 99.989999999999995 113.327 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -101.59 -9.44 20.96 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.408 0.892 . . . . 99.989999999999995 113.408 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 62.53 -55.39 0.15 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.076 2.551 . . . . 99.989999999999995 115.413 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.15 4.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 126.462 1.905 . . . . 99.989999999999995 115.421 -166.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.285 15.0 pt-20 54.36 -38.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 121.545 3.905 . . . . 99.989999999999995 121.545 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -22.32 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 128.523 2.729 . . . . 99.989999999999995 118.201 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.21 147.37 78.67 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.026 2.484 . . . . 0.0 111.273 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 66.04 -38.58 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.584 1.954 . . . . 99.989999999999995 115.466 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -53.47 -73.84 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.36 1.064 . . . . 99.989999999999995 113.674 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.22 52.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 124.043 1.877 . . . . 99.989999999999995 111.618 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.8 tp -154.31 -79.4 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 112.336 -2.211 . . . . 99.989999999999995 108.57 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.0 -43.8 98.36 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.33 1.233 . . . . 99.989999999999995 114.33 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.59 67.5 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.298 1.222 . . . . 99.989999999999995 114.298 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.92 71.16 7.18 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.917 0.887 . . . . 99.989999999999995 112.666 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.98 40.04 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.755 2.97 . . . . 0.0 114.921 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -147.9 131.26 16.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.321 1.848 . . . . 99.989999999999995 109.576 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' A' ' 34' ' ' ILE 0.285 0.5 OUTLIER -61.34 -21.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 114.56 -1.2 . . . . 99.989999999999995 113.865 -179.771 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.11 -60.87 2.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.583 1.153 . . . . 99.989999999999995 110.112 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -34.84 74.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.05 -0.977 . . . . 99.989999999999995 113.468 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.86 -47.24 85.6 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.696 0.628 . . . . 99.989999999999995 112.696 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.82 96.29 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.953 0.901 . . . . 99.989999999999995 112.378 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.466 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -55.92 -51.96 65.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 99.989999999999995 112.019 169.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.052 1.871 . . . . 99.989999999999995 116.052 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.309 6.6 m -108.41 -72.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 114.461 1.282 . . . . 99.989999999999995 114.461 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.42 64.46 3.51 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.371 1.557 . . . . 99.989999999999995 112.78 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 77.5 m -166.7 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.399 2.68 . . . . 99.989999999999995 108.702 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.431 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -110.19 -29.5 8.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.71 2.115 . . . . 99.989999999999995 116.71 176.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.517 -1.706 . . . . 99.989999999999995 115.424 -177.235 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.86 25.05 4.93 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 118.286 2.698 . . . . 0.0 118.286 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 5.2 tp-100 -46.26 -36.04 5.81 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.1 t80 177.2 -60.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.162 0.985 . . . . 0.0 111.699 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 57.33 79.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.139 2.176 . . . . 0.0 113.68 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -131.33 89.44 41.08 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.493 169.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.76 -152.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.596 2.864 . . . . 0.0 113.792 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.82 -83.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.666 0.786 . . . . 0.0 109.343 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -109.65 -175.19 2.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.487 1.115 . . . . 0.0 112.203 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.91 -58.24 5.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.435 1.094 . . . . 0.0 113.171 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.19 -49.87 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.207 1.003 . . . . 0.0 111.307 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HA ' HD12 ' A' ' 74' ' ' ILE . 19.9 mm-40 -50.6 -62.67 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.661 1.184 . . . . 0.0 113.068 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 t -67.98 -47.28 69.0 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.909 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 22' ' ' ILE . 45.3 tptt -61.69 -47.06 87.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.83 0.852 . . . . 0.0 111.616 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -68.02 -36.58 80.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.07 85.51 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.113 0.415 . . . . 0.0 111.649 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 38.2 tt0 -58.62 -55.11 39.36 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.544 1.538 . . . . 0.0 111.829 171.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.7 mm -55.27 -51.04 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.207 1.003 . . . . 0.0 110.892 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.3 m95 -55.98 -55.95 26.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.943 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.6 pt-20 -61.2 -28.04 68.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -76.69 -61.15 2.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.324 1.05 . . . . 0.0 111.59 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG12 ' HZ3' ' A' ' 47' ' ' LYS . 93.3 t -60.64 -40.69 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.602 1.561 . . . . 0.0 112.637 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 23.4 tp -61.09 -19.3 61.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.984 1.313 . . . . 0.0 114.238 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.71 0.92 Allowed Glycine 0 N--CA 1.474 1.187 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 p -13.83 90.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.422 2.289 . . . . 0.0 115.53 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.493 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 16.7 p -141.89 -69.37 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 112.816 -1.993 . . . . 0.0 114.501 -174.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 126.99 94.72 0.89 Allowed Glycine 0 N--CA 1.48 1.617 0 O-C-N 123.943 0.777 . . . . 0.0 112.58 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 5' ' ' GLU . 21.8 pt -101.74 -177.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.822 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -105.37 171.67 18.76 Favored Glycine 0 N--CA 1.477 1.368 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.119 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 10' ' ' ALA . 39.7 mm -57.33 -48.65 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.353 1.061 . . . . 0.0 111.884 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.2 -6.53 2.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.881 1.673 . . . . 0.0 114.399 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 54.46 -154.06 0.28 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.715 2.006 . . . . 0.0 110.059 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -101.24 13.74 34.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.258 -0.276 . . . . 0.0 111.311 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.256 50.1 p90 37.56 5.38 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -116.38 -79.25 0.59 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.768 1.227 . . . . 0.0 111.741 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.6 -31.55 47.41 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 118.588 2.811 . . . . 0.0 118.588 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -32.7 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -66.93 -53.18 28.32 Favored Glycine 0 CA--C 1.538 1.488 0 O-C-N 124.076 0.86 . . . . 0.0 112.659 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.63 105.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -75.08 53.88 0.64 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.498 1.519 . . . . 0.0 114.118 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.5 p -163.59 -146.92 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.629 1.972 . . . . 0.0 109.002 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -54.41 -25.24 23.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 61.7 mmtt -50.22 -55.38 15.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.338 1.055 . . . . 0.0 113.72 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 -42.79 38.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.48 -53.02 39.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.46 1.104 . . . . 0.0 112.988 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.161 0.985 . . . . 0.0 112.889 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 ' CH2' ' A' ' 23' ' ' TRP . 46.1 t -66.27 -42.9 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.649 0.78 . . . . 0.0 110.18 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.05 -42.25 72.47 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -56.83 -46.67 81.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -64.09 -46.92 82.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.643 1.177 . . . . 0.0 112.579 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 59.5 t -61.45 -28.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.167 1.387 . . . . 0.0 112.318 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.24 -77.92 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.625 0.77 . . . . 0.0 110.727 166.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 9.1 ptt180 -59.72 -37.87 80.1 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -172.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.49 -30.51 9.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-30 -93.92 -27.44 16.38 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 61.73 1.91 0.66 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.842 2.457 . . . . 0.0 116.684 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.07 -12.44 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.94 41.53 3.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 120.076 3.362 . . . . 0.0 120.076 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -109.82 93.01 13.59 Favored Pre-proline 0 N--CA 1.482 1.138 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.4 Cg_endo -66.35 149.67 84.84 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.493 2.795 . . . . 0.0 111.97 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.7 tt 60.98 -46.87 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.251 2.22 . . . . 0.0 114.917 -174.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -55.97 -65.47 0.59 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.722 1.209 . . . . 0.0 112.436 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -62.65 -25.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.524 HD23 ' HA2' ' A' ' 42' ' ' GLY . 7.5 mp -72.21 -41.6 66.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.951 1.7 . . . . 0.0 113.579 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -103.71 -39.54 6.64 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.63 62.44 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.582 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 11.3 mp0 -119.57 61.93 6.81 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.944 0.498 . . . . 0.0 111.654 171.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 22.2 Cg_endo -79.87 38.17 0.72 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.175 3.25 . . . . 0.0 114.081 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -157.15 131.72 8.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.142 2.177 . . . . 0.0 108.864 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.289 0.5 OUTLIER -62.37 -21.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.244 179.925 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.67 -53.62 56.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.343 0.657 . . . . 0.0 110.69 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.8 74.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 83.9 mt -55.35 -48.97 73.44 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.51 0.724 . . . . 0.0 112.579 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.35 93.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.003 0.921 . . . . 0.0 112.717 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.03 -26.93 68.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -77.72 -27.03 50.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 59' ' ' TYR . 32.8 m -116.35 -30.18 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 -174.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.42 56.13 0.8 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.477 1.608 . . . . 0.0 109.89 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 m -162.35 -65.55 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.988 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.645 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -101.53 -33.17 10.04 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 114.823 1.416 . . . . 99.99 114.823 172.491 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 8.0 mm-40 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.203 0.525 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.76 -179.8 4.98 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.061 1.745 . . . . 0.0 114.508 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -168.58 -99.51 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.06 1.744 . . . . 0.0 108.903 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.43 -57.28 12.85 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t 56.25 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 126.352 1.861 . . . . 0.0 113.897 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.08 98.24 33.53 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 168.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.75 -154.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.752 2.968 . . . . 0.0 113.994 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.438 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -159.73 -85.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.003 0.521 . . . . 0.0 110.202 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.438 ' H ' ' HB ' ' A' ' 12' ' ' THR . 38.8 p-10 -107.9 -176.89 3.19 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.389 0.676 . . . . 0.0 111.481 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.15 -51.98 16.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.295 1.038 . . . . 0.0 113.071 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.37 -54.53 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.512 1.125 . . . . 0.0 111.46 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 74' ' ' ILE . 22.3 mm-40 -49.93 -59.9 3.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.233 . . . . 0.0 112.255 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.1 m -65.17 -44.85 87.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 22' ' ' ILE . 47.0 tptt -57.98 -58.51 8.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.413 1.485 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.81 -33.77 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -57.21 -45.17 84.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.1 -48.95 79.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.557 1.143 . . . . 0.0 111.763 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 18' ' ' LYS . 42.0 mm -54.44 -54.77 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.099 0.96 . . . . 0.0 110.685 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.481 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 11.6 m95 -56.56 -53.32 58.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.882 0.873 . . . . 0.0 113.332 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 27' ' ' LEU . 21.1 pt-20 -60.27 -30.12 69.24 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -77.01 -63.72 1.3 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.972 1.42 . . . . 0.0 111.148 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.6 -43.45 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.498 1.519 . . . . 0.0 113.204 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -65.56 -14.98 62.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.229 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.31 72.46 0.18 Allowed Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.552 1.157 . . . . 0.0 110.789 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.274 12.9 p -10.45 87.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 128.314 2.646 . . . . 0.0 116.968 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 48.9 m -139.19 -50.66 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.299 -1.773 . . . . 0.0 115.496 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 125.57 3.0 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 20' ' ' ALA . 2.5 pp -125.72 165.17 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 113.07 0.766 . . . . 0.0 113.07 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.34 162.4 14.41 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.295 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.97 -40.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.321 0.648 . . . . 0.0 111.734 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.2 -21.07 58.89 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 167.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.649 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.1 m-20 56.96 -163.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.441 1.897 . . . . 0.0 111.788 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -101.58 1.11 37.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.295 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.307 53.5 p90 53.97 -38.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -171.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.09 -81.57 0.06 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.364 1.466 . . . . 0.0 112.252 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.19 21.98 0.07 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -173.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 36' ' ' ASP . 2.5 pp -101.23 -44.95 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.22 -40.9 60.66 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.964 0.79 . . . . 0.0 113.642 170.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.69 116.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.671 1.029 . . . . 0.0 115.671 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -82.55 46.63 1.08 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.924 -1.638 . . . . 0.0 114.041 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.8 p -150.48 -150.51 0.35 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.848 1.659 . . . . 0.0 109.608 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.56 -18.65 7.9 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 33.3 mmtp -48.49 -51.14 28.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.055 0.942 . . . . 0.0 112.261 172.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.14 -47.03 62.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 ptm -70.53 -41.6 72.32 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.86 97.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.292 0.637 . . . . 0.0 112.483 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' LYS . 40.7 t -66.08 -47.64 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.915 0.886 . . . . 0.0 109.7 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.81 -39.84 62.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.89 -57.3 12.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.682 0.793 . . . . 0.0 112.775 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.32 -34.69 78.92 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.939 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 92.0 t -64.7 -27.82 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.653 1.181 . . . . 0.0 112.908 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 18.6 t-160 -77.13 -63.21 1.42 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.72 0.808 . . . . 0.0 112.166 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.2 ptt85 -70.92 -38.98 72.95 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.22 -36.38 6.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.625 0.77 . . . . 0.0 112.745 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.939 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m-85 -84.81 -27.92 26.48 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 34.2 tt0 65.69 -36.39 0.23 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.174 2.589 . . . . 0.0 116.661 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 t -57.73 -23.45 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.311 1.444 . . . . 0.0 114.646 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.8 tm-20 45.89 67.92 0.67 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -136.96 87.4 19.16 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.0 Cg_endo -64.82 148.05 89.81 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.431 2.754 . . . . 0.0 112.096 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 6.5 tt 62.37 -43.96 0.18 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.403 2.281 . . . . 0.0 114.584 -172.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.16 -68.76 0.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.248 1.419 . . . . 0.0 113.117 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.87 12.93 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.7 -41.65 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 111.935 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 53.1 m-85 -106.83 -45.87 4.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.027 1.331 . . . . 0.0 113.329 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.86 73.68 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -120.24 65.53 11.1 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 170.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.502 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 19.6 Cg_endo -80.24 27.55 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.571 2.847 . . . . 0.0 114.973 -170.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -139.68 136.31 34.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.617 1.167 . . . . 0.0 110.568 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.278 0.4 OUTLIER -61.85 -19.77 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.752 175.879 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.63 -61.9 2.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 0.0 110.348 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.46 80.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 88.3 mt -58.03 -46.55 85.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.146 0.578 . . . . 0.0 112.262 172.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.62 85.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.277 1.031 . . . . 0.0 112.755 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -62.3 -40.6 96.84 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 170.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 2.8 m-85 -66.81 -39.23 87.64 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 171.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 77' ' ' LEU . 24.0 m -99.59 -40.37 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.87 50.9 0.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.174 1.464 . . . . 0.0 110.451 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 69.0 m -160.26 -55.11 0.06 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.553 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.461 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.05 -35.02 5.79 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 169.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 116.009 -1.948 . . . . 99.99 116.027 175.105 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.2 pm0 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.43 -71.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.607 1.963 . . . . 0.0 111.903 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.306 4.8 pt20 46.38 -56.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -175.99 -65.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.674 1.59 . . . . 0.0 111.471 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 11' ' ' PRO . 3.7 t 57.99 95.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 126.339 1.856 . . . . 0.0 112.888 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.85 81.58 19.39 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 9' ' ' VAL . 75.9 Cg_endo -67.67 147.59 76.25 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 122.904 2.403 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -80.31 0.59 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.475 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -113.86 -176.51 2.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 112.335 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.25 19.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.253 1.021 . . . . 0.0 113.585 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.94 -54.22 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.161 0.984 . . . . 0.0 110.424 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 74' ' ' ILE . 11.1 mm-40 -49.26 -59.62 3.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.678 1.191 . . . . 0.0 113.339 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -68.34 -51.12 48.0 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 83.1 tttt -64.48 -40.68 96.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.976 . . . . 0.0 112.425 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.39 -43.86 84.71 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.69 172.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.06 77.74 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.0 tt0 -57.2 -57.05 14.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.499 1.519 . . . . 0.0 111.721 170.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.266 2.5 pp -62.64 -36.99 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 177.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 32' ' ' ILE . 7.4 m95 -56.69 -58.11 9.51 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 112.119 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.499 ' HB3' ' H ' ' A' ' 32' ' ' ILE . 20.5 pt-20 -59.85 -30.02 68.68 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -71.48 -62.65 1.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.195 1.398 . . . . 0.0 112.033 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.9 -37.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 125.713 1.605 . . . . 0.0 113.251 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.535 HD11 ' HG3' ' A' ' 40' ' ' GLN . 7.9 tt -57.86 -23.16 51.65 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.006 1.323 . . . . 0.0 113.488 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.58 73.24 0.39 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.6 p 1.62 79.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 128.244 2.618 . . . . 0.0 116.304 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -123.52 -47.31 1.98 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -172.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 104.14 91.9 2.23 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 23' ' ' TRP . 6.5 pt -119.96 167.17 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 120.727 0.299 . . . . 0.0 111.117 -174.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.73 168.97 24.09 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 123.116 1.398 . . . . 0.0 113.901 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.7 mm -48.68 -36.6 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 111.833 -2.184 . . . . 0.0 112.804 173.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' THR . 2.9 mm? -68.12 -20.11 64.88 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.57 1.548 . . . . 0.0 114.307 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 58.77 -156.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.721 1.608 . . . . 0.0 109.865 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -119.1 13.38 12.92 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 36.87 34.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -152.49 -81.42 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.775 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' HD11 ' A' ' 27' ' ' LEU . 9.5 pt20 -70.94 29.91 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.82 -40.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -64.34 -40.3 97.73 Favored Glycine 0 N--CA 1.48 1.603 0 O-C-N 123.813 0.696 . . . . 0.0 113.279 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.69 149.64 0.11 Allowed Glycine 0 N--CA 1.477 1.4 0 O-C-N 125.101 1.118 . . . . 0.0 114.022 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -93.05 45.95 1.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 113.627 -1.286 . . . . 0.0 112.189 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.8 m -174.94 -159.76 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.28 1.832 . . . . 0.0 111.38 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -58.04 -5.44 0.45 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.9 mptt -52.63 -51.97 57.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.066 0.947 . . . . 0.0 110.901 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.74 60.93 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.0 mmt -68.74 -47.41 66.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.967 0.907 . . . . 0.0 112.896 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.99 80.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.497 0.719 . . . . 0.0 111.835 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 45.5 t -64.87 -47.81 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.024 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.37 -42.82 64.27 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.803 0.729 . . . . 0.0 112.225 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.661 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -60.48 -52.18 66.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.631 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.3 pt20 -65.01 -38.94 92.59 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.9 t -67.56 -28.64 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.498 1.119 . . . . 0.0 112.203 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.51 -59.25 3.82 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.327 167.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.661 HH21 ' HB1' ' A' ' 53' ' ' ALA . 11.6 ptp180 -71.84 -46.46 57.98 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -173.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -100.41 -30.69 11.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.632 1.573 . . . . 0.0 112.609 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -94.65 -30.83 14.12 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.9 12.72 2.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.275 2.23 . . . . 0.0 115.998 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 59' ' ' TYR . 3.5 t -116.39 12.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 121.172 0.511 . . . . 0.0 111.867 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.61 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.1 pm0 6.99 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.0 pt? -121.31 87.18 44.38 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 63' ' ' LEU . 69.4 Cg_endo -65.65 154.78 72.29 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 123.02 2.48 . . . . 0.0 111.214 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.5 tt 66.53 -44.45 0.42 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.639 1.976 . . . . 0.0 114.332 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.59 -61.11 2.52 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.406 0.682 . . . . 0.0 112.776 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.57 -8.93 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.622 HD13 ' HA2' ' A' ' 42' ' ' GLY . 65.7 mt -104.72 -24.49 12.93 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.306 1.443 . . . . 0.0 114.871 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 74.3 m-85 -117.91 -40.92 2.94 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.41 -49.12 14.09 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.609 0.764 . . . . 0.0 112.801 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -121.43 59.18 8.86 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.2 Cg_endo -75.35 19.18 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.335 3.357 . . . . 0.0 116.777 -170.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 80.7 p -120.86 137.36 54.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.333 0.5 OUTLIER -63.19 -20.99 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.956 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -52.55 -66.33 0.4 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.759 1.224 . . . . 0.0 109.567 165.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.98 85.79 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.173 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 89.5 mt -58.18 -44.75 88.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.313 0.645 . . . . 0.0 112.648 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.31 98.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.5 0.72 . . . . 0.0 112.34 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.2 mp0 -62.35 -39.89 94.61 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 172.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -71.44 -29.84 65.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.275 33.4 m -116.83 -41.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.62 57.27 1.01 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 123.335 1.54 . . . . 0.0 109.476 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.1 m -165.46 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.205 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.561 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.2 -31.16 8.01 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.969 1.47 . . . . 99.99 114.969 176.869 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.11 72.01 0.3 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.243 1.817 . . . . 0.0 115.187 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.535 ' OE1' ' HA ' ' A' ' 37' ' ' ASN . 39.2 tt0 -78.7 -75.43 0.23 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.946 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -121.54 -44.58 2.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' H ' ' HA2' ' A' ' 33' ' ' GLY . 5.3 t 48.94 82.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.444 1.898 . . . . 0.0 114.057 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.36 88.47 54.27 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.865 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.48 149.97 75.07 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 122.988 2.459 . . . . 0.0 112.642 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -122.35 -84.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.843 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.3 p-10 -109.9 -178.02 3.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.606 0.762 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.06 -45.54 43.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.87 -58.79 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.06 0.944 . . . . 0.0 110.392 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 74' ' ' ILE . 52.5 mm-40 -51.08 -56.03 14.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.261 1.024 . . . . 0.0 112.604 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.84 -57.85 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.164 0.986 . . . . 0.0 113.537 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 21.0 ttpp -66.51 -36.55 82.98 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.83 -45.94 76.68 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.601 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.71 78.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 40.8 tt0 -56.57 -58.8 6.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.474 1.51 . . . . 0.0 111.229 170.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.268 2.6 pp -60.89 -38.39 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.81 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 32' ' ' ILE . 11.4 m95 -55.85 -59.08 5.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.505 0.722 . . . . 0.0 112.266 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.533 ' HB3' HG12 ' A' ' 32' ' ' ILE . 11.8 pt-20 -62.43 -30.29 71.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -75.9 -58.19 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.02 0.928 . . . . 0.0 112.335 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.09 -35.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.963 1.305 . . . . 0.0 112.557 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.33 -21.34 59.62 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.51 72.1 0.29 Allowed Glycine 0 N--CA 1.476 1.333 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.4 p 0.91 80.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 128.484 2.714 . . . . 0.0 116.187 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 m -119.74 -70.44 0.79 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.098 -172.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 123.75 101.98 1.51 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.533 HG12 ' HB3' ' A' ' 24' ' ' GLU . 24.6 pt -125.05 167.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' H ' ' A' ' 9' ' ' VAL . . . -71.37 157.91 53.48 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.911 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -57.01 -40.99 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.727 -0.737 . . . . 0.0 112.273 164.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD23 ' HB ' ' A' ' 73' ' ' THR . 4.3 mt -68.61 13.52 0.09 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 162.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.2 m-20 50.76 -140.48 0.84 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.143 1.777 . . . . 0.0 110.348 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.535 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 17.6 t-20 -115.77 22.67 12.89 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.194 0.521 . . . . 0.0 111.05 154.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.255 53.1 p90 42.11 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 1 N-CA-C 122.135 4.124 . . . . 0.0 122.135 -178.523 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -112.8 -84.02 0.59 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.065 1.346 . . . . 0.0 112.335 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -48.24 -31.84 6.41 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' ASP . 2.6 pp -62.42 -34.31 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.97 75.2 Favored Glycine 0 N--CA 1.478 1.447 0 O-C-N 123.9 0.75 . . . . 0.0 113.029 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.98 127.08 0.01 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 53.38 2.63 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.516 -2.342 . . . . 0.0 112.555 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 17.0 m -169.89 -152.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.052 1.741 . . . . 0.0 110.369 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 49' ' ' MET . 1.9 pt? -51.32 -22.13 2.64 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.8 mptt -48.19 -62.1 1.65 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.917 1.287 . . . . 0.0 111.818 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.23 -45.66 44.89 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 2.1 ptm -69.81 -41.34 75.14 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.09 86.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.159 0.584 . . . . 0.0 112.06 171.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 68' ' ' LEU . 6.0 t -67.82 -43.75 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.576 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.39 -42.58 64.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.552 0.615 . . . . 0.0 112.385 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -59.1 -51.73 68.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 10.5 pt20 -66.68 -38.58 87.09 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 62' ' ' GLU . 96.3 t -67.83 -27.31 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.657 1.183 . . . . 0.0 112.254 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -70.34 -61.46 1.76 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.385 0.274 . . . . 0.0 111.445 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.634 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 15.0 ptp180 -65.38 -42.05 93.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -173.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -107.15 -32.74 7.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.868 1.267 . . . . 0.0 113.076 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.5 m-85 -94.69 -20.58 19.42 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 61.96 -47.69 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.68 28.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 55' ' ' VAL . 14.5 pt-20 -9.9 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.637 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -123.44 82.69 52.97 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 69.4 Cg_endo -66.11 148.39 85.24 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 123.401 2.734 . . . . 0.0 111.52 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.0 tt 63.31 -47.84 0.23 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.731 2.012 . . . . 0.0 113.563 -172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -46.24 -66.82 0.35 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.068 1.747 . . . . 0.0 112.207 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -68.27 -4.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.774 HD11 HG11 ' A' ' 51' ' ' VAL . 3.1 mm? -107.86 -31.45 8.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -175.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 58.0 m-85 -107.8 -37.27 6.17 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.78 -44.17 56.77 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.55 0.34 . . . . 0.0 111.856 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.1 pm0 -123.21 71.83 45.69 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 62.3 Cg_endo -76.57 38.33 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.567 3.511 . . . . 0.0 115.924 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.6 t -144.44 133.55 22.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.569 1.548 . . . . 0.0 110.59 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.277 0.4 OUTLIER -63.91 -23.11 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.544 178.878 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.6 tmmt? -55.59 -61.96 2.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.85 0.86 . . . . 0.0 110.131 170.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.6 76.23 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.707 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 96.3 mt -56.09 -47.46 77.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.79 0.436 . . . . 0.0 112.154 171.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.55 94.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.523 0.729 . . . . 0.0 112.866 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -61.03 -43.51 98.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.15 -26.49 67.45 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.329 7.2 m -114.98 -73.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.81 64.48 0.67 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 123.471 1.605 . . . . 0.0 112.563 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 88.4 m -169.4 -53.53 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 129.075 2.95 . . . . 0.0 108.622 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -115.97 -28.91 6.5 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 175.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.465 2.024 . . . . 99.99 116.465 -175.274 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HG2' ' H ' ' A' ' 6' ' ' ALA . 7.9 pm0 . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.693 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -72.15 172.15 10.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.721 1.208 . . . . 0.0 112.957 164.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -169.54 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.739 1.616 . . . . 0.0 107.422 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -60.92 -64.03 1.1 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.421 HG22 ' HA2' ' A' ' 33' ' ' GLY . 2.8 t 57.55 82.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 126.49 1.916 . . . . 0.0 113.456 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.01 91.6 49.06 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.063 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.38 143.21 47.2 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.121 2.547 . . . . 0.0 113.696 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -106.02 -81.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.911 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -116.44 -174.36 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.91 -57.01 6.25 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.099 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.6 -52.41 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.323 1.049 . . . . 0.0 111.023 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.58 ' HA ' HD12 ' A' ' 74' ' ' ILE . 3.7 mt-10 -55.08 -60.32 3.53 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 t -64.33 -43.68 93.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.003 0.815 . . . . 0.0 113.197 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -57.74 -57.03 14.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 110.659 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.35 -38.71 92.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -59.24 -41.99 90.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 44.9 tt0 -60.73 -50.82 71.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.734 1.214 . . . . 0.0 111.573 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -54.82 -54.24 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.962 0.905 . . . . 0.0 110.357 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -56.2 -52.45 64.36 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.312 -0.852 . . . . 0.0 113.015 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 32' ' ' ILE . 14.9 pt-20 -60.75 -30.26 69.89 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -74.26 -62.47 1.5 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.2 -45.76 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.785 1.634 . . . . 0.0 113.412 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 41' ' ' ILE . 10.1 tt -56.14 -25.61 46.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.086 1.754 . . . . 0.0 113.87 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.89 81.5 0.33 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.265 13.1 p -17.02 92.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.959 2.504 . . . . 0.0 116.197 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 p -149.86 -49.0 0.14 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 113.139 -1.846 . . . . 0.0 115.933 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.36 119.01 2.32 Favored Glycine 0 N--CA 1.481 1.664 0 O-C-N 123.695 0.622 . . . . 0.0 111.758 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.4 pp -121.66 158.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -87.17 152.23 24.32 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.695 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm -50.02 -40.32 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.318 1.047 . . . . 0.0 112.445 168.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -50.46 -34.4 24.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.583 1.553 . . . . 0.0 113.786 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.561 ' HB3' HG21 ' A' ' 41' ' ' ILE . 8.2 m-20 61.17 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.356 -168.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 40' ' ' GLN . 26.5 t-20 -57.17 -22.04 37.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.562 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.282 38.0 p90 60.42 -7.47 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.8 -71.97 0.74 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.424 1.09 . . . . 0.0 112.261 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 37' ' ' ASN . 9.1 pt20 -72.69 11.79 0.59 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -69.54 -51.48 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 68' ' ' LEU . . . -135.01 14.85 4.32 Favored Glycine 0 CA--C 1.541 1.709 0 O-C-N 124.288 0.993 . . . . 0.0 114.559 167.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.97 62.31 4.39 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -125.18 -130.22 0.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.473 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 p -110.01 -86.42 0.53 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.771 0.828 . . . . 0.0 111.273 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.89 -18.95 37.8 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -56.1 -36.35 68.07 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.97 74.15 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.59 -48.2 67.51 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.906 1.282 . . . . 0.0 112.483 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.59 85.76 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.26 -49.52 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.176 0.99 . . . . 0.0 110.225 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.52 -41.36 66.29 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -54.52 43.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.363 1.065 . . . . 0.0 112.367 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.86 -43.63 90.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.338 1.055 . . . . 0.0 112.896 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.761 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 48.2 t -68.1 -25.58 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.81 1.244 . . . . 0.0 113.353 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -85.2 -27.01 26.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -97.64 -56.19 2.59 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.25 -32.17 17.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.642 1.177 . . . . 0.0 112.315 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.761 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.3 m-85 -85.72 -33.18 21.55 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 58.02 3.65 0.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.16 10.99 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 55' ' ' VAL . 30.4 tt0 15.47 81.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.8 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.4 pt? -128.39 77.59 76.89 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 64.8 Cg_endo -64.57 145.95 88.2 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 123.361 2.707 . . . . 0.0 111.987 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 64' ' ' PRO 0.281 3.0 pp 58.75 -39.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.843 2.457 . . . . 0.0 115.861 -170.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HD3' ' HB2' ' A' ' 63' ' ' LEU . 75.2 tttt -52.8 -65.6 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.065 2.146 . . . . 0.0 110.517 176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.8 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 3.0 p -61.94 -22.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 57.3 tp -95.4 -26.88 15.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.803 1.641 . . . . 0.0 115.123 -166.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -114.88 -38.96 3.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.386 1.074 . . . . 0.0 113.603 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.35 49.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' CD ' ' HA ' ' A' ' 67' ' ' VAL . 10.7 pm0 -121.56 59.45 9.52 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.8 Cg_endo -75.63 24.32 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.953 3.769 . . . . 0.0 116.68 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.5 t -126.0 138.85 53.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 110.159 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.258 0.4 OUTLIER -60.64 -27.39 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.548 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -55.16 -55.37 31.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.386 0.675 . . . . 0.0 110.855 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -69.87 -40.19 75.88 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 82.1 mt -55.2 -46.34 75.9 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.535 0.734 . . . . 0.0 112.173 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.51 85.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.179 0.992 . . . . 0.0 112.317 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.79 -32.75 74.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -69.47 -16.08 63.4 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 77' ' ' LEU 0.274 15.6 m -117.72 -71.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 175.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 61.11 3.16 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.797 1.761 . . . . 0.0 111.622 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.1 m -165.44 -57.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.616 2.367 . . . . 0.0 108.338 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.77 -27.88 7.98 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 177.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.575 -1.679 . . . . 99.99 115.149 -174.535 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.6 pm0 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.61 21.03 5.39 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -38.76 -35.74 0.22 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 119.373 3.101 . . . . 0.0 119.373 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.8 t80 176.96 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.072 1.349 . . . . 0.0 110.697 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.9 t 65.72 93.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 127.092 2.157 . . . . 0.0 112.785 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -129.68 82.15 67.8 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.784 169.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 137.38 32.56 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.602 2.201 . . . . 0.0 112.539 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -76.37 0.55 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.612 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -118.84 -176.49 3.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.618 1.167 . . . . 0.0 112.582 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.11 54.25 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -57.08 -56.22 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.346 1.058 . . . . 0.0 110.022 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' ILE . 6.3 mm-40 -48.96 -56.38 9.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.895 1.278 . . . . 0.0 113.555 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 t -67.42 -55.04 15.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.158 0.983 . . . . 0.0 113.561 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 37.9 ttpt -64.18 -38.67 91.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.854 0.862 . . . . 0.0 112.889 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -65.24 -45.83 83.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.759 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.75 76.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.8 tt0 -57.92 -58.88 6.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.211 1.404 . . . . 0.0 111.677 171.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 19' ' ' LEU . 2.5 pp -61.5 -38.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.06 -57.39 12.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 0.0 112.161 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.665 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 pt-20 -61.18 -31.55 71.3 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -69.38 -62.0 1.56 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.752 1.282 . . . . 0.0 111.927 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' HE3' ' A' ' 47' ' ' LYS . 99.4 t -61.6 -37.88 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.576 1.551 . . . . 0.0 113.193 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.69 -25.5 60.39 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.377 1.071 . . . . 0.0 113.623 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.4 62.19 0.14 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.155 0.909 . . . . 0.0 111.587 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.262 10.3 p 16.67 67.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 127.888 2.475 . . . . 0.0 114.997 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 60.6 m -109.9 -49.86 3.04 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 112.372 -2.194 . . . . 0.0 116.667 -167.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 102.96 92.07 2.21 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.665 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -117.66 159.23 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -170.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -77.24 153.3 41.15 Favored Glycine 0 N--CA 1.475 1.285 0 CA-C-N 113.889 -1.505 . . . . 0.0 113.34 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.0 mm -48.56 -40.99 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.753 1.221 . . . . 0.0 113.121 167.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.13 -14.09 33.51 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.705 1.602 . . . . 0.0 114.753 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.04 -158.8 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.097 2.159 . . . . 0.0 110.455 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -111.25 17.92 19.79 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.3 p90 40.51 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -124.27 -85.91 0.64 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 111.605 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -71.81 33.22 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 119.441 3.126 . . . . 0.0 119.441 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.455 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -113.02 -40.26 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.948 172.477 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 68' ' ' LEU . . . -60.64 -64.26 4.26 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.918 0.761 . . . . 0.0 112.966 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.55 100.05 0.14 Allowed Glycine 0 N--CA 1.476 1.361 0 CA-C-N 114.471 -0.865 . . . . 0.0 113.49 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -63.22 -36.91 85.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.34 0.656 . . . . 0.0 112.459 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -151.12 -90.4 0.06 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.398 1.479 . . . . 0.0 108.932 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -93.92 -11.0 31.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HE3' HG12 ' A' ' 26' ' ' VAL . 30.2 mttp -42.29 -37.21 1.45 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.21 -38.69 41.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 79.3 mtm -71.49 -45.37 62.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.04 88.35 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.667 0.787 . . . . 0.0 112.385 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HD21 ' A' ' 68' ' ' LEU . 5.6 t -71.27 -42.59 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.699 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -38.42 63.81 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.422 0.555 . . . . 0.0 112.406 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.56 -58.16 8.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.721 0.808 . . . . 0.0 112.525 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 12.0 pt20 -63.55 -37.48 87.49 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.863 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 94.3 t -66.03 -24.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.671 1.188 . . . . 0.0 112.93 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 12.8 t-160 -87.18 -58.35 2.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.238 0.615 . . . . 0.0 112.272 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.1 ppt_? -68.78 -37.91 79.65 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -106.64 -46.62 3.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.367 1.067 . . . . 0.0 111.759 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.863 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-85 -75.76 -32.49 59.98 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' HIS 0.25 94.6 mt-30 66.97 -31.49 0.17 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -178.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.49 -30.3 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.176 1.39 . . . . 0.0 113.47 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' A' ' 55' ' ' VAL . 25.3 tt0 47.61 79.19 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.181 1.792 . . . . 0.0 115.368 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 1.8 pt? -142.19 83.32 12.45 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.582 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -63.87 152.82 79.01 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.132 2.555 . . . . 0.0 110.939 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' H ' HD12 ' A' ' 68' ' ' LEU 0.303 3.7 pp 60.65 -41.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.7 2.4 . . . . 0.0 116.724 -172.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 63' ' ' LEU . 99.6 mttt -56.83 -67.01 0.35 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.89 1.276 . . . . 0.0 111.897 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.682 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 3.8 p -76.13 13.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 65' ' ' LEU . 94.3 mt -123.85 -35.54 2.85 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.89 -48.26 3.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.68 1.192 . . . . 0.0 110.979 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.42 76.02 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 170.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 46.3 mt-30 -121.33 55.8 5.43 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 23.2 Cg_endo -76.32 24.54 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.387 3.391 . . . . 0.0 116.58 -167.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -132.94 141.11 48.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.092 1.357 . . . . 0.0 110.169 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.273 0.4 OUTLIER -62.99 -22.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.092 178.393 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -57.82 -52.0 67.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.283 0.633 . . . . 0.0 110.793 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.43 74.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.211 1.005 . . . . 0.0 113.403 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.567 HD23 HG22 ' A' ' 67' ' ' VAL . 81.7 mt -56.02 -47.67 77.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.33 98.73 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 0.0 112.705 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.549 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -54.59 -44.95 73.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.221 1.008 . . . . 0.0 112.796 171.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' HE2' HD11 ' A' ' 63' ' ' LEU . 2.0 m-30 -71.31 -22.54 61.92 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.28 11.6 m -108.42 -70.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.18 60.0 3.52 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.416 1.579 . . . . 0.0 111.748 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 98.8 m -166.37 -60.56 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 128.202 2.601 . . . . 0.0 108.384 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.07 -27.61 7.62 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.837 2.532 . . . . 0.0 117.837 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 116.226 1.936 . . . . 99.99 116.226 -174.641 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.94 35.13 11.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.893 2.077 . . . . 0.0 116.375 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -42.25 -46.73 4.58 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.6 t80 172.88 -59.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.775 1.23 . . . . 0.0 112.463 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 32' ' ' ILE 0.319 5.4 p 56.56 98.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.864 2.465 . . . . 0.0 116.199 -175.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.21 84.81 34.92 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.982 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.08 153.15 78.6 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.151 2.567 . . . . 0.0 112.744 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -129.23 -82.41 0.57 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.938 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -113.2 -177.39 3.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.758 1.223 . . . . 0.0 112.034 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -55.74 10.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.411 1.084 . . . . 0.0 113.444 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.27 -51.29 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.232 1.013 . . . . 0.0 111.089 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.736 ' HA ' HD12 ' A' ' 74' ' ' ILE . 43.2 mm-40 -50.93 -58.73 5.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.345 1.058 . . . . 0.0 112.581 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -67.94 -50.35 56.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.257 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 1.7 tpmt? -57.75 -50.38 73.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.194 1.397 . . . . 0.0 112.066 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.45 -43.79 84.6 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.747 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.96 83.82 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 44.9 tt0 -57.02 -60.28 3.82 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 110.673 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.264 2.6 pp -60.51 -36.75 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.95 -63.91 1.0 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.802 0.841 . . . . 0.0 111.552 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.727 ' HB3' HG12 ' A' ' 32' ' ' ILE . 17.9 pt-20 -61.44 -33.97 74.63 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -67.71 -63.29 1.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.137 1.375 . . . . 0.0 111.717 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.29 -30.03 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.038 1.335 . . . . 0.0 112.469 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.88 -34.8 70.17 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.24 61.96 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.434 1.084 . . . . 0.0 111.557 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.255 7.4 p 17.7 62.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 128.615 2.766 . . . . 0.0 115.272 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -102.91 -47.36 4.4 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.121 -1.854 . . . . 0.0 115.473 -165.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 24' ' ' GLU . . . 92.55 105.22 1.59 Allowed Glycine 0 N--CA 1.48 1.6 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.727 HG12 ' HB3' ' A' ' 24' ' ' GLU . 18.3 pt -120.28 -151.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.89 160.41 18.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.18 -40.48 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.96 -0.69 4.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 7.5 m-20 55.95 -145.58 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.287 1.835 . . . . 0.0 111.6 -174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -139.76 42.05 1.99 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.773 0.429 . . . . 0.0 111.835 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -6.01 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.427 2.291 . . . . 0.0 117.027 -169.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 40' ' ' GLN . 25.4 t80 173.67 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.814 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 39' ' ' PHE . 6.5 pt20 -70.83 19.33 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -104.22 -40.55 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -72.07 -32.23 63.39 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.85 166.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.99 -162.71 26.55 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.445 -0.878 . . . . 0.0 111.413 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -70.8 -44.23 67.03 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.5 p -174.83 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.2 -36.76 80.78 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.9 mmtp -58.87 -49.89 76.05 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.822 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -37.64 57.14 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -63.12 -50.72 69.36 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.548 0.739 . . . . 0.0 112.492 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 47' ' ' LYS . 95.5 t -59.2 -50.49 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.746 1.218 . . . . 0.0 110.077 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.56 -42.9 67.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.221 0.608 . . . . 0.0 112.531 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -61.2 -51.51 68.7 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 13.6 pt20 -66.98 -38.6 86.35 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 93.3 t -66.38 -30.01 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.088 . . . . 0.0 111.816 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -69.29 -68.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.692 HH21 ' HB1' ' A' ' 53' ' ' ALA . 10.9 ptp180 -59.38 -42.52 91.88 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.55 -38.93 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -170.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -78.02 -25.04 47.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 69.92 -44.84 0.57 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.639 2.776 . . . . 0.0 114.998 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.03 27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 126.663 1.985 . . . . 0.0 116.14 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 55' ' ' VAL . 13.7 pt-20 -8.93 77.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.3 pt? -125.72 91.46 48.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.6 Cg_endo -66.42 152.03 81.83 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.986 2.457 . . . . 0.0 111.891 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tt 65.15 -42.29 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.068 2.147 . . . . 0.0 116.051 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -54.1 -71.69 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG22 HD23 ' A' ' 77' ' ' LEU 0.255 4.0 p -84.63 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 123.819 1.771 . . . . 0.0 110.464 177.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 47.6 tp -162.5 -49.76 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.402 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.63 -62.59 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.527 1.131 . . . . 0.0 111.566 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.31 78.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.307 0.643 . . . . 0.0 112.624 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 38.4 mt-30 -120.9 83.2 36.71 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.201 170.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 27.0 Cg_endo -85.62 26.78 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.223 2.615 . . . . 0.0 114.776 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -136.21 136.08 39.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.033 0.533 . . . . 0.0 111.404 -171.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.264 0.4 OUTLIER -62.73 -22.34 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.911 177.268 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 18.9 tptm -58.52 -57.56 12.4 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.184 0.594 . . . . 0.0 110.097 172.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.25 -35.51 81.07 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 HG12 ' A' ' 74' ' ' ILE . 23.8 mt -59.24 -46.12 89.33 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.585 0.354 . . . . 0.0 110.876 173.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.87 85.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.065 0.946 . . . . 0.0 112.844 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.676 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -59.39 -39.93 84.97 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 169.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.81 -38.35 79.86 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 77' ' ' LEU 0.314 28.1 m -106.59 -57.18 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -178.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.38 49.27 1.72 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 122.963 1.364 . . . . 0.0 111.369 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 86.5 m -161.38 -65.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.556 1.942 . . . . 0.0 109.212 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 -30.04 8.64 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.592 1.701 . . . . 99.99 115.592 174.882 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.0 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.831 2.052 . . . . 0.0 111.423 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.314 5.1 pt20 46.82 -45.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 120.856 3.651 . . . . 0.0 120.856 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -175.32 -67.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.935 1.694 . . . . 0.0 111.757 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.15 84.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 126.573 1.949 . . . . 0.0 112.406 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 88.93 30.19 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.005 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.64 146.96 75.14 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.875 2.384 . . . . 0.0 112.17 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 -79.85 0.5 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -116.51 178.23 4.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.046 0.938 . . . . 0.0 111.304 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.24 37.06 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.88 -60.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.879 1.272 . . . . 0.0 110.586 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -53.08 -49.85 65.57 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.136 0.974 . . . . 0.0 112.941 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -61.68 -55.6 28.67 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.071 0.949 . . . . 0.0 113.165 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.24 -44.12 97.77 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.053 0.941 . . . . 0.0 112.242 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.63 -47.55 80.88 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.17 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 45.0 tt0 -57.84 -58.08 9.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.92 1.288 . . . . 0.0 111.942 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 pt -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -59.4 -46.55 88.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 21' ' ' GLU . 11.9 pt-20 -65.8 -26.83 67.87 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -46.42 20.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.314 1.045 . . . . 0.0 111.42 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.48 -42.4 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.683 1.593 . . . . 0.0 112.173 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 7.3 tt -55.77 -25.14 39.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.713 1.205 . . . . 0.0 114.096 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.63 87.13 1.46 Allowed Glycine 0 CA--C 1.531 1.074 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -166.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -18.15 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 127.288 2.235 . . . . 0.0 115.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 p -140.96 -52.44 0.47 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 112.77 -2.014 . . . . 0.0 114.873 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 98.22 2.06 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.736 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.52 146.63 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.532 0.682 . . . . 0.0 111.732 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.22 164.27 47.61 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.758 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -50.42 -34.57 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 113.36 -1.42 . . . . 0.0 112.598 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.87 -23.89 67.37 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.23 -175.3 0.15 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.247 1.819 . . . . 0.0 111.323 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -96.06 14.15 24.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 p90 32.36 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -162.58 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.83 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.06 43.17 0.35 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 -43.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.128 170.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.32 -51.43 43.51 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.214 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -174.23 102.14 0.17 Allowed Glycine 0 N--CA 1.476 1.331 0 O-C-N 124.526 0.78 . . . . 0.0 114.857 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -29.12 70.32 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.394 -0.903 . . . . 0.0 112.09 156.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.2 p 174.19 -93.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 130.723 3.609 . . . . 0.0 108.14 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -26.64 68.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 38.4 mttp -39.5 -38.72 0.61 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 -55.04 18.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ptm -70.96 -41.19 71.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.94 92.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.8 -39.73 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.262 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.55 -40.69 68.95 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.37 -43.78 79.51 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.518 0.727 . . . . 0.0 112.871 173.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.37 -43.22 74.0 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.813 1.245 . . . . 0.0 112.372 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 57.0 t -58.41 -31.3 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.41 1.084 . . . . 0.0 111.33 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.49 -80.06 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 165.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.488 ' C ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.9 -31.49 66.81 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 117.265 2.321 . . . . 0.0 117.265 -168.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -109.15 -37.41 5.8 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.148 0.979 . . . . 0.0 112.983 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.852 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 4.1 m-30 -94.72 -18.8 20.95 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 68.63 -39.03 0.4 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.239 2.616 . . . . 0.0 115.722 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.84 -23.49 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 125.072 1.349 . . . . 0.0 113.712 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 50.57 23.22 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 1.1 pt? -106.1 104.93 51.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -174.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.68 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.0 Cg_endo -63.73 152.63 79.66 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 123.509 2.806 . . . . 0.0 112.132 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 69' ' ' PHE . 8.5 tt 63.81 -56.65 0.21 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.7 2.0 . . . . 0.0 114.241 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.12 -64.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.431 1.493 . . . . 0.0 113.082 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.63 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 4.7 p -60.94 -29.57 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.51 -24.24 34.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 63.6 m-85 -109.33 -37.51 5.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.75 77.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.726 0.41 . . . . 0.0 111.655 173.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.4 pm0 -123.62 73.06 52.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.063 168.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.71 24.63 0.37 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.62 3.547 . . . . 0.0 117.158 -170.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t -135.2 137.0 42.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.105 1.362 . . . . 0.0 110.697 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -60.08 -26.3 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.56 175.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -58.61 -50.03 75.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.844 0.458 . . . . 0.0 110.962 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.91 68.48 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 91.4 mt -56.32 -43.16 78.71 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.955 0.902 . . . . 0.0 113.201 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.7 79.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 112.42 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 83' ' ' THR . 3.0 mp0 -66.61 -37.41 84.82 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -60.91 -17.85 53.33 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.267 16.5 m -110.75 -73.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 170.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.92 74.54 6.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.392 1.568 . . . . 0.0 111.353 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 39.0 m -173.27 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 129.409 3.084 . . . . 0.0 107.341 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.485 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -113.69 -30.18 6.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 116.148 1.907 . . . . 99.99 116.148 -177.388 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.91 20.39 8.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.43 -28.11 0.83 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 120.19 3.404 . . . . 0.0 120.19 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 t80 176.2 -70.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.326 1.45 . . . . 0.0 110.921 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t 62.75 85.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 126.926 2.09 . . . . 0.0 113.009 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.11 90.61 48.93 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.563 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.71 156.72 44.28 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 123.341 2.694 . . . . 0.0 113.466 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.3 -83.35 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.056 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.86 -171.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 112.457 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.79 -50.8 55.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.198 0.999 . . . . 0.0 113.467 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.7 -53.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.11 0.964 . . . . 0.0 110.235 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.72 -62.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.617 1.167 . . . . 0.0 113.176 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -64.58 -51.45 62.71 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 22' ' ' ILE . 27.7 ttpt -63.6 -45.73 89.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.584 0.754 . . . . 0.0 112.197 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.0 -39.3 90.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.87 85.34 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.209 0.459 . . . . 0.0 112.054 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 32.8 tt0 -57.33 -53.72 54.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.7 1.2 . . . . 0.0 111.068 171.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 18' ' ' LYS . 41.2 mm -53.67 -53.46 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.34 1.056 . . . . 0.0 110.638 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HB3' HD11 ' A' ' 32' ' ' ILE . 21.3 m95 -54.28 -60.4 3.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.266 1.027 . . . . 0.0 112.779 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -58.66 -31.98 68.67 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -69.87 -63.81 1.01 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 111.376 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG12 ' HE2' ' A' ' 47' ' ' LYS . 57.8 t -62.85 -36.45 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.149 1.38 . . . . 0.0 112.801 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 9.4 tt -56.92 -24.5 52.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.666 1.586 . . . . 0.0 113.956 173.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.19 71.29 0.24 Allowed Glycine 0 N--CA 1.476 1.314 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.271 12.2 p 3.52 78.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 128.475 2.71 . . . . 0.0 116.127 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 21.4 m -121.56 -67.61 0.95 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 112.597 -2.092 . . . . 0.0 116.284 -171.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 121.71 95.76 1.37 Allowed Glycine 0 N--CA 1.479 1.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 23' ' ' TRP . 14.8 pt -121.58 159.28 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 121.333 0.587 . . . . 0.0 112.526 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 9' ' ' VAL . . . -82.65 151.57 29.41 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.214 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 43.4 mm -45.49 -41.99 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.856 1.662 . . . . 0.0 112.892 171.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.49 -29.92 68.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 36.5 m-20 62.97 149.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.123 2.169 . . . . 0.0 111.858 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.55 24.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.9 p90 22.55 47.82 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 118.343 2.719 . . . . 0.0 118.343 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -160.12 -78.22 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.401 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HG3' HD11 ' A' ' 27' ' ' LEU . 11.0 pt20 -70.0 27.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -115.78 -35.97 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.307 1.043 . . . . 0.0 111.698 172.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -59.26 -63.21 5.37 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 124.334 0.969 . . . . 0.0 113.398 171.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.77 121.64 0.01 OUTLIER Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.226 -1.487 . . . . 0.0 115.838 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -81.01 49.95 1.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.754 -1.723 . . . . 0.0 113.467 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -159.72 -154.04 0.38 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.502 1.921 . . . . 0.0 108.905 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -62.67 -0.87 0.7 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 26' ' ' VAL . 22.5 mmtp -56.16 -61.61 2.27 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.352 1.061 . . . . 0.0 112.748 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.65 -36.31 24.31 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.0 mmm -65.28 -52.3 55.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.598 1.159 . . . . 0.0 112.841 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.27 77.83 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.308 1.043 . . . . 0.0 112.668 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 74.0 t -62.81 -50.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.067 0.947 . . . . 0.0 110.177 171.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.97 -42.65 65.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.321 0.648 . . . . 0.0 112.566 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.46 -56.28 23.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -65.68 -38.64 89.83 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.681 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -66.55 -27.98 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 111.951 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -71.14 -69.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.806 0.443 . . . . 0.0 111.222 166.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.93 -44.01 3.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.999 0.92 . . . . 0.0 113.243 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.681 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.2 m-85 -82.62 -20.98 35.32 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -46.67 0.62 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.658 2.783 . . . . 0.0 114.189 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.77 26.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.652 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.1 pt-20 -6.72 76.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 120.29 3.441 . . . . 0.0 120.29 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -123.97 86.7 53.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 73.0 Cg_endo -66.24 150.8 84.64 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.17 2.58 . . . . 0.0 111.629 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 -48.73 0.35 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.605 1.962 . . . . 0.0 114.78 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -52.08 -69.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.616 1.566 . . . . 0.0 112.904 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.623 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -61.55 -20.46 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 HD21 ' HA2' ' A' ' 42' ' ' GLY . 59.3 tp -93.44 -29.02 15.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.258 1.823 . . . . 0.0 114.633 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -108.1 -40.33 5.24 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.607 1.163 . . . . 0.0 113.705 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.26 73.02 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.0 pm0 -122.97 70.23 39.62 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.679 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.38 32.83 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.536 3.49 . . . . 0.0 115.097 -173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.483 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 8.6 t -139.03 137.51 36.35 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.856 1.262 . . . . 0.0 111.125 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 23' ' ' TRP 0.306 3.2 mm -57.86 -27.94 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -66.19 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.991 0.807 . . . . 0.0 110.169 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.5 78.5 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 87.3 mt -58.2 -44.39 88.09 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.16 93.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 112.653 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.603 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.3 mp0 -60.83 -46.28 91.16 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 171.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -65.46 -26.97 68.18 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.316 9.5 m -112.07 -75.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 60.56 1.25 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.351 1.548 . . . . 0.0 113.428 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.4 m -161.69 -54.16 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.629 2.372 . . . . 0.0 109.05 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -106.03 -31.97 8.5 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 173.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 127.353 2.261 . . . . 99.99 116.436 -178.326 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 21.7 mp0 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 111.18 0.067 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.71 147.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.276 1.83 . . . . 0.0 113.465 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.43 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.556 -173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -118.25 -61.73 1.63 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 11' ' ' PRO . 4.0 t 67.46 98.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 126.389 1.876 . . . . 0.0 111.553 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -121.58 78.86 38.06 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.018 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' HG12 ' A' ' 9' ' ' VAL . 72.5 Cg_endo -66.56 145.68 77.16 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.665 2.244 . . . . 0.0 112.013 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -122.76 -87.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.046 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.9 p-10 -105.26 -176.38 3.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.49 -50.39 31.83 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.061 0.944 . . . . 0.0 113.119 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.91 -58.49 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.323 1.049 . . . . 0.0 110.504 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 74' ' ' ILE . 7.5 mm-40 -49.28 -58.89 4.27 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.745 1.218 . . . . 0.0 113.277 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -67.97 -54.25 20.04 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 38.2 ttpt -64.89 -41.29 95.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.713 1.205 . . . . 0.0 113.291 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.95 -43.04 84.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.494 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.2 78.35 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 30.2 tt0 -57.92 -58.71 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.11 1.364 . . . . 0.0 111.452 171.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.259 2.6 pp -61.35 -36.13 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.8 m95 -57.47 -60.74 3.19 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.485 0.714 . . . . 0.0 111.996 170.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 13.7 pt-20 -59.13 -26.8 65.03 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -73.23 -70.48 0.36 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.808 1.243 . . . . 0.0 112.289 167.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.82 -39.91 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 125.162 1.385 . . . . 0.0 113.024 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 23' ' ' TRP . 1.5 tt -61.06 -25.89 67.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.914 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.38 0.05 OUTLIER Glycine 0 N--CA 1.478 1.463 0 O-C-N 124.106 0.879 . . . . 0.0 111.38 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.27 13.3 p -20.7 88.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.39 2.676 . . . . 0.0 116.625 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 14.4 m -149.68 -51.82 0.15 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.006 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 130.02 124.14 2.59 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.804 0.69 . . . . 0.0 112.463 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.2 pt -134.11 177.38 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.411 0.685 . . . . 0.0 110.884 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 150.88 17.27 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.762 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ALA . 49.2 mm -28.23 -42.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.672 2.389 . . . . 0.0 114.463 164.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 73' ' ' THR . 6.4 mp -62.4 -34.17 76.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.991 1.716 . . . . 0.0 114.742 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.11 146.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.136 1.774 . . . . 0.0 113.171 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.45 25.92 0.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.1 p90 21.1 49.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -167.66 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.681 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.1 -14.49 17.08 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -33.04 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.47 12.57 15.98 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.743 0.652 . . . . 0.0 113.978 169.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 39.45 -155.68 0.03 OUTLIER Glycine 0 N--CA 1.48 1.574 0 C-N-CA 124.786 1.184 . . . . 0.0 114.759 -172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -123.39 52.14 1.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.332 -1.434 . . . . 0.0 110.7 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -171.49 -162.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.839 1.656 . . . . 0.0 112.02 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -51.82 -21.7 3.08 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.0 mmtp -52.58 -43.68 65.42 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.17 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.9 mtp -69.95 -45.65 66.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.763 1.225 . . . . 0.0 112.144 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.831 0.852 . . . . 0.0 112.536 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 68' ' ' LEU . 20.7 t -67.27 -49.32 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.072 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -50.3 -39.58 45.96 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.9 -59.63 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.941 0.897 . . . . 0.0 112.339 172.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 8.3 pt20 -63.52 -31.95 73.26 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.011 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 76.1 t -62.24 -37.57 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.795 1.238 . . . . 0.0 112.748 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.4 -33.79 61.01 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.4 ptt85 -102.59 -37.65 7.86 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -108.32 -35.35 6.55 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.777 0.831 . . . . 0.0 112.403 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.3 m-85 -80.12 -28.34 38.99 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 173.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 68.25 -30.96 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.521 2.328 . . . . 0.0 115.18 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.59 -31.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 127.988 2.515 . . . . 0.0 115.785 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.723 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 24.1 tt0 66.87 141.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.326 1.85 . . . . 0.0 113.185 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.723 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 97.7 mt 65.22 154.75 0.12 Allowed Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 172.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 94.5 Cg_endo -71.51 -162.81 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.314 2.009 . . . . 0.0 111.476 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp 66.92 -51.15 0.47 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.712 2.005 . . . . 0.0 115.466 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -57.75 -85.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.779 1.632 . . . . 0.0 110.52 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 11.8 m -79.07 46.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.497 1.141 . . . . 0.0 113.885 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 51' ' ' VAL . 13.3 mt -144.36 -50.34 0.29 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.508 -1.678 . . . . 0.0 114.839 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -109.84 -49.69 3.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.018 0.927 . . . . 0.0 111.662 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.94 79.14 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.674 0.609 . . . . 0.0 111.563 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 4.5 mp0 -116.9 87.28 21.65 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.73 167.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.98 -26.68 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.674 2.25 . . . . 0.0 114.653 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 44.0 p -80.5 138.0 36.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 0.0 109.97 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.496 HG12 HD12 ' A' ' 77' ' ' LEU 0.255 0.4 OUTLIER -62.09 -23.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.913 172.584 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -59.6 -51.51 69.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.36 0.664 . . . . 0.0 111.818 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.59 95.02 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 73' ' ' THR . 51.4 mt -57.97 -46.63 84.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.389 0.676 . . . . 0.0 112.254 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -45.33 85.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.609 1.164 . . . . 0.0 112.97 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.44 -31.91 71.56 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -74.25 -22.36 59.36 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 169.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 77' ' ' LEU 0.269 32.6 m -104.25 -73.97 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -85.5 61.21 6.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 123.894 1.807 . . . . 0.0 111.196 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.4 m -161.17 -56.43 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.278 -2.237 . . . . 0.0 108.461 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.22 -30.87 6.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 175.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.595 1.702 . . . . 99.99 115.595 -175.095 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.51 92.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.68 1.592 . . . . 0.0 113.786 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 4.6 tp60 -98.97 -62.86 1.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.548 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -148.75 -60.57 0.23 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.857 1.263 . . . . 0.0 111.078 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 t 65.33 84.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.771 2.028 . . . . 0.0 112.598 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -128.65 85.02 61.4 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.988 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.97 143.68 61.28 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.779 2.319 . . . . 0.0 112.436 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -77.04 0.6 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.777 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' GLU . 26.1 p30 -117.04 -172.85 2.29 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.563 1.145 . . . . 0.0 112.583 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.92 -63.29 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.71 1.204 . . . . 0.0 113.169 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.17 -47.17 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.401 1.081 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.608 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.3 mm-40 -50.58 -63.54 1.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.72 1.208 . . . . 0.0 113.173 174.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 t -67.26 -45.44 76.63 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.27 -54.11 50.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.003 1.321 . . . . 0.0 111.297 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.99 -36.81 82.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.18 89.14 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.486 0.585 . . . . 0.0 112.437 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.36 -51.42 70.01 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.149 1.38 . . . . 0.0 111.278 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.85 -54.19 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.276 1.03 . . . . 0.0 110.517 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.574 ' HB3' HD11 ' A' ' 32' ' ' ILE . 9.8 m95 -55.29 -53.99 49.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.262 1.025 . . . . 0.0 113.51 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -61.51 -30.75 70.83 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.75 -56.56 4.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.325 1.05 . . . . 0.0 111.93 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.0 -38.74 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 125.501 1.52 . . . . 0.0 113.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 40' ' ' GLN . 8.0 tt -59.81 -22.84 62.75 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.334 1.453 . . . . 0.0 113.585 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.85 74.74 0.3 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.272 13.0 p 0.78 81.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 128.32 2.648 . . . . 0.0 116.397 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 m -127.36 -80.32 0.59 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 112.579 -2.101 . . . . 0.0 115.17 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.88 102.37 0.67 Allowed Glycine 0 N--CA 1.479 1.523 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' ASP . 15.3 pt -125.05 166.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -72.22 158.84 53.5 Favored Glycine 0 N--CA 1.477 1.397 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.026 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' ALA . 40.5 mm -52.9 -42.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 114.179 -1.01 . . . . 0.0 111.75 164.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.16 9.23 0.33 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 166.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 32' ' ' ILE . 6.5 m-20 55.64 -137.47 1.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.677 1.591 . . . . 0.0 109.562 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -123.41 28.85 6.87 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.836 0.454 . . . . 0.0 110.276 156.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.281 53.2 p90 35.73 -0.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 1 N-CA-C 123.402 4.593 . . . . 0.0 123.402 -174.905 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -115.34 -74.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.922 1.689 . . . . 0.0 111.276 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.536 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.8 pt20 -67.71 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -112.44 -29.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.579 0.751 . . . . 0.0 112.434 171.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -57.51 -48.08 83.61 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 123.968 0.792 . . . . 0.0 113.349 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.93 99.32 0.01 OUTLIER Glycine 0 N--CA 1.478 1.46 0 O-C-N 125.1 1.118 . . . . 0.0 113.673 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -70.39 54.56 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.378 1.871 . . . . 0.0 114.747 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -165.3 -142.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.552 2.341 . . . . 0.0 108.078 -176.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -63.31 -18.36 63.54 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.56 -48.5 71.97 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.1 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.15 60.52 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.5 mtm -69.94 -44.54 69.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.717 0.807 . . . . 0.0 112.952 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.83 79.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.472 0.709 . . . . 0.0 112.568 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LYS . 94.3 t -62.95 -50.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.018 0.927 . . . . 0.0 109.865 170.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.678 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.46 -43.58 65.04 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.416 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -56.65 -54.37 46.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.277 1.031 . . . . 0.0 113.394 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.659 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 9.2 pt20 -66.75 -37.06 83.87 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.93 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 72.5 t -65.08 -25.22 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.373 1.069 . . . . 0.0 112.587 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 3.2 t60 -81.67 -54.59 5.27 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 168.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 18.8 ptp180 -71.02 -37.7 72.61 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -110.33 -31.43 7.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.933 1.293 . . . . 0.0 112.557 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.93 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.4 m-30 -102.84 -10.3 19.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tp60 62.05 -46.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 126.371 1.868 . . . . 0.0 115.81 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 52.54 28.23 5.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 167.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -109.21 94.89 16.44 Favored Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -173.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.678 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -66.13 151.01 84.76 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 123.709 2.94 . . . . 0.0 111.889 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 9.0 tt 63.88 -44.95 0.26 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.745 2.018 . . . . 0.0 114.087 -175.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -51.85 -69.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.984 1.714 . . . . 0.0 111.555 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.642 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 3.6 p -76.46 22.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 62.9 tp -130.94 -37.22 1.31 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.018 0.927 . . . . 0.0 113.482 -169.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.554 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 26.0 m-85 -101.31 -39.41 7.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.354 1.062 . . . . 0.0 113.797 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.42 90.22 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.642 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.1 pm0 -124.87 73.12 63.91 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.53 1.132 . . . . 0.0 112.005 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -77.99 34.78 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.125 3.217 . . . . 0.0 114.754 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 t -142.02 131.95 24.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.847 1.659 . . . . 0.0 110.502 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.285 0.5 OUTLIER -63.8 -20.33 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.591 178.843 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.98 -56.63 19.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.17 0.588 . . . . 0.0 110.439 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.05 75.42 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.088 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.3 mt -58.89 -45.51 90.05 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.17 91.46 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 0.0 111.881 172.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.4 tm0? -59.47 -45.08 92.67 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.42 0.688 . . . . 0.0 112.74 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.51 -28.63 67.99 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.299 16.7 m -113.37 -68.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 61.53 2.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 123.228 1.49 . . . . 0.0 112.203 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 99.7 m -164.81 -69.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.951 2.501 . . . . 0.0 108.084 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.51 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -97.43 -29.08 13.7 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 115.732 -2.08 . . . . 99.99 114.336 179.233 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 21.8 mm-40 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.07 119.1 1.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.692 1.197 . . . . 0.0 114.045 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.56 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 63.3 tp60 -122.77 -80.07 0.62 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.793 -1.549 . . . . 0.0 112.75 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.471 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 46.0 t80 -135.38 -64.29 0.65 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t 72.15 98.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.814 2.045 . . . . 0.0 112.394 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -144.18 82.99 10.42 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.432 167.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.05 147.52 61.16 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 122.923 2.416 . . . . 0.0 112.674 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.01 -82.78 0.58 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.007 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -108.47 -177.36 3.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.718 0.807 . . . . 0.0 111.833 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.99 50.39 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.09 -59.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.761 1.224 . . . . 0.0 110.357 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.657 ' HA ' HD12 ' A' ' 74' ' ' ILE . 9.1 mm-40 -49.08 -59.57 3.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.981 1.312 . . . . 0.0 113.439 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.6 t -64.84 -56.37 13.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.085 0.954 . . . . 0.0 113.252 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 32.3 ttpt -67.14 -40.86 86.82 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.08 -40.64 94.92 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.913 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.83 84.6 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 33.4 tt0 -58.17 -53.14 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.581 1.152 . . . . 0.0 111.186 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.87 -50.96 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.327 1.051 . . . . 0.0 110.663 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -52.67 -60.11 3.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.32 1.048 . . . . 0.0 112.335 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HB3' HG13 ' A' ' 32' ' ' ILE . 15.4 pt-20 -60.13 -31.36 69.99 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -61.54 1.94 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.928 1.291 . . . . 0.0 111.865 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.21 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.28 1.032 . . . . 0.0 112.669 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 34.9 tp -62.3 -32.7 73.47 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.67 56.44 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 O-C-N 124.47 1.106 . . . . 0.0 112.94 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.276 12.1 p -0.74 75.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 128.914 2.885 . . . . 0.0 116.955 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.662 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 56.3 m -138.77 -48.0 0.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.589 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 125.05 112.14 1.9 Allowed Glycine 0 N--CA 1.477 1.406 0 O-C-N 123.714 0.634 . . . . 0.0 113.381 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -108.72 173.73 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.623 -0.789 . . . . 0.0 111.58 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -99.46 153.17 19.61 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.839 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 10' ' ' ALA . 43.5 mm -40.97 -47.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.995 1.318 . . . . 0.0 113.803 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.08 -21.07 63.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 17.7 m-20 58.98 157.46 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.603 1.961 . . . . 0.0 113.324 -172.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.95 8.92 3.29 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.6 p90 39.61 22.5 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -118.59 -85.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.776 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 40' ' ' GLN . 5.5 pm0 -59.5 -16.62 25.61 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -33.34 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.78 -53.08 0.6 Allowed Glycine 0 N--CA 1.476 1.326 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.344 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.32 -144.88 18.82 Favored Glycine 0 N--CA 1.478 1.485 0 O-C-N 124.506 0.768 . . . . 0.0 112.333 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -139.48 41.85 2.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.979 1.371 . . . . 0.0 112.991 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.3 m -130.62 -154.46 0.63 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.048 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -49.94 -33.08 16.45 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 mmtp -46.51 -73.04 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.398 1.479 . . . . 0.0 112.766 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.74 4.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.26 -53.56 35.45 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.97 91.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.909 0.884 . . . . 0.0 112.227 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 68' ' ' LEU . 27.6 t -66.87 -40.26 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.995 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.34 -45.71 72.74 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.934 0.788 . . . . 0.0 111.67 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.89 -49.87 76.14 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.387 172.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -54.56 -51.91 63.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.426 1.49 . . . . 0.0 112.446 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 60.2 t -65.68 -29.58 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.416 1.486 . . . . 0.0 112.56 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -68.1 -72.16 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.114 0.566 . . . . 0.0 111.28 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 6.3 ptt180 -64.5 -41.38 96.47 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 -173.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.35 -29.07 10.99 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.733 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.3 m-85 -94.62 -22.58 18.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 64.26 -33.78 0.15 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.664 2.468 . . . . 0.0 117.664 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -18.83 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.774 1.23 . . . . 0.0 114.168 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 47.76 39.01 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 66' ' ' LYS . 1.1 pt? -122.47 99.52 42.52 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 63.7 Cg_endo -65.6 160.76 41.64 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.3 2.666 . . . . 0.0 111.902 174.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 68' ' ' LEU . 7.3 tt 66.09 -47.57 0.42 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.971 2.108 . . . . 0.0 114.852 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HD2' HD12 ' A' ' 63' ' ' LEU . 32.7 mttp -56.75 -55.59 32.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.417 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.8 t -68.21 4.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 51' ' ' VAL . 61.0 mt -119.2 -29.66 5.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 75.0 m-85 -112.16 -38.06 4.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.89 -44.78 30.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.406 0.682 . . . . 0.0 112.244 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -119.31 67.0 9.06 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 168.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 41.5 Cg_endo -77.06 26.16 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.057 3.172 . . . . 0.0 115.802 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.2 t -137.96 136.05 36.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.988 1.315 . . . . 0.0 110.714 -171.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.271 0.4 OUTLIER -62.31 -23.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.905 178.299 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -54.87 -62.81 1.41 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.373 1.069 . . . . 0.0 110.258 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.45 -35.25 80.34 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.34 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 73' ' ' THR . 81.9 mt -57.54 -45.35 85.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.33 85.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.207 1.003 . . . . 0.0 112.834 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -63.19 -47.75 81.24 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.188 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.93 -25.41 68.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 82' ' ' ALA 0.272 5.2 m -101.13 -81.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 168.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -80.43 65.72 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.52 1.629 . . . . 0.0 112.404 -173.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.8 m -165.0 -50.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.155 2.582 . . . . 0.0 108.457 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -116.69 -30.7 5.72 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 174.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 116.639 -1.648 . . . . 99.99 115.098 -174.096 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 2.5 pp20? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.14 20.96 8.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 119.123 3.008 . . . . 0.0 119.123 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.94 -40.62 30.9 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 t80 174.54 -68.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.089 0.956 . . . . 0.0 111.235 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.6 t 66.33 93.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 127.339 2.256 . . . . 0.0 112.222 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -124.72 82.59 59.77 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.361 170.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -68.66 150.45 74.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.894 2.396 . . . . 0.0 112.696 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 -81.04 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.932 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -113.95 -174.76 2.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.276 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.56 10.1 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.197 0.999 . . . . 0.0 113.24 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.26 -52.0 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.669 1.188 . . . . 0.0 110.954 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HA ' HD12 ' A' ' 74' ' ' ILE . 15.0 mm-40 -51.02 -64.34 0.84 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.101 1.361 . . . . 0.0 113.495 175.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 t -66.91 -46.87 73.52 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 22' ' ' ILE . 51.2 tptt -60.76 -51.74 68.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.104 0.962 . . . . 0.0 111.053 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.98 -36.13 82.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.727 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.5 91.27 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.895 0.77 . . . . 0.0 112.587 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.7 tt0 -59.07 -50.43 74.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.753 1.221 . . . . 0.0 111.344 170.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.4 mm -54.7 -52.17 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 110.617 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 15.8 m95 -56.7 -54.83 41.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.346 1.058 . . . . 0.0 113.697 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.3 pt-20 -59.16 -28.27 66.44 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -77.72 -61.53 1.96 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.794 1.638 . . . . 0.0 111.602 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.24 -39.62 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.517 1.927 . . . . 0.0 113.818 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 32' ' ' ILE . 5.9 tt -58.72 -24.22 61.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.385 1.474 . . . . 0.0 113.819 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.67 0.73 Allowed Glycine 0 N--CA 1.473 1.149 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.25 13.1 p -22.52 95.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 127.404 2.282 . . . . 0.0 115.474 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.609 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 24.1 p -148.19 -58.8 0.24 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 112.608 -2.087 . . . . 0.0 114.505 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 127.69 95.58 0.88 Allowed Glycine 0 N--CA 1.48 1.594 0 O-C-N 123.824 0.702 . . . . 0.0 113.37 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.4 pt -107.57 166.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 121.441 0.639 . . . . 0.0 112.501 -174.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -88.76 160.48 30.09 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.144 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 10' ' ' ALA . 47.7 mm -45.3 -51.34 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 125.319 1.448 . . . . 0.0 112.497 170.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.17 -27.66 69.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.412 1.485 . . . . 0.0 114.398 171.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' A' ' 32' ' ' ILE . 4.4 p-10 46.07 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.26 -167.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -93.5 24.96 3.68 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 34.15 43.07 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -138.77 -82.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.426 -1.715 . . . . 0.0 110.426 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -71.39 36.77 0.06 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.66 -42.46 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.592 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -67.06 -48.45 59.81 Favored Glycine 0 N--CA 1.479 1.527 0 O-C-N 123.839 0.712 . . . . 0.0 114.457 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.33 115.13 0.01 OUTLIER Glycine 0 N--CA 1.478 1.454 0 O-C-N 125.171 1.159 . . . . 0.0 114.218 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -75.7 56.22 0.9 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 123.282 1.515 . . . . 0.0 112.725 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -169.73 -155.93 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.439 2.296 . . . . 0.0 109.438 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.8 pt? -53.98 -20.47 6.27 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 22.1 mmtp -55.42 -40.23 71.24 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.06 -41.95 65.34 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 170.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 mmt -68.53 -49.94 55.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.812 1.245 . . . . 0.0 112.367 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.87 81.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.183 0.993 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 68' ' ' LEU . 10.4 t -72.07 -42.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.725 173.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.65 -40.79 63.18 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -58.7 6.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.005 0.922 . . . . 0.0 112.895 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 11.7 pt20 -63.92 -36.72 84.89 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 89.0 t -68.59 -24.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.311 1.044 . . . . 0.0 112.791 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -80.54 -57.54 3.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.3 ppt_? -69.72 -39.26 76.94 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -174.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -103.5 -45.83 4.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.165 0.986 . . . . 0.0 111.802 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.3 m-85 -76.95 -28.6 55.26 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 57.77 19.41 5.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.16 -29.64 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 45.98 73.88 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.927 1.691 . . . . 0.0 115.173 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.777 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -126.53 81.01 68.91 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.9 Cg_endo -63.81 148.51 91.9 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.097 2.531 . . . . 0.0 111.07 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp 64.44 -50.74 0.3 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.651 1.98 . . . . 0.0 113.958 -172.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -51.29 -60.21 3.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.011 1.324 . . . . 0.0 113.01 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.777 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -63.96 -13.68 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.834 HD11 HG11 ' A' ' 51' ' ' VAL . 2.8 mm? -102.68 -25.22 13.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -111.17 -38.03 5.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.83 -42.47 40.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.194 0.598 . . . . 0.0 112.085 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.5 pm0 -120.9 67.64 15.32 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.16 50.33 3.46 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.81 3.674 . . . . 0.0 115.111 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.424 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -161.38 137.74 8.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.754 1.221 . . . . 0.0 110.656 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.272 0.4 OUTLIER -63.87 -22.24 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.9 -179.688 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -57.43 -61.38 2.53 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.96 -34.46 78.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.677 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.5 mt -57.66 -47.42 82.33 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.655 0.382 . . . . 0.0 111.971 171.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.07 99.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.924 0.89 . . . . 0.0 111.905 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 76' ' ' ALA . 1.2 mp0 -58.03 -40.31 80.55 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.06 -29.86 69.76 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.289 15.7 m -113.76 -60.54 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.35 36.89 0.25 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.083 1.753 . . . . 0.0 114.574 -173.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -124.02 -49.33 1.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.389 1.876 . . . . 0.0 108.925 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -32.6 5.91 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 116.42 2.008 . . . . 99.99 116.42 -171.76 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 4.4 pm0 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.097 1.759 . . . . 0.0 112.992 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -170.77 -118.9 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.344 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.483 ' CE2' ' HB ' ' A' ' 34' ' ' ILE . 22.0 t80 -50.77 -45.03 58.85 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.304 9.2 p 2.43 56.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 -170.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -113.98 102.64 55.0 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.28 -157.82 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.192 2.595 . . . . 0.0 112.559 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 1.9 m -159.07 -100.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.742 0.817 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' THR . 13.6 p30 -76.3 167.54 21.67 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.908 1.283 . . . . 0.0 112.978 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.27 -48.06 24.84 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.41 -60.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.325 1.05 . . . . 0.0 110.178 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 74' ' ' ILE . 39.3 mt-10 -58.18 -45.34 87.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -65.54 -55.81 15.74 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.621 0.768 . . . . 0.0 112.624 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.61 -43.61 98.53 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 22' ' ' ILE . 4.1 mm? -63.45 -46.52 85.84 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.56 82.01 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.2 tt0 -58.7 -59.17 5.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.291 1.436 . . . . 0.0 111.498 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 19' ' ' LEU . 19.9 pt -62.18 -35.75 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 4.8 m95 -56.62 -59.09 5.51 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.424 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 18.0 pt-20 -61.25 -27.77 68.69 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -64.3 0.89 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.582 1.153 . . . . 0.0 112.289 168.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.82 -37.68 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.921 1.689 . . . . 0.0 113.298 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.1 tt -58.6 -23.58 59.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.337 1.455 . . . . 0.0 113.707 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.31 84.45 0.83 Allowed Glycine 0 N--CA 1.475 1.245 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.266 13.9 p -16.16 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 127.77 2.428 . . . . 0.0 116.039 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 24.0 p -146.01 -74.11 0.22 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 112.81 -1.995 . . . . 0.0 115.0 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 140.04 111.14 0.91 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 33' ' ' GLY . 11.1 pt -113.27 -82.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' H ' HG13 ' A' ' 32' ' ' ILE . . . 120.95 -169.37 14.25 Favored Glycine 0 N--CA 1.479 1.535 0 C-N-CA 123.871 0.748 . . . . 0.0 112.753 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.631 ' HA ' HG22 ' A' ' 74' ' ' ILE . 49.0 mt -53.71 -46.47 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.61 -24.65 67.69 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.39 -149.67 0.42 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.553 1.141 . . . . 0.0 109.014 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 5.3 t-20 -115.43 13.02 16.42 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 164.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.2 p90 41.23 14.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -135.77 -68.77 0.5 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.714 1.206 . . . . 0.0 112.417 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 27' ' ' LEU . 21.1 pt20 -68.53 32.21 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -118.44 -37.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.386 1.074 . . . . 0.0 112.932 174.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -76.68 -44.96 14.03 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.343 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.46 -179.2 2.77 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 122.278 0.932 . . . . 0.0 113.286 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -121.82 56.57 1.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.67 1.224 . . . . 0.0 111.641 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -173.54 -159.4 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.199 1.8 . . . . 0.0 111.063 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -53.3 -20.69 4.55 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.7 mmmt -45.94 -59.8 2.62 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.356 1.062 . . . . 0.0 113.285 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.23 -37.77 56.14 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.8 mmm -65.34 -50.05 67.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.431 1.092 . . . . 0.0 112.326 175.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.34 82.04 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.432 1.093 . . . . 0.0 112.573 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 68' ' ' LEU . 26.1 t -65.98 -47.09 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 118.698 -0.667 . . . . 0.0 110.537 171.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.41 -41.94 66.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 118.356 0.525 . . . . 0.0 112.402 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -56.1 26.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.129 0.972 . . . . 0.0 113.239 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.6 pt20 -64.44 -37.99 89.46 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 62' ' ' GLU . 75.0 t -64.96 -37.36 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.951 0.9 . . . . 0.0 111.629 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -63.0 -44.2 96.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 19.6 ptp180 -86.5 -44.44 11.96 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.87 -28.99 13.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.01 1.324 . . . . 0.0 112.911 -173.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -97.99 -22.81 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -48.56 0.41 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.568 2.747 . . . . 0.0 115.025 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.04 32.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.648 2.379 . . . . 0.0 116.897 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.715 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.7 pt-20 -10.08 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 119.718 3.229 . . . . 0.0 119.718 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -122.11 85.09 46.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.5 Cg_endo -65.22 150.13 87.85 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.779 2.319 . . . . 0.0 111.105 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.0 tp 66.05 -49.83 0.41 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.021 2.128 . . . . 0.0 114.623 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.38 -58.79 5.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.353 1.061 . . . . 0.0 113.014 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -63.69 -16.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 51' ' ' VAL . 47.5 mt -97.54 -25.39 15.17 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.08 -37.85 3.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.91 -49.59 19.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 4.3 pm0 -128.72 52.7 9.56 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 174.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 95.9 Cg_endo -63.99 -23.59 67.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 116.214 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.5 p -68.03 132.6 47.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.348 0.659 . . . . 0.0 110.095 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.339 0.4 OUTLIER -61.27 -19.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.982 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -57.24 -63.84 1.09 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.864 0.866 . . . . 0.0 109.727 165.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -63.0 -37.93 89.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.332 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.9 mt -55.9 -46.72 78.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.139 0.576 . . . . 0.0 111.903 171.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.82 -40.08 96.3 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.5 mp0 -61.97 -43.39 98.95 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.39 -25.37 67.99 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.303 30.8 m -114.88 -65.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.77 57.92 2.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 123.348 1.547 . . . . 0.0 111.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.2 m -165.65 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.86 2.464 . . . . 0.0 108.604 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -107.67 -30.9 8.32 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 175.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 125.623 1.569 . . . . 99.99 115.072 176.917 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.7 pt-20 . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.2 -153.35 0.55 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.947 0.499 . . . . 0.0 109.976 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -160.32 -45.27 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.187 0.995 . . . . 0.0 111.049 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 17.6 p90 -63.98 40.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 11.5 p -80.82 89.17 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.131 0.967 . . . . 0.0 112.309 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.18 87.29 4.73 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.516 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.39 161.05 47.43 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.385 2.724 . . . . 0.0 112.975 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -78.52 0.58 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.824 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -114.58 -173.71 2.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 112.54 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -59.31 3.56 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 0.0 113.166 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.23 -50.97 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.61 1.164 . . . . 0.0 110.932 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -51.48 -59.75 3.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.723 1.209 . . . . 0.0 113.318 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -69.04 -45.42 70.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -57.33 -53.66 55.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.381 1.472 . . . . 0.0 110.977 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -38.92 92.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.29 85.14 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.82 -49.97 75.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.55 1.14 . . . . 0.0 111.456 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.78 -53.88 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.16 0.984 . . . . 0.0 110.632 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -55.45 -53.12 60.22 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.17 0.988 . . . . 0.0 113.192 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.671 ' HB3' HG13 ' A' ' 32' ' ' ILE . 12.5 pt-20 -60.72 -33.12 72.42 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -70.29 -58.94 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.43 1.081 . . . . 0.0 113.097 169.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.01 -40.18 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.025 1.33 . . . . 0.0 113.326 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.9 tt -60.96 -26.49 67.58 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.272 . . . . 0.0 113.986 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.55 73.47 0.12 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.278 12.7 p -2.12 80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.481 2.712 . . . . 0.0 116.933 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.4 m -134.14 -108.02 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.001 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -176.86 101.45 0.16 Allowed Glycine 0 N--CA 1.48 1.612 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -96.79 -163.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . -131.09 161.4 23.53 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mm -55.54 -44.39 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.253 1.021 . . . . 0.0 111.777 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 37.3 tp -58.45 -29.61 66.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 169.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 41' ' ' ILE . 21.8 m-20 58.69 175.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.806 1.643 . . . . 0.0 112.389 -171.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.61 1.61 45.29 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.0 p90 49.8 0.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 120.086 3.365 . . . . 0.0 120.086 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -108.28 -84.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.913 1.285 . . . . 0.0 110.401 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG3' HD11 ' A' ' 27' ' ' LEU . 2.4 pt20 -68.74 22.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 72' ' ' PRO . 2.3 pp -98.56 -31.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.961 0.504 . . . . 0.0 111.418 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.618 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.71 -47.09 92.91 Favored Glycine 0 N--CA 1.479 1.53 0 O-C-N 124.152 0.908 . . . . 0.0 113.706 170.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.46 104.41 0.01 OUTLIER Glycine 0 N--CA 1.479 1.51 0 CA-C-N 114.361 -0.919 . . . . 0.0 115.279 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -73.88 58.13 0.64 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.738 1.615 . . . . 0.0 114.286 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 m -172.64 -154.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.25 2.22 . . . . 0.0 110.468 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.63 -18.27 1.69 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 8.8 mptt -48.48 -47.5 38.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.343 1.057 . . . . 0.0 112.01 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.77 66.61 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -71.66 -45.92 60.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.674 1.189 . . . . 0.0 112.74 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.78 78.22 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.743 0.817 . . . . 0.0 112.22 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 82.2 t -65.99 -48.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.267 1.027 . . . . 0.0 110.568 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -51.97 -41.3 62.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.36 -60.91 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.056 0.942 . . . . 0.0 112.937 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 7.1 pt20 -60.7 -36.8 79.69 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 88.3 t -68.11 -30.36 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 0.0 113.194 176.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -78.76 -55.31 5.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.113 0.565 . . . . 0.0 111.989 171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -76.35 -35.09 58.91 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -111.27 -36.94 5.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.138 0.975 . . . . 0.0 112.84 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.8 m-85 -82.69 -28.73 30.39 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 57.69 7.42 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.31 -18.83 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 50.38 58.58 5.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 1.7 pt? -130.82 86.68 51.59 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.4 Cg_endo -64.21 151.1 86.81 Favored 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 123.098 2.532 . . . . 0.0 111.665 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 tp 67.75 -37.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.556 1.943 . . . . 0.0 115.26 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -55.37 -71.99 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.044 0.938 . . . . 0.0 111.213 173.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.698 HG12 HE22 ' A' ' 71' ' ' GLN . 22.5 m -76.47 58.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-O 123.162 1.458 . . . . 0.0 111.93 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.618 ' HG ' ' HA2' ' A' ' 42' ' ' GLY . 44.5 tp -168.35 -54.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.242 -171.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.7 -45.77 8.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.74 88.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.979 0.511 . . . . 0.0 111.979 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.698 HE22 HG12 ' A' ' 67' ' ' VAL . 8.7 mp0 -115.2 81.09 7.78 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.074 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HA ' HD11 ' A' ' 41' ' ' ILE . 37.9 Cg_endo -82.08 36.92 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.113 2.542 . . . . 0.0 113.974 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -160.74 134.45 6.87 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.193 1.397 . . . . 0.0 110.728 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.273 0.5 OUTLIER -65.73 -22.92 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.842 179.8 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -59.52 -51.58 69.25 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.958 0.345 . . . . 0.0 110.973 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.03 83.97 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 93.5 mt -58.37 -44.3 88.79 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.6 89.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.142 0.977 . . . . 0.0 112.159 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.29 -31.36 72.46 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.22 -19.95 60.97 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 77' ' ' LEU 0.275 14.0 m -114.87 -69.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.75 61.25 4.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.656 1.693 . . . . 0.0 111.142 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.4 m -164.53 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.121 2.169 . . . . 0.0 108.286 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.541 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.52 -33.19 7.12 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 176.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 116.947 2.203 . . . . 99.99 116.947 -177.277 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.9 pp20? . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.82 25.12 15.07 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -46.67 -33.1 3.98 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 t80 174.76 -70.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.843 1.657 . . . . 0.0 110.937 -173.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG22 ' HA2' ' A' ' 33' ' ' GLY . 3.0 t 62.73 88.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 126.904 2.081 . . . . 0.0 112.286 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.6 88.91 35.79 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.054 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.09 152.29 80.24 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 123.209 2.606 . . . . 0.0 113.167 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.549 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -112.33 -85.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.713 179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -108.93 -176.85 3.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.181 0.593 . . . . 0.0 111.265 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -53.65 14.29 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 118.13 -0.938 . . . . 0.0 113.141 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.53 -52.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.947 0.899 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.716 ' HA ' HD12 ' A' ' 74' ' ' ILE . 53.9 mm-40 -51.8 -59.62 4.1 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.297 1.039 . . . . 0.0 112.336 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -66.27 -50.36 63.99 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -63.92 -46.94 82.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.753 1.221 . . . . 0.0 112.034 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.09 -37.64 84.33 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.4 89.82 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 44.5 tt0 -59.77 -50.68 72.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.848 1.259 . . . . 0.0 111.419 171.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.52 -50.52 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.861 0.864 . . . . 0.0 110.298 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 5.5 m95 -57.01 -54.91 41.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.9 pt-20 -58.0 -30.21 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -74.96 -60.24 2.38 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.781 1.301 . . . . 0.0 111.862 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.13 -37.14 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.762 1.625 . . . . 0.0 113.195 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 6.9 tt -58.65 -19.66 41.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.85 1.66 . . . . 0.0 114.38 173.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.04 69.23 0.4 Allowed Glycine 0 N--CA 1.476 1.321 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.269 12.3 p 3.85 78.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 128.402 2.681 . . . . 0.0 115.611 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -121.18 -49.17 2.19 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 112.67 -2.059 . . . . 0.0 115.289 -168.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 106.1 84.42 1.72 Allowed Glycine 0 N--CA 1.48 1.628 0 O-C-N 123.748 0.655 . . . . 0.0 112.331 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.573 HD13 HD13 ' A' ' 27' ' ' LEU . 9.4 pt -113.67 153.86 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -68.25 158.44 52.16 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 113.496 -1.683 . . . . 0.0 113.27 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 10' ' ' ALA . 46.9 mm -45.45 -39.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.251 1.42 . . . . 0.0 112.261 166.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.6 tp -56.49 -31.77 64.36 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.92 1.688 . . . . 0.0 114.626 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 6.8 m-20 61.68 162.14 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.03 1.732 . . . . 0.0 111.627 -169.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.04 4.25 1.29 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.264 54.7 p90 48.96 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -175.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -109.11 -74.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.133 1.773 . . . . 0.0 112.558 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.411 ' HG3' HD11 ' A' ' 27' ' ' LEU . 12.8 pt20 -73.08 33.58 0.07 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -100.92 -37.4 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.97 -30.48 4.8 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.274 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.43 -172.96 7.22 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-O 122.627 1.126 . . . . 0.0 113.849 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -116.97 53.9 0.88 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.911 -1.144 . . . . 0.0 111.862 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.444 ' HB3' HD23 ' A' ' 46' ' ' LEU . 3.8 m -173.49 -166.83 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.701 1.6 . . . . 0.0 112.39 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 45' ' ' SER . 1.9 pt? -50.64 -22.5 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.579 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 12.4 mmmt -42.34 -49.41 5.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.068 1.347 . . . . 0.0 112.07 168.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.57 71.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.795 1.238 . . . . 0.0 114.132 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -69.39 -45.7 68.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.215 1.006 . . . . 0.0 112.319 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.39 91.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.584 0.754 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 68' ' ' LEU . 40.8 t -64.96 -46.65 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.701 172.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -52.58 -42.52 64.59 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -58.11 -48.26 80.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 0.0 112.28 174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.38 -43.65 98.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 0.0 112.343 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.8 t -59.52 -34.58 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.153 1.381 . . . . 0.0 112.986 176.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -72.99 -39.55 65.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.519 HH21 ' HB1' ' A' ' 53' ' ' ALA . 2.1 ptt180 -91.12 -53.31 4.42 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.77 -29.01 22.65 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 113.041 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 54.8 m-85 -103.23 -18.24 14.98 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -38.95 0.13 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.811 2.444 . . . . 0.0 117.47 -174.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.29 -22.89 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 127.67 2.388 . . . . 0.0 115.476 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 59.74 152.33 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.862 2.465 . . . . 0.0 116.4 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt 65.9 150.26 0.12 Allowed Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 126.032 1.733 . . . . 0.0 115.47 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 83.4 Cg_endo -68.1 172.93 10.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.036 1.824 . . . . 0.0 110.881 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 69' ' ' PHE . 8.0 tt 70.25 -40.28 0.46 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.188 1.795 . . . . 0.0 114.653 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -48.92 -92.36 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.054 2.141 . . . . 0.0 112.283 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 13.8 p -89.1 62.18 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 123.431 1.586 . . . . 0.0 109.304 171.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 tp -157.51 -76.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 112.589 -2.096 . . . . 0.0 112.924 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.722 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 20.6 m-85 -77.82 -41.4 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.325 0.65 . . . . 0.0 112.508 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.22 73.18 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.08 81.92 60.51 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 166.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 44.5 Cg_endo -78.22 30.56 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.641 2.894 . . . . 0.0 116.339 -172.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -139.93 131.85 27.7 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.397 1.479 . . . . 0.0 109.835 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.285 0.4 OUTLIER -63.64 -21.69 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.65 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.3 tmmt? -57.24 -56.15 25.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.514 0.726 . . . . 0.0 110.495 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.07 73.55 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.9 mt -54.4 -48.59 71.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.432 0.693 . . . . 0.0 112.533 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.96 96.54 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -32.72 73.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -71.64 -21.69 61.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 77' ' ' LEU 0.281 29.8 m -110.27 -69.35 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.41 56.12 3.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.599 1.666 . . . . 0.0 111.797 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 m -156.55 -61.41 0.1 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.882 -1.963 . . . . 0.0 108.843 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.639 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -102.27 -32.71 9.92 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 116.201 1.926 . . . . 99.99 116.201 177.239 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 40.1 mt-10 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.45 ' HB3' ' N ' ' A' ' 33' ' ' GLY . . . -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.827 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -102.03 -40.0 7.05 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.761 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 10.7 p90 -67.75 42.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 9.6 p -86.62 90.35 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 122.018 0.913 . . . . 0.0 112.071 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -111.03 87.53 7.21 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.916 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.07 144.84 38.51 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.081 2.521 . . . . 0.0 113.223 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -75.55 0.47 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.467 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -116.58 -172.97 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.061 0.945 . . . . 0.0 112.486 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.06 57.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.157 0.983 . . . . 0.0 113.468 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -55.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.025 0.93 . . . . 0.0 110.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.5 mm-40 -51.12 -57.48 8.6 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.34 1.056 . . . . 0.0 113.597 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 t -65.1 -54.4 30.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 65.5 tttp -60.96 -46.36 91.03 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.035 0.934 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.86 -40.97 95.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.219 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 41.8 tt0 -59.64 -54.91 40.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.63 1.172 . . . . 0.0 111.545 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -52.83 -49.84 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.671 1.188 . . . . 0.0 110.593 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.491 ' HB3' HD11 ' A' ' 32' ' ' ILE . 20.1 m95 -53.71 -65.15 0.62 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.459 1.104 . . . . 0.0 111.907 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HB3' HG12 ' A' ' 32' ' ' ILE . 12.3 pt-20 -57.45 -29.63 64.36 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -72.63 -66.79 0.62 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.255 1.422 . . . . 0.0 111.919 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.31 -35.45 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.837 1.255 . . . . 0.0 113.342 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.51 -19.35 47.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.583 . . . . 0.0 114.089 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.37 71.9 0.2 Allowed Glycine 0 N--CA 1.476 1.364 0 C-N-CA 124.18 0.895 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.7 p 0.65 82.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.502 2.721 . . . . 0.0 115.878 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 21.7 m -123.38 -81.62 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.863 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.21 96.95 0.57 Allowed Glycine 0 N--CA 1.478 1.457 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 24' ' ' GLU . 11.8 pt -124.37 -177.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 114.608 -0.796 . . . . 0.0 112.312 -171.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 9' ' ' VAL . . . -112.41 166.11 12.15 Favored Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.906 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' ALA . 41.3 mm -55.16 -45.27 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.092 1.357 . . . . 0.0 112.324 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 36.3 tp -61.21 -18.27 57.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.851 1.661 . . . . 0.0 114.408 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 11.1 m-20 60.21 -163.95 0.23 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.162 1.785 . . . . 0.0 110.412 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -108.63 22.94 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.188 0.518 . . . . 0.0 110.967 165.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.6 p90 36.5 16.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 121.565 3.913 . . . . 0.0 121.565 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -119.83 -76.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 111.642 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -73.66 31.61 0.08 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -106.22 -38.12 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.338 0.655 . . . . 0.0 112.251 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.54 -55.08 27.39 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.193 0.933 . . . . 0.0 113.359 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.87 114.22 0.01 OUTLIER Glycine 0 N--CA 1.478 1.447 0 O-C-N 125.348 1.263 . . . . 0.0 114.867 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -78.66 59.76 2.57 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.917 1.341 . . . . 0.0 112.543 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -174.96 -157.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.816 2.446 . . . . 0.0 110.358 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -54.2 -17.58 2.98 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.2 mmtt -46.1 -52.65 11.7 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.229 1.011 . . . . 0.0 113.06 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.11 -38.43 62.62 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -68.98 -48.55 62.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.454 1.102 . . . . 0.0 112.674 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.7 84.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.895 0.878 . . . . 0.0 112.47 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 63.7 t -63.9 -50.21 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.133 0.973 . . . . 0.0 110.099 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.6 63.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.522 0.729 . . . . 0.0 112.912 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.03 -57.17 13.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.896 0.878 . . . . 0.0 112.878 173.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 6.6 pt20 -66.16 -36.93 84.41 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 61.3 t -64.44 -29.52 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.298 1.039 . . . . 0.0 112.304 174.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -79.85 -67.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.8 0.44 . . . . 0.0 111.598 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.514 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -65.61 -35.98 82.38 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -171.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -107.68 -34.28 7.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.568 0.747 . . . . 0.0 112.938 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.1 m-30 -87.46 -25.73 23.6 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 69.47 -43.61 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 129.049 2.94 . . . . 0.0 115.964 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 85' ' ' SER . 12.9 p -59.54 -21.25 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HA ' HG12 ' A' ' 55' ' ' VAL . 27.5 tt0 47.62 79.56 0.06 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 2.1 pt? -136.69 83.71 29.18 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 169.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -65.75 150.05 86.41 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.328 2.686 . . . . 0.0 111.952 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.2 tt 65.65 -41.58 0.34 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.812 2.045 . . . . 0.0 114.546 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -51.1 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.935 1.694 . . . . 0.0 112.183 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 63' ' ' LEU . 9.4 p -84.69 64.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.514 1.626 . . . . 0.0 110.049 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD22 HG11 ' A' ' 51' ' ' VAL . 55.7 tp -163.48 -63.69 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.219 -175.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 22.8 m-85 -79.94 -57.47 3.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.46 1.104 . . . . 0.0 112.706 174.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.89 71.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.282 0.633 . . . . 0.0 112.696 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -123.01 82.09 50.79 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.247 1.019 . . . . 0.0 111.099 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -82.76 31.89 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.376 2.717 . . . . 0.0 115.143 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 4.1 t -148.31 135.75 20.53 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.239 1.015 . . . . 0.0 111.307 -171.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.279 0.4 OUTLIER -63.97 -23.54 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.467 -178.905 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -52.94 -62.25 1.77 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.298 1.039 . . . . 0.0 110.485 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.37 80.51 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.821 -1.082 . . . . 0.0 113.912 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD12 HG12 ' A' ' 74' ' ' ILE . 32.1 mt -58.25 -47.29 84.03 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.727 0.411 . . . . 0.0 110.934 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.03 92.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.41 1.084 . . . . 0.0 112.841 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.596 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -60.27 -36.63 78.24 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 3.1 m-85 -73.34 -39.84 64.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 171.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.627 HG11 ' CD2' ' A' ' 59' ' ' TYR 0.251 26.2 m -105.95 -28.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -170.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.71 50.71 0.94 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.982 1.373 . . . . 0.0 109.834 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 90.6 m -162.27 -61.74 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.574 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.6 -33.18 7.1 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 170.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 38.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 116.732 2.123 . . . . 99.99 116.732 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.84 -135.04 0.06 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.331 1.452 . . . . 0.0 110.163 166.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -172.55 -66.74 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.569 1.547 . . . . 0.0 108.515 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -66.75 47.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.673 2.789 . . . . 0.0 117.117 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -96.13 87.24 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 122.346 1.069 . . . . 0.0 111.871 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 83.87 15.45 Favored Pre-proline 0 N--CA 1.477 0.893 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.857 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -67.98 133.07 27.97 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.074 2.516 . . . . 0.0 113.401 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -78.49 -77.6 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.673 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.56 -174.46 2.57 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.125 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -57.21 4.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.643 1.177 . . . . 0.0 113.388 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.81 -51.66 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.722 0.809 . . . . 0.0 111.813 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HA ' HD12 ' A' ' 74' ' ' ILE . 26.0 mm-40 -52.06 -57.07 10.62 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.691 0.797 . . . . 0.0 112.504 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.2 -53.33 46.39 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.199 0.999 . . . . 0.0 113.501 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -55.6 -48.57 74.66 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 111.292 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.1 mm? -69.68 -44.21 70.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.28 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.44 78.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.4 tt0 -59.74 -59.64 5.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.306 1.442 . . . . 0.0 111.523 172.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.267 2.7 pp -61.12 -36.85 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.461 ' HB3' HD11 ' A' ' 32' ' ' ILE . 6.7 m95 -59.75 -54.91 40.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.993 172.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB3' HG12 ' A' ' 32' ' ' ILE . 13.6 pt-20 -60.49 -29.85 69.33 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -71.69 -66.84 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.682 1.593 . . . . 0.0 111.933 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 47' ' ' LYS . 62.1 t -63.86 -34.3 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.219 1.808 . . . . 0.0 113.763 -172.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 32' ' ' ILE . 7.6 tt -56.54 -24.82 49.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.598 1.159 . . . . 0.0 113.812 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.77 75.43 0.49 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.289 12.2 p -4.47 83.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 128.247 2.619 . . . . 0.0 116.208 -178.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 m -116.7 -39.04 3.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.113 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.2 91.46 1.08 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -169.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 27' ' ' LEU . 47.3 pt -111.09 -143.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.63 -174.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.41 -150.58 5.65 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 122.747 1.193 . . . . 0.0 113.772 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 58.3 mt -93.99 -61.12 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 111.685 -2.258 . . . . 0.0 108.757 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.31 -29.77 66.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.157 1.383 . . . . 0.0 113.34 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 58.33 -148.24 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.882 1.273 . . . . 0.0 109.517 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -99.49 13.9 31.74 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.64 0.587 . . . . 0.0 111.351 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.26 35.5 p90 41.23 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 121.636 3.939 . . . . 0.0 121.636 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -96.05 -79.69 0.44 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.889 1.276 . . . . 0.0 112.816 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -74.33 35.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -112.83 -35.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.61 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.27 -54.66 35.47 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 123.876 0.735 . . . . 0.0 112.546 171.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.39 97.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.122 -1.039 . . . . 0.0 115.399 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -74.41 63.55 1.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.17 1.388 . . . . 0.0 112.809 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 14.0 m -171.79 -153.03 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.838 2.455 . . . . 0.0 109.635 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.41 ' H ' ' HB3' ' A' ' 45' ' ' SER . 1.7 pt? -51.79 -22.57 3.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 26' ' ' VAL . 3.9 mmpm? -46.43 -48.55 18.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.76 -1.114 . . . . 0.0 113.814 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.27 65.3 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.95 -51.48 54.67 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.595 1.158 . . . . 0.0 112.606 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.15 92.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 0.0 112.664 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.492 HG11 HD13 ' A' ' 68' ' ' LEU . 91.2 t -63.1 -47.12 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.329 1.052 . . . . 0.0 110.007 174.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.58 -45.25 69.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.73 75.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.447 0.699 . . . . 0.0 112.707 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -64.62 -39.26 93.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.095 0.958 . . . . 0.0 113.514 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.868 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 86.3 t -69.58 -30.13 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.989 1.315 . . . . 0.0 112.882 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 17.1 t-160 -76.11 -40.18 53.49 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -76.11 -91.23 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.664 1.186 . . . . 0.0 112.575 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.92 -30.09 67.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.929 1.692 . . . . 0.0 114.381 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.868 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.2 m-30 -98.23 -18.43 18.42 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tt0 57.69 -45.16 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -170.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 59' ' ' TYR . 2.7 t -59.31 -12.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.598 1.959 . . . . 0.0 115.208 -171.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 48.41 44.88 20.65 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 167.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -113.26 88.86 13.34 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.2 Cg_endo -65.87 152.8 80.51 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.427 2.752 . . . . 0.0 112.0 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tt 64.97 -43.73 0.33 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.705 2.002 . . . . 0.0 114.833 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.45 -69.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.563 1.145 . . . . 0.0 111.889 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.15 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 123.923 1.821 . . . . 0.0 111.224 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 51' ' ' VAL . 55.1 tp -153.66 -78.06 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.32 -46.51 60.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.82 -31.56 72.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -124.71 75.65 64.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.876 0.871 . . . . 0.0 112.064 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.78 54.26 4.39 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.574 2.182 . . . . 0.0 113.396 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -169.16 131.34 1.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.161 1.384 . . . . 0.0 111.044 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.487 HG22 HG23 ' A' ' 34' ' ' ILE 0.321 0.5 OUTLIER -62.88 -20.49 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.948 179.724 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -58.64 -52.8 64.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.564 0.746 . . . . 0.0 111.022 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -40.2 77.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.69 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 73' ' ' THR . 60.6 mt -57.98 -48.51 79.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 0.0 112.582 176.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.0 96.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.01 0.924 . . . . 0.0 112.341 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 0.6 OUTLIER -62.1 -31.66 72.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 174.158 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.71 -35.37 62.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 169.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 77' ' ' LEU . 27.4 m -110.27 -26.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 119.023 2.971 . . . . 0.0 119.023 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.3 22.42 12.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.405 1.082 . . . . 0.0 113.816 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 79' ' ' GLN . 19.4 m -123.55 -59.39 1.54 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.499 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.624 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -98.13 -31.05 12.31 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 115.527 -2.178 . . . . 99.99 115.763 173.48 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 1.4 pm0 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.35 33.77 13.64 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -45.91 -33.86 3.52 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -177.54 -68.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.175 1.39 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t 61.2 78.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 172.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 87.23 56.46 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.941 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 149.3 82.87 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.269 2.646 . . . . 0.0 113.054 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.05 -80.77 0.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.794 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -111.89 -174.87 2.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.431 1.092 . . . . 0.0 112.089 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.9 -61.94 1.63 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.588 1.155 . . . . 0.0 113.478 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.89 -48.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.238 1.015 . . . . 0.0 111.548 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 74' ' ' ILE . 29.2 mm-40 -52.56 -58.05 8.03 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.36 1.064 . . . . 0.0 112.714 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -67.73 -48.77 65.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.001 0.92 . . . . 0.0 112.978 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 22' ' ' ILE . 49.8 tptt -55.15 -53.57 54.32 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.391 1.476 . . . . 0.0 110.961 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.549 HD21 ' HG2' ' A' ' 58' ' ' GLU . 4.6 mm? -63.96 -45.62 88.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.3 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.81 79.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 35.4 tt0 -60.29 -61.99 2.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.602 1.561 . . . . 0.0 111.551 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' LYS 0.274 37.6 pt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.066 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.3 m95 -59.22 -59.35 5.61 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.692 168.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.2 pt-20 -58.75 -32.16 69.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -65.43 -68.39 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.519 1.528 . . . . 0.0 111.112 171.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.36 -37.05 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.724 1.61 . . . . 0.0 113.482 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.35 -21.0 61.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.1 61.42 0.16 Allowed Glycine 0 N--CA 1.477 1.407 0 O-C-N 124.167 0.917 . . . . 0.0 112.265 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.259 9.2 p 19.49 66.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 127.874 2.469 . . . . 0.0 114.757 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -107.06 -61.77 1.5 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.577 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 113.94 89.42 1.72 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.557 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.3 pt -127.97 -153.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.69 -148.31 7.02 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.561 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.874 ' HA ' HG22 ' A' ' 74' ' ' ILE . 1.9 mp -47.86 -69.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 111.551 -2.324 . . . . 0.0 113.0 -172.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.49 -15.15 48.52 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.99 -143.24 0.73 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.323 1.449 . . . . 0.0 108.861 -172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -112.14 18.15 18.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 163.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 48.7 p90 39.72 15.85 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -173.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -131.03 -82.18 0.53 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.518 1.527 . . . . 0.0 111.572 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.25 -40.52 11.61 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -28.14 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.42 65.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.543 1.068 . . . . 0.0 114.039 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.84 96.39 2.46 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 123.937 0.433 . . . . 0.0 113.768 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 1.22 1.62 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.9 m 177.03 -150.02 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.87 2.468 . . . . 0.0 109.715 -165.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.83 -7.12 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.48 -31.57 6.56 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 173.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.05 45.27 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -65.26 -48.98 71.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.452 1.101 . . . . 0.0 111.722 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.64 90.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.031 0.932 . . . . 0.0 112.47 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 68' ' ' LEU . 61.6 t -61.77 -52.22 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.595 0.758 . . . . 0.0 110.014 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.51 -39.87 71.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.03 0.932 . . . . 0.0 113.152 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.39 -50.51 72.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.54 0.736 . . . . 0.0 112.481 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.88 -44.92 96.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.98 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 59.6 t -66.63 -32.28 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.081 0.952 . . . . 0.0 112.495 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 1.5 t60 -68.89 -42.95 76.26 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -82.45 -61.98 1.74 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' HD21 ' A' ' 19' ' ' LEU . 5.1 tp10 -77.28 -32.98 55.89 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.393 1.477 . . . . 0.0 113.327 -175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 1.7 m-85 -101.59 -9.44 20.96 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 27.0 tt0 62.53 -55.39 0.15 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.076 2.551 . . . . 0.0 115.413 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.15 4.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 126.462 1.905 . . . . 0.0 115.421 -166.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.285 15.0 pt-20 54.36 -38.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 121.545 3.905 . . . . 0.0 121.545 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.4 pt? -22.32 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 128.523 2.729 . . . . 0.0 118.201 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 72.6 Cg_endo -67.21 147.37 78.67 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.026 2.484 . . . . 0.0 111.273 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 66.04 -38.58 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.584 1.954 . . . . 0.0 115.466 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -53.47 -73.84 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.22 52.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 124.043 1.877 . . . . 0.0 111.618 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 51' ' ' VAL . 56.8 tp -154.31 -79.4 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.57 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.0 -43.8 98.36 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.59 67.5 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.92 71.16 7.18 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 112.666 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 56.1 Cg_endo -79.98 40.04 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.755 2.97 . . . . 0.0 114.921 -172.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -147.9 131.26 16.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.321 1.848 . . . . 0.0 109.576 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.874 HG22 ' HA ' ' A' ' 34' ' ' ILE 0.285 0.5 OUTLIER -61.34 -21.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.865 -179.771 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.11 -60.87 2.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.583 1.153 . . . . 0.0 110.112 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 79' ' ' GLN . . . -69.59 -34.84 74.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.468 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 79.1 mt -58.86 -47.24 85.6 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.82 96.29 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.953 0.901 . . . . 0.0 112.378 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -55.92 -51.96 65.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 0.0 112.019 169.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.309 6.6 m -108.41 -72.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.42 64.46 3.51 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.371 1.557 . . . . 0.0 112.78 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 77.5 m -166.7 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.399 2.68 . . . . 0.0 108.702 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -110.19 -29.5 8.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 176.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.517 -1.706 . . . . 99.99 115.424 -177.235 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 tpt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 122.882 1.325 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.75 -146.44 16.35 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t 62.84 130.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 125.696 1.598 . . . . 0.0 112.233 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 5' ' ' GLU . 10.0 t -104.13 -40.49 6.14 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -125.11 -166.11 1.49 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.681 0.792 . . . . 0.0 112.578 -172.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.86 25.05 4.93 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 118.286 2.698 . . . . 0.0 118.286 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 5.2 tp-100 -46.26 -36.04 5.81 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.1 t80 177.2 -60.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.162 0.985 . . . . 0.0 111.699 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 57.33 79.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.139 2.176 . . . . 0.0 113.68 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -131.33 89.44 41.08 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.493 169.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.76 -152.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.596 2.864 . . . . 0.0 113.792 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.82 -83.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.666 0.786 . . . . 0.0 109.343 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -109.65 -175.19 2.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.487 1.115 . . . . 0.0 112.203 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.91 -58.24 5.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.435 1.094 . . . . 0.0 113.171 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.19 -49.87 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.207 1.003 . . . . 0.0 111.307 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HA ' HD12 ' A' ' 74' ' ' ILE . 19.9 mm-40 -50.6 -62.67 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.661 1.184 . . . . 0.0 113.068 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 t -67.98 -47.28 69.0 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.909 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 22' ' ' ILE . 45.3 tptt -61.69 -47.06 87.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.83 0.852 . . . . 0.0 111.616 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -68.02 -36.58 80.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.07 85.51 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.113 0.415 . . . . 0.0 111.649 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 38.2 tt0 -58.62 -55.11 39.36 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.544 1.538 . . . . 0.0 111.829 171.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.7 mm -55.27 -51.04 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.207 1.003 . . . . 0.0 110.892 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.3 m95 -55.98 -55.95 26.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.943 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.6 pt-20 -61.2 -28.04 68.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -76.69 -61.15 2.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.324 1.05 . . . . 0.0 111.59 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG12 ' HZ3' ' A' ' 47' ' ' LYS . 93.3 t -60.64 -40.69 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.602 1.561 . . . . 0.0 112.637 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 23.4 tp -61.09 -19.3 61.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.984 1.313 . . . . 0.0 114.238 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.71 0.92 Allowed Glycine 0 N--CA 1.474 1.187 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 p -13.83 90.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.422 2.289 . . . . 0.0 115.53 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.493 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 16.7 p -141.89 -69.37 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 112.816 -1.993 . . . . 0.0 114.501 -174.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 126.99 94.72 0.89 Allowed Glycine 0 N--CA 1.48 1.617 0 O-C-N 123.943 0.777 . . . . 0.0 112.58 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 5' ' ' GLU . 21.8 pt -101.74 -177.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.822 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -105.37 171.67 18.76 Favored Glycine 0 N--CA 1.477 1.368 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.119 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 10' ' ' ALA . 39.7 mm -57.33 -48.65 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.353 1.061 . . . . 0.0 111.884 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.2 -6.53 2.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.881 1.673 . . . . 0.0 114.399 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 54.46 -154.06 0.28 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.715 2.006 . . . . 0.0 110.059 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -101.24 13.74 34.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.258 -0.276 . . . . 0.0 111.311 166.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.256 50.1 p90 37.56 5.38 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -116.38 -79.25 0.59 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.768 1.227 . . . . 0.0 111.741 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -53.6 -31.55 47.41 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 118.588 2.811 . . . . 0.0 118.588 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -32.7 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -66.93 -53.18 28.32 Favored Glycine 0 CA--C 1.538 1.488 0 O-C-N 124.076 0.86 . . . . 0.0 112.659 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.63 105.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -75.08 53.88 0.64 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.498 1.519 . . . . 0.0 114.118 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.5 p -163.59 -146.92 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.629 1.972 . . . . 0.0 109.002 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -54.41 -25.24 23.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 61.7 mmtt -50.22 -55.38 15.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.338 1.055 . . . . 0.0 113.72 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 -42.79 38.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.48 -53.02 39.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.46 1.104 . . . . 0.0 112.988 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.161 0.985 . . . . 0.0 112.889 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 ' CH2' ' A' ' 23' ' ' TRP . 46.1 t -66.27 -42.9 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.649 0.78 . . . . 0.0 110.18 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.05 -42.25 72.47 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -56.83 -46.67 81.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -64.09 -46.92 82.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.643 1.177 . . . . 0.0 112.579 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 59.5 t -61.45 -28.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.167 1.387 . . . . 0.0 112.318 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.24 -77.92 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.625 0.77 . . . . 0.0 110.727 166.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 9.1 ptt180 -59.72 -37.87 80.1 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -172.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.49 -30.51 9.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-30 -93.92 -27.44 16.38 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 61.73 1.91 0.66 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.842 2.457 . . . . 0.0 116.684 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.07 -12.44 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.94 41.53 3.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 120.076 3.362 . . . . 0.0 120.076 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -109.82 93.01 13.59 Favored Pre-proline 0 N--CA 1.482 1.138 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.4 Cg_endo -66.35 149.67 84.84 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.493 2.795 . . . . 0.0 111.97 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.7 tt 60.98 -46.87 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.251 2.22 . . . . 0.0 114.917 -174.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -55.97 -65.47 0.59 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.722 1.209 . . . . 0.0 112.436 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -62.65 -25.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.524 HD23 ' HA2' ' A' ' 42' ' ' GLY . 7.5 mp -72.21 -41.6 66.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.951 1.7 . . . . 0.0 113.579 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -103.71 -39.54 6.64 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.63 62.44 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.582 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 11.3 mp0 -119.57 61.93 6.81 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.944 0.498 . . . . 0.0 111.654 171.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 22.2 Cg_endo -79.87 38.17 0.72 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.175 3.25 . . . . 0.0 114.081 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -157.15 131.72 8.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.142 2.177 . . . . 0.0 108.864 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.289 0.5 OUTLIER -62.37 -21.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.244 179.925 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.67 -53.62 56.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.343 0.657 . . . . 0.0 110.69 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.8 74.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 83.9 mt -55.35 -48.97 73.44 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.51 0.724 . . . . 0.0 112.579 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.35 93.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.003 0.921 . . . . 0.0 112.717 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.03 -26.93 68.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -77.72 -27.03 50.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 59' ' ' TYR . 32.8 m -116.35 -30.18 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 -174.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.42 56.13 0.8 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.477 1.608 . . . . 0.0 109.89 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 m -162.35 -65.55 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.988 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.645 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -101.53 -33.17 10.04 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 114.823 1.416 . . . . 99.99 114.823 172.491 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ttt . . . . . 0 CA--C 1.553 1.088 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.67 77.33 0.63 Allowed Glycine 0 N--CA 1.478 1.48 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 171.43 -51.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 130.375 3.47 . . . . 0.0 110.768 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 t -176.09 -144.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.944 1.698 . . . . 0.0 108.91 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 8.0 mm-40 -57.05 -54.39 47.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.986 2.114 . . . . 0.0 111.481 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.76 -179.8 4.98 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.061 1.745 . . . . 0.0 114.508 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -168.58 -99.51 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.06 1.744 . . . . 0.0 108.903 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.43 -57.28 12.85 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t 56.25 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 126.352 1.861 . . . . 0.0 113.897 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.08 98.24 33.53 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 168.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.75 -154.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.752 2.968 . . . . 0.0 113.994 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.438 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -159.73 -85.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.003 0.521 . . . . 0.0 110.202 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.438 ' H ' ' HB ' ' A' ' 12' ' ' THR . 38.8 p-10 -107.9 -176.89 3.19 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.389 0.676 . . . . 0.0 111.481 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.15 -51.98 16.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.295 1.038 . . . . 0.0 113.071 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.37 -54.53 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.512 1.125 . . . . 0.0 111.46 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 74' ' ' ILE . 22.3 mm-40 -49.93 -59.9 3.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.233 . . . . 0.0 112.255 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.1 m -65.17 -44.85 87.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 22' ' ' ILE . 47.0 tptt -57.98 -58.51 8.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.413 1.485 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.81 -33.77 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -57.21 -45.17 84.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.1 -48.95 79.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.557 1.143 . . . . 0.0 111.763 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 18' ' ' LYS . 42.0 mm -54.44 -54.77 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.099 0.96 . . . . 0.0 110.685 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.481 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 11.6 m95 -56.56 -53.32 58.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.882 0.873 . . . . 0.0 113.332 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 27' ' ' LEU . 21.1 pt-20 -60.27 -30.12 69.24 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -77.01 -63.72 1.3 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.972 1.42 . . . . 0.0 111.148 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.6 -43.45 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.498 1.519 . . . . 0.0 113.204 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -65.56 -14.98 62.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.31 72.46 0.18 Allowed Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.552 1.157 . . . . 0.0 110.789 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.274 12.9 p -10.45 87.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 128.314 2.646 . . . . 0.0 116.968 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 48.9 m -139.19 -50.66 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.299 -1.773 . . . . 0.0 115.496 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 125.57 3.0 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 20' ' ' ALA . 2.5 pp -125.72 165.17 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 113.07 0.766 . . . . 0.0 113.07 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.34 162.4 14.41 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.295 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.97 -40.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.321 0.648 . . . . 0.0 111.734 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.2 -21.07 58.89 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 167.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.649 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.1 m-20 56.96 -163.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.441 1.897 . . . . 0.0 111.788 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -101.58 1.11 37.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.295 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.307 53.5 p90 53.97 -38.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -171.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.09 -81.57 0.06 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.364 1.466 . . . . 0.0 112.252 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.19 21.98 0.07 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -173.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 36' ' ' ASP . 2.5 pp -101.23 -44.95 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.22 -40.9 60.66 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.964 0.79 . . . . 0.0 113.642 170.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.69 116.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.671 1.029 . . . . 0.0 115.671 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -82.55 46.63 1.08 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.924 -1.638 . . . . 0.0 114.041 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.8 p -150.48 -150.51 0.35 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.848 1.659 . . . . 0.0 109.608 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.56 -18.65 7.9 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 33.3 mmtp -48.49 -51.14 28.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.055 0.942 . . . . 0.0 112.261 172.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.14 -47.03 62.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 ptm -70.53 -41.6 72.32 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.86 97.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.292 0.637 . . . . 0.0 112.483 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' LYS . 40.7 t -66.08 -47.64 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.915 0.886 . . . . 0.0 109.7 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.81 -39.84 62.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.89 -57.3 12.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.682 0.793 . . . . 0.0 112.775 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.32 -34.69 78.92 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.939 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 92.0 t -64.7 -27.82 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.653 1.181 . . . . 0.0 112.908 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 18.6 t-160 -77.13 -63.21 1.42 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.72 0.808 . . . . 0.0 112.166 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.2 ptt85 -70.92 -38.98 72.95 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.22 -36.38 6.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.625 0.77 . . . . 0.0 112.745 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.939 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m-85 -84.81 -27.92 26.48 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 34.2 tt0 65.69 -36.39 0.23 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.174 2.589 . . . . 0.0 116.661 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 t -57.73 -23.45 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.311 1.444 . . . . 0.0 114.646 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.8 tm-20 45.89 67.92 0.67 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -136.96 87.4 19.16 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.0 Cg_endo -64.82 148.05 89.81 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.431 2.754 . . . . 0.0 112.096 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 6.5 tt 62.37 -43.96 0.18 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.403 2.281 . . . . 0.0 114.584 -172.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.16 -68.76 0.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.248 1.419 . . . . 0.0 113.117 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.87 12.93 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.7 -41.65 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 111.935 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 53.1 m-85 -106.83 -45.87 4.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.027 1.331 . . . . 0.0 113.329 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.86 73.68 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -120.24 65.53 11.1 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 170.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 19.6 Cg_endo -80.24 27.55 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.571 2.847 . . . . 0.0 114.973 -170.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -139.68 136.31 34.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.617 1.167 . . . . 0.0 110.568 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.278 0.4 OUTLIER -61.85 -19.77 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.752 175.879 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.63 -61.9 2.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 0.0 110.348 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.46 80.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 88.3 mt -58.03 -46.55 85.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.146 0.578 . . . . 0.0 112.262 172.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.62 85.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.277 1.031 . . . . 0.0 112.755 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -62.3 -40.6 96.84 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 170.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 2.8 m-85 -66.81 -39.23 87.64 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 171.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 77' ' ' LEU . 24.0 m -99.59 -40.37 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.87 50.9 0.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.174 1.464 . . . . 0.0 110.451 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 69.0 m -160.26 -55.11 0.06 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.553 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.05 -35.02 5.79 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 169.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 116.009 -1.948 . . . . 99.99 116.027 175.105 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.77 140.36 5.97 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.837 -169.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.272 16.1 m -12.94 78.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 119.46 3.133 . . . . 0.0 119.46 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 t -86.32 -37.23 18.7 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.33 -1.759 . . . . 0.0 112.638 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.2 pm0 -61.09 -174.56 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.365 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.43 -71.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.607 1.963 . . . . 0.0 111.903 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.306 4.8 pt20 46.38 -56.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -175.99 -65.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.674 1.59 . . . . 0.0 111.471 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 11' ' ' PRO . 3.7 t 57.99 95.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 126.339 1.856 . . . . 0.0 112.888 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.85 81.58 19.39 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 9' ' ' VAL . 75.9 Cg_endo -67.67 147.59 76.25 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 122.904 2.403 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -80.31 0.59 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.475 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -113.86 -176.51 2.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 112.335 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.25 19.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.253 1.021 . . . . 0.0 113.585 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.94 -54.22 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.161 0.984 . . . . 0.0 110.424 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 74' ' ' ILE . 11.1 mm-40 -49.26 -59.62 3.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.678 1.191 . . . . 0.0 113.339 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -68.34 -51.12 48.0 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 83.1 tttt -64.48 -40.68 96.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.976 . . . . 0.0 112.425 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.39 -43.86 84.71 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.69 172.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.06 77.74 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.0 tt0 -57.2 -57.05 14.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.499 1.519 . . . . 0.0 111.721 170.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.266 2.5 pp -62.64 -36.99 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 177.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 32' ' ' ILE . 7.4 m95 -56.69 -58.11 9.51 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 112.119 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.499 ' HB3' ' H ' ' A' ' 32' ' ' ILE . 20.5 pt-20 -59.85 -30.02 68.68 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -71.48 -62.65 1.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.195 1.398 . . . . 0.0 112.033 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.9 -37.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 125.713 1.605 . . . . 0.0 113.251 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.535 HD11 ' HG3' ' A' ' 40' ' ' GLN . 7.9 tt -57.86 -23.16 51.65 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.006 1.323 . . . . 0.0 113.488 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.58 73.24 0.39 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.6 p 1.62 79.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 128.244 2.618 . . . . 0.0 116.304 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -123.52 -47.31 1.98 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -172.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 104.14 91.9 2.23 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 23' ' ' TRP . 6.5 pt -119.96 167.17 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 120.727 0.299 . . . . 0.0 111.117 -174.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.73 168.97 24.09 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 123.116 1.398 . . . . 0.0 113.901 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.7 mm -48.68 -36.6 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 111.833 -2.184 . . . . 0.0 112.804 173.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' THR . 2.9 mm? -68.12 -20.11 64.88 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.57 1.548 . . . . 0.0 114.307 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 58.77 -156.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.721 1.608 . . . . 0.0 109.865 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -119.1 13.38 12.92 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 36.87 34.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -152.49 -81.42 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.775 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' HD11 ' A' ' 27' ' ' LEU . 1.7 pt20 -70.94 29.91 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.82 -40.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -64.34 -40.3 97.73 Favored Glycine 0 N--CA 1.48 1.603 0 O-C-N 123.813 0.696 . . . . 0.0 113.279 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.69 149.64 0.11 Allowed Glycine 0 N--CA 1.477 1.4 0 O-C-N 125.101 1.118 . . . . 0.0 114.022 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -93.05 45.95 1.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 113.627 -1.286 . . . . 0.0 112.189 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.8 m -174.94 -159.76 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.28 1.832 . . . . 0.0 111.38 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -58.04 -5.44 0.45 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.9 mptt -52.63 -51.97 57.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.066 0.947 . . . . 0.0 110.901 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.74 60.93 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.0 mmt -68.74 -47.41 66.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.967 0.907 . . . . 0.0 112.896 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.99 80.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.497 0.719 . . . . 0.0 111.835 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 45.5 t -64.87 -47.81 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.024 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.37 -42.82 64.27 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.803 0.729 . . . . 0.0 112.225 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.661 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -60.48 -52.18 66.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.631 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.3 pt20 -65.01 -38.94 92.59 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.9 t -67.56 -28.64 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.498 1.119 . . . . 0.0 112.203 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -66.51 -59.25 3.82 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.327 167.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.661 HH21 ' HB1' ' A' ' 53' ' ' ALA . 11.6 ptp180 -71.84 -46.46 57.98 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -173.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -100.41 -30.69 11.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.632 1.573 . . . . 0.0 112.609 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -94.65 -30.83 14.12 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.9 12.72 2.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.275 2.23 . . . . 0.0 115.998 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 59' ' ' TYR . 3.5 t -116.39 12.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 121.172 0.511 . . . . 0.0 111.867 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.61 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.1 pm0 6.99 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.0 pt? -121.31 87.18 44.38 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 63' ' ' LEU . 69.4 Cg_endo -65.65 154.78 72.29 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 123.02 2.48 . . . . 0.0 111.214 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.5 tt 66.53 -44.45 0.42 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.639 1.976 . . . . 0.0 114.332 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.59 -61.11 2.52 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.406 0.682 . . . . 0.0 112.776 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.57 -8.93 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.622 HD13 ' HA2' ' A' ' 42' ' ' GLY . 65.7 mt -104.72 -24.49 12.93 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.306 1.443 . . . . 0.0 114.871 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 74.3 m-85 -117.91 -40.92 2.94 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.41 -49.12 14.09 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.609 0.764 . . . . 0.0 112.801 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -121.43 59.18 8.86 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.2 Cg_endo -75.35 19.18 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.335 3.357 . . . . 0.0 116.777 -170.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 80.7 p -120.86 137.36 54.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.333 0.5 OUTLIER -63.19 -20.99 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.956 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -52.55 -66.33 0.4 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.759 1.224 . . . . 0.0 109.567 165.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.98 85.79 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.173 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 89.5 mt -58.18 -44.75 88.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.313 0.645 . . . . 0.0 112.648 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.31 98.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.5 0.72 . . . . 0.0 112.34 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.2 mp0 -62.35 -39.89 94.61 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 172.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -71.44 -29.84 65.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.275 33.4 m -116.83 -41.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.62 57.27 1.01 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 123.335 1.54 . . . . 0.0 109.476 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.1 m -165.46 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.205 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.561 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.2 -31.16 8.01 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.969 1.47 . . . . 99.99 114.969 176.869 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.11 -151.73 21.93 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 p -22.67 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 127.231 2.213 . . . . 0.0 116.444 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -115.64 -25.49 7.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.891 -1.959 . . . . 0.0 114.675 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -125.06 178.49 5.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.371 -170.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.11 72.01 0.3 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.243 1.817 . . . . 0.0 115.187 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.535 ' OE1' ' HA ' ' A' ' 37' ' ' ASN . 39.2 tt0 -78.7 -75.43 0.23 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.946 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -121.54 -44.58 2.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' H ' ' HA2' ' A' ' 33' ' ' GLY . 5.3 t 48.94 82.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.444 1.898 . . . . 0.0 114.057 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.36 88.47 54.27 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.865 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.48 149.97 75.07 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 122.988 2.459 . . . . 0.0 112.642 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -122.35 -84.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.843 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.3 p-10 -109.9 -178.02 3.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.606 0.762 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.06 -45.54 43.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.87 -58.79 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.06 0.944 . . . . 0.0 110.392 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 74' ' ' ILE . 52.5 mm-40 -51.08 -56.03 14.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.261 1.024 . . . . 0.0 112.604 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.84 -57.85 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.164 0.986 . . . . 0.0 113.537 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 21.0 ttpp -66.51 -36.55 82.98 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.83 -45.94 76.68 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.601 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.71 78.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 40.8 tt0 -56.57 -58.8 6.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.474 1.51 . . . . 0.0 111.229 170.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.268 2.6 pp -60.89 -38.39 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.81 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 32' ' ' ILE . 11.4 m95 -55.85 -59.08 5.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.505 0.722 . . . . 0.0 112.266 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.533 ' HB3' HG12 ' A' ' 32' ' ' ILE . 11.8 pt-20 -62.43 -30.29 71.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -75.9 -58.19 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.02 0.928 . . . . 0.0 112.335 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.09 -35.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.963 1.305 . . . . 0.0 112.557 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.33 -21.34 59.62 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.51 72.1 0.29 Allowed Glycine 0 N--CA 1.476 1.333 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.4 p 0.91 80.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 128.484 2.714 . . . . 0.0 116.187 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 m -119.74 -70.44 0.79 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.098 -172.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 123.75 101.98 1.51 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.533 HG12 ' HB3' ' A' ' 24' ' ' GLU . 24.6 pt -125.05 167.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' H ' ' A' ' 9' ' ' VAL . . . -71.37 157.91 53.48 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.911 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -57.01 -40.99 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.727 -0.737 . . . . 0.0 112.273 164.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD23 ' HB ' ' A' ' 73' ' ' THR . 4.3 mt -68.61 13.52 0.09 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 162.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.2 m-20 50.76 -140.48 0.84 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.143 1.777 . . . . 0.0 110.348 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.535 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 17.6 t-20 -115.77 22.67 12.89 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.194 0.521 . . . . 0.0 111.05 154.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.255 53.1 p90 42.11 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 1 N-CA-C 122.135 4.124 . . . . 0.0 122.135 -178.523 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -112.8 -84.02 0.59 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.065 1.346 . . . . 0.0 112.335 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -48.24 -31.84 6.41 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' ASP . 2.6 pp -62.42 -34.31 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.97 75.2 Favored Glycine 0 N--CA 1.478 1.447 0 O-C-N 123.9 0.75 . . . . 0.0 113.029 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.98 127.08 0.01 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 53.38 2.63 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.516 -2.342 . . . . 0.0 112.555 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 17.0 m -169.89 -152.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.052 1.741 . . . . 0.0 110.369 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 49' ' ' MET . 1.9 pt? -51.32 -22.13 2.64 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.8 mptt -48.19 -62.1 1.65 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.917 1.287 . . . . 0.0 111.818 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.23 -45.66 44.89 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 2.1 ptm -69.81 -41.34 75.14 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.09 86.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.159 0.584 . . . . 0.0 112.06 171.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 68' ' ' LEU . 6.0 t -67.82 -43.75 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.576 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.39 -42.58 64.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.552 0.615 . . . . 0.0 112.385 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -59.1 -51.73 68.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 10.5 pt20 -66.68 -38.58 87.09 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 62' ' ' GLU . 96.3 t -67.83 -27.31 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.657 1.183 . . . . 0.0 112.254 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -70.34 -61.46 1.76 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.385 0.274 . . . . 0.0 111.445 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.634 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 15.0 ptp180 -65.38 -42.05 93.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -173.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -107.15 -32.74 7.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.868 1.267 . . . . 0.0 113.076 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.5 m-85 -94.69 -20.58 19.42 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 61.96 -47.69 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.68 28.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 55' ' ' VAL . 14.5 pt-20 -9.9 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.637 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -123.44 82.69 52.97 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 69.4 Cg_endo -66.11 148.39 85.24 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 123.401 2.734 . . . . 0.0 111.52 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.0 tt 63.31 -47.84 0.23 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.731 2.012 . . . . 0.0 113.563 -172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -46.24 -66.82 0.35 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.068 1.747 . . . . 0.0 112.207 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -68.27 -4.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.774 HD11 HG11 ' A' ' 51' ' ' VAL . 3.1 mm? -107.86 -31.45 8.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -175.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 58.0 m-85 -107.8 -37.27 6.17 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.78 -44.17 56.77 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.55 0.34 . . . . 0.0 111.856 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.1 pm0 -123.21 71.83 45.69 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 62.3 Cg_endo -76.57 38.33 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.567 3.511 . . . . 0.0 115.924 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.6 t -144.44 133.55 22.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.569 1.548 . . . . 0.0 110.59 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.277 0.4 OUTLIER -63.91 -23.11 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.544 178.878 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.6 tmmt? -55.59 -61.96 2.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.85 0.86 . . . . 0.0 110.131 170.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.6 76.23 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.707 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 96.3 mt -56.09 -47.46 77.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.79 0.436 . . . . 0.0 112.154 171.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.55 94.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.523 0.729 . . . . 0.0 112.866 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -61.03 -43.51 98.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.15 -26.49 67.45 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.329 7.2 m -114.98 -73.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.81 64.48 0.67 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 123.471 1.605 . . . . 0.0 112.563 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 88.4 m -169.4 -53.53 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 129.075 2.95 . . . . 0.0 108.622 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -115.97 -28.91 6.5 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 175.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.465 2.024 . . . . 99.99 116.465 -175.274 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.95 -133.1 40.25 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.26 79.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 122.631 1.205 . . . . 0.0 113.223 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.7 t -95.88 -40.15 9.45 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.585 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HG2' ' H ' ' A' ' 6' ' ' ALA . 7.9 pm0 -63.18 -76.32 0.07 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.784 1.634 . . . . 0.0 113.062 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.693 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -72.15 172.15 10.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.721 1.208 . . . . 0.0 112.957 164.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -169.54 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.739 1.616 . . . . 0.0 107.422 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -60.92 -64.03 1.1 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG22 ' HA2' ' A' ' 33' ' ' GLY . 2.8 t 57.55 82.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 126.49 1.916 . . . . 0.0 113.456 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.01 91.6 49.06 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.063 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.38 143.21 47.2 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.121 2.547 . . . . 0.0 113.696 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -106.02 -81.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.911 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -116.44 -174.36 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.91 -57.01 6.25 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.099 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.6 -52.41 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.323 1.049 . . . . 0.0 111.023 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.58 ' HA ' HD12 ' A' ' 74' ' ' ILE . 3.7 mt-10 -55.08 -60.32 3.53 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 t -64.33 -43.68 93.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.003 0.815 . . . . 0.0 113.197 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -57.74 -57.03 14.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 110.659 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.35 -38.71 92.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -59.24 -41.99 90.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 44.9 tt0 -60.73 -50.82 71.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.734 1.214 . . . . 0.0 111.573 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -54.82 -54.24 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.962 0.905 . . . . 0.0 110.357 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -56.2 -52.45 64.36 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.312 -0.852 . . . . 0.0 113.015 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 32' ' ' ILE . 14.9 pt-20 -60.75 -30.26 69.89 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -74.26 -62.47 1.5 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.2 -45.76 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.785 1.634 . . . . 0.0 113.412 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 41' ' ' ILE . 10.1 tt -56.14 -25.61 46.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.086 1.754 . . . . 0.0 113.87 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.89 81.5 0.33 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.265 13.1 p -17.02 92.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.959 2.504 . . . . 0.0 116.197 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 p -149.86 -49.0 0.14 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 113.139 -1.846 . . . . 0.0 115.933 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.36 119.01 2.32 Favored Glycine 0 N--CA 1.481 1.664 0 O-C-N 123.695 0.622 . . . . 0.0 111.758 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.4 pp -121.66 158.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -87.17 152.23 24.32 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.695 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm -50.02 -40.32 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.318 1.047 . . . . 0.0 112.445 168.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -50.46 -34.4 24.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.583 1.553 . . . . 0.0 113.786 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.561 ' HB3' HG21 ' A' ' 41' ' ' ILE . 8.2 m-20 61.17 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.356 -168.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 40' ' ' GLN . 26.5 t-20 -57.17 -22.04 37.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.562 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.282 38.0 p90 60.42 -7.47 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.8 -71.97 0.74 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.424 1.09 . . . . 0.0 112.261 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.451 ' HG2' ' OD1' ' A' ' 37' ' ' ASN . 9.1 pt20 -72.69 11.79 0.59 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -69.54 -51.48 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 68' ' ' LEU . . . -135.01 14.85 4.32 Favored Glycine 0 CA--C 1.541 1.709 0 O-C-N 124.288 0.993 . . . . 0.0 114.559 167.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.97 62.31 4.39 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -125.18 -130.22 0.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.473 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 p -110.01 -86.42 0.53 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.771 0.828 . . . . 0.0 111.273 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.89 -18.95 37.8 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -56.1 -36.35 68.07 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.97 74.15 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.59 -48.2 67.51 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.906 1.282 . . . . 0.0 112.483 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.59 85.76 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.26 -49.52 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.176 0.99 . . . . 0.0 110.225 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.52 -41.36 66.29 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -54.52 43.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.363 1.065 . . . . 0.0 112.367 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.86 -43.63 90.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.338 1.055 . . . . 0.0 112.896 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.761 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 48.2 t -68.1 -25.58 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.81 1.244 . . . . 0.0 113.353 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -85.2 -27.01 26.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -97.64 -56.19 2.59 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.25 -32.17 17.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.642 1.177 . . . . 0.0 112.315 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.761 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.3 m-85 -85.72 -33.18 21.55 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 58.02 3.65 0.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.16 10.99 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 55' ' ' VAL . 30.4 tt0 15.47 81.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.8 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.4 pt? -128.39 77.59 76.89 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 64.8 Cg_endo -64.57 145.95 88.2 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 123.361 2.707 . . . . 0.0 111.987 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 64' ' ' PRO 0.281 3.0 pp 58.75 -39.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.843 2.457 . . . . 0.0 115.861 -170.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HD3' ' HB2' ' A' ' 63' ' ' LEU . 75.2 tttt -52.8 -65.6 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.065 2.146 . . . . 0.0 110.517 176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.8 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 3.0 p -61.94 -22.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 57.3 tp -95.4 -26.88 15.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.803 1.641 . . . . 0.0 115.123 -166.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -114.88 -38.96 3.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.386 1.074 . . . . 0.0 113.603 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.35 49.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' CD ' ' HA ' ' A' ' 67' ' ' VAL . 10.7 pm0 -121.56 59.45 9.52 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.8 Cg_endo -75.63 24.32 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.953 3.769 . . . . 0.0 116.68 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.5 t -126.0 138.85 53.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 110.159 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.258 0.4 OUTLIER -60.64 -27.39 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.548 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -55.16 -55.37 31.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.386 0.675 . . . . 0.0 110.855 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -69.87 -40.19 75.88 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 82.1 mt -55.2 -46.34 75.9 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.535 0.734 . . . . 0.0 112.173 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.51 85.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.179 0.992 . . . . 0.0 112.317 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.79 -32.75 74.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -69.47 -16.08 63.4 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 77' ' ' LEU 0.274 15.6 m -117.72 -71.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 175.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 61.11 3.16 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.797 1.761 . . . . 0.0 111.622 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.1 m -165.44 -57.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.616 2.367 . . . . 0.0 108.338 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.77 -27.88 7.98 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 177.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.575 -1.679 . . . . 99.99 115.149 -174.535 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.41 165.52 11.81 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.309 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t 69.13 140.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.268 1.427 . . . . 0.0 112.595 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 t -115.58 -45.31 2.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.784 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.6 pm0 -59.75 179.54 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.028 1.331 . . . . 0.0 114.121 168.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.61 21.03 5.39 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -38.76 -35.74 0.22 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 119.373 3.101 . . . . 0.0 119.373 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.8 t80 176.96 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.072 1.349 . . . . 0.0 110.697 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.9 t 65.72 93.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 127.092 2.157 . . . . 0.0 112.785 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -129.68 82.15 67.8 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.784 169.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 137.38 32.56 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.602 2.201 . . . . 0.0 112.539 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -76.37 0.55 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.612 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -118.84 -176.49 3.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.618 1.167 . . . . 0.0 112.582 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.11 54.25 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -57.08 -56.22 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.346 1.058 . . . . 0.0 110.022 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' ILE . 6.3 mm-40 -48.96 -56.38 9.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.895 1.278 . . . . 0.0 113.555 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 t -67.42 -55.04 15.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.158 0.983 . . . . 0.0 113.561 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 37.9 ttpt -64.18 -38.67 91.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.854 0.862 . . . . 0.0 112.889 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -65.24 -45.83 83.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.759 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.75 76.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.8 tt0 -57.92 -58.88 6.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.211 1.404 . . . . 0.0 111.677 171.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 19' ' ' LEU . 2.5 pp -61.5 -38.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.06 -57.39 12.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 0.0 112.161 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.665 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 pt-20 -61.18 -31.55 71.3 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -69.38 -62.0 1.56 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.752 1.282 . . . . 0.0 111.927 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' HE3' ' A' ' 47' ' ' LYS . 99.4 t -61.6 -37.88 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.576 1.551 . . . . 0.0 113.193 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.69 -25.5 60.39 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.377 1.071 . . . . 0.0 113.623 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.4 62.19 0.14 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.155 0.909 . . . . 0.0 111.587 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.262 10.3 p 16.67 67.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 127.888 2.475 . . . . 0.0 114.997 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 60.6 m -109.9 -49.86 3.04 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 112.372 -2.194 . . . . 0.0 116.667 -167.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 102.96 92.07 2.21 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.665 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -117.66 159.23 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -170.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -77.24 153.3 41.15 Favored Glycine 0 N--CA 1.475 1.285 0 CA-C-N 113.889 -1.505 . . . . 0.0 113.34 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.0 mm -48.56 -40.99 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.753 1.221 . . . . 0.0 113.121 167.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.13 -14.09 33.51 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.705 1.602 . . . . 0.0 114.753 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.04 -158.8 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.097 2.159 . . . . 0.0 110.455 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -111.25 17.92 19.79 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.3 p90 40.51 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -124.27 -85.91 0.64 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 111.605 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -71.81 33.22 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 119.441 3.126 . . . . 0.0 119.441 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.455 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -113.02 -40.26 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.948 172.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 68' ' ' LEU . . . -60.64 -64.26 4.26 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.918 0.761 . . . . 0.0 112.966 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.55 100.05 0.14 Allowed Glycine 0 N--CA 1.476 1.361 0 CA-C-N 114.471 -0.865 . . . . 0.0 113.49 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -63.22 -36.91 85.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.34 0.656 . . . . 0.0 112.459 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -151.12 -90.4 0.06 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.398 1.479 . . . . 0.0 108.932 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -93.92 -11.0 31.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HE3' HG12 ' A' ' 26' ' ' VAL . 30.2 mttp -42.29 -37.21 1.45 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.21 -38.69 41.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 79.3 mtm -71.49 -45.37 62.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.04 88.35 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.667 0.787 . . . . 0.0 112.385 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HD21 ' A' ' 68' ' ' LEU . 5.6 t -71.27 -42.59 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.699 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -38.42 63.81 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.422 0.555 . . . . 0.0 112.406 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.56 -58.16 8.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.721 0.808 . . . . 0.0 112.525 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 12.0 pt20 -63.55 -37.48 87.49 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.863 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 94.3 t -66.03 -24.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.671 1.188 . . . . 0.0 112.93 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 12.8 t-160 -87.18 -58.35 2.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.238 0.615 . . . . 0.0 112.272 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.1 ppt_? -68.78 -37.91 79.65 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -106.64 -46.62 3.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.367 1.067 . . . . 0.0 111.759 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.863 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-85 -75.76 -32.49 59.98 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' HIS 0.25 94.6 mt-30 66.97 -31.49 0.17 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -178.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.49 -30.3 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.176 1.39 . . . . 0.0 113.47 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' A' ' 55' ' ' VAL . 25.3 tt0 47.61 79.19 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.181 1.792 . . . . 0.0 115.368 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 1.8 pt? -142.19 83.32 12.45 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.582 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -63.87 152.82 79.01 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.132 2.555 . . . . 0.0 110.939 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' H ' HD12 ' A' ' 68' ' ' LEU 0.303 3.7 pp 60.65 -41.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.7 2.4 . . . . 0.0 116.724 -172.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 63' ' ' LEU . 99.6 mttt -56.83 -67.01 0.35 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.89 1.276 . . . . 0.0 111.897 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.682 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 3.8 p -76.13 13.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 65' ' ' LEU . 94.3 mt -123.85 -35.54 2.85 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.89 -48.26 3.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.68 1.192 . . . . 0.0 110.979 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.42 76.02 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 170.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 46.3 mt-30 -121.33 55.8 5.43 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 23.2 Cg_endo -76.32 24.54 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.387 3.391 . . . . 0.0 116.58 -167.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -132.94 141.11 48.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.092 1.357 . . . . 0.0 110.169 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.273 0.4 OUTLIER -62.99 -22.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.092 178.393 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -57.82 -52.0 67.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.283 0.633 . . . . 0.0 110.793 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.43 74.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.211 1.005 . . . . 0.0 113.403 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.567 HD23 HG22 ' A' ' 67' ' ' VAL . 81.7 mt -56.02 -47.67 77.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.33 98.73 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 0.0 112.705 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.549 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -54.59 -44.95 73.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.221 1.008 . . . . 0.0 112.796 171.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' HE2' HD11 ' A' ' 63' ' ' LEU . 2.0 m-30 -71.31 -22.54 61.92 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.28 11.6 m -108.42 -70.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.18 60.0 3.52 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.416 1.579 . . . . 0.0 111.748 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 98.8 m -166.37 -60.56 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 128.202 2.601 . . . . 0.0 108.384 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.07 -27.61 7.62 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.837 2.532 . . . . 0.0 117.837 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 116.226 1.936 . . . . 99.99 116.226 -174.641 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.78 -83.04 1.63 Allowed Glycine 0 N--CA 1.477 1.379 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.914 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 m -1.22 87.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 118.371 2.73 . . . . 0.0 118.371 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -135.5 -71.85 0.47 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.749 -178.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -45.02 171.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.313 1.845 . . . . 0.0 114.978 173.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.94 35.13 11.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.893 2.077 . . . . 0.0 116.375 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -42.25 -46.73 4.58 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.6 t80 172.88 -59.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.775 1.23 . . . . 0.0 112.463 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 32' ' ' ILE 0.319 5.4 p 56.56 98.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.864 2.465 . . . . 0.0 116.199 -175.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.21 84.81 34.92 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.982 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.08 153.15 78.6 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.151 2.567 . . . . 0.0 112.744 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -129.23 -82.41 0.57 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.938 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -113.2 -177.39 3.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.758 1.223 . . . . 0.0 112.034 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -55.74 10.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.411 1.084 . . . . 0.0 113.444 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.27 -51.29 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.232 1.013 . . . . 0.0 111.089 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.736 ' HA ' HD12 ' A' ' 74' ' ' ILE . 43.2 mm-40 -50.93 -58.73 5.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.345 1.058 . . . . 0.0 112.581 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -67.94 -50.35 56.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.257 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 1.7 tpmt? -57.75 -50.38 73.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.194 1.397 . . . . 0.0 112.066 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.45 -43.79 84.6 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.747 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.96 83.82 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 44.9 tt0 -57.02 -60.28 3.82 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 110.673 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.264 2.6 pp -60.51 -36.75 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.95 -63.91 1.0 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.802 0.841 . . . . 0.0 111.552 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.727 ' HB3' HG12 ' A' ' 32' ' ' ILE . 17.9 pt-20 -61.44 -33.97 74.63 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -67.71 -63.29 1.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.137 1.375 . . . . 0.0 111.717 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.29 -30.03 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.038 1.335 . . . . 0.0 112.469 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.88 -34.8 70.17 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.24 61.96 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.434 1.084 . . . . 0.0 111.557 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.255 7.4 p 17.7 62.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 128.615 2.766 . . . . 0.0 115.272 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -102.91 -47.36 4.4 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.121 -1.854 . . . . 0.0 115.473 -165.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 24' ' ' GLU . . . 92.55 105.22 1.59 Allowed Glycine 0 N--CA 1.48 1.6 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.727 HG12 ' HB3' ' A' ' 24' ' ' GLU . 18.3 pt -120.28 -151.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.89 160.41 18.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.18 -40.48 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.96 -0.69 4.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 7.5 m-20 55.95 -145.58 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.287 1.835 . . . . 0.0 111.6 -174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -139.76 42.05 1.99 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.773 0.429 . . . . 0.0 111.835 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -6.01 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.427 2.291 . . . . 0.0 117.027 -169.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 40' ' ' GLN . 25.4 t80 173.67 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.814 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 39' ' ' PHE . 6.5 pt20 -70.83 19.33 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -104.22 -40.55 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -72.07 -32.23 63.39 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.85 166.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.99 -162.71 26.55 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.445 -0.878 . . . . 0.0 111.413 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -70.8 -44.23 67.03 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.5 p -174.83 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.2 -36.76 80.78 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.9 mmtp -58.87 -49.89 76.05 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.822 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -37.64 57.14 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -63.12 -50.72 69.36 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.548 0.739 . . . . 0.0 112.492 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 47' ' ' LYS . 95.5 t -59.2 -50.49 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.746 1.218 . . . . 0.0 110.077 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.56 -42.9 67.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.221 0.608 . . . . 0.0 112.531 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -61.2 -51.51 68.7 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 13.6 pt20 -66.98 -38.6 86.35 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 93.3 t -66.38 -30.01 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.088 . . . . 0.0 111.816 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -69.29 -68.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.692 HH21 ' HB1' ' A' ' 53' ' ' ALA . 10.9 ptp180 -59.38 -42.52 91.88 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.55 -38.93 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -170.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -78.02 -25.04 47.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 69.92 -44.84 0.57 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.639 2.776 . . . . 0.0 114.998 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.03 27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 126.663 1.985 . . . . 0.0 116.14 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 55' ' ' VAL . 13.7 pt-20 -8.93 77.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.3 pt? -125.72 91.46 48.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.6 Cg_endo -66.42 152.03 81.83 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.986 2.457 . . . . 0.0 111.891 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tt 65.15 -42.29 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.068 2.147 . . . . 0.0 116.051 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -54.1 -71.69 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG22 HD23 ' A' ' 77' ' ' LEU 0.255 4.0 p -84.63 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 123.819 1.771 . . . . 0.0 110.464 177.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 47.6 tp -162.5 -49.76 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.402 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.63 -62.59 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.527 1.131 . . . . 0.0 111.566 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.31 78.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.307 0.643 . . . . 0.0 112.624 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 38.4 mt-30 -120.9 83.2 36.71 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.201 170.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 27.0 Cg_endo -85.62 26.78 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.223 2.615 . . . . 0.0 114.776 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -136.21 136.08 39.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.033 0.533 . . . . 0.0 111.404 -171.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.264 0.4 OUTLIER -62.73 -22.34 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.911 177.268 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 18.9 tptm -58.52 -57.56 12.4 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.184 0.594 . . . . 0.0 110.097 172.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.25 -35.51 81.07 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 HG12 ' A' ' 74' ' ' ILE . 23.8 mt -59.24 -46.12 89.33 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.585 0.354 . . . . 0.0 110.876 173.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.87 85.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.065 0.946 . . . . 0.0 112.844 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.676 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -59.39 -39.93 84.97 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 169.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.81 -38.35 79.86 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 77' ' ' LEU 0.314 28.1 m -106.59 -57.18 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -178.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.38 49.27 1.72 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 122.963 1.364 . . . . 0.0 111.369 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 86.5 m -161.38 -65.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.556 1.942 . . . . 0.0 109.212 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 -30.04 8.64 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.592 1.701 . . . . 99.99 115.592 174.882 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.0 118.62 4.05 Favored Glycine 0 N--CA 1.478 1.454 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.845 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.22 92.81 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.645 0.736 . . . . 0.0 110.861 -173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 t -64.66 -34.35 78.08 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.178 170.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.0 -168.93 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.884 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.0 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.831 2.052 . . . . 0.0 111.423 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.314 5.1 pt20 46.82 -45.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 120.856 3.651 . . . . 0.0 120.856 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -175.32 -67.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.935 1.694 . . . . 0.0 111.757 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.15 84.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 126.573 1.949 . . . . 0.0 112.406 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 88.93 30.19 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.005 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.64 146.96 75.14 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.875 2.384 . . . . 0.0 112.17 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 -79.85 0.5 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -116.51 178.23 4.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.046 0.938 . . . . 0.0 111.304 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.24 37.06 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.88 -60.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.879 1.272 . . . . 0.0 110.586 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -53.08 -49.85 65.57 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.136 0.974 . . . . 0.0 112.941 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -61.68 -55.6 28.67 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.071 0.949 . . . . 0.0 113.165 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.24 -44.12 97.77 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.053 0.941 . . . . 0.0 112.242 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.63 -47.55 80.88 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.17 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 45.0 tt0 -57.84 -58.08 9.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.92 1.288 . . . . 0.0 111.942 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 pt -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -59.4 -46.55 88.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 21' ' ' GLU . 11.9 pt-20 -65.8 -26.83 67.87 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -46.42 20.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.314 1.045 . . . . 0.0 111.42 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.48 -42.4 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.683 1.593 . . . . 0.0 112.173 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 7.3 tt -55.77 -25.14 39.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.713 1.205 . . . . 0.0 114.096 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.63 87.13 1.46 Allowed Glycine 0 CA--C 1.531 1.074 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -166.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -18.15 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 127.288 2.235 . . . . 0.0 115.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 p -140.96 -52.44 0.47 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 112.77 -2.014 . . . . 0.0 114.873 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 98.22 2.06 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.736 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.52 146.63 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.532 0.682 . . . . 0.0 111.732 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.22 164.27 47.61 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.758 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -50.42 -34.57 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 113.36 -1.42 . . . . 0.0 112.598 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.87 -23.89 67.37 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.23 -175.3 0.15 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.247 1.819 . . . . 0.0 111.323 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -96.06 14.15 24.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 p90 32.36 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -162.58 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.83 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.06 43.17 0.35 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 -43.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.128 170.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.32 -51.43 43.51 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.214 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -174.23 102.14 0.17 Allowed Glycine 0 N--CA 1.476 1.331 0 O-C-N 124.526 0.78 . . . . 0.0 114.857 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -29.12 70.32 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.394 -0.903 . . . . 0.0 112.09 156.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.2 p 174.19 -93.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 130.723 3.609 . . . . 0.0 108.14 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -26.64 68.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 38.4 mttp -39.5 -38.72 0.61 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 -55.04 18.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ptm -70.96 -41.19 71.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.94 92.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.8 -39.73 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.262 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.55 -40.69 68.95 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.37 -43.78 79.51 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.518 0.727 . . . . 0.0 112.871 173.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.37 -43.22 74.0 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.813 1.245 . . . . 0.0 112.372 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 57.0 t -58.41 -31.3 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.41 1.084 . . . . 0.0 111.33 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.49 -80.06 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 165.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' C ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.9 -31.49 66.81 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 117.265 2.321 . . . . 0.0 117.265 -168.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -109.15 -37.41 5.8 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.148 0.979 . . . . 0.0 112.983 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.852 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 4.1 m-30 -94.72 -18.8 20.95 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 68.63 -39.03 0.4 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.239 2.616 . . . . 0.0 115.722 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.84 -23.49 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 125.072 1.349 . . . . 0.0 113.712 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 50.57 23.22 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 1.1 pt? -106.1 104.93 51.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -174.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.68 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.0 Cg_endo -63.73 152.63 79.66 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 123.509 2.806 . . . . 0.0 112.132 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 69' ' ' PHE . 8.5 tt 63.81 -56.65 0.21 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.7 2.0 . . . . 0.0 114.241 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.12 -64.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.431 1.493 . . . . 0.0 113.082 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.63 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 4.7 p -60.94 -29.57 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.51 -24.24 34.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 63.6 m-85 -109.33 -37.51 5.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.75 77.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.726 0.41 . . . . 0.0 111.655 173.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.4 pm0 -123.62 73.06 52.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.063 168.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.71 24.63 0.37 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.62 3.547 . . . . 0.0 117.158 -170.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t -135.2 137.0 42.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.105 1.362 . . . . 0.0 110.697 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -60.08 -26.3 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.56 175.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -58.61 -50.03 75.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.844 0.458 . . . . 0.0 110.962 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.91 68.48 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 91.4 mt -56.32 -43.16 78.71 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.955 0.902 . . . . 0.0 113.201 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.7 79.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 112.42 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 83' ' ' THR . 3.0 mp0 -66.61 -37.41 84.82 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -60.91 -17.85 53.33 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.267 16.5 m -110.75 -73.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 170.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.92 74.54 6.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.392 1.568 . . . . 0.0 111.353 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 39.0 m -173.27 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 129.409 3.084 . . . . 0.0 107.341 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.485 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -113.69 -30.18 6.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 116.148 1.907 . . . . 99.99 116.148 -177.388 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.96 89.01 0.23 Allowed Glycine 0 N--CA 1.479 1.56 0 CA-C-N 114.42 -1.264 . . . . 0.0 113.255 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.61 138.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.783 0.801 . . . . 0.0 111.993 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -133.96 -56.85 0.87 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 113.358 -1.747 . . . . 0.0 111.686 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -51.18 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.817 1.647 . . . . 0.0 114.704 166.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.91 20.39 8.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.43 -28.11 0.83 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 120.19 3.404 . . . . 0.0 120.19 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 t80 176.2 -70.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.326 1.45 . . . . 0.0 110.921 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t 62.75 85.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 126.926 2.09 . . . . 0.0 113.009 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.11 90.61 48.93 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.563 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.71 156.72 44.28 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 123.341 2.694 . . . . 0.0 113.466 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.3 -83.35 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.056 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.86 -171.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 112.457 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.79 -50.8 55.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.198 0.999 . . . . 0.0 113.467 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.7 -53.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.11 0.964 . . . . 0.0 110.235 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.72 -62.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.617 1.167 . . . . 0.0 113.176 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -64.58 -51.45 62.71 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 22' ' ' ILE . 27.7 ttpt -63.6 -45.73 89.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.584 0.754 . . . . 0.0 112.197 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.0 -39.3 90.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.87 85.34 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.209 0.459 . . . . 0.0 112.054 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 32.8 tt0 -57.33 -53.72 54.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.7 1.2 . . . . 0.0 111.068 171.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 18' ' ' LYS . 41.2 mm -53.67 -53.46 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.34 1.056 . . . . 0.0 110.638 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HB3' HD11 ' A' ' 32' ' ' ILE . 21.3 m95 -54.28 -60.4 3.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.266 1.027 . . . . 0.0 112.779 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -58.66 -31.98 68.67 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -69.87 -63.81 1.01 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 111.376 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG12 ' HE2' ' A' ' 47' ' ' LYS . 57.8 t -62.85 -36.45 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.149 1.38 . . . . 0.0 112.801 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD21 HE21 ' A' ' 40' ' ' GLN . 9.4 tt -56.92 -24.5 52.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.666 1.586 . . . . 0.0 113.956 173.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.19 71.29 0.24 Allowed Glycine 0 N--CA 1.476 1.314 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.271 12.2 p 3.52 78.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 128.475 2.71 . . . . 0.0 116.127 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 21.4 m -121.56 -67.61 0.95 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 112.597 -2.092 . . . . 0.0 116.284 -171.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 121.71 95.76 1.37 Allowed Glycine 0 N--CA 1.479 1.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 23' ' ' TRP . 14.8 pt -121.58 159.28 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 121.333 0.587 . . . . 0.0 112.526 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 9' ' ' VAL . . . -82.65 151.57 29.41 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.214 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 43.4 mm -45.49 -41.99 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.856 1.662 . . . . 0.0 112.892 171.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.49 -29.92 68.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 36.5 m-20 62.97 149.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.123 2.169 . . . . 0.0 111.858 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.55 24.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.9 p90 22.55 47.82 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 118.343 2.719 . . . . 0.0 118.343 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -160.12 -78.22 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.401 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.493 HE21 HD21 ' A' ' 27' ' ' LEU . 20.4 pt20 -70.0 27.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -115.78 -35.97 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.307 1.043 . . . . 0.0 111.698 172.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -59.26 -63.21 5.37 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 124.334 0.969 . . . . 0.0 113.398 171.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.77 121.64 0.01 OUTLIER Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.226 -1.487 . . . . 0.0 115.838 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -81.01 49.95 1.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.754 -1.723 . . . . 0.0 113.467 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -159.72 -154.04 0.38 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.502 1.921 . . . . 0.0 108.905 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -62.67 -0.87 0.7 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 26' ' ' VAL . 22.5 mmtp -56.16 -61.61 2.27 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.352 1.061 . . . . 0.0 112.748 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.65 -36.31 24.31 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.0 mmm -65.28 -52.3 55.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.598 1.159 . . . . 0.0 112.841 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.27 77.83 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.308 1.043 . . . . 0.0 112.668 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 74.0 t -62.81 -50.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.067 0.947 . . . . 0.0 110.177 171.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.97 -42.65 65.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.321 0.648 . . . . 0.0 112.566 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.46 -56.28 23.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -65.68 -38.64 89.83 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.681 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -66.55 -27.98 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 111.951 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -71.14 -69.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.806 0.443 . . . . 0.0 111.222 166.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.93 -44.01 3.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.999 0.92 . . . . 0.0 113.243 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.681 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.2 m-85 -82.62 -20.98 35.32 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -46.67 0.62 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.658 2.783 . . . . 0.0 114.189 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.77 26.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.652 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.1 pt-20 -6.72 76.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 120.29 3.441 . . . . 0.0 120.29 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -123.97 86.7 53.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 73.0 Cg_endo -66.24 150.8 84.64 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.17 2.58 . . . . 0.0 111.629 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 -48.73 0.35 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.605 1.962 . . . . 0.0 114.78 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -52.08 -69.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.616 1.566 . . . . 0.0 112.904 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.623 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -61.55 -20.46 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 HD21 ' HA2' ' A' ' 42' ' ' GLY . 59.3 tp -93.44 -29.02 15.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.258 1.823 . . . . 0.0 114.633 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -108.1 -40.33 5.24 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.607 1.163 . . . . 0.0 113.705 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.26 73.02 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.0 pm0 -122.97 70.23 39.62 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.679 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.38 32.83 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.536 3.49 . . . . 0.0 115.097 -173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.483 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 8.6 t -139.03 137.51 36.35 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.856 1.262 . . . . 0.0 111.125 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 23' ' ' TRP 0.306 3.2 mm -57.86 -27.94 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -66.19 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.991 0.807 . . . . 0.0 110.169 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.5 78.5 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 87.3 mt -58.2 -44.39 88.09 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.16 93.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 112.653 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.603 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.3 mp0 -60.83 -46.28 91.16 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 171.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -65.46 -26.97 68.18 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.316 9.5 m -112.07 -75.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 60.56 1.25 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.351 1.548 . . . . 0.0 113.428 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.4 m -161.69 -54.16 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.629 2.372 . . . . 0.0 109.05 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -106.03 -31.97 8.5 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 173.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 127.353 2.261 . . . . 99.99 116.436 -178.326 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.01 79.83 0.21 Allowed Glycine 0 N--CA 1.478 1.49 0 CA-C-N 114.409 -1.269 . . . . 0.0 113.708 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.81 129.64 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.453 -0.873 . . . . 0.0 110.424 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.9 t -125.46 -30.36 3.12 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.635 -1.62 . . . . 0.0 114.571 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 21.7 mp0 -68.35 161.44 27.44 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.721 0.809 . . . . 0.0 111.18 168.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.71 147.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.276 1.83 . . . . 0.0 113.465 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.43 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.556 -173.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -118.25 -61.73 1.63 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 11' ' ' PRO . 4.0 t 67.46 98.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 126.389 1.876 . . . . 0.0 111.553 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -121.58 78.86 38.06 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.018 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' HG12 ' A' ' 9' ' ' VAL . 72.5 Cg_endo -66.56 145.68 77.16 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.665 2.244 . . . . 0.0 112.013 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -122.76 -87.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.046 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.9 p-10 -105.26 -176.38 3.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.49 -50.39 31.83 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.061 0.944 . . . . 0.0 113.119 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.91 -58.49 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.323 1.049 . . . . 0.0 110.504 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 74' ' ' ILE . 7.5 mm-40 -49.28 -58.89 4.27 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.745 1.218 . . . . 0.0 113.277 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -67.97 -54.25 20.04 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 38.2 ttpt -64.89 -41.29 95.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.713 1.205 . . . . 0.0 113.291 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.95 -43.04 84.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.494 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.2 78.35 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 30.2 tt0 -57.92 -58.71 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.11 1.364 . . . . 0.0 111.452 171.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.259 2.6 pp -61.35 -36.13 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.8 m95 -57.47 -60.74 3.19 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.485 0.714 . . . . 0.0 111.996 170.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 13.7 pt-20 -59.13 -26.8 65.03 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -73.23 -70.48 0.36 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.808 1.243 . . . . 0.0 112.289 167.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.82 -39.91 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 125.162 1.385 . . . . 0.0 113.024 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 23' ' ' TRP . 1.5 tt -61.06 -25.89 67.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.914 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.38 0.05 OUTLIER Glycine 0 N--CA 1.478 1.463 0 O-C-N 124.106 0.879 . . . . 0.0 111.38 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.27 13.3 p -20.7 88.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.39 2.676 . . . . 0.0 116.625 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 14.4 m -149.68 -51.82 0.15 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.006 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 130.02 124.14 2.59 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.804 0.69 . . . . 0.0 112.463 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.2 pt -134.11 177.38 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.411 0.685 . . . . 0.0 110.884 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 150.88 17.27 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.762 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ALA . 49.2 mm -28.23 -42.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.672 2.389 . . . . 0.0 114.463 164.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 73' ' ' THR . 6.4 mp -62.4 -34.17 76.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.991 1.716 . . . . 0.0 114.742 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.11 146.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.136 1.774 . . . . 0.0 113.171 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.45 25.92 0.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.1 p90 21.1 49.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -167.66 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.681 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.1 -14.49 17.08 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -33.04 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.47 12.57 15.98 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.743 0.652 . . . . 0.0 113.978 169.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 39.45 -155.68 0.03 OUTLIER Glycine 0 N--CA 1.48 1.574 0 C-N-CA 124.786 1.184 . . . . 0.0 114.759 -172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -123.39 52.14 1.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.332 -1.434 . . . . 0.0 110.7 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -171.49 -162.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.839 1.656 . . . . 0.0 112.02 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -51.82 -21.7 3.08 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.0 mmtp -52.58 -43.68 65.42 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.17 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.9 mtp -69.95 -45.65 66.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.763 1.225 . . . . 0.0 112.144 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.831 0.852 . . . . 0.0 112.536 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 68' ' ' LEU . 20.7 t -67.27 -49.32 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.072 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -50.3 -39.58 45.96 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.9 -59.63 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.941 0.897 . . . . 0.0 112.339 172.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 8.3 pt20 -63.52 -31.95 73.26 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.011 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 76.1 t -62.24 -37.57 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.795 1.238 . . . . 0.0 112.748 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.4 -33.79 61.01 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.4 ptt85 -102.59 -37.65 7.86 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -108.32 -35.35 6.55 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.777 0.831 . . . . 0.0 112.403 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.3 m-85 -80.12 -28.34 38.99 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 173.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 68.25 -30.96 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.521 2.328 . . . . 0.0 115.18 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.59 -31.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 127.988 2.515 . . . . 0.0 115.785 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.723 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 24.1 tt0 66.87 141.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.326 1.85 . . . . 0.0 113.185 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.723 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 97.7 mt 65.22 154.75 0.12 Allowed Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 172.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 94.5 Cg_endo -71.51 -162.81 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.314 2.009 . . . . 0.0 111.476 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp 66.92 -51.15 0.47 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.712 2.005 . . . . 0.0 115.466 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -57.75 -85.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.779 1.632 . . . . 0.0 110.52 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 11.8 m -79.07 46.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.497 1.141 . . . . 0.0 113.885 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 51' ' ' VAL . 13.3 mt -144.36 -50.34 0.29 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.508 -1.678 . . . . 0.0 114.839 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -109.84 -49.69 3.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.018 0.927 . . . . 0.0 111.662 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.94 79.14 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.674 0.609 . . . . 0.0 111.563 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 4.5 mp0 -116.9 87.28 21.65 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.73 167.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.98 -26.68 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.674 2.25 . . . . 0.0 114.653 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 44.0 p -80.5 138.0 36.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 0.0 109.97 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.496 HG12 HD12 ' A' ' 77' ' ' LEU 0.255 0.4 OUTLIER -62.09 -23.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.913 172.584 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -59.6 -51.51 69.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.36 0.664 . . . . 0.0 111.818 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.59 95.02 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 73' ' ' THR . 51.4 mt -57.97 -46.63 84.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.389 0.676 . . . . 0.0 112.254 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -45.33 85.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.609 1.164 . . . . 0.0 112.97 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.44 -31.91 71.56 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -74.25 -22.36 59.36 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 169.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 77' ' ' LEU 0.269 32.6 m -104.25 -73.97 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -85.5 61.21 6.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 123.894 1.807 . . . . 0.0 111.196 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.4 m -161.17 -56.43 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.278 -2.237 . . . . 0.0 108.461 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.22 -30.87 6.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 175.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.595 1.702 . . . . 99.99 115.595 -175.095 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.32 -168.92 16.33 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.874 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.37 139.22 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 114.308 -0.946 . . . . 0.0 111.289 -174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -96.07 -15.38 22.24 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.372 1.082 . . . . 0.0 113.886 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -106.88 173.55 6.27 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.029 1.331 . . . . 0.0 110.507 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.51 92.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.68 1.592 . . . . 0.0 113.786 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 4.6 tp60 -98.97 -62.86 1.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.548 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -148.75 -60.57 0.23 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.857 1.263 . . . . 0.0 111.078 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 t 65.33 84.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.771 2.028 . . . . 0.0 112.598 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -128.65 85.02 61.4 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.988 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.97 143.68 61.28 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.779 2.319 . . . . 0.0 112.436 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -77.04 0.6 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.777 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' GLU . 26.1 p30 -117.04 -172.85 2.29 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.563 1.145 . . . . 0.0 112.583 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.92 -63.29 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.71 1.204 . . . . 0.0 113.169 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.17 -47.17 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.401 1.081 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.608 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.3 mm-40 -50.58 -63.54 1.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.72 1.208 . . . . 0.0 113.173 174.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 t -67.26 -45.44 76.63 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.27 -54.11 50.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.003 1.321 . . . . 0.0 111.297 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.99 -36.81 82.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.18 89.14 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.486 0.585 . . . . 0.0 112.437 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.36 -51.42 70.01 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.149 1.38 . . . . 0.0 111.278 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.85 -54.19 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.276 1.03 . . . . 0.0 110.517 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.574 ' HB3' HD11 ' A' ' 32' ' ' ILE . 9.8 m95 -55.29 -53.99 49.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.262 1.025 . . . . 0.0 113.51 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -61.51 -30.75 70.83 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.75 -56.56 4.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.325 1.05 . . . . 0.0 111.93 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.0 -38.74 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 125.501 1.52 . . . . 0.0 113.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 40' ' ' GLN . 8.0 tt -59.81 -22.84 62.75 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.334 1.453 . . . . 0.0 113.585 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.85 74.74 0.3 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.272 13.0 p 0.78 81.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 128.32 2.648 . . . . 0.0 116.397 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 m -127.36 -80.32 0.59 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 112.579 -2.101 . . . . 0.0 115.17 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.88 102.37 0.67 Allowed Glycine 0 N--CA 1.479 1.523 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' ASP . 15.3 pt -125.05 166.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -72.22 158.84 53.5 Favored Glycine 0 N--CA 1.477 1.397 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.026 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' ALA . 40.5 mm -52.9 -42.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 114.179 -1.01 . . . . 0.0 111.75 164.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.16 9.23 0.33 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 166.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 32' ' ' ILE . 6.5 m-20 55.64 -137.47 1.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.677 1.591 . . . . 0.0 109.562 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -123.41 28.85 6.87 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.836 0.454 . . . . 0.0 110.276 156.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.281 53.2 p90 35.73 -0.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 1 N-CA-C 123.402 4.593 . . . . 0.0 123.402 -174.905 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -115.34 -74.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.922 1.689 . . . . 0.0 111.276 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.536 ' HG3' HD11 ' A' ' 27' ' ' LEU . 3.8 pt20 -67.71 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -112.44 -29.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.579 0.751 . . . . 0.0 112.434 171.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -57.51 -48.08 83.61 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 123.968 0.792 . . . . 0.0 113.349 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.93 99.32 0.01 OUTLIER Glycine 0 N--CA 1.478 1.46 0 O-C-N 125.1 1.118 . . . . 0.0 113.673 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -70.39 54.56 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.378 1.871 . . . . 0.0 114.747 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -165.3 -142.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.552 2.341 . . . . 0.0 108.078 -176.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -63.31 -18.36 63.54 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.56 -48.5 71.97 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.15 60.52 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.5 mtm -69.94 -44.54 69.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.717 0.807 . . . . 0.0 112.952 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.83 79.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.472 0.709 . . . . 0.0 112.568 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LYS . 94.3 t -62.95 -50.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.018 0.927 . . . . 0.0 109.865 170.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.678 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.46 -43.58 65.04 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.416 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -56.65 -54.37 46.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.277 1.031 . . . . 0.0 113.394 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.659 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 9.2 pt20 -66.75 -37.06 83.87 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.93 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 72.5 t -65.08 -25.22 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.373 1.069 . . . . 0.0 112.587 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 3.2 t60 -81.67 -54.59 5.27 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 168.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 18.8 ptp180 -71.02 -37.7 72.61 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -110.33 -31.43 7.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.933 1.293 . . . . 0.0 112.557 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.93 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.4 m-30 -102.84 -10.3 19.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tp60 62.05 -46.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 126.371 1.868 . . . . 0.0 115.81 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 52.54 28.23 5.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 167.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -109.21 94.89 16.44 Favored Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -173.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.678 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -66.13 151.01 84.76 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 123.709 2.94 . . . . 0.0 111.889 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 9.0 tt 63.88 -44.95 0.26 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.745 2.018 . . . . 0.0 114.087 -175.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -51.85 -69.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.984 1.714 . . . . 0.0 111.555 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.642 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 3.6 p -76.46 22.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 62.9 tp -130.94 -37.22 1.31 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.018 0.927 . . . . 0.0 113.482 -169.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.554 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 26.0 m-85 -101.31 -39.41 7.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.354 1.062 . . . . 0.0 113.797 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.42 90.22 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.642 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.1 pm0 -124.87 73.12 63.91 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.53 1.132 . . . . 0.0 112.005 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -77.99 34.78 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.125 3.217 . . . . 0.0 114.754 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 t -142.02 131.95 24.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.847 1.659 . . . . 0.0 110.502 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.285 0.5 OUTLIER -63.8 -20.33 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.591 178.843 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.98 -56.63 19.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.17 0.588 . . . . 0.0 110.439 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.05 75.42 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.088 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.3 mt -58.89 -45.51 90.05 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.17 91.46 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 0.0 111.881 172.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.4 tm0? -59.47 -45.08 92.67 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.42 0.688 . . . . 0.0 112.74 171.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.51 -28.63 67.99 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.299 16.7 m -113.37 -68.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 61.53 2.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 123.228 1.49 . . . . 0.0 112.203 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 99.7 m -164.81 -69.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.951 2.501 . . . . 0.0 108.084 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.51 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -97.43 -29.08 13.7 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 115.732 -2.08 . . . . 99.99 114.336 179.233 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.89 -151.71 22.19 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.56 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.1 p -157.22 149.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.617 1.167 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 t -55.2 -38.1 67.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 21.8 mm-40 -132.08 -73.01 0.52 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.07 119.1 1.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.692 1.197 . . . . 0.0 114.045 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.56 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 63.3 tp60 -122.77 -80.07 0.62 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.793 -1.549 . . . . 0.0 112.75 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.471 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 46.0 t80 -135.38 -64.29 0.65 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t 72.15 98.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.814 2.045 . . . . 0.0 112.394 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -144.18 82.99 10.42 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.432 167.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.05 147.52 61.16 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 122.923 2.416 . . . . 0.0 112.674 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.01 -82.78 0.58 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.007 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -108.47 -177.36 3.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.718 0.807 . . . . 0.0 111.833 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.99 50.39 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.09 -59.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.761 1.224 . . . . 0.0 110.357 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.657 ' HA ' HD12 ' A' ' 74' ' ' ILE . 9.1 mm-40 -49.08 -59.57 3.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.981 1.312 . . . . 0.0 113.439 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.6 t -64.84 -56.37 13.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.085 0.954 . . . . 0.0 113.252 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 32.3 ttpt -67.14 -40.86 86.82 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.08 -40.64 94.92 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.913 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.83 84.6 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 33.4 tt0 -58.17 -53.14 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.581 1.152 . . . . 0.0 111.186 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.87 -50.96 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.327 1.051 . . . . 0.0 110.663 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -52.67 -60.11 3.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.32 1.048 . . . . 0.0 112.335 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HB3' HG13 ' A' ' 32' ' ' ILE . 15.4 pt-20 -60.13 -31.36 69.99 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -61.54 1.94 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.928 1.291 . . . . 0.0 111.865 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.21 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.28 1.032 . . . . 0.0 112.669 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 34.9 tp -62.3 -32.7 73.47 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.67 56.44 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 O-C-N 124.47 1.106 . . . . 0.0 112.94 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.276 12.1 p -0.74 75.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 128.914 2.885 . . . . 0.0 116.955 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.662 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 56.3 m -138.77 -48.0 0.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.589 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 125.05 112.14 1.9 Allowed Glycine 0 N--CA 1.477 1.406 0 O-C-N 123.714 0.634 . . . . 0.0 113.381 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -108.72 173.73 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.623 -0.789 . . . . 0.0 111.58 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -99.46 153.17 19.61 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.839 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 10' ' ' ALA . 43.5 mm -40.97 -47.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.995 1.318 . . . . 0.0 113.803 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.08 -21.07 63.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 17.7 m-20 58.98 157.46 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.603 1.961 . . . . 0.0 113.324 -172.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.95 8.92 3.29 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.6 p90 39.61 22.5 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -118.59 -85.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.776 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 40' ' ' GLN . 5.5 pm0 -59.5 -16.62 25.61 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -33.34 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.78 -53.08 0.6 Allowed Glycine 0 N--CA 1.476 1.326 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.344 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.32 -144.88 18.82 Favored Glycine 0 N--CA 1.478 1.485 0 O-C-N 124.506 0.768 . . . . 0.0 112.333 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -139.48 41.85 2.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.979 1.371 . . . . 0.0 112.991 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.3 m -130.62 -154.46 0.63 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.048 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -49.94 -33.08 16.45 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 mmtp -46.51 -73.04 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.398 1.479 . . . . 0.0 112.766 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.74 4.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.26 -53.56 35.45 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.97 91.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.909 0.884 . . . . 0.0 112.227 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 68' ' ' LEU . 27.6 t -66.87 -40.26 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.995 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.34 -45.71 72.74 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.934 0.788 . . . . 0.0 111.67 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.89 -49.87 76.14 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.387 172.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -54.56 -51.91 63.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.426 1.49 . . . . 0.0 112.446 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 60.2 t -65.68 -29.58 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.416 1.486 . . . . 0.0 112.56 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -68.1 -72.16 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.114 0.566 . . . . 0.0 111.28 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 6.3 ptt180 -64.5 -41.38 96.47 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 -173.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.35 -29.07 10.99 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.733 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.3 m-85 -94.62 -22.58 18.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 64.26 -33.78 0.15 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.664 2.468 . . . . 0.0 117.664 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -18.83 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.774 1.23 . . . . 0.0 114.168 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 47.76 39.01 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 66' ' ' LYS . 1.1 pt? -122.47 99.52 42.52 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 63.7 Cg_endo -65.6 160.76 41.64 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.3 2.666 . . . . 0.0 111.902 174.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 68' ' ' LEU . 7.3 tt 66.09 -47.57 0.42 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.971 2.108 . . . . 0.0 114.852 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HD2' HD12 ' A' ' 63' ' ' LEU . 32.7 mttp -56.75 -55.59 32.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.417 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.8 t -68.21 4.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 51' ' ' VAL . 61.0 mt -119.2 -29.66 5.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 75.0 m-85 -112.16 -38.06 4.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.89 -44.78 30.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.406 0.682 . . . . 0.0 112.244 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -119.31 67.0 9.06 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 168.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 41.5 Cg_endo -77.06 26.16 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.057 3.172 . . . . 0.0 115.802 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.2 t -137.96 136.05 36.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.988 1.315 . . . . 0.0 110.714 -171.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.271 0.4 OUTLIER -62.31 -23.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.905 178.299 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -54.87 -62.81 1.41 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.373 1.069 . . . . 0.0 110.258 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.45 -35.25 80.34 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.34 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 73' ' ' THR . 81.9 mt -57.54 -45.35 85.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.33 85.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.207 1.003 . . . . 0.0 112.834 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -63.19 -47.75 81.24 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.188 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.93 -25.41 68.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 82' ' ' ALA 0.272 5.2 m -101.13 -81.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 168.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -80.43 65.72 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.52 1.629 . . . . 0.0 112.404 -173.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.8 m -165.0 -50.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.155 2.582 . . . . 0.0 108.457 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -116.69 -30.7 5.72 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 174.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 116.639 -1.648 . . . . 99.99 115.098 -174.096 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.09 -149.72 44.71 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.523 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -156.02 164.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.845 1.258 . . . . 0.0 111.765 -174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 t -52.1 -31.27 29.91 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 2.5 pp20? -152.39 -169.71 3.43 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.718 0.807 . . . . 0.0 112.881 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.14 20.96 8.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 119.123 3.008 . . . . 0.0 119.123 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.94 -40.62 30.9 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 t80 174.54 -68.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.089 0.956 . . . . 0.0 111.235 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.6 t 66.33 93.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 127.339 2.256 . . . . 0.0 112.222 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -124.72 82.59 59.77 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.361 170.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -68.66 150.45 74.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.894 2.396 . . . . 0.0 112.696 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 -81.04 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.932 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -113.95 -174.76 2.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.276 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.56 10.1 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.197 0.999 . . . . 0.0 113.24 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.26 -52.0 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.669 1.188 . . . . 0.0 110.954 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HA ' HD12 ' A' ' 74' ' ' ILE . 15.0 mm-40 -51.02 -64.34 0.84 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.101 1.361 . . . . 0.0 113.495 175.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 t -66.91 -46.87 73.52 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 22' ' ' ILE . 51.2 tptt -60.76 -51.74 68.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.104 0.962 . . . . 0.0 111.053 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.98 -36.13 82.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.727 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.5 91.27 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.895 0.77 . . . . 0.0 112.587 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.7 tt0 -59.07 -50.43 74.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.753 1.221 . . . . 0.0 111.344 170.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.4 mm -54.7 -52.17 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 110.617 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 15.8 m95 -56.7 -54.83 41.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.346 1.058 . . . . 0.0 113.697 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.3 pt-20 -59.16 -28.27 66.44 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -77.72 -61.53 1.96 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.794 1.638 . . . . 0.0 111.602 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.24 -39.62 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.517 1.927 . . . . 0.0 113.818 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 32' ' ' ILE . 5.9 tt -58.72 -24.22 61.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.385 1.474 . . . . 0.0 113.819 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.67 0.73 Allowed Glycine 0 N--CA 1.473 1.149 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.25 13.1 p -22.52 95.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 127.404 2.282 . . . . 0.0 115.474 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.609 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 24.1 p -148.19 -58.8 0.24 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 112.608 -2.087 . . . . 0.0 114.505 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 127.69 95.58 0.88 Allowed Glycine 0 N--CA 1.48 1.594 0 O-C-N 123.824 0.702 . . . . 0.0 113.37 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.4 pt -107.57 166.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 121.441 0.639 . . . . 0.0 112.501 -174.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -88.76 160.48 30.09 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.144 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 10' ' ' ALA . 47.7 mm -45.3 -51.34 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 125.319 1.448 . . . . 0.0 112.497 170.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.17 -27.66 69.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.412 1.485 . . . . 0.0 114.398 171.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' A' ' 32' ' ' ILE . 4.4 p-10 46.07 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.26 -167.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -93.5 24.96 3.68 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 34.15 43.07 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -138.77 -82.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.426 -1.715 . . . . 0.0 110.426 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -71.39 36.77 0.06 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.66 -42.46 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.592 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -67.06 -48.45 59.81 Favored Glycine 0 N--CA 1.479 1.527 0 O-C-N 123.839 0.712 . . . . 0.0 114.457 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.33 115.13 0.01 OUTLIER Glycine 0 N--CA 1.478 1.454 0 O-C-N 125.171 1.159 . . . . 0.0 114.218 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -75.7 56.22 0.9 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 123.282 1.515 . . . . 0.0 112.725 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -169.73 -155.93 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.439 2.296 . . . . 0.0 109.438 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.8 pt? -53.98 -20.47 6.27 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 22.1 mmtp -55.42 -40.23 71.24 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.06 -41.95 65.34 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 170.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 mmt -68.53 -49.94 55.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.812 1.245 . . . . 0.0 112.367 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.87 81.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.183 0.993 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 68' ' ' LEU . 10.4 t -72.07 -42.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.725 173.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.65 -40.79 63.18 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -58.7 6.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.005 0.922 . . . . 0.0 112.895 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 11.7 pt20 -63.92 -36.72 84.89 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 89.0 t -68.59 -24.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.311 1.044 . . . . 0.0 112.791 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -80.54 -57.54 3.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.3 ppt_? -69.72 -39.26 76.94 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -174.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -103.5 -45.83 4.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.165 0.986 . . . . 0.0 111.802 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.3 m-85 -76.95 -28.6 55.26 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 57.77 19.41 5.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.16 -29.64 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 45.98 73.88 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.927 1.691 . . . . 0.0 115.173 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.777 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -126.53 81.01 68.91 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.9 Cg_endo -63.81 148.51 91.9 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.097 2.531 . . . . 0.0 111.07 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp 64.44 -50.74 0.3 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.651 1.98 . . . . 0.0 113.958 -172.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -51.29 -60.21 3.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.011 1.324 . . . . 0.0 113.01 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.777 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -63.96 -13.68 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD11 HG11 ' A' ' 51' ' ' VAL . 2.8 mm? -102.68 -25.22 13.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -111.17 -38.03 5.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.83 -42.47 40.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.194 0.598 . . . . 0.0 112.085 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.5 pm0 -120.9 67.64 15.32 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.16 50.33 3.46 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.81 3.674 . . . . 0.0 115.111 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.424 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -161.38 137.74 8.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.754 1.221 . . . . 0.0 110.656 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.272 0.4 OUTLIER -63.87 -22.24 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.9 -179.688 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -57.43 -61.38 2.53 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.96 -34.46 78.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.677 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.5 mt -57.66 -47.42 82.33 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.655 0.382 . . . . 0.0 111.971 171.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.07 99.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.924 0.89 . . . . 0.0 111.905 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 76' ' ' ALA . 1.2 mp0 -58.03 -40.31 80.55 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.06 -29.86 69.76 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.289 15.7 m -113.76 -60.54 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.35 36.89 0.25 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.083 1.753 . . . . 0.0 114.574 -173.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -124.02 -49.33 1.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.389 1.876 . . . . 0.0 108.925 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -32.6 5.91 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 116.42 2.008 . . . . 99.99 116.42 -171.76 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.25 -83.25 1.26 Allowed Glycine 0 N--CA 1.476 1.314 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.797 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.02 144.06 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.656 -0.772 . . . . 0.0 112.661 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -125.04 -55.83 1.57 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.359 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 4.4 pm0 -57.02 174.75 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.699 1.2 . . . . 0.0 113.019 164.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.097 1.759 . . . . 0.0 112.992 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -170.77 -118.9 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.344 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.483 ' CE2' ' HB ' ' A' ' 34' ' ' ILE . 22.0 t80 -50.77 -45.03 58.85 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.304 9.2 p 2.43 56.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 -170.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -113.98 102.64 55.0 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.28 -157.82 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.192 2.595 . . . . 0.0 112.559 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 1.9 m -159.07 -100.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.742 0.817 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' THR . 13.6 p30 -76.3 167.54 21.67 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.908 1.283 . . . . 0.0 112.978 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.27 -48.06 24.84 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.41 -60.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.325 1.05 . . . . 0.0 110.178 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 74' ' ' ILE . 39.3 mt-10 -58.18 -45.34 87.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -65.54 -55.81 15.74 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.621 0.768 . . . . 0.0 112.624 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.61 -43.61 98.53 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 22' ' ' ILE . 4.1 mm? -63.45 -46.52 85.84 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.56 82.01 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.2 tt0 -58.7 -59.17 5.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.291 1.436 . . . . 0.0 111.498 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 19' ' ' LEU . 19.9 pt -62.18 -35.75 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 4.8 m95 -56.62 -59.09 5.51 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.424 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 18.0 pt-20 -61.25 -27.77 68.69 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -64.3 0.89 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.582 1.153 . . . . 0.0 112.289 168.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.82 -37.68 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.921 1.689 . . . . 0.0 113.298 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.1 tt -58.6 -23.58 59.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.337 1.455 . . . . 0.0 113.707 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.31 84.45 0.83 Allowed Glycine 0 N--CA 1.475 1.245 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.266 13.9 p -16.16 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 127.77 2.428 . . . . 0.0 116.039 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 24.0 p -146.01 -74.11 0.22 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 112.81 -1.995 . . . . 0.0 115.0 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 140.04 111.14 0.91 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 33' ' ' GLY . 11.1 pt -113.27 -82.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' H ' HG13 ' A' ' 32' ' ' ILE . . . 120.95 -169.37 14.25 Favored Glycine 0 N--CA 1.479 1.535 0 C-N-CA 123.871 0.748 . . . . 0.0 112.753 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.631 ' HA ' HG22 ' A' ' 74' ' ' ILE . 49.0 mt -53.71 -46.47 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.61 -24.65 67.69 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.39 -149.67 0.42 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.553 1.141 . . . . 0.0 109.014 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 5.3 t-20 -115.43 13.02 16.42 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 164.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.2 p90 41.23 14.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -135.77 -68.77 0.5 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.714 1.206 . . . . 0.0 112.417 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 27' ' ' LEU . 21.1 pt20 -68.53 32.21 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -118.44 -37.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.386 1.074 . . . . 0.0 112.932 174.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -76.68 -44.96 14.03 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.343 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.46 -179.2 2.77 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 122.278 0.932 . . . . 0.0 113.286 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -121.82 56.57 1.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.67 1.224 . . . . 0.0 111.641 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -173.54 -159.4 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.199 1.8 . . . . 0.0 111.063 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -53.3 -20.69 4.55 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.7 mmmt -45.94 -59.8 2.62 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.356 1.062 . . . . 0.0 113.285 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.23 -37.77 56.14 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.8 mmm -65.34 -50.05 67.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.431 1.092 . . . . 0.0 112.326 175.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.34 82.04 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.432 1.093 . . . . 0.0 112.573 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 68' ' ' LEU . 26.1 t -65.98 -47.09 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 118.698 -0.667 . . . . 0.0 110.537 171.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.41 -41.94 66.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 118.356 0.525 . . . . 0.0 112.402 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -56.1 26.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.129 0.972 . . . . 0.0 113.239 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.6 pt20 -64.44 -37.99 89.46 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 62' ' ' GLU . 75.0 t -64.96 -37.36 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.951 0.9 . . . . 0.0 111.629 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -63.0 -44.2 96.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 19.6 ptp180 -86.5 -44.44 11.96 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.87 -28.99 13.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.01 1.324 . . . . 0.0 112.911 -173.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -97.99 -22.81 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -48.56 0.41 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.568 2.747 . . . . 0.0 115.025 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.04 32.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.648 2.379 . . . . 0.0 116.897 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.715 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.7 pt-20 -10.08 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 119.718 3.229 . . . . 0.0 119.718 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -122.11 85.09 46.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.5 Cg_endo -65.22 150.13 87.85 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.779 2.319 . . . . 0.0 111.105 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.0 tp 66.05 -49.83 0.41 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.021 2.128 . . . . 0.0 114.623 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.38 -58.79 5.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.353 1.061 . . . . 0.0 113.014 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -63.69 -16.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 51' ' ' VAL . 47.5 mt -97.54 -25.39 15.17 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.08 -37.85 3.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.91 -49.59 19.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 4.3 pm0 -128.72 52.7 9.56 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 174.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 95.9 Cg_endo -63.99 -23.59 67.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 116.214 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.5 p -68.03 132.6 47.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.348 0.659 . . . . 0.0 110.095 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.339 0.4 OUTLIER -61.27 -19.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.982 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -57.24 -63.84 1.09 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.864 0.866 . . . . 0.0 109.727 165.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -63.0 -37.93 89.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.332 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.9 mt -55.9 -46.72 78.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.139 0.576 . . . . 0.0 111.903 171.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.82 -40.08 96.3 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.5 mp0 -61.97 -43.39 98.95 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.39 -25.37 67.99 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.303 30.8 m -114.88 -65.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.77 57.92 2.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 123.348 1.547 . . . . 0.0 111.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.2 m -165.65 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.86 2.464 . . . . 0.0 108.604 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -107.67 -30.9 8.32 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 175.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 125.623 1.569 . . . . 99.99 115.072 176.917 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.68 144.39 31.39 Favored Glycine 0 N--CA 1.478 1.446 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.007 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.16 126.41 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.451 -0.875 . . . . 0.0 109.085 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 5' ' ' GLU . 1.7 t -161.78 -72.47 0.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.603 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.7 pt-20 -119.79 -159.97 0.8 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.675 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.2 -153.35 0.55 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.947 0.499 . . . . 0.0 109.976 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -160.32 -45.27 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.187 0.995 . . . . 0.0 111.049 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 17.6 p90 -63.98 40.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 11.5 p -80.82 89.17 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.131 0.967 . . . . 0.0 112.309 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.18 87.29 4.73 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.516 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.39 161.05 47.43 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.385 2.724 . . . . 0.0 112.975 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -78.52 0.58 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.824 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -114.58 -173.71 2.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 112.54 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -59.31 3.56 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 0.0 113.166 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.23 -50.97 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.61 1.164 . . . . 0.0 110.932 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -51.48 -59.75 3.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.723 1.209 . . . . 0.0 113.318 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -69.04 -45.42 70.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -57.33 -53.66 55.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.381 1.472 . . . . 0.0 110.977 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -38.92 92.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.29 85.14 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.82 -49.97 75.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.55 1.14 . . . . 0.0 111.456 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.78 -53.88 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.16 0.984 . . . . 0.0 110.632 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -55.45 -53.12 60.22 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.17 0.988 . . . . 0.0 113.192 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.671 ' HB3' HG13 ' A' ' 32' ' ' ILE . 12.5 pt-20 -60.72 -33.12 72.42 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -70.29 -58.94 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.43 1.081 . . . . 0.0 113.097 169.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.01 -40.18 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.025 1.33 . . . . 0.0 113.326 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.9 tt -60.96 -26.49 67.58 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.272 . . . . 0.0 113.986 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.55 73.47 0.12 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.278 12.7 p -2.12 80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.481 2.712 . . . . 0.0 116.933 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.4 m -134.14 -108.02 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.001 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -176.86 101.45 0.16 Allowed Glycine 0 N--CA 1.48 1.612 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -96.79 -163.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . -131.09 161.4 23.53 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mm -55.54 -44.39 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.253 1.021 . . . . 0.0 111.777 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 37.3 tp -58.45 -29.61 66.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 169.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 41' ' ' ILE . 21.8 m-20 58.69 175.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.806 1.643 . . . . 0.0 112.389 -171.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.61 1.61 45.29 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.0 p90 49.8 0.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 120.086 3.365 . . . . 0.0 120.086 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -108.28 -84.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.913 1.285 . . . . 0.0 110.401 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG3' HD11 ' A' ' 27' ' ' LEU . 15.7 pt20 -68.74 22.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 72' ' ' PRO . 2.3 pp -98.56 -31.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.961 0.504 . . . . 0.0 111.418 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.618 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.71 -47.09 92.91 Favored Glycine 0 N--CA 1.479 1.53 0 O-C-N 124.152 0.908 . . . . 0.0 113.706 170.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.46 104.41 0.01 OUTLIER Glycine 0 N--CA 1.479 1.51 0 CA-C-N 114.361 -0.919 . . . . 0.0 115.279 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -73.88 58.13 0.64 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.738 1.615 . . . . 0.0 114.286 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 m -172.64 -154.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.25 2.22 . . . . 0.0 110.468 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.63 -18.27 1.69 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 8.8 mptt -48.48 -47.5 38.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.343 1.057 . . . . 0.0 112.01 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.77 66.61 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -71.66 -45.92 60.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.674 1.189 . . . . 0.0 112.74 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.78 78.22 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.743 0.817 . . . . 0.0 112.22 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 82.2 t -65.99 -48.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.267 1.027 . . . . 0.0 110.568 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -51.97 -41.3 62.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.36 -60.91 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.056 0.942 . . . . 0.0 112.937 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 7.1 pt20 -60.7 -36.8 79.69 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 88.3 t -68.11 -30.36 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 0.0 113.194 176.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -78.76 -55.31 5.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.113 0.565 . . . . 0.0 111.989 171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -76.35 -35.09 58.91 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -111.27 -36.94 5.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.138 0.975 . . . . 0.0 112.84 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.8 m-85 -82.69 -28.73 30.39 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 57.69 7.42 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.31 -18.83 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 50.38 58.58 5.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 1.7 pt? -130.82 86.68 51.59 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.4 Cg_endo -64.21 151.1 86.81 Favored 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 123.098 2.532 . . . . 0.0 111.665 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 tp 67.75 -37.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.556 1.943 . . . . 0.0 115.26 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -55.37 -71.99 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.044 0.938 . . . . 0.0 111.213 173.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.698 HG12 HE22 ' A' ' 71' ' ' GLN . 22.5 m -76.47 58.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-O 123.162 1.458 . . . . 0.0 111.93 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.618 ' HG ' ' HA2' ' A' ' 42' ' ' GLY . 44.5 tp -168.35 -54.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.242 -171.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.7 -45.77 8.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.74 88.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.979 0.511 . . . . 0.0 111.979 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.698 HE22 HG12 ' A' ' 67' ' ' VAL . 8.7 mp0 -115.2 81.09 7.78 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.074 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HA ' HD11 ' A' ' 41' ' ' ILE . 37.9 Cg_endo -82.08 36.92 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.113 2.542 . . . . 0.0 113.974 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -160.74 134.45 6.87 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.193 1.397 . . . . 0.0 110.728 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.273 0.5 OUTLIER -65.73 -22.92 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.842 179.8 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -59.52 -51.58 69.25 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.958 0.345 . . . . 0.0 110.973 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.03 83.97 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 93.5 mt -58.37 -44.3 88.79 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.6 89.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.142 0.977 . . . . 0.0 112.159 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.29 -31.36 72.46 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.22 -19.95 60.97 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 77' ' ' LEU 0.275 14.0 m -114.87 -69.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.75 61.25 4.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.656 1.693 . . . . 0.0 111.142 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.4 m -164.53 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.121 2.169 . . . . 0.0 108.286 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.541 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.52 -33.19 7.12 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 176.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 116.947 2.203 . . . . 99.99 116.947 -177.277 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.7 -72.4 0.48 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.438 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.605 ' HB ' ' HG3' ' A' ' 5' ' ' GLU . 16.0 m -59.61 133.98 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 t -59.93 -37.39 79.38 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.573 -1.649 . . . . 0.0 113.511 165.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' HG3' ' HB ' ' A' ' 3' ' ' VAL . 2.9 pp20? -69.9 166.74 18.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.393 1.077 . . . . 0.0 113.438 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.82 25.12 15.07 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -46.67 -33.1 3.98 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 t80 174.76 -70.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.843 1.657 . . . . 0.0 110.937 -173.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG22 ' HA2' ' A' ' 33' ' ' GLY . 3.0 t 62.73 88.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 126.904 2.081 . . . . 0.0 112.286 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.6 88.91 35.79 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.054 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.09 152.29 80.24 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 123.209 2.606 . . . . 0.0 113.167 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.549 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -112.33 -85.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.713 179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -108.93 -176.85 3.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.181 0.593 . . . . 0.0 111.265 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -53.65 14.29 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 118.13 -0.938 . . . . 0.0 113.141 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.53 -52.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.947 0.899 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.716 ' HA ' HD12 ' A' ' 74' ' ' ILE . 53.9 mm-40 -51.8 -59.62 4.1 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.297 1.039 . . . . 0.0 112.336 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -66.27 -50.36 63.99 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -63.92 -46.94 82.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.753 1.221 . . . . 0.0 112.034 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.09 -37.64 84.33 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.4 89.82 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 44.5 tt0 -59.77 -50.68 72.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.848 1.259 . . . . 0.0 111.419 171.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.52 -50.52 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.861 0.864 . . . . 0.0 110.298 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 5.5 m95 -57.01 -54.91 41.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.9 pt-20 -58.0 -30.21 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -74.96 -60.24 2.38 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.781 1.301 . . . . 0.0 111.862 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.13 -37.14 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.762 1.625 . . . . 0.0 113.195 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 6.9 tt -58.65 -19.66 41.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.85 1.66 . . . . 0.0 114.38 173.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.04 69.23 0.4 Allowed Glycine 0 N--CA 1.476 1.321 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.269 12.3 p 3.85 78.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 128.402 2.681 . . . . 0.0 115.611 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -121.18 -49.17 2.19 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 112.67 -2.059 . . . . 0.0 115.289 -168.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 106.1 84.42 1.72 Allowed Glycine 0 N--CA 1.48 1.628 0 O-C-N 123.748 0.655 . . . . 0.0 112.331 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.573 HD13 HD13 ' A' ' 27' ' ' LEU . 9.4 pt -113.67 153.86 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -68.25 158.44 52.16 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 113.496 -1.683 . . . . 0.0 113.27 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 10' ' ' ALA . 46.9 mm -45.45 -39.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.251 1.42 . . . . 0.0 112.261 166.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.6 tp -56.49 -31.77 64.36 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.92 1.688 . . . . 0.0 114.626 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 6.8 m-20 61.68 162.14 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.03 1.732 . . . . 0.0 111.627 -169.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.04 4.25 1.29 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.264 54.7 p90 48.96 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -175.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -109.11 -74.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.133 1.773 . . . . 0.0 112.558 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.411 ' HG3' HD11 ' A' ' 27' ' ' LEU . 12.8 pt20 -73.08 33.58 0.07 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -100.92 -37.4 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.97 -30.48 4.8 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.274 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.43 -172.96 7.22 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-O 122.627 1.126 . . . . 0.0 113.849 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -116.97 53.9 0.88 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.911 -1.144 . . . . 0.0 111.862 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.444 ' HB3' HD23 ' A' ' 46' ' ' LEU . 3.8 m -173.49 -166.83 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.701 1.6 . . . . 0.0 112.39 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 45' ' ' SER . 1.9 pt? -50.64 -22.5 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.579 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 12.4 mmmt -42.34 -49.41 5.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.068 1.347 . . . . 0.0 112.07 168.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.57 71.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.795 1.238 . . . . 0.0 114.132 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -69.39 -45.7 68.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.215 1.006 . . . . 0.0 112.319 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.39 91.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.584 0.754 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 68' ' ' LEU . 40.8 t -64.96 -46.65 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.701 172.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -52.58 -42.52 64.59 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -58.11 -48.26 80.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 0.0 112.28 174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.38 -43.65 98.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 0.0 112.343 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.8 t -59.52 -34.58 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.153 1.381 . . . . 0.0 112.986 176.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -72.99 -39.55 65.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.519 HH21 ' HB1' ' A' ' 53' ' ' ALA . 2.1 ptt180 -91.12 -53.31 4.42 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.77 -29.01 22.65 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 113.041 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 54.8 m-85 -103.23 -18.24 14.98 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -38.95 0.13 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.811 2.444 . . . . 0.0 117.47 -174.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.29 -22.89 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 127.67 2.388 . . . . 0.0 115.476 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 59.74 152.33 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.862 2.465 . . . . 0.0 116.4 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt 65.9 150.26 0.12 Allowed Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 126.032 1.733 . . . . 0.0 115.47 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 83.4 Cg_endo -68.1 172.93 10.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.036 1.824 . . . . 0.0 110.881 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 69' ' ' PHE . 8.0 tt 70.25 -40.28 0.46 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.188 1.795 . . . . 0.0 114.653 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -48.92 -92.36 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.054 2.141 . . . . 0.0 112.283 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 13.8 p -89.1 62.18 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 123.431 1.586 . . . . 0.0 109.304 171.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 tp -157.51 -76.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 112.589 -2.096 . . . . 0.0 112.924 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.722 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 20.6 m-85 -77.82 -41.4 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.325 0.65 . . . . 0.0 112.508 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.22 73.18 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.08 81.92 60.51 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 166.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 44.5 Cg_endo -78.22 30.56 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.641 2.894 . . . . 0.0 116.339 -172.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -139.93 131.85 27.7 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.397 1.479 . . . . 0.0 109.835 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.285 0.4 OUTLIER -63.64 -21.69 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.65 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.3 tmmt? -57.24 -56.15 25.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.514 0.726 . . . . 0.0 110.495 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.07 73.55 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.9 mt -54.4 -48.59 71.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.432 0.693 . . . . 0.0 112.533 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.96 96.54 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -32.72 73.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -71.64 -21.69 61.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 77' ' ' LEU 0.281 29.8 m -110.27 -69.35 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.41 56.12 3.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.599 1.666 . . . . 0.0 111.797 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 m -156.55 -61.41 0.1 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.882 -1.963 . . . . 0.0 108.843 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.639 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -102.27 -32.71 9.92 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 116.201 1.926 . . . . 99.99 116.201 177.239 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 mtt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.77 149.67 48.9 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.848 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 5' ' ' GLU . 48.9 t -109.67 143.56 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 t -57.43 -33.51 67.97 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 40.1 mt-10 -75.98 151.14 37.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.056 1.342 . . . . 0.0 112.697 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.45 ' HB3' ' N ' ' A' ' 33' ' ' GLY . . . -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.827 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -102.03 -40.0 7.05 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.761 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 10.7 p90 -67.75 42.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 9.6 p -86.62 90.35 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 122.018 0.913 . . . . 0.0 112.071 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -111.03 87.53 7.21 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.916 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.07 144.84 38.51 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.081 2.521 . . . . 0.0 113.223 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -75.55 0.47 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.467 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -116.58 -172.97 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.061 0.945 . . . . 0.0 112.486 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.06 57.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.157 0.983 . . . . 0.0 113.468 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -55.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.025 0.93 . . . . 0.0 110.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.5 mm-40 -51.12 -57.48 8.6 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.34 1.056 . . . . 0.0 113.597 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 t -65.1 -54.4 30.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 65.5 tttp -60.96 -46.36 91.03 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.035 0.934 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.86 -40.97 95.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.219 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 41.8 tt0 -59.64 -54.91 40.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.63 1.172 . . . . 0.0 111.545 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -52.83 -49.84 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.671 1.188 . . . . 0.0 110.593 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.491 ' HB3' HD11 ' A' ' 32' ' ' ILE . 20.1 m95 -53.71 -65.15 0.62 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.459 1.104 . . . . 0.0 111.907 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HB3' HG12 ' A' ' 32' ' ' ILE . 12.3 pt-20 -57.45 -29.63 64.36 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -72.63 -66.79 0.62 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.255 1.422 . . . . 0.0 111.919 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.31 -35.45 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.837 1.255 . . . . 0.0 113.342 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.51 -19.35 47.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.583 . . . . 0.0 114.089 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.37 71.9 0.2 Allowed Glycine 0 N--CA 1.476 1.364 0 C-N-CA 124.18 0.895 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.7 p 0.65 82.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.502 2.721 . . . . 0.0 115.878 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 21.7 m -123.38 -81.62 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.863 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.21 96.95 0.57 Allowed Glycine 0 N--CA 1.478 1.457 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 24' ' ' GLU . 11.8 pt -124.37 -177.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 114.608 -0.796 . . . . 0.0 112.312 -171.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 9' ' ' VAL . . . -112.41 166.11 12.15 Favored Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.906 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' ALA . 41.3 mm -55.16 -45.27 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.092 1.357 . . . . 0.0 112.324 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 36.3 tp -61.21 -18.27 57.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.851 1.661 . . . . 0.0 114.408 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 11.1 m-20 60.21 -163.95 0.23 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.162 1.785 . . . . 0.0 110.412 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -108.63 22.94 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.188 0.518 . . . . 0.0 110.967 165.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.6 p90 36.5 16.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 121.565 3.913 . . . . 0.0 121.565 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -119.83 -76.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 111.642 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -73.66 31.61 0.08 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -175.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -106.22 -38.12 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.338 0.655 . . . . 0.0 112.251 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.54 -55.08 27.39 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.193 0.933 . . . . 0.0 113.359 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.87 114.22 0.01 OUTLIER Glycine 0 N--CA 1.478 1.447 0 O-C-N 125.348 1.263 . . . . 0.0 114.867 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -78.66 59.76 2.57 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.917 1.341 . . . . 0.0 112.543 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -174.96 -157.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.816 2.446 . . . . 0.0 110.358 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -54.2 -17.58 2.98 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.2 mmtt -46.1 -52.65 11.7 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.229 1.011 . . . . 0.0 113.06 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.11 -38.43 62.62 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -68.98 -48.55 62.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.454 1.102 . . . . 0.0 112.674 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.7 84.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.895 0.878 . . . . 0.0 112.47 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 63.7 t -63.9 -50.21 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.133 0.973 . . . . 0.0 110.099 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.6 63.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.522 0.729 . . . . 0.0 112.912 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.03 -57.17 13.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.896 0.878 . . . . 0.0 112.878 173.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 6.6 pt20 -66.16 -36.93 84.41 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 61.3 t -64.44 -29.52 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.298 1.039 . . . . 0.0 112.304 174.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -79.85 -67.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.8 0.44 . . . . 0.0 111.598 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.514 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -65.61 -35.98 82.38 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -171.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -107.68 -34.28 7.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.568 0.747 . . . . 0.0 112.938 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.1 m-30 -87.46 -25.73 23.6 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 69.47 -43.61 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 129.049 2.94 . . . . 0.0 115.964 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 85' ' ' SER . 12.9 p -59.54 -21.25 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HA ' HG12 ' A' ' 55' ' ' VAL . 27.5 tt0 47.62 79.56 0.06 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 2.1 pt? -136.69 83.71 29.18 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 169.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -65.75 150.05 86.41 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.328 2.686 . . . . 0.0 111.952 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.2 tt 65.65 -41.58 0.34 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.812 2.045 . . . . 0.0 114.546 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -51.1 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.935 1.694 . . . . 0.0 112.183 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 63' ' ' LEU . 9.4 p -84.69 64.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.514 1.626 . . . . 0.0 110.049 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD22 HG11 ' A' ' 51' ' ' VAL . 55.7 tp -163.48 -63.69 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.219 -175.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 22.8 m-85 -79.94 -57.47 3.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.46 1.104 . . . . 0.0 112.706 174.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.89 71.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.282 0.633 . . . . 0.0 112.696 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -123.01 82.09 50.79 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.247 1.019 . . . . 0.0 111.099 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -82.76 31.89 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.376 2.717 . . . . 0.0 115.143 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 4.1 t -148.31 135.75 20.53 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.239 1.015 . . . . 0.0 111.307 -171.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.279 0.4 OUTLIER -63.97 -23.54 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.467 -178.905 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -52.94 -62.25 1.77 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.298 1.039 . . . . 0.0 110.485 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.37 80.51 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.821 -1.082 . . . . 0.0 113.912 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD12 HG12 ' A' ' 74' ' ' ILE . 32.1 mt -58.25 -47.29 84.03 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.727 0.411 . . . . 0.0 110.934 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.03 92.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.41 1.084 . . . . 0.0 112.841 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.596 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -60.27 -36.63 78.24 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 3.1 m-85 -73.34 -39.84 64.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 171.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.627 HG11 ' CD2' ' A' ' 59' ' ' TYR 0.251 26.2 m -105.95 -28.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -170.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.71 50.71 0.94 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.982 1.373 . . . . 0.0 109.834 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 90.6 m -162.27 -61.74 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.574 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.6 -33.18 7.1 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 170.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 38.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 116.732 2.123 . . . . 99.99 116.732 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.25 -178.57 39.52 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.914 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.04 146.44 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.583 0.753 . . . . 0.0 112.285 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.498 HG21 HE21 ' A' ' 40' ' ' GLN . 5.9 t -54.45 -46.17 73.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 39.76 -153.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.84 -135.04 0.06 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.331 1.452 . . . . 0.0 110.163 166.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -172.55 -66.74 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.569 1.547 . . . . 0.0 108.515 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -66.75 47.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.673 2.789 . . . . 0.0 117.117 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -96.13 87.24 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 122.346 1.069 . . . . 0.0 111.871 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 83.87 15.45 Favored Pre-proline 0 N--CA 1.477 0.893 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.857 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -67.98 133.07 27.97 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.074 2.516 . . . . 0.0 113.401 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -78.49 -77.6 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.673 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.56 -174.46 2.57 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.125 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -57.21 4.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.643 1.177 . . . . 0.0 113.388 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.81 -51.66 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.722 0.809 . . . . 0.0 111.813 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HA ' HD12 ' A' ' 74' ' ' ILE . 26.0 mm-40 -52.06 -57.07 10.62 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.691 0.797 . . . . 0.0 112.504 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.2 -53.33 46.39 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.199 0.999 . . . . 0.0 113.501 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -55.6 -48.57 74.66 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 111.292 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.1 mm? -69.68 -44.21 70.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.28 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.44 78.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.4 tt0 -59.74 -59.64 5.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.306 1.442 . . . . 0.0 111.523 172.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.267 2.7 pp -61.12 -36.85 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.461 ' HB3' HD11 ' A' ' 32' ' ' ILE . 6.7 m95 -59.75 -54.91 40.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.993 172.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB3' HG12 ' A' ' 32' ' ' ILE . 13.6 pt-20 -60.49 -29.85 69.33 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -71.69 -66.84 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.682 1.593 . . . . 0.0 111.933 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 47' ' ' LYS . 62.1 t -63.86 -34.3 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.219 1.808 . . . . 0.0 113.763 -172.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 32' ' ' ILE . 7.6 tt -56.54 -24.82 49.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.598 1.159 . . . . 0.0 113.812 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.77 75.43 0.49 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.289 12.2 p -4.47 83.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 128.247 2.619 . . . . 0.0 116.208 -178.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 m -116.7 -39.04 3.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.113 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.2 91.46 1.08 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -169.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 27' ' ' LEU . 47.3 pt -111.09 -143.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.63 -174.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.41 -150.58 5.65 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 122.747 1.193 . . . . 0.0 113.772 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 58.3 mt -93.99 -61.12 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 111.685 -2.258 . . . . 0.0 108.757 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.31 -29.77 66.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.157 1.383 . . . . 0.0 113.34 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 58.33 -148.24 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.882 1.273 . . . . 0.0 109.517 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -99.49 13.9 31.74 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.64 0.587 . . . . 0.0 111.351 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.26 35.5 p90 41.23 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 121.636 3.939 . . . . 0.0 121.636 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -96.05 -79.69 0.44 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.889 1.276 . . . . 0.0 112.816 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.498 HE21 HG21 ' A' ' 4' ' ' THR . 8.1 pm0 -74.33 35.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -112.83 -35.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.61 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.27 -54.66 35.47 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 123.876 0.735 . . . . 0.0 112.546 171.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.39 97.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.122 -1.039 . . . . 0.0 115.399 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -74.41 63.55 1.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.17 1.388 . . . . 0.0 112.809 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 14.0 m -171.79 -153.03 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.838 2.455 . . . . 0.0 109.635 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.41 ' H ' ' HB3' ' A' ' 45' ' ' SER . 1.7 pt? -51.79 -22.57 3.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 26' ' ' VAL . 3.9 mmpm? -46.43 -48.55 18.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.76 -1.114 . . . . 0.0 113.814 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.27 65.3 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.95 -51.48 54.67 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.595 1.158 . . . . 0.0 112.606 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.15 92.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 0.0 112.664 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.492 HG11 HD13 ' A' ' 68' ' ' LEU . 91.2 t -63.1 -47.12 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.329 1.052 . . . . 0.0 110.007 174.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.58 -45.25 69.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.73 75.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.447 0.699 . . . . 0.0 112.707 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -64.62 -39.26 93.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.095 0.958 . . . . 0.0 113.514 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.868 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 86.3 t -69.58 -30.13 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.989 1.315 . . . . 0.0 112.882 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 17.1 t-160 -76.11 -40.18 53.49 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -76.11 -91.23 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.664 1.186 . . . . 0.0 112.575 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.92 -30.09 67.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.929 1.692 . . . . 0.0 114.381 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.868 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.2 m-30 -98.23 -18.43 18.42 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tt0 57.69 -45.16 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -170.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 59' ' ' TYR . 2.7 t -59.31 -12.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.598 1.959 . . . . 0.0 115.208 -171.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 48.41 44.88 20.65 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 167.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -113.26 88.86 13.34 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.2 Cg_endo -65.87 152.8 80.51 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.427 2.752 . . . . 0.0 112.0 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tt 64.97 -43.73 0.33 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.705 2.002 . . . . 0.0 114.833 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.45 -69.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.563 1.145 . . . . 0.0 111.889 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.15 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 123.923 1.821 . . . . 0.0 111.224 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 51' ' ' VAL . 55.1 tp -153.66 -78.06 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.32 -46.51 60.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.82 -31.56 72.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -124.71 75.65 64.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.876 0.871 . . . . 0.0 112.064 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.78 54.26 4.39 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.574 2.182 . . . . 0.0 113.396 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -169.16 131.34 1.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.161 1.384 . . . . 0.0 111.044 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.487 HG22 HG23 ' A' ' 34' ' ' ILE 0.321 0.5 OUTLIER -62.88 -20.49 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.948 179.724 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -58.64 -52.8 64.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.564 0.746 . . . . 0.0 111.022 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -40.2 77.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.69 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 73' ' ' THR . 60.6 mt -57.98 -48.51 79.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 0.0 112.582 176.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.0 96.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.01 0.924 . . . . 0.0 112.341 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 0.6 OUTLIER -62.1 -31.66 72.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 174.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.71 -35.37 62.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 169.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 77' ' ' LEU . 27.4 m -110.27 -26.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 119.023 2.971 . . . . 0.0 119.023 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.3 22.42 12.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.405 1.082 . . . . 0.0 113.816 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 79' ' ' GLN . 19.4 m -123.55 -59.39 1.54 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.499 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.624 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -98.13 -31.05 12.31 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 115.527 -2.178 . . . . 99.99 115.763 173.48 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.54 -149.97 13.2 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.556 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 16.5 m -110.32 141.02 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 t -64.11 -40.76 96.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.163 169.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 1.4 pm0 -72.67 175.84 6.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.077 1.351 . . . . 0.0 114.405 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.35 33.77 13.64 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -45.91 -33.86 3.52 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -177.54 -68.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.175 1.39 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t 61.2 78.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 172.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 87.23 56.46 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.941 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 149.3 82.87 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.269 2.646 . . . . 0.0 113.054 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.05 -80.77 0.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.794 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -111.89 -174.87 2.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.431 1.092 . . . . 0.0 112.089 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.9 -61.94 1.63 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.588 1.155 . . . . 0.0 113.478 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.89 -48.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.238 1.015 . . . . 0.0 111.548 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 74' ' ' ILE . 29.2 mm-40 -52.56 -58.05 8.03 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.36 1.064 . . . . 0.0 112.714 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -67.73 -48.77 65.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.001 0.92 . . . . 0.0 112.978 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 22' ' ' ILE . 49.8 tptt -55.15 -53.57 54.32 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.391 1.476 . . . . 0.0 110.961 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.549 HD21 ' HG2' ' A' ' 58' ' ' GLU . 4.6 mm? -63.96 -45.62 88.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.3 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.81 79.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 35.4 tt0 -60.29 -61.99 2.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.602 1.561 . . . . 0.0 111.551 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' LYS 0.274 37.6 pt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.066 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.3 m95 -59.22 -59.35 5.61 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.692 168.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.2 pt-20 -58.75 -32.16 69.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -65.43 -68.39 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.519 1.528 . . . . 0.0 111.112 171.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.36 -37.05 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.724 1.61 . . . . 0.0 113.482 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.35 -21.0 61.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.1 61.42 0.16 Allowed Glycine 0 N--CA 1.477 1.407 0 O-C-N 124.167 0.917 . . . . 0.0 112.265 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.259 9.2 p 19.49 66.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 127.874 2.469 . . . . 0.0 114.757 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -107.06 -61.77 1.5 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.577 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 113.94 89.42 1.72 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.557 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.3 pt -127.97 -153.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.69 -148.31 7.02 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.561 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.874 ' HA ' HG22 ' A' ' 74' ' ' ILE . 1.9 mp -47.86 -69.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 111.551 -2.324 . . . . 0.0 113.0 -172.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.49 -15.15 48.52 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.99 -143.24 0.73 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.323 1.449 . . . . 0.0 108.861 -172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -112.14 18.15 18.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 163.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 48.7 p90 39.72 15.85 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -173.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -131.03 -82.18 0.53 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.518 1.527 . . . . 0.0 111.572 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.25 -40.52 11.61 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -28.14 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.42 65.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.543 1.068 . . . . 0.0 114.039 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.84 96.39 2.46 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 123.937 0.433 . . . . 0.0 113.768 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 1.22 1.62 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.9 m 177.03 -150.02 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.87 2.468 . . . . 0.0 109.715 -165.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.83 -7.12 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.48 -31.57 6.56 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 173.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.05 45.27 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -65.26 -48.98 71.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.452 1.101 . . . . 0.0 111.722 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.64 90.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.031 0.932 . . . . 0.0 112.47 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 68' ' ' LEU . 61.6 t -61.77 -52.22 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.595 0.758 . . . . 0.0 110.014 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.51 -39.87 71.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.03 0.932 . . . . 0.0 113.152 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.39 -50.51 72.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.54 0.736 . . . . 0.0 112.481 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.88 -44.92 96.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.98 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 59.6 t -66.63 -32.28 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.081 0.952 . . . . 0.0 112.495 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 1.5 t60 -68.89 -42.95 76.26 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -82.45 -61.98 1.74 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' HD21 ' A' ' 19' ' ' LEU . 5.1 tp10 -77.28 -32.98 55.89 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.393 1.477 . . . . 0.0 113.327 -175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 1.7 m-85 -101.59 -9.44 20.96 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 27.0 tt0 62.53 -55.39 0.15 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.076 2.551 . . . . 0.0 115.413 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.15 4.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 126.462 1.905 . . . . 0.0 115.421 -166.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.285 15.0 pt-20 54.36 -38.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 121.545 3.905 . . . . 0.0 121.545 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.4 pt? -22.32 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 128.523 2.729 . . . . 0.0 118.201 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 72.6 Cg_endo -67.21 147.37 78.67 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.026 2.484 . . . . 0.0 111.273 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 66.04 -38.58 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.584 1.954 . . . . 0.0 115.466 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -53.47 -73.84 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.22 52.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 124.043 1.877 . . . . 0.0 111.618 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 51' ' ' VAL . 56.8 tp -154.31 -79.4 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.57 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.0 -43.8 98.36 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.59 67.5 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.92 71.16 7.18 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 112.666 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 56.1 Cg_endo -79.98 40.04 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.755 2.97 . . . . 0.0 114.921 -172.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -147.9 131.26 16.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.321 1.848 . . . . 0.0 109.576 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.874 HG22 ' HA ' ' A' ' 34' ' ' ILE 0.285 0.5 OUTLIER -61.34 -21.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.865 -179.771 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.11 -60.87 2.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.583 1.153 . . . . 0.0 110.112 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 79' ' ' GLN . . . -69.59 -34.84 74.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.468 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 79.1 mt -58.86 -47.24 85.6 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.82 96.29 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.953 0.901 . . . . 0.0 112.378 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -55.92 -51.96 65.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 0.0 112.019 169.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.309 6.6 m -108.41 -72.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.42 64.46 3.51 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.371 1.557 . . . . 0.0 112.78 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 77.5 m -166.7 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.399 2.68 . . . . 0.0 108.702 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -110.19 -29.5 8.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 176.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.517 -1.706 . . . . 99.99 115.424 -177.235 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.86 25.05 4.93 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 118.286 2.698 . . . . 0.0 118.286 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 5.2 tp-100 -46.26 -36.04 5.81 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.1 t80 177.2 -60.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.162 0.985 . . . . 0.0 111.699 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 57.33 79.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.139 2.176 . . . . 0.0 113.68 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -131.33 89.44 41.08 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.493 169.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.76 -152.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.596 2.864 . . . . 0.0 113.792 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.82 -83.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.666 0.786 . . . . 0.0 109.343 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -109.65 -175.19 2.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.487 1.115 . . . . 0.0 112.203 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.91 -58.24 5.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.435 1.094 . . . . 0.0 113.171 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.19 -49.87 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.207 1.003 . . . . 0.0 111.307 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HA ' HD12 ' A' ' 74' ' ' ILE . 19.9 mm-40 -50.6 -62.67 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.661 1.184 . . . . 0.0 113.068 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 t -67.98 -47.28 69.0 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.909 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 22' ' ' ILE . 45.3 tptt -61.69 -47.06 87.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.83 0.852 . . . . 0.0 111.616 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -68.02 -36.58 80.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.07 85.51 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.113 0.415 . . . . 0.0 111.649 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 38.2 tt0 -58.62 -55.11 39.36 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.544 1.538 . . . . 0.0 111.829 171.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.7 mm -55.27 -51.04 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.207 1.003 . . . . 0.0 110.892 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.3 m95 -55.98 -55.95 26.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.943 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.6 pt-20 -61.2 -28.04 68.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -76.69 -61.15 2.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.324 1.05 . . . . 0.0 111.59 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG12 ' HZ3' ' A' ' 47' ' ' LYS . 93.3 t -60.64 -40.69 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.602 1.561 . . . . 0.0 112.637 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 23.4 tp -61.09 -19.3 61.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.984 1.313 . . . . 0.0 114.238 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.71 0.92 Allowed Glycine 0 N--CA 1.474 1.187 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 p -13.83 90.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.422 2.289 . . . . 0.0 115.53 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.493 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 16.7 p -141.89 -69.37 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 112.816 -1.993 . . . . 0.0 114.501 -174.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 126.99 94.72 0.89 Allowed Glycine 0 N--CA 1.48 1.617 0 O-C-N 123.943 0.777 . . . . 0.0 112.58 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 5' ' ' GLU . 21.8 pt -101.74 -177.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.822 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -105.37 171.67 18.76 Favored Glycine 0 N--CA 1.477 1.368 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.119 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 10' ' ' ALA . 39.7 mm -57.33 -48.65 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.353 1.061 . . . . 0.0 111.884 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.2 -6.53 2.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.881 1.673 . . . . 0.0 114.399 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 54.46 -154.06 0.28 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.715 2.006 . . . . 0.0 110.059 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.47 ' CG ' HE21 ' A' ' 40' ' ' GLN . 29.0 t-20 -101.24 13.74 34.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.258 -0.276 . . . . 0.0 111.311 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.256 50.1 p90 37.56 5.38 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -116.38 -79.25 0.59 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.768 1.227 . . . . 0.0 111.741 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.47 HE21 ' CG ' ' A' ' 37' ' ' ASN . 23.2 pt20 -53.6 -31.55 47.41 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 118.588 2.811 . . . . 0.0 118.588 -171.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -32.7 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -66.93 -53.18 28.32 Favored Glycine 0 CA--C 1.538 1.488 0 O-C-N 124.076 0.86 . . . . 0.0 112.659 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.63 105.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -75.08 53.88 0.64 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.498 1.519 . . . . 0.0 114.118 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.5 p -163.59 -146.92 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.629 1.972 . . . . 0.0 109.002 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -54.41 -25.24 23.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 61.7 mmtt -50.22 -55.38 15.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.338 1.055 . . . . 0.0 113.72 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 -42.79 38.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.48 -53.02 39.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.46 1.104 . . . . 0.0 112.988 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.161 0.985 . . . . 0.0 112.889 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 ' CH2' ' A' ' 23' ' ' TRP . 46.1 t -66.27 -42.9 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.649 0.78 . . . . 0.0 110.18 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.05 -42.25 72.47 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -56.83 -46.67 81.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -64.09 -46.92 82.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.643 1.177 . . . . 0.0 112.579 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 59.5 t -61.45 -28.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.167 1.387 . . . . 0.0 112.318 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.24 -77.92 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.625 0.77 . . . . 0.0 110.727 166.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 9.1 ptt180 -59.72 -37.87 80.1 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -172.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.49 -30.51 9.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-30 -93.92 -27.44 16.38 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 61.73 1.91 0.66 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.842 2.457 . . . . 0.0 116.684 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.07 -12.44 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.94 41.53 3.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 120.076 3.362 . . . . 0.0 120.076 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -109.82 93.01 13.59 Favored Pre-proline 0 N--CA 1.482 1.138 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.4 Cg_endo -66.35 149.67 84.84 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.493 2.795 . . . . 0.0 111.97 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.7 tt 60.98 -46.87 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.251 2.22 . . . . 0.0 114.917 -174.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -55.97 -65.47 0.59 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.722 1.209 . . . . 0.0 112.436 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -62.65 -25.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.524 HD23 ' HA2' ' A' ' 42' ' ' GLY . 7.5 mp -72.21 -41.6 66.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.951 1.7 . . . . 0.0 113.579 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -103.71 -39.54 6.64 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.63 62.44 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.582 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 11.3 mp0 -119.57 61.93 6.81 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.944 0.498 . . . . 0.0 111.654 171.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 22.2 Cg_endo -79.87 38.17 0.72 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.175 3.25 . . . . 0.0 114.081 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -157.15 131.72 8.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.142 2.177 . . . . 0.0 108.864 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.289 0.5 OUTLIER -62.37 -21.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.244 179.925 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.67 -53.62 56.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.343 0.657 . . . . 0.0 110.69 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.8 74.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 83.9 mt -55.35 -48.97 73.44 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.51 0.724 . . . . 0.0 112.579 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.35 93.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.003 0.921 . . . . 0.0 112.717 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.03 -26.93 68.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -77.72 -27.03 50.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 59' ' ' TYR . 32.8 m -116.35 -30.18 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 -174.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.42 56.13 0.8 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.477 1.608 . . . . 0.0 109.89 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 m -162.35 -65.55 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.988 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.645 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -101.53 -33.17 10.04 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 114.823 1.416 . . . . 99.99 114.823 172.491 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 8.0 mm-40 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 121.203 0.525 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.76 -179.8 4.98 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.061 1.745 . . . . 0.0 114.508 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -168.58 -99.51 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.06 1.744 . . . . 0.0 108.903 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.43 -57.28 12.85 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t 56.25 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 126.352 1.861 . . . . 0.0 113.897 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.08 98.24 33.53 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 168.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.75 -154.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.752 2.968 . . . . 0.0 113.994 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.438 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -159.73 -85.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.003 0.521 . . . . 0.0 110.202 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.438 ' H ' ' HB ' ' A' ' 12' ' ' THR . 38.8 p-10 -107.9 -176.89 3.19 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.389 0.676 . . . . 0.0 111.481 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.15 -51.98 16.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.295 1.038 . . . . 0.0 113.071 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.37 -54.53 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.512 1.125 . . . . 0.0 111.46 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 74' ' ' ILE . 22.3 mm-40 -49.93 -59.9 3.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.233 . . . . 0.0 112.255 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.1 m -65.17 -44.85 87.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 22' ' ' ILE . 47.0 tptt -57.98 -58.51 8.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.413 1.485 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.81 -33.77 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -57.21 -45.17 84.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.1 -48.95 79.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.557 1.143 . . . . 0.0 111.763 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 18' ' ' LYS . 42.0 mm -54.44 -54.77 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.099 0.96 . . . . 0.0 110.685 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.481 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 11.6 m95 -56.56 -53.32 58.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.882 0.873 . . . . 0.0 113.332 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 27' ' ' LEU . 21.1 pt-20 -60.27 -30.12 69.24 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -77.01 -63.72 1.3 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.972 1.42 . . . . 0.0 111.148 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.6 -43.45 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.498 1.519 . . . . 0.0 113.204 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -65.56 -14.98 62.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.31 72.46 0.18 Allowed Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.552 1.157 . . . . 0.0 110.789 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.274 12.9 p -10.45 87.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 128.314 2.646 . . . . 0.0 116.968 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 48.9 m -139.19 -50.66 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.299 -1.773 . . . . 0.0 115.496 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 125.57 3.0 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 20' ' ' ALA . 2.5 pp -125.72 165.17 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 113.07 0.766 . . . . 0.0 113.07 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.34 162.4 14.41 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.295 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.97 -40.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.321 0.648 . . . . 0.0 111.734 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.2 -21.07 58.89 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 167.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.649 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.1 m-20 56.96 -163.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.441 1.897 . . . . 0.0 111.788 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -101.58 1.11 37.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.295 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.307 53.5 p90 53.97 -38.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -171.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.09 -81.57 0.06 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.364 1.466 . . . . 0.0 112.252 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.19 21.98 0.07 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -173.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 36' ' ' ASP . 2.5 pp -101.23 -44.95 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.22 -40.9 60.66 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.964 0.79 . . . . 0.0 113.642 170.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.69 116.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.671 1.029 . . . . 0.0 115.671 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.55 46.63 1.08 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.924 -1.638 . . . . 0.0 114.041 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.8 p -150.48 -150.51 0.35 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.848 1.659 . . . . 0.0 109.608 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.56 -18.65 7.9 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 33.3 mmtp -48.49 -51.14 28.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.055 0.942 . . . . 0.0 112.261 172.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.14 -47.03 62.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 ptm -70.53 -41.6 72.32 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.86 97.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.292 0.637 . . . . 0.0 112.483 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' LYS . 40.7 t -66.08 -47.64 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.915 0.886 . . . . 0.0 109.7 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.81 -39.84 62.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.89 -57.3 12.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.682 0.793 . . . . 0.0 112.775 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.32 -34.69 78.92 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.939 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 92.0 t -64.7 -27.82 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.653 1.181 . . . . 0.0 112.908 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 18.6 t-160 -77.13 -63.21 1.42 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.72 0.808 . . . . 0.0 112.166 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.2 ptt85 -70.92 -38.98 72.95 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.22 -36.38 6.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.625 0.77 . . . . 0.0 112.745 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.939 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m-85 -84.81 -27.92 26.48 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 34.2 tt0 65.69 -36.39 0.23 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.174 2.589 . . . . 0.0 116.661 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 t -57.73 -23.45 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.311 1.444 . . . . 0.0 114.646 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.8 tm-20 45.89 67.92 0.67 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -136.96 87.4 19.16 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.0 Cg_endo -64.82 148.05 89.81 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.431 2.754 . . . . 0.0 112.096 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 6.5 tt 62.37 -43.96 0.18 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.403 2.281 . . . . 0.0 114.584 -172.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.16 -68.76 0.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.248 1.419 . . . . 0.0 113.117 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.87 12.93 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.7 -41.65 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 111.935 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 53.1 m-85 -106.83 -45.87 4.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.027 1.331 . . . . 0.0 113.329 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.86 73.68 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -120.24 65.53 11.1 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 170.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.502 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 19.6 Cg_endo -80.24 27.55 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.571 2.847 . . . . 0.0 114.973 -170.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -139.68 136.31 34.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.617 1.167 . . . . 0.0 110.568 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.278 0.4 OUTLIER -61.85 -19.77 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.752 175.879 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.63 -61.9 2.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 0.0 110.348 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.46 80.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 88.3 mt -58.03 -46.55 85.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.146 0.578 . . . . 0.0 112.262 172.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.62 85.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.277 1.031 . . . . 0.0 112.755 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -62.3 -40.6 96.84 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 170.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 2.8 m-85 -66.81 -39.23 87.64 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 171.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 77' ' ' LEU . 24.0 m -99.59 -40.37 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.87 50.9 0.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.174 1.464 . . . . 0.0 110.451 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 69.0 m -160.26 -55.11 0.06 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.553 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.461 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.05 -35.02 5.79 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 169.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 116.009 -1.948 . . . . 99.99 116.027 175.105 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.2 pm0 . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.43 -71.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.607 1.963 . . . . 0.0 111.903 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.306 4.8 pt20 46.38 -56.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -175.99 -65.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.674 1.59 . . . . 0.0 111.471 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 11' ' ' PRO . 3.7 t 57.99 95.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 126.339 1.856 . . . . 0.0 112.888 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.85 81.58 19.39 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 9' ' ' VAL . 75.9 Cg_endo -67.67 147.59 76.25 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 122.904 2.403 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -80.31 0.59 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.475 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -113.86 -176.51 2.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 112.335 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.25 19.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.253 1.021 . . . . 0.0 113.585 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.94 -54.22 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.161 0.984 . . . . 0.0 110.424 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 74' ' ' ILE . 11.1 mm-40 -49.26 -59.62 3.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.678 1.191 . . . . 0.0 113.339 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -68.34 -51.12 48.0 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 83.1 tttt -64.48 -40.68 96.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.976 . . . . 0.0 112.425 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.39 -43.86 84.71 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.69 172.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.06 77.74 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.0 tt0 -57.2 -57.05 14.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.499 1.519 . . . . 0.0 111.721 170.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.266 2.5 pp -62.64 -36.99 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 177.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 32' ' ' ILE . 7.4 m95 -56.69 -58.11 9.51 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 112.119 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.499 ' HB3' ' H ' ' A' ' 32' ' ' ILE . 20.5 pt-20 -59.85 -30.02 68.68 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -71.48 -62.65 1.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.195 1.398 . . . . 0.0 112.033 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.9 -37.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 125.713 1.605 . . . . 0.0 113.251 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.535 HD11 ' HG3' ' A' ' 40' ' ' GLN . 7.9 tt -57.86 -23.16 51.65 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.006 1.323 . . . . 0.0 113.488 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.58 73.24 0.39 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.6 p 1.62 79.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 128.244 2.618 . . . . 0.0 116.304 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -123.52 -47.31 1.98 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -172.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 104.14 91.9 2.23 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 23' ' ' TRP . 6.5 pt -119.96 167.17 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 120.727 0.299 . . . . 0.0 111.117 -174.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.73 168.97 24.09 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 123.116 1.398 . . . . 0.0 113.901 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.7 mm -48.68 -36.6 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 111.833 -2.184 . . . . 0.0 112.804 173.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' THR . 2.9 mm? -68.12 -20.11 64.88 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.57 1.548 . . . . 0.0 114.307 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 58.77 -156.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.721 1.608 . . . . 0.0 109.865 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -119.1 13.38 12.92 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 36.87 34.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -152.49 -81.42 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.775 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' HD11 ' A' ' 27' ' ' LEU . 9.5 pt20 -70.94 29.91 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.82 -40.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -64.34 -40.3 97.73 Favored Glycine 0 N--CA 1.48 1.603 0 O-C-N 123.813 0.696 . . . . 0.0 113.279 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.69 149.64 0.11 Allowed Glycine 0 N--CA 1.477 1.4 0 O-C-N 125.101 1.118 . . . . 0.0 114.022 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' H ' ' HD2' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -93.05 45.95 1.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 113.627 -1.286 . . . . 0.0 112.189 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.8 m -174.94 -159.76 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.28 1.832 . . . . 0.0 111.38 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -58.04 -5.44 0.45 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.9 mptt -52.63 -51.97 57.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.066 0.947 . . . . 0.0 110.901 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.74 60.93 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.0 mmt -68.74 -47.41 66.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.967 0.907 . . . . 0.0 112.896 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.99 80.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.497 0.719 . . . . 0.0 111.835 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 45.5 t -64.87 -47.81 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.024 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.37 -42.82 64.27 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.803 0.729 . . . . 0.0 112.225 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.661 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -60.48 -52.18 66.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.631 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.3 pt20 -65.01 -38.94 92.59 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.9 t -67.56 -28.64 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.498 1.119 . . . . 0.0 112.203 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -66.51 -59.25 3.82 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.327 167.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.661 HH21 ' HB1' ' A' ' 53' ' ' ALA . 11.6 ptp180 -71.84 -46.46 57.98 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -173.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -100.41 -30.69 11.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.632 1.573 . . . . 0.0 112.609 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -94.65 -30.83 14.12 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.9 12.72 2.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.275 2.23 . . . . 0.0 115.998 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 59' ' ' TYR . 3.5 t -116.39 12.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 121.172 0.511 . . . . 0.0 111.867 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.61 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.1 pm0 6.99 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.0 pt? -121.31 87.18 44.38 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 63' ' ' LEU . 69.4 Cg_endo -65.65 154.78 72.29 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 123.02 2.48 . . . . 0.0 111.214 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.5 tt 66.53 -44.45 0.42 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.639 1.976 . . . . 0.0 114.332 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.59 -61.11 2.52 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.406 0.682 . . . . 0.0 112.776 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.57 -8.93 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.622 HD13 ' HA2' ' A' ' 42' ' ' GLY . 65.7 mt -104.72 -24.49 12.93 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.306 1.443 . . . . 0.0 114.871 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 74.3 m-85 -117.91 -40.92 2.94 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.41 -49.12 14.09 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.609 0.764 . . . . 0.0 112.801 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -121.43 59.18 8.86 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.2 Cg_endo -75.35 19.18 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.335 3.357 . . . . 0.0 116.777 -170.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 80.7 p -120.86 137.36 54.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.333 0.5 OUTLIER -63.19 -20.99 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.956 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -52.55 -66.33 0.4 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.759 1.224 . . . . 0.0 109.567 165.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.98 85.79 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.173 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 89.5 mt -58.18 -44.75 88.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.313 0.645 . . . . 0.0 112.648 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.31 98.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.5 0.72 . . . . 0.0 112.34 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.2 mp0 -62.35 -39.89 94.61 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 172.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -71.44 -29.84 65.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.275 33.4 m -116.83 -41.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.62 57.27 1.01 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 123.335 1.54 . . . . 0.0 109.476 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.1 m -165.46 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.205 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.561 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.2 -31.16 8.01 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.969 1.47 . . . . 99.99 114.969 176.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.11 72.01 0.3 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.243 1.817 . . . . 0.0 115.187 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.535 ' OE1' ' HA ' ' A' ' 37' ' ' ASN . 39.2 tt0 -78.7 -75.43 0.23 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.946 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -121.54 -44.58 2.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' H ' ' HA2' ' A' ' 33' ' ' GLY . 5.3 t 48.94 82.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.444 1.898 . . . . 0.0 114.057 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.36 88.47 54.27 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.865 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.48 149.97 75.07 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 122.988 2.459 . . . . 0.0 112.642 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -122.35 -84.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.843 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.3 p-10 -109.9 -178.02 3.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.606 0.762 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.06 -45.54 43.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.87 -58.79 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.06 0.944 . . . . 0.0 110.392 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 74' ' ' ILE . 52.5 mm-40 -51.08 -56.03 14.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.261 1.024 . . . . 0.0 112.604 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.84 -57.85 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.164 0.986 . . . . 0.0 113.537 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 21.0 ttpp -66.51 -36.55 82.98 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.83 -45.94 76.68 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.601 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.71 78.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 40.8 tt0 -56.57 -58.8 6.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.474 1.51 . . . . 0.0 111.229 170.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.268 2.6 pp -60.89 -38.39 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.81 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 32' ' ' ILE . 11.4 m95 -55.85 -59.08 5.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.505 0.722 . . . . 0.0 112.266 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.533 ' HB3' HG12 ' A' ' 32' ' ' ILE . 11.8 pt-20 -62.43 -30.29 71.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -75.9 -58.19 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.02 0.928 . . . . 0.0 112.335 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.09 -35.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.963 1.305 . . . . 0.0 112.557 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.33 -21.34 59.62 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.51 72.1 0.29 Allowed Glycine 0 N--CA 1.476 1.333 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.4 p 0.91 80.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 128.484 2.714 . . . . 0.0 116.187 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 m -119.74 -70.44 0.79 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.098 -172.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 123.75 101.98 1.51 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.533 HG12 ' HB3' ' A' ' 24' ' ' GLU . 24.6 pt -125.05 167.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' H ' ' A' ' 9' ' ' VAL . . . -71.37 157.91 53.48 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.911 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -57.01 -40.99 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.727 -0.737 . . . . 0.0 112.273 164.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD23 ' HB ' ' A' ' 73' ' ' THR . 4.3 mt -68.61 13.52 0.09 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 162.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.2 m-20 50.76 -140.48 0.84 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.143 1.777 . . . . 0.0 110.348 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.535 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 17.6 t-20 -115.77 22.67 12.89 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.194 0.521 . . . . 0.0 111.05 154.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.255 53.1 p90 42.11 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 1 N-CA-C 122.135 4.124 . . . . 0.0 122.135 -178.523 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -112.8 -84.02 0.59 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.065 1.346 . . . . 0.0 112.335 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -48.24 -31.84 6.41 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' ASP . 2.6 pp -62.42 -34.31 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.97 75.2 Favored Glycine 0 N--CA 1.478 1.447 0 O-C-N 123.9 0.75 . . . . 0.0 113.029 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.98 127.08 0.01 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 53.38 2.63 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.516 -2.342 . . . . 0.0 112.555 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 17.0 m -169.89 -152.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.052 1.741 . . . . 0.0 110.369 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 49' ' ' MET . 1.9 pt? -51.32 -22.13 2.64 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.8 mptt -48.19 -62.1 1.65 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.917 1.287 . . . . 0.0 111.818 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.23 -45.66 44.89 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 2.1 ptm -69.81 -41.34 75.14 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.09 86.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.159 0.584 . . . . 0.0 112.06 171.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 68' ' ' LEU . 6.0 t -67.82 -43.75 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.576 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.39 -42.58 64.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.552 0.615 . . . . 0.0 112.385 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -59.1 -51.73 68.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 10.5 pt20 -66.68 -38.58 87.09 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 62' ' ' GLU . 96.3 t -67.83 -27.31 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.657 1.183 . . . . 0.0 112.254 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -70.34 -61.46 1.76 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.385 0.274 . . . . 0.0 111.445 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.634 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 15.0 ptp180 -65.38 -42.05 93.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -173.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -107.15 -32.74 7.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.868 1.267 . . . . 0.0 113.076 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.5 m-85 -94.69 -20.58 19.42 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 61.96 -47.69 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.68 28.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 55' ' ' VAL . 14.5 pt-20 -9.9 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.637 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -123.44 82.69 52.97 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 69.4 Cg_endo -66.11 148.39 85.24 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 123.401 2.734 . . . . 0.0 111.52 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.0 tt 63.31 -47.84 0.23 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.731 2.012 . . . . 0.0 113.563 -172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -46.24 -66.82 0.35 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.068 1.747 . . . . 0.0 112.207 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -68.27 -4.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.774 HD11 HG11 ' A' ' 51' ' ' VAL . 3.1 mm? -107.86 -31.45 8.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -175.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 58.0 m-85 -107.8 -37.27 6.17 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.78 -44.17 56.77 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.55 0.34 . . . . 0.0 111.856 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.1 pm0 -123.21 71.83 45.69 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 62.3 Cg_endo -76.57 38.33 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.567 3.511 . . . . 0.0 115.924 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.6 t -144.44 133.55 22.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.569 1.548 . . . . 0.0 110.59 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.277 0.4 OUTLIER -63.91 -23.11 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.544 178.878 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.6 tmmt? -55.59 -61.96 2.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.85 0.86 . . . . 0.0 110.131 170.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.6 76.23 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.707 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 96.3 mt -56.09 -47.46 77.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.79 0.436 . . . . 0.0 112.154 171.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.55 94.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.523 0.729 . . . . 0.0 112.866 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -61.03 -43.51 98.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.15 -26.49 67.45 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.329 7.2 m -114.98 -73.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.81 64.48 0.67 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 123.471 1.605 . . . . 0.0 112.563 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 88.4 m -169.4 -53.53 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 129.075 2.95 . . . . 0.0 108.622 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -115.97 -28.91 6.5 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 175.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.465 2.024 . . . . 99.99 116.465 -175.274 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HG2' ' H ' ' A' ' 6' ' ' ALA . 7.9 pm0 . . . . . 0 CA--C 1.55 0.953 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.693 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -72.15 172.15 10.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.721 1.208 . . . . 0.0 112.957 164.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -169.54 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.739 1.616 . . . . 0.0 107.422 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -60.92 -64.03 1.1 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.421 HG22 ' HA2' ' A' ' 33' ' ' GLY . 2.8 t 57.55 82.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 126.49 1.916 . . . . 0.0 113.456 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.01 91.6 49.06 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.063 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.38 143.21 47.2 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.121 2.547 . . . . 0.0 113.696 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -106.02 -81.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.911 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -116.44 -174.36 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.91 -57.01 6.25 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.099 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.6 -52.41 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.323 1.049 . . . . 0.0 111.023 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.58 ' HA ' HD12 ' A' ' 74' ' ' ILE . 3.7 mt-10 -55.08 -60.32 3.53 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 t -64.33 -43.68 93.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.003 0.815 . . . . 0.0 113.197 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -57.74 -57.03 14.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 110.659 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.35 -38.71 92.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -59.24 -41.99 90.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 44.9 tt0 -60.73 -50.82 71.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.734 1.214 . . . . 0.0 111.573 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -54.82 -54.24 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.962 0.905 . . . . 0.0 110.357 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -56.2 -52.45 64.36 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.312 -0.852 . . . . 0.0 113.015 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 32' ' ' ILE . 14.9 pt-20 -60.75 -30.26 69.89 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -74.26 -62.47 1.5 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.2 -45.76 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.785 1.634 . . . . 0.0 113.412 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 41' ' ' ILE . 10.1 tt -56.14 -25.61 46.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.086 1.754 . . . . 0.0 113.87 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.89 81.5 0.33 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.265 13.1 p -17.02 92.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.959 2.504 . . . . 0.0 116.197 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 p -149.86 -49.0 0.14 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 113.139 -1.846 . . . . 0.0 115.933 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.36 119.01 2.32 Favored Glycine 0 N--CA 1.481 1.664 0 O-C-N 123.695 0.622 . . . . 0.0 111.758 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.4 pp -121.66 158.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -87.17 152.23 24.32 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.695 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm -50.02 -40.32 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.318 1.047 . . . . 0.0 112.445 168.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -50.46 -34.4 24.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.583 1.553 . . . . 0.0 113.786 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.561 ' HB3' HG21 ' A' ' 41' ' ' ILE . 8.2 m-20 61.17 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.356 -168.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.768 ' ND2' HE21 ' A' ' 40' ' ' GLN . 26.5 t-20 -57.17 -22.04 37.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.562 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.282 38.0 p90 60.42 -7.47 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.8 -71.97 0.74 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.424 1.09 . . . . 0.0 112.261 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.768 HE21 ' ND2' ' A' ' 37' ' ' ASN . 25.8 pt20 -72.69 11.79 0.59 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -69.54 -51.48 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 68' ' ' LEU . . . -135.01 14.85 4.32 Favored Glycine 0 CA--C 1.541 1.709 0 O-C-N 124.288 0.993 . . . . 0.0 114.559 167.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.97 62.31 4.39 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -125.18 -130.22 0.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.473 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 p -110.01 -86.42 0.53 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.771 0.828 . . . . 0.0 111.273 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.89 -18.95 37.8 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -56.1 -36.35 68.07 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.97 74.15 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.59 -48.2 67.51 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.906 1.282 . . . . 0.0 112.483 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.59 85.76 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.26 -49.52 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.176 0.99 . . . . 0.0 110.225 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.52 -41.36 66.29 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -54.52 43.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.363 1.065 . . . . 0.0 112.367 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.86 -43.63 90.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.338 1.055 . . . . 0.0 112.896 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.761 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 48.2 t -68.1 -25.58 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.81 1.244 . . . . 0.0 113.353 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -85.2 -27.01 26.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -97.64 -56.19 2.59 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.25 -32.17 17.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.642 1.177 . . . . 0.0 112.315 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.761 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.3 m-85 -85.72 -33.18 21.55 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 58.02 3.65 0.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.16 10.99 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 55' ' ' VAL . 30.4 tt0 15.47 81.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.8 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.4 pt? -128.39 77.59 76.89 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 64.8 Cg_endo -64.57 145.95 88.2 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 123.361 2.707 . . . . 0.0 111.987 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 64' ' ' PRO 0.281 3.0 pp 58.75 -39.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.843 2.457 . . . . 0.0 115.861 -170.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HD3' ' HB2' ' A' ' 63' ' ' LEU . 75.2 tttt -52.8 -65.6 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.065 2.146 . . . . 0.0 110.517 176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.8 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 3.0 p -61.94 -22.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 57.3 tp -95.4 -26.88 15.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.803 1.641 . . . . 0.0 115.123 -166.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -114.88 -38.96 3.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.386 1.074 . . . . 0.0 113.603 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.35 49.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' CD ' ' HA ' ' A' ' 67' ' ' VAL . 10.7 pm0 -121.56 59.45 9.52 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.8 Cg_endo -75.63 24.32 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.953 3.769 . . . . 0.0 116.68 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.5 t -126.0 138.85 53.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 110.159 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.258 0.4 OUTLIER -60.64 -27.39 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.548 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -55.16 -55.37 31.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.386 0.675 . . . . 0.0 110.855 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -69.87 -40.19 75.88 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 82.1 mt -55.2 -46.34 75.9 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.535 0.734 . . . . 0.0 112.173 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.51 85.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.179 0.992 . . . . 0.0 112.317 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.79 -32.75 74.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -69.47 -16.08 63.4 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 77' ' ' LEU 0.274 15.6 m -117.72 -71.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 175.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 61.11 3.16 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.797 1.761 . . . . 0.0 111.622 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.1 m -165.44 -57.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.616 2.367 . . . . 0.0 108.338 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.77 -27.88 7.98 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 177.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.575 -1.679 . . . . 99.99 115.149 -174.535 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.6 pm0 . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.61 21.03 5.39 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -38.76 -35.74 0.22 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 119.373 3.101 . . . . 0.0 119.373 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.8 t80 176.96 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.072 1.349 . . . . 0.0 110.697 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.9 t 65.72 93.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 127.092 2.157 . . . . 0.0 112.785 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -129.68 82.15 67.8 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.784 169.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 137.38 32.56 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.602 2.201 . . . . 0.0 112.539 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -76.37 0.55 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.612 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -118.84 -176.49 3.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.618 1.167 . . . . 0.0 112.582 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.11 54.25 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -57.08 -56.22 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.346 1.058 . . . . 0.0 110.022 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' ILE . 6.3 mm-40 -48.96 -56.38 9.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.895 1.278 . . . . 0.0 113.555 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 t -67.42 -55.04 15.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.158 0.983 . . . . 0.0 113.561 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 37.9 ttpt -64.18 -38.67 91.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.854 0.862 . . . . 0.0 112.889 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -65.24 -45.83 83.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.759 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.75 76.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.8 tt0 -57.92 -58.88 6.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.211 1.404 . . . . 0.0 111.677 171.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 19' ' ' LEU . 2.5 pp -61.5 -38.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.06 -57.39 12.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 0.0 112.161 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.665 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 pt-20 -61.18 -31.55 71.3 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -69.38 -62.0 1.56 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.752 1.282 . . . . 0.0 111.927 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' HE3' ' A' ' 47' ' ' LYS . 99.4 t -61.6 -37.88 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.576 1.551 . . . . 0.0 113.193 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.69 -25.5 60.39 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.377 1.071 . . . . 0.0 113.623 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.4 62.19 0.14 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.155 0.909 . . . . 0.0 111.587 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.262 10.3 p 16.67 67.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 127.888 2.475 . . . . 0.0 114.997 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 60.6 m -109.9 -49.86 3.04 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 112.372 -2.194 . . . . 0.0 116.667 -167.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 102.96 92.07 2.21 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.665 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -117.66 159.23 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -170.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -77.24 153.3 41.15 Favored Glycine 0 N--CA 1.475 1.285 0 CA-C-N 113.889 -1.505 . . . . 0.0 113.34 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.0 mm -48.56 -40.99 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.753 1.221 . . . . 0.0 113.121 167.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.13 -14.09 33.51 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.705 1.602 . . . . 0.0 114.753 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.04 -158.8 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.097 2.159 . . . . 0.0 110.455 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -111.25 17.92 19.79 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.3 p90 40.51 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -124.27 -85.91 0.64 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 111.605 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -71.81 33.22 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 119.441 3.126 . . . . 0.0 119.441 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.455 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -113.02 -40.26 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.948 172.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 68' ' ' LEU . . . -60.64 -64.26 4.26 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.918 0.761 . . . . 0.0 112.966 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.55 100.05 0.14 Allowed Glycine 0 N--CA 1.476 1.361 0 CA-C-N 114.471 -0.865 . . . . 0.0 113.49 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.22 -36.91 85.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.34 0.656 . . . . 0.0 112.459 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -151.12 -90.4 0.06 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.398 1.479 . . . . 0.0 108.932 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -93.92 -11.0 31.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HE3' HG12 ' A' ' 26' ' ' VAL . 30.2 mttp -42.29 -37.21 1.45 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.21 -38.69 41.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 79.3 mtm -71.49 -45.37 62.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.04 88.35 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.667 0.787 . . . . 0.0 112.385 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HD21 ' A' ' 68' ' ' LEU . 5.6 t -71.27 -42.59 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.699 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -38.42 63.81 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.422 0.555 . . . . 0.0 112.406 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.56 -58.16 8.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.721 0.808 . . . . 0.0 112.525 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 12.0 pt20 -63.55 -37.48 87.49 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.863 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 94.3 t -66.03 -24.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.671 1.188 . . . . 0.0 112.93 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 12.8 t-160 -87.18 -58.35 2.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.238 0.615 . . . . 0.0 112.272 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.1 ppt_? -68.78 -37.91 79.65 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -106.64 -46.62 3.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.367 1.067 . . . . 0.0 111.759 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.863 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-85 -75.76 -32.49 59.98 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' HIS 0.25 94.6 mt-30 66.97 -31.49 0.17 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -178.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.49 -30.3 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.176 1.39 . . . . 0.0 113.47 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' A' ' 55' ' ' VAL . 25.3 tt0 47.61 79.19 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.181 1.792 . . . . 0.0 115.368 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 1.8 pt? -142.19 83.32 12.45 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.582 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -63.87 152.82 79.01 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.132 2.555 . . . . 0.0 110.939 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' H ' HD12 ' A' ' 68' ' ' LEU 0.303 3.7 pp 60.65 -41.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.7 2.4 . . . . 0.0 116.724 -172.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 63' ' ' LEU . 99.6 mttt -56.83 -67.01 0.35 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.89 1.276 . . . . 0.0 111.897 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.682 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 3.8 p -76.13 13.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 65' ' ' LEU . 94.3 mt -123.85 -35.54 2.85 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.89 -48.26 3.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.68 1.192 . . . . 0.0 110.979 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.42 76.02 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 170.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 46.3 mt-30 -121.33 55.8 5.43 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 23.2 Cg_endo -76.32 24.54 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.387 3.391 . . . . 0.0 116.58 -167.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -132.94 141.11 48.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.092 1.357 . . . . 0.0 110.169 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.273 0.4 OUTLIER -62.99 -22.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.092 178.393 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -57.82 -52.0 67.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.283 0.633 . . . . 0.0 110.793 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.43 74.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.211 1.005 . . . . 0.0 113.403 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.567 HD23 HG22 ' A' ' 67' ' ' VAL . 81.7 mt -56.02 -47.67 77.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.33 98.73 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 0.0 112.705 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.549 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -54.59 -44.95 73.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.221 1.008 . . . . 0.0 112.796 171.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' HE2' HD11 ' A' ' 63' ' ' LEU . 2.0 m-30 -71.31 -22.54 61.92 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.28 11.6 m -108.42 -70.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.18 60.0 3.52 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.416 1.579 . . . . 0.0 111.748 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 98.8 m -166.37 -60.56 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 128.202 2.601 . . . . 0.0 108.384 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.07 -27.61 7.62 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.837 2.532 . . . . 0.0 117.837 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 116.226 1.936 . . . . 99.99 116.226 -174.641 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.94 35.13 11.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.893 2.077 . . . . 0.0 116.375 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -42.25 -46.73 4.58 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.6 t80 172.88 -59.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.775 1.23 . . . . 0.0 112.463 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 32' ' ' ILE 0.319 5.4 p 56.56 98.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.864 2.465 . . . . 0.0 116.199 -175.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.21 84.81 34.92 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.982 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.08 153.15 78.6 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.151 2.567 . . . . 0.0 112.744 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -129.23 -82.41 0.57 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.938 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -113.2 -177.39 3.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.758 1.223 . . . . 0.0 112.034 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -55.74 10.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.411 1.084 . . . . 0.0 113.444 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.27 -51.29 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.232 1.013 . . . . 0.0 111.089 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.736 ' HA ' HD12 ' A' ' 74' ' ' ILE . 43.2 mm-40 -50.93 -58.73 5.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.345 1.058 . . . . 0.0 112.581 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -67.94 -50.35 56.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.257 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 1.7 tpmt? -57.75 -50.38 73.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.194 1.397 . . . . 0.0 112.066 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.45 -43.79 84.6 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.747 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.96 83.82 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 44.9 tt0 -57.02 -60.28 3.82 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 110.673 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.264 2.6 pp -60.51 -36.75 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.95 -63.91 1.0 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.802 0.841 . . . . 0.0 111.552 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.727 ' HB3' HG12 ' A' ' 32' ' ' ILE . 17.9 pt-20 -61.44 -33.97 74.63 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -67.71 -63.29 1.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.137 1.375 . . . . 0.0 111.717 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.29 -30.03 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.038 1.335 . . . . 0.0 112.469 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.88 -34.8 70.17 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.24 61.96 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.434 1.084 . . . . 0.0 111.557 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.255 7.4 p 17.7 62.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 128.615 2.766 . . . . 0.0 115.272 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -102.91 -47.36 4.4 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.121 -1.854 . . . . 0.0 115.473 -165.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 24' ' ' GLU . . . 92.55 105.22 1.59 Allowed Glycine 0 N--CA 1.48 1.6 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.727 HG12 ' HB3' ' A' ' 24' ' ' GLU . 18.3 pt -120.28 -151.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.89 160.41 18.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.18 -40.48 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.96 -0.69 4.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 7.5 m-20 55.95 -145.58 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.287 1.835 . . . . 0.0 111.6 -174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -139.76 42.05 1.99 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.773 0.429 . . . . 0.0 111.835 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -6.01 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.427 2.291 . . . . 0.0 117.027 -169.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 40' ' ' GLN . 25.4 t80 173.67 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.814 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 39' ' ' PHE . 6.5 pt20 -70.83 19.33 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -104.22 -40.55 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -72.07 -32.23 63.39 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.85 166.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.99 -162.71 26.55 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.445 -0.878 . . . . 0.0 111.413 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -70.8 -44.23 67.03 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.5 p -174.83 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.2 -36.76 80.78 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.9 mmtp -58.87 -49.89 76.05 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.822 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -37.64 57.14 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -63.12 -50.72 69.36 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.548 0.739 . . . . 0.0 112.492 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 47' ' ' LYS . 95.5 t -59.2 -50.49 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.746 1.218 . . . . 0.0 110.077 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.56 -42.9 67.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.221 0.608 . . . . 0.0 112.531 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -61.2 -51.51 68.7 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 13.6 pt20 -66.98 -38.6 86.35 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 93.3 t -66.38 -30.01 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.088 . . . . 0.0 111.816 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -69.29 -68.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.692 HH21 ' HB1' ' A' ' 53' ' ' ALA . 10.9 ptp180 -59.38 -42.52 91.88 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.55 -38.93 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -170.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -78.02 -25.04 47.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 69.92 -44.84 0.57 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.639 2.776 . . . . 0.0 114.998 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.03 27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 126.663 1.985 . . . . 0.0 116.14 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 55' ' ' VAL . 13.7 pt-20 -8.93 77.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.3 pt? -125.72 91.46 48.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.6 Cg_endo -66.42 152.03 81.83 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.986 2.457 . . . . 0.0 111.891 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tt 65.15 -42.29 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.068 2.147 . . . . 0.0 116.051 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -54.1 -71.69 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG22 HD23 ' A' ' 77' ' ' LEU 0.255 4.0 p -84.63 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 123.819 1.771 . . . . 0.0 110.464 177.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 47.6 tp -162.5 -49.76 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.402 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.63 -62.59 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.527 1.131 . . . . 0.0 111.566 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.31 78.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.307 0.643 . . . . 0.0 112.624 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 38.4 mt-30 -120.9 83.2 36.71 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.201 170.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 27.0 Cg_endo -85.62 26.78 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.223 2.615 . . . . 0.0 114.776 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -136.21 136.08 39.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.033 0.533 . . . . 0.0 111.404 -171.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.264 0.4 OUTLIER -62.73 -22.34 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.911 177.268 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 18.9 tptm -58.52 -57.56 12.4 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.184 0.594 . . . . 0.0 110.097 172.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.25 -35.51 81.07 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 HG12 ' A' ' 74' ' ' ILE . 23.8 mt -59.24 -46.12 89.33 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.585 0.354 . . . . 0.0 110.876 173.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.87 85.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.065 0.946 . . . . 0.0 112.844 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.676 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -59.39 -39.93 84.97 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 169.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.81 -38.35 79.86 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 77' ' ' LEU 0.314 28.1 m -106.59 -57.18 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -178.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.38 49.27 1.72 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 122.963 1.364 . . . . 0.0 111.369 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 86.5 m -161.38 -65.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.556 1.942 . . . . 0.0 109.212 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 -30.04 8.64 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.592 1.701 . . . . 99.99 115.592 174.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.0 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.831 2.052 . . . . 0.0 111.423 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.314 5.1 pt20 46.82 -45.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 120.856 3.651 . . . . 0.0 120.856 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -175.32 -67.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.935 1.694 . . . . 0.0 111.757 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.15 84.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 126.573 1.949 . . . . 0.0 112.406 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 88.93 30.19 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.005 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.64 146.96 75.14 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.875 2.384 . . . . 0.0 112.17 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 -79.85 0.5 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -116.51 178.23 4.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.046 0.938 . . . . 0.0 111.304 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.24 37.06 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.88 -60.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.879 1.272 . . . . 0.0 110.586 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -53.08 -49.85 65.57 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.136 0.974 . . . . 0.0 112.941 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -61.68 -55.6 28.67 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.071 0.949 . . . . 0.0 113.165 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.24 -44.12 97.77 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.053 0.941 . . . . 0.0 112.242 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.63 -47.55 80.88 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.17 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 45.0 tt0 -57.84 -58.08 9.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.92 1.288 . . . . 0.0 111.942 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 pt -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -59.4 -46.55 88.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 21' ' ' GLU . 11.9 pt-20 -65.8 -26.83 67.87 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -46.42 20.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.314 1.045 . . . . 0.0 111.42 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.48 -42.4 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.683 1.593 . . . . 0.0 112.173 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 7.3 tt -55.77 -25.14 39.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.713 1.205 . . . . 0.0 114.096 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.63 87.13 1.46 Allowed Glycine 0 CA--C 1.531 1.074 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -166.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -18.15 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 127.288 2.235 . . . . 0.0 115.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 p -140.96 -52.44 0.47 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 112.77 -2.014 . . . . 0.0 114.873 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 98.22 2.06 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.736 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.52 146.63 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.532 0.682 . . . . 0.0 111.732 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.22 164.27 47.61 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.758 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -50.42 -34.57 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 113.36 -1.42 . . . . 0.0 112.598 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.87 -23.89 67.37 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.23 -175.3 0.15 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.247 1.819 . . . . 0.0 111.323 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -96.06 14.15 24.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 p90 32.36 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -162.58 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.83 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.06 43.17 0.35 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 -43.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.128 170.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.32 -51.43 43.51 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.214 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -174.23 102.14 0.17 Allowed Glycine 0 N--CA 1.476 1.331 0 O-C-N 124.526 0.78 . . . . 0.0 114.857 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -29.12 70.32 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.394 -0.903 . . . . 0.0 112.09 156.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.2 p 174.19 -93.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 130.723 3.609 . . . . 0.0 108.14 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -26.64 68.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 38.4 mttp -39.5 -38.72 0.61 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 -55.04 18.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ptm -70.96 -41.19 71.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.94 92.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.8 -39.73 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.262 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.55 -40.69 68.95 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.37 -43.78 79.51 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.518 0.727 . . . . 0.0 112.871 173.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.37 -43.22 74.0 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.813 1.245 . . . . 0.0 112.372 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 57.0 t -58.41 -31.3 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.41 1.084 . . . . 0.0 111.33 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.49 -80.06 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 165.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.488 ' C ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.9 -31.49 66.81 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 117.265 2.321 . . . . 0.0 117.265 -168.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -109.15 -37.41 5.8 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.148 0.979 . . . . 0.0 112.983 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.852 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 4.1 m-30 -94.72 -18.8 20.95 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 68.63 -39.03 0.4 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.239 2.616 . . . . 0.0 115.722 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.84 -23.49 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 125.072 1.349 . . . . 0.0 113.712 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 50.57 23.22 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 1.1 pt? -106.1 104.93 51.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -174.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.68 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.0 Cg_endo -63.73 152.63 79.66 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 123.509 2.806 . . . . 0.0 112.132 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 69' ' ' PHE . 8.5 tt 63.81 -56.65 0.21 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.7 2.0 . . . . 0.0 114.241 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.12 -64.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.431 1.493 . . . . 0.0 113.082 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.63 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 4.7 p -60.94 -29.57 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.51 -24.24 34.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.444 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 63.6 m-85 -109.33 -37.51 5.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.75 77.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.726 0.41 . . . . 0.0 111.655 173.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.4 pm0 -123.62 73.06 52.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.063 168.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.71 24.63 0.37 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.62 3.547 . . . . 0.0 117.158 -170.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t -135.2 137.0 42.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.105 1.362 . . . . 0.0 110.697 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -60.08 -26.3 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.56 175.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -58.61 -50.03 75.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.844 0.458 . . . . 0.0 110.962 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.91 68.48 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 91.4 mt -56.32 -43.16 78.71 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.955 0.902 . . . . 0.0 113.201 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.7 79.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 112.42 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 83' ' ' THR . 3.0 mp0 -66.61 -37.41 84.82 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -60.91 -17.85 53.33 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.267 16.5 m -110.75 -73.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 170.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.92 74.54 6.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.392 1.568 . . . . 0.0 111.353 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 39.0 m -173.27 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 129.409 3.084 . . . . 0.0 107.341 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.485 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -113.69 -30.18 6.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 116.148 1.907 . . . . 99.99 116.148 -177.388 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.91 20.39 8.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.43 -28.11 0.83 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 120.19 3.404 . . . . 0.0 120.19 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 t80 176.2 -70.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.326 1.45 . . . . 0.0 110.921 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t 62.75 85.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 126.926 2.09 . . . . 0.0 113.009 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.11 90.61 48.93 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.563 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.71 156.72 44.28 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 123.341 2.694 . . . . 0.0 113.466 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.3 -83.35 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.056 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.86 -171.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 112.457 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.79 -50.8 55.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.198 0.999 . . . . 0.0 113.467 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.7 -53.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.11 0.964 . . . . 0.0 110.235 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.72 -62.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.617 1.167 . . . . 0.0 113.176 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -64.58 -51.45 62.71 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 22' ' ' ILE . 27.7 ttpt -63.6 -45.73 89.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.584 0.754 . . . . 0.0 112.197 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.0 -39.3 90.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.87 85.34 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.209 0.459 . . . . 0.0 112.054 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 32.8 tt0 -57.33 -53.72 54.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.7 1.2 . . . . 0.0 111.068 171.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 18' ' ' LYS . 41.2 mm -53.67 -53.46 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.34 1.056 . . . . 0.0 110.638 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HB3' HD11 ' A' ' 32' ' ' ILE . 21.3 m95 -54.28 -60.4 3.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.266 1.027 . . . . 0.0 112.779 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -58.66 -31.98 68.67 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -69.87 -63.81 1.01 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 111.376 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG12 ' HE2' ' A' ' 47' ' ' LYS . 57.8 t -62.85 -36.45 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.149 1.38 . . . . 0.0 112.801 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD21 HE21 ' A' ' 40' ' ' GLN . 9.4 tt -56.92 -24.5 52.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.666 1.586 . . . . 0.0 113.956 173.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.19 71.29 0.24 Allowed Glycine 0 N--CA 1.476 1.314 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.271 12.2 p 3.52 78.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 128.475 2.71 . . . . 0.0 116.127 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 21.4 m -121.56 -67.61 0.95 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 112.597 -2.092 . . . . 0.0 116.284 -171.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 121.71 95.76 1.37 Allowed Glycine 0 N--CA 1.479 1.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 23' ' ' TRP . 14.8 pt -121.58 159.28 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 121.333 0.587 . . . . 0.0 112.526 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 9' ' ' VAL . . . -82.65 151.57 29.41 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.214 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 43.4 mm -45.49 -41.99 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.856 1.662 . . . . 0.0 112.892 171.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.49 -29.92 68.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 36.5 m-20 62.97 149.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.123 2.169 . . . . 0.0 111.858 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.55 24.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.9 p90 22.55 47.82 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 118.343 2.719 . . . . 0.0 118.343 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -160.12 -78.22 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.401 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.493 HE21 HD21 ' A' ' 27' ' ' LEU . 20.4 pt20 -70.0 27.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -115.78 -35.97 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.307 1.043 . . . . 0.0 111.698 172.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -59.26 -63.21 5.37 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 124.334 0.969 . . . . 0.0 113.398 171.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.77 121.64 0.01 OUTLIER Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.226 -1.487 . . . . 0.0 115.838 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -81.01 49.95 1.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.754 -1.723 . . . . 0.0 113.467 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -159.72 -154.04 0.38 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.502 1.921 . . . . 0.0 108.905 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -62.67 -0.87 0.7 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 26' ' ' VAL . 22.5 mmtp -56.16 -61.61 2.27 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.352 1.061 . . . . 0.0 112.748 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.65 -36.31 24.31 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.0 mmm -65.28 -52.3 55.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.598 1.159 . . . . 0.0 112.841 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.27 77.83 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.308 1.043 . . . . 0.0 112.668 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 74.0 t -62.81 -50.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.067 0.947 . . . . 0.0 110.177 171.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.97 -42.65 65.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.321 0.648 . . . . 0.0 112.566 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.46 -56.28 23.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -65.68 -38.64 89.83 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.681 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -66.55 -27.98 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 111.951 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -71.14 -69.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.806 0.443 . . . . 0.0 111.222 166.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.93 -44.01 3.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.999 0.92 . . . . 0.0 113.243 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.681 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.2 m-85 -82.62 -20.98 35.32 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -46.67 0.62 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.658 2.783 . . . . 0.0 114.189 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.77 26.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.652 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.1 pt-20 -6.72 76.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 120.29 3.441 . . . . 0.0 120.29 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -123.97 86.7 53.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 73.0 Cg_endo -66.24 150.8 84.64 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.17 2.58 . . . . 0.0 111.629 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 -48.73 0.35 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.605 1.962 . . . . 0.0 114.78 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -52.08 -69.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.616 1.566 . . . . 0.0 112.904 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.623 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -61.55 -20.46 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 HD21 ' HA2' ' A' ' 42' ' ' GLY . 59.3 tp -93.44 -29.02 15.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.258 1.823 . . . . 0.0 114.633 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -108.1 -40.33 5.24 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.607 1.163 . . . . 0.0 113.705 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.26 73.02 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.0 pm0 -122.97 70.23 39.62 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.679 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.38 32.83 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.536 3.49 . . . . 0.0 115.097 -173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.483 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 8.6 t -139.03 137.51 36.35 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.856 1.262 . . . . 0.0 111.125 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 23' ' ' TRP 0.306 3.2 mm -57.86 -27.94 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -66.19 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.991 0.807 . . . . 0.0 110.169 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.5 78.5 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 87.3 mt -58.2 -44.39 88.09 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.16 93.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 112.653 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.603 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.3 mp0 -60.83 -46.28 91.16 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 171.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -65.46 -26.97 68.18 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.316 9.5 m -112.07 -75.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 60.56 1.25 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.351 1.548 . . . . 0.0 113.428 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.4 m -161.69 -54.16 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.629 2.372 . . . . 0.0 109.05 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -106.03 -31.97 8.5 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 173.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 127.353 2.261 . . . . 99.99 116.436 -178.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 21.7 mp0 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 111.18 0.067 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.71 147.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.276 1.83 . . . . 0.0 113.465 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.43 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.556 -173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -118.25 -61.73 1.63 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 11' ' ' PRO . 4.0 t 67.46 98.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 126.389 1.876 . . . . 0.0 111.553 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -121.58 78.86 38.06 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.018 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' HG12 ' A' ' 9' ' ' VAL . 72.5 Cg_endo -66.56 145.68 77.16 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.665 2.244 . . . . 0.0 112.013 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -122.76 -87.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.046 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.9 p-10 -105.26 -176.38 3.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.49 -50.39 31.83 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.061 0.944 . . . . 0.0 113.119 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.91 -58.49 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.323 1.049 . . . . 0.0 110.504 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 74' ' ' ILE . 7.5 mm-40 -49.28 -58.89 4.27 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.745 1.218 . . . . 0.0 113.277 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -67.97 -54.25 20.04 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 38.2 ttpt -64.89 -41.29 95.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.713 1.205 . . . . 0.0 113.291 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.95 -43.04 84.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.494 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.2 78.35 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 30.2 tt0 -57.92 -58.71 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.11 1.364 . . . . 0.0 111.452 171.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.259 2.6 pp -61.35 -36.13 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.8 m95 -57.47 -60.74 3.19 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.485 0.714 . . . . 0.0 111.996 170.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 13.7 pt-20 -59.13 -26.8 65.03 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -73.23 -70.48 0.36 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.808 1.243 . . . . 0.0 112.289 167.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.82 -39.91 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 125.162 1.385 . . . . 0.0 113.024 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 23' ' ' TRP . 1.5 tt -61.06 -25.89 67.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.914 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.38 0.05 OUTLIER Glycine 0 N--CA 1.478 1.463 0 O-C-N 124.106 0.879 . . . . 0.0 111.38 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.27 13.3 p -20.7 88.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.39 2.676 . . . . 0.0 116.625 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 14.4 m -149.68 -51.82 0.15 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.006 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 130.02 124.14 2.59 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.804 0.69 . . . . 0.0 112.463 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.2 pt -134.11 177.38 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.411 0.685 . . . . 0.0 110.884 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 150.88 17.27 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.762 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ALA . 49.2 mm -28.23 -42.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.672 2.389 . . . . 0.0 114.463 164.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 73' ' ' THR . 6.4 mp -62.4 -34.17 76.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.991 1.716 . . . . 0.0 114.742 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.11 146.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.136 1.774 . . . . 0.0 113.171 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.45 25.92 0.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.1 p90 21.1 49.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -167.66 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.681 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.1 -14.49 17.08 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -33.04 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.47 12.57 15.98 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.743 0.652 . . . . 0.0 113.978 169.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 39.45 -155.68 0.03 OUTLIER Glycine 0 N--CA 1.48 1.574 0 C-N-CA 124.786 1.184 . . . . 0.0 114.759 -172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.39 52.14 1.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.332 -1.434 . . . . 0.0 110.7 171.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -171.49 -162.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.839 1.656 . . . . 0.0 112.02 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -51.82 -21.7 3.08 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.0 mmtp -52.58 -43.68 65.42 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.17 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.9 mtp -69.95 -45.65 66.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.763 1.225 . . . . 0.0 112.144 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.831 0.852 . . . . 0.0 112.536 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 68' ' ' LEU . 20.7 t -67.27 -49.32 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.072 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -50.3 -39.58 45.96 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.9 -59.63 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.941 0.897 . . . . 0.0 112.339 172.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 8.3 pt20 -63.52 -31.95 73.26 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.011 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 76.1 t -62.24 -37.57 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.795 1.238 . . . . 0.0 112.748 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.4 -33.79 61.01 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.4 ptt85 -102.59 -37.65 7.86 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -108.32 -35.35 6.55 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.777 0.831 . . . . 0.0 112.403 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.3 m-85 -80.12 -28.34 38.99 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 173.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 68.25 -30.96 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.521 2.328 . . . . 0.0 115.18 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.59 -31.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 127.988 2.515 . . . . 0.0 115.785 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.723 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 24.1 tt0 66.87 141.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.326 1.85 . . . . 0.0 113.185 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.723 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 97.7 mt 65.22 154.75 0.12 Allowed Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 172.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 94.5 Cg_endo -71.51 -162.81 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.314 2.009 . . . . 0.0 111.476 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp 66.92 -51.15 0.47 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.712 2.005 . . . . 0.0 115.466 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -57.75 -85.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.779 1.632 . . . . 0.0 110.52 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 11.8 m -79.07 46.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.497 1.141 . . . . 0.0 113.885 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 51' ' ' VAL . 13.3 mt -144.36 -50.34 0.29 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.508 -1.678 . . . . 0.0 114.839 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -109.84 -49.69 3.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.018 0.927 . . . . 0.0 111.662 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.94 79.14 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.674 0.609 . . . . 0.0 111.563 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 4.5 mp0 -116.9 87.28 21.65 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.73 167.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.98 -26.68 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.674 2.25 . . . . 0.0 114.653 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 44.0 p -80.5 138.0 36.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 0.0 109.97 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.496 HG12 HD12 ' A' ' 77' ' ' LEU 0.255 0.4 OUTLIER -62.09 -23.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.913 172.584 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -59.6 -51.51 69.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.36 0.664 . . . . 0.0 111.818 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.59 95.02 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 73' ' ' THR . 51.4 mt -57.97 -46.63 84.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.389 0.676 . . . . 0.0 112.254 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -45.33 85.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.609 1.164 . . . . 0.0 112.97 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.44 -31.91 71.56 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -74.25 -22.36 59.36 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 169.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 77' ' ' LEU 0.269 32.6 m -104.25 -73.97 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -85.5 61.21 6.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 123.894 1.807 . . . . 0.0 111.196 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.4 m -161.17 -56.43 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.278 -2.237 . . . . 0.0 108.461 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.22 -30.87 6.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 175.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.595 1.702 . . . . 99.99 115.595 -175.095 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.51 92.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.68 1.592 . . . . 0.0 113.786 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 4.6 tp60 -98.97 -62.86 1.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.548 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -148.75 -60.57 0.23 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.857 1.263 . . . . 0.0 111.078 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 t 65.33 84.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.771 2.028 . . . . 0.0 112.598 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -128.65 85.02 61.4 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.988 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.97 143.68 61.28 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.779 2.319 . . . . 0.0 112.436 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -77.04 0.6 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.777 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' GLU . 26.1 p30 -117.04 -172.85 2.29 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.563 1.145 . . . . 0.0 112.583 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.92 -63.29 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.71 1.204 . . . . 0.0 113.169 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.17 -47.17 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.401 1.081 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.608 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.3 mm-40 -50.58 -63.54 1.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.72 1.208 . . . . 0.0 113.173 174.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 t -67.26 -45.44 76.63 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.27 -54.11 50.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.003 1.321 . . . . 0.0 111.297 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.99 -36.81 82.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.18 89.14 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.486 0.585 . . . . 0.0 112.437 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.36 -51.42 70.01 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.149 1.38 . . . . 0.0 111.278 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.85 -54.19 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.276 1.03 . . . . 0.0 110.517 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.574 ' HB3' HD11 ' A' ' 32' ' ' ILE . 9.8 m95 -55.29 -53.99 49.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.262 1.025 . . . . 0.0 113.51 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -61.51 -30.75 70.83 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.75 -56.56 4.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.325 1.05 . . . . 0.0 111.93 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.0 -38.74 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 125.501 1.52 . . . . 0.0 113.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 40' ' ' GLN . 8.0 tt -59.81 -22.84 62.75 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.334 1.453 . . . . 0.0 113.585 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.85 74.74 0.3 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.272 13.0 p 0.78 81.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 128.32 2.648 . . . . 0.0 116.397 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 m -127.36 -80.32 0.59 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 112.579 -2.101 . . . . 0.0 115.17 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.88 102.37 0.67 Allowed Glycine 0 N--CA 1.479 1.523 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' ASP . 15.3 pt -125.05 166.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -72.22 158.84 53.5 Favored Glycine 0 N--CA 1.477 1.397 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.026 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' ALA . 40.5 mm -52.9 -42.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 114.179 -1.01 . . . . 0.0 111.75 164.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.16 9.23 0.33 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 166.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 32' ' ' ILE . 6.5 m-20 55.64 -137.47 1.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.677 1.591 . . . . 0.0 109.562 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.691 HD22 ' NE2' ' A' ' 40' ' ' GLN . 54.9 t30 -123.41 28.85 6.87 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.836 0.454 . . . . 0.0 110.276 156.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.281 53.2 p90 35.73 -0.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 1 N-CA-C 123.402 4.593 . . . . 0.0 123.402 -174.905 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -115.34 -74.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.922 1.689 . . . . 0.0 111.276 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.691 ' NE2' HD22 ' A' ' 37' ' ' ASN . 14.3 pt20 -67.71 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -112.44 -29.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.579 0.751 . . . . 0.0 112.434 171.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -57.51 -48.08 83.61 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 123.968 0.792 . . . . 0.0 113.349 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.93 99.32 0.01 OUTLIER Glycine 0 N--CA 1.478 1.46 0 O-C-N 125.1 1.118 . . . . 0.0 113.673 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -70.39 54.56 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.378 1.871 . . . . 0.0 114.747 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -165.3 -142.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.552 2.341 . . . . 0.0 108.078 -176.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -63.31 -18.36 63.54 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.56 -48.5 71.97 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.15 60.52 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.5 mtm -69.94 -44.54 69.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.717 0.807 . . . . 0.0 112.952 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.83 79.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.472 0.709 . . . . 0.0 112.568 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LYS . 94.3 t -62.95 -50.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.018 0.927 . . . . 0.0 109.865 170.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.678 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.46 -43.58 65.04 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.416 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -56.65 -54.37 46.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.277 1.031 . . . . 0.0 113.394 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.659 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 9.2 pt20 -66.75 -37.06 83.87 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.93 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 72.5 t -65.08 -25.22 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.373 1.069 . . . . 0.0 112.587 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 3.2 t60 -81.67 -54.59 5.27 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 168.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 18.8 ptp180 -71.02 -37.7 72.61 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -110.33 -31.43 7.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.933 1.293 . . . . 0.0 112.557 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.93 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.4 m-30 -102.84 -10.3 19.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tp60 62.05 -46.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 126.371 1.868 . . . . 0.0 115.81 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 52.54 28.23 5.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 167.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -109.21 94.89 16.44 Favored Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -173.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.678 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -66.13 151.01 84.76 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 123.709 2.94 . . . . 0.0 111.889 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 9.0 tt 63.88 -44.95 0.26 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.745 2.018 . . . . 0.0 114.087 -175.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -51.85 -69.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.984 1.714 . . . . 0.0 111.555 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.642 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 3.6 p -76.46 22.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 62.9 tp -130.94 -37.22 1.31 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.018 0.927 . . . . 0.0 113.482 -169.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.554 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 26.0 m-85 -101.31 -39.41 7.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.354 1.062 . . . . 0.0 113.797 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.42 90.22 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.642 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.1 pm0 -124.87 73.12 63.91 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.53 1.132 . . . . 0.0 112.005 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -77.99 34.78 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.125 3.217 . . . . 0.0 114.754 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 t -142.02 131.95 24.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.847 1.659 . . . . 0.0 110.502 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.285 0.5 OUTLIER -63.8 -20.33 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.591 178.843 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.98 -56.63 19.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.17 0.588 . . . . 0.0 110.439 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.05 75.42 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.088 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.3 mt -58.89 -45.51 90.05 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.17 91.46 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 0.0 111.881 172.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -59.47 -45.08 92.67 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.42 0.688 . . . . 0.0 112.74 171.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.51 -28.63 67.99 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.299 16.7 m -113.37 -68.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 61.53 2.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 123.228 1.49 . . . . 0.0 112.203 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 99.7 m -164.81 -69.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.951 2.501 . . . . 0.0 108.084 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.51 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -97.43 -29.08 13.7 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 115.732 -2.08 . . . . 99.99 114.336 179.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 21.8 mm-40 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.07 119.1 1.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.692 1.197 . . . . 0.0 114.045 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.56 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 63.3 tp60 -122.77 -80.07 0.62 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.793 -1.549 . . . . 0.0 112.75 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.471 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 46.0 t80 -135.38 -64.29 0.65 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t 72.15 98.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.814 2.045 . . . . 0.0 112.394 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -144.18 82.99 10.42 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.432 167.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.05 147.52 61.16 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 122.923 2.416 . . . . 0.0 112.674 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.01 -82.78 0.58 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.007 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -108.47 -177.36 3.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.718 0.807 . . . . 0.0 111.833 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.99 50.39 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.09 -59.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.761 1.224 . . . . 0.0 110.357 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.657 ' HA ' HD12 ' A' ' 74' ' ' ILE . 9.1 mm-40 -49.08 -59.57 3.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.981 1.312 . . . . 0.0 113.439 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.6 t -64.84 -56.37 13.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.085 0.954 . . . . 0.0 113.252 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 32.3 ttpt -67.14 -40.86 86.82 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.08 -40.64 94.92 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.913 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.83 84.6 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 33.4 tt0 -58.17 -53.14 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.581 1.152 . . . . 0.0 111.186 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.87 -50.96 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.327 1.051 . . . . 0.0 110.663 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -52.67 -60.11 3.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.32 1.048 . . . . 0.0 112.335 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HB3' HG13 ' A' ' 32' ' ' ILE . 15.4 pt-20 -60.13 -31.36 69.99 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -61.54 1.94 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.928 1.291 . . . . 0.0 111.865 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.21 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.28 1.032 . . . . 0.0 112.669 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 34.9 tp -62.3 -32.7 73.47 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.67 56.44 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 O-C-N 124.47 1.106 . . . . 0.0 112.94 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.276 12.1 p -0.74 75.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 128.914 2.885 . . . . 0.0 116.955 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.662 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 56.3 m -138.77 -48.0 0.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.589 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 125.05 112.14 1.9 Allowed Glycine 0 N--CA 1.477 1.406 0 O-C-N 123.714 0.634 . . . . 0.0 113.381 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -108.72 173.73 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.623 -0.789 . . . . 0.0 111.58 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -99.46 153.17 19.61 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.839 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 10' ' ' ALA . 43.5 mm -40.97 -47.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.995 1.318 . . . . 0.0 113.803 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.08 -21.07 63.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 17.7 m-20 58.98 157.46 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.603 1.961 . . . . 0.0 113.324 -172.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.95 8.92 3.29 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.6 p90 39.61 22.5 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -118.59 -85.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.776 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 40' ' ' GLN . 5.5 pm0 -59.5 -16.62 25.61 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -33.34 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.78 -53.08 0.6 Allowed Glycine 0 N--CA 1.476 1.326 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.344 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.32 -144.88 18.82 Favored Glycine 0 N--CA 1.478 1.485 0 O-C-N 124.506 0.768 . . . . 0.0 112.333 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -139.48 41.85 2.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.979 1.371 . . . . 0.0 112.991 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.3 m -130.62 -154.46 0.63 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.048 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -49.94 -33.08 16.45 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 mmtp -46.51 -73.04 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.398 1.479 . . . . 0.0 112.766 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.74 4.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.26 -53.56 35.45 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.97 91.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.909 0.884 . . . . 0.0 112.227 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 68' ' ' LEU . 27.6 t -66.87 -40.26 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.995 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.34 -45.71 72.74 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.934 0.788 . . . . 0.0 111.67 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.89 -49.87 76.14 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.387 172.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -54.56 -51.91 63.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.426 1.49 . . . . 0.0 112.446 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 60.2 t -65.68 -29.58 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.416 1.486 . . . . 0.0 112.56 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -68.1 -72.16 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.114 0.566 . . . . 0.0 111.28 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 6.3 ptt180 -64.5 -41.38 96.47 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 -173.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.35 -29.07 10.99 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.733 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.3 m-85 -94.62 -22.58 18.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 64.26 -33.78 0.15 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.664 2.468 . . . . 0.0 117.664 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -18.83 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.774 1.23 . . . . 0.0 114.168 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 47.76 39.01 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 66' ' ' LYS . 1.1 pt? -122.47 99.52 42.52 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 63.7 Cg_endo -65.6 160.76 41.64 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.3 2.666 . . . . 0.0 111.902 174.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 68' ' ' LEU . 7.3 tt 66.09 -47.57 0.42 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.971 2.108 . . . . 0.0 114.852 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HD2' HD12 ' A' ' 63' ' ' LEU . 32.7 mttp -56.75 -55.59 32.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.417 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.8 t -68.21 4.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 51' ' ' VAL . 61.0 mt -119.2 -29.66 5.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 75.0 m-85 -112.16 -38.06 4.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.89 -44.78 30.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.406 0.682 . . . . 0.0 112.244 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -119.31 67.0 9.06 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 168.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 41.5 Cg_endo -77.06 26.16 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.057 3.172 . . . . 0.0 115.802 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.2 t -137.96 136.05 36.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.988 1.315 . . . . 0.0 110.714 -171.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.271 0.4 OUTLIER -62.31 -23.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.905 178.299 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -54.87 -62.81 1.41 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.373 1.069 . . . . 0.0 110.258 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.45 -35.25 80.34 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.34 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 73' ' ' THR . 81.9 mt -57.54 -45.35 85.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.33 85.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.207 1.003 . . . . 0.0 112.834 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -63.19 -47.75 81.24 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.93 -25.41 68.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 82' ' ' ALA 0.272 5.2 m -101.13 -81.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 168.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -80.43 65.72 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.52 1.629 . . . . 0.0 112.404 -173.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.8 m -165.0 -50.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.155 2.582 . . . . 0.0 108.457 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -116.69 -30.7 5.72 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 174.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 116.639 -1.648 . . . . 99.99 115.098 -174.096 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 2.5 pp20? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.14 20.96 8.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 119.123 3.008 . . . . 0.0 119.123 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.94 -40.62 30.9 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 t80 174.54 -68.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.089 0.956 . . . . 0.0 111.235 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.6 t 66.33 93.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 127.339 2.256 . . . . 0.0 112.222 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -124.72 82.59 59.77 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.361 170.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -68.66 150.45 74.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.894 2.396 . . . . 0.0 112.696 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 -81.04 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.932 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -113.95 -174.76 2.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.276 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.56 10.1 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.197 0.999 . . . . 0.0 113.24 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.26 -52.0 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.669 1.188 . . . . 0.0 110.954 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HA ' HD12 ' A' ' 74' ' ' ILE . 15.0 mm-40 -51.02 -64.34 0.84 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.101 1.361 . . . . 0.0 113.495 175.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 t -66.91 -46.87 73.52 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 22' ' ' ILE . 51.2 tptt -60.76 -51.74 68.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.104 0.962 . . . . 0.0 111.053 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.98 -36.13 82.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.727 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.5 91.27 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.895 0.77 . . . . 0.0 112.587 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.7 tt0 -59.07 -50.43 74.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.753 1.221 . . . . 0.0 111.344 170.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.4 mm -54.7 -52.17 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 110.617 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 15.8 m95 -56.7 -54.83 41.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.346 1.058 . . . . 0.0 113.697 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.3 pt-20 -59.16 -28.27 66.44 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -77.72 -61.53 1.96 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.794 1.638 . . . . 0.0 111.602 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.24 -39.62 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.517 1.927 . . . . 0.0 113.818 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 32' ' ' ILE . 5.9 tt -58.72 -24.22 61.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.385 1.474 . . . . 0.0 113.819 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.67 0.73 Allowed Glycine 0 N--CA 1.473 1.149 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.25 13.1 p -22.52 95.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 127.404 2.282 . . . . 0.0 115.474 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.609 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 24.1 p -148.19 -58.8 0.24 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 112.608 -2.087 . . . . 0.0 114.505 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 127.69 95.58 0.88 Allowed Glycine 0 N--CA 1.48 1.594 0 O-C-N 123.824 0.702 . . . . 0.0 113.37 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.4 pt -107.57 166.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 121.441 0.639 . . . . 0.0 112.501 -174.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -88.76 160.48 30.09 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.144 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 10' ' ' ALA . 47.7 mm -45.3 -51.34 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 125.319 1.448 . . . . 0.0 112.497 170.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.17 -27.66 69.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.412 1.485 . . . . 0.0 114.398 171.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' A' ' 32' ' ' ILE . 4.4 p-10 46.07 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.26 -167.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -93.5 24.96 3.68 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 34.15 43.07 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -138.77 -82.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.426 -1.715 . . . . 0.0 110.426 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.39 36.77 0.06 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.66 -42.46 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.592 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -67.06 -48.45 59.81 Favored Glycine 0 N--CA 1.479 1.527 0 O-C-N 123.839 0.712 . . . . 0.0 114.457 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.33 115.13 0.01 OUTLIER Glycine 0 N--CA 1.478 1.454 0 O-C-N 125.171 1.159 . . . . 0.0 114.218 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -75.7 56.22 0.9 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 123.282 1.515 . . . . 0.0 112.725 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -169.73 -155.93 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.439 2.296 . . . . 0.0 109.438 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.8 pt? -53.98 -20.47 6.27 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 22.1 mmtp -55.42 -40.23 71.24 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.06 -41.95 65.34 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 170.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 mmt -68.53 -49.94 55.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.812 1.245 . . . . 0.0 112.367 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.87 81.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.183 0.993 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 68' ' ' LEU . 10.4 t -72.07 -42.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.725 173.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.65 -40.79 63.18 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -58.7 6.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.005 0.922 . . . . 0.0 112.895 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.551 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 11.7 pt20 -63.92 -36.72 84.89 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 89.0 t -68.59 -24.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.311 1.044 . . . . 0.0 112.791 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -80.54 -57.54 3.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.3 ppt_? -69.72 -39.26 76.94 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -174.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -103.5 -45.83 4.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.165 0.986 . . . . 0.0 111.802 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.3 m-85 -76.95 -28.6 55.26 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 57.77 19.41 5.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.16 -29.64 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 45.98 73.88 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.927 1.691 . . . . 0.0 115.173 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.777 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -126.53 81.01 68.91 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.9 Cg_endo -63.81 148.51 91.9 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.097 2.531 . . . . 0.0 111.07 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp 64.44 -50.74 0.3 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.651 1.98 . . . . 0.0 113.958 -172.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -51.29 -60.21 3.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.011 1.324 . . . . 0.0 113.01 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.777 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -63.96 -13.68 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.834 HD11 HG11 ' A' ' 51' ' ' VAL . 2.8 mm? -102.68 -25.22 13.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -111.17 -38.03 5.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.83 -42.47 40.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.194 0.598 . . . . 0.0 112.085 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.5 pm0 -120.9 67.64 15.32 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.16 50.33 3.46 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.81 3.674 . . . . 0.0 115.111 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.424 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -161.38 137.74 8.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.754 1.221 . . . . 0.0 110.656 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.272 0.4 OUTLIER -63.87 -22.24 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.9 -179.688 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -57.43 -61.38 2.53 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.96 -34.46 78.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.677 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.5 mt -57.66 -47.42 82.33 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.655 0.382 . . . . 0.0 111.971 171.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.07 99.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.924 0.89 . . . . 0.0 111.905 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 76' ' ' ALA . 1.2 mp0 -58.03 -40.31 80.55 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.06 -29.86 69.76 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.289 15.7 m -113.76 -60.54 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.35 36.89 0.25 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.083 1.753 . . . . 0.0 114.574 -173.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -124.02 -49.33 1.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.389 1.876 . . . . 0.0 108.925 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -32.6 5.91 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 116.42 2.008 . . . . 99.99 116.42 -171.76 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 4.4 pm0 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.097 1.759 . . . . 0.0 112.992 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -170.77 -118.9 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.344 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.483 ' CE2' ' HB ' ' A' ' 34' ' ' ILE . 22.0 t80 -50.77 -45.03 58.85 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.304 9.2 p 2.43 56.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 -170.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -113.98 102.64 55.0 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.28 -157.82 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.192 2.595 . . . . 0.0 112.559 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 1.9 m -159.07 -100.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.742 0.817 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' THR . 13.6 p30 -76.3 167.54 21.67 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.908 1.283 . . . . 0.0 112.978 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.27 -48.06 24.84 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.41 -60.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.325 1.05 . . . . 0.0 110.178 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 74' ' ' ILE . 39.3 mt-10 -58.18 -45.34 87.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -65.54 -55.81 15.74 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.621 0.768 . . . . 0.0 112.624 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.61 -43.61 98.53 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 22' ' ' ILE . 4.1 mm? -63.45 -46.52 85.84 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.56 82.01 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.2 tt0 -58.7 -59.17 5.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.291 1.436 . . . . 0.0 111.498 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 19' ' ' LEU . 19.9 pt -62.18 -35.75 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 4.8 m95 -56.62 -59.09 5.51 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.424 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 18.0 pt-20 -61.25 -27.77 68.69 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -64.3 0.89 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.582 1.153 . . . . 0.0 112.289 168.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.82 -37.68 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.921 1.689 . . . . 0.0 113.298 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.1 tt -58.6 -23.58 59.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.337 1.455 . . . . 0.0 113.707 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.31 84.45 0.83 Allowed Glycine 0 N--CA 1.475 1.245 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.266 13.9 p -16.16 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 127.77 2.428 . . . . 0.0 116.039 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 24.0 p -146.01 -74.11 0.22 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 112.81 -1.995 . . . . 0.0 115.0 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 140.04 111.14 0.91 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 33' ' ' GLY . 11.1 pt -113.27 -82.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.593 ' H ' HG13 ' A' ' 32' ' ' ILE . . . 120.95 -169.37 14.25 Favored Glycine 0 N--CA 1.479 1.535 0 C-N-CA 123.871 0.748 . . . . 0.0 112.753 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.631 ' HA ' HG22 ' A' ' 74' ' ' ILE . 49.0 mt -53.71 -46.47 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.61 -24.65 67.69 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.39 -149.67 0.42 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.553 1.141 . . . . 0.0 109.014 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 5.3 t-20 -115.43 13.02 16.42 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 164.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.2 p90 41.23 14.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -135.77 -68.77 0.5 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.714 1.206 . . . . 0.0 112.417 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 27' ' ' LEU . 21.1 pt20 -68.53 32.21 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -118.44 -37.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.386 1.074 . . . . 0.0 112.932 174.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -76.68 -44.96 14.03 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.343 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.46 -179.2 2.77 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 122.278 0.932 . . . . 0.0 113.286 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.82 56.57 1.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.67 1.224 . . . . 0.0 111.641 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -173.54 -159.4 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.199 1.8 . . . . 0.0 111.063 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -53.3 -20.69 4.55 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.7 mmmt -45.94 -59.8 2.62 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.356 1.062 . . . . 0.0 113.285 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.23 -37.77 56.14 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.8 mmm -65.34 -50.05 67.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.431 1.092 . . . . 0.0 112.326 175.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.34 82.04 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.432 1.093 . . . . 0.0 112.573 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 68' ' ' LEU . 26.1 t -65.98 -47.09 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 118.698 -0.667 . . . . 0.0 110.537 171.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.41 -41.94 66.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 118.356 0.525 . . . . 0.0 112.402 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -56.1 26.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.129 0.972 . . . . 0.0 113.239 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.6 pt20 -64.44 -37.99 89.46 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 62' ' ' GLU . 75.0 t -64.96 -37.36 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.951 0.9 . . . . 0.0 111.629 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -63.0 -44.2 96.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 19.6 ptp180 -86.5 -44.44 11.96 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.87 -28.99 13.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.01 1.324 . . . . 0.0 112.911 -173.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -97.99 -22.81 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -48.56 0.41 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.568 2.747 . . . . 0.0 115.025 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.04 32.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.648 2.379 . . . . 0.0 116.897 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.715 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.7 pt-20 -10.08 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 119.718 3.229 . . . . 0.0 119.718 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -122.11 85.09 46.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.5 Cg_endo -65.22 150.13 87.85 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.779 2.319 . . . . 0.0 111.105 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.0 tp 66.05 -49.83 0.41 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.021 2.128 . . . . 0.0 114.623 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.38 -58.79 5.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.353 1.061 . . . . 0.0 113.014 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -63.69 -16.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 51' ' ' VAL . 47.5 mt -97.54 -25.39 15.17 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.08 -37.85 3.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.91 -49.59 19.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 4.3 pm0 -128.72 52.7 9.56 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 174.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 95.9 Cg_endo -63.99 -23.59 67.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 116.214 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.5 p -68.03 132.6 47.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.348 0.659 . . . . 0.0 110.095 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.339 0.4 OUTLIER -61.27 -19.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.982 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -57.24 -63.84 1.09 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.864 0.866 . . . . 0.0 109.727 165.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -63.0 -37.93 89.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.332 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.9 mt -55.9 -46.72 78.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.139 0.576 . . . . 0.0 111.903 171.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.82 -40.08 96.3 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.602 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.5 mp0 -61.97 -43.39 98.95 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.39 -25.37 67.99 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.303 30.8 m -114.88 -65.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.77 57.92 2.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 123.348 1.547 . . . . 0.0 111.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.2 m -165.65 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.86 2.464 . . . . 0.0 108.604 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -107.67 -30.9 8.32 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 175.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 125.623 1.569 . . . . 99.99 115.072 176.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.7 pt-20 . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.2 -153.35 0.55 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.947 0.499 . . . . 0.0 109.976 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -160.32 -45.27 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.187 0.995 . . . . 0.0 111.049 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 17.6 p90 -63.98 40.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 11.5 p -80.82 89.17 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.131 0.967 . . . . 0.0 112.309 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.18 87.29 4.73 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.516 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.39 161.05 47.43 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.385 2.724 . . . . 0.0 112.975 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -78.52 0.58 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.824 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -114.58 -173.71 2.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 112.54 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -59.31 3.56 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 0.0 113.166 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.23 -50.97 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.61 1.164 . . . . 0.0 110.932 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -51.48 -59.75 3.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.723 1.209 . . . . 0.0 113.318 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -69.04 -45.42 70.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -57.33 -53.66 55.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.381 1.472 . . . . 0.0 110.977 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -38.92 92.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.29 85.14 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.82 -49.97 75.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.55 1.14 . . . . 0.0 111.456 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.78 -53.88 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.16 0.984 . . . . 0.0 110.632 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -55.45 -53.12 60.22 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.17 0.988 . . . . 0.0 113.192 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.671 ' HB3' HG13 ' A' ' 32' ' ' ILE . 12.5 pt-20 -60.72 -33.12 72.42 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -70.29 -58.94 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.43 1.081 . . . . 0.0 113.097 169.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.01 -40.18 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.025 1.33 . . . . 0.0 113.326 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.9 tt -60.96 -26.49 67.58 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.272 . . . . 0.0 113.986 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.55 73.47 0.12 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.278 12.7 p -2.12 80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.481 2.712 . . . . 0.0 116.933 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.4 m -134.14 -108.02 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.001 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -176.86 101.45 0.16 Allowed Glycine 0 N--CA 1.48 1.612 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -96.79 -163.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . -131.09 161.4 23.53 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mm -55.54 -44.39 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.253 1.021 . . . . 0.0 111.777 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 37.3 tp -58.45 -29.61 66.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 169.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 41' ' ' ILE . 21.8 m-20 58.69 175.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.806 1.643 . . . . 0.0 112.389 -171.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.61 1.61 45.29 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.0 p90 49.8 0.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 120.086 3.365 . . . . 0.0 120.086 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -108.28 -84.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.913 1.285 . . . . 0.0 110.401 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG3' HD11 ' A' ' 27' ' ' LEU . 15.7 pt20 -68.74 22.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 72' ' ' PRO . 2.3 pp -98.56 -31.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.961 0.504 . . . . 0.0 111.418 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.618 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.71 -47.09 92.91 Favored Glycine 0 N--CA 1.479 1.53 0 O-C-N 124.152 0.908 . . . . 0.0 113.706 170.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.46 104.41 0.01 OUTLIER Glycine 0 N--CA 1.479 1.51 0 CA-C-N 114.361 -0.919 . . . . 0.0 115.279 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.88 58.13 0.64 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.738 1.615 . . . . 0.0 114.286 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 m -172.64 -154.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.25 2.22 . . . . 0.0 110.468 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.63 -18.27 1.69 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 8.8 mptt -48.48 -47.5 38.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.343 1.057 . . . . 0.0 112.01 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.77 66.61 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -71.66 -45.92 60.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.674 1.189 . . . . 0.0 112.74 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.78 78.22 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.743 0.817 . . . . 0.0 112.22 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 82.2 t -65.99 -48.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.267 1.027 . . . . 0.0 110.568 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -51.97 -41.3 62.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.36 -60.91 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.056 0.942 . . . . 0.0 112.937 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 7.1 pt20 -60.7 -36.8 79.69 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 88.3 t -68.11 -30.36 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 0.0 113.194 176.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -78.76 -55.31 5.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.113 0.565 . . . . 0.0 111.989 171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -76.35 -35.09 58.91 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -111.27 -36.94 5.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.138 0.975 . . . . 0.0 112.84 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.8 m-85 -82.69 -28.73 30.39 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 57.69 7.42 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.31 -18.83 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 50.38 58.58 5.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 1.7 pt? -130.82 86.68 51.59 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.4 Cg_endo -64.21 151.1 86.81 Favored 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 123.098 2.532 . . . . 0.0 111.665 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 tp 67.75 -37.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.556 1.943 . . . . 0.0 115.26 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -55.37 -71.99 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.044 0.938 . . . . 0.0 111.213 173.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.698 HG12 HE22 ' A' ' 71' ' ' GLN . 22.5 m -76.47 58.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-O 123.162 1.458 . . . . 0.0 111.93 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.618 ' HG ' ' HA2' ' A' ' 42' ' ' GLY . 44.5 tp -168.35 -54.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.242 -171.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.7 -45.77 8.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.74 88.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.979 0.511 . . . . 0.0 111.979 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.698 HE22 HG12 ' A' ' 67' ' ' VAL . 8.7 mp0 -115.2 81.09 7.78 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.074 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HA ' HD11 ' A' ' 41' ' ' ILE . 37.9 Cg_endo -82.08 36.92 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.113 2.542 . . . . 0.0 113.974 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -160.74 134.45 6.87 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.193 1.397 . . . . 0.0 110.728 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.273 0.5 OUTLIER -65.73 -22.92 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.842 179.8 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -59.52 -51.58 69.25 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.958 0.345 . . . . 0.0 110.973 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.03 83.97 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 93.5 mt -58.37 -44.3 88.79 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.6 89.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.142 0.977 . . . . 0.0 112.159 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.29 -31.36 72.46 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.22 -19.95 60.97 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 77' ' ' LEU 0.275 14.0 m -114.87 -69.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.75 61.25 4.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.656 1.693 . . . . 0.0 111.142 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.4 m -164.53 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.121 2.169 . . . . 0.0 108.286 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.541 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.52 -33.19 7.12 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 176.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 116.947 2.203 . . . . 99.99 116.947 -177.277 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.9 pp20? . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.82 25.12 15.07 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -46.67 -33.1 3.98 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 t80 174.76 -70.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.843 1.657 . . . . 0.0 110.937 -173.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG22 ' HA2' ' A' ' 33' ' ' GLY . 3.0 t 62.73 88.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 126.904 2.081 . . . . 0.0 112.286 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.6 88.91 35.79 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.054 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.09 152.29 80.24 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 123.209 2.606 . . . . 0.0 113.167 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.549 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -112.33 -85.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.713 179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -108.93 -176.85 3.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.181 0.593 . . . . 0.0 111.265 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -53.65 14.29 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 118.13 -0.938 . . . . 0.0 113.141 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.53 -52.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.947 0.899 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.716 ' HA ' HD12 ' A' ' 74' ' ' ILE . 53.9 mm-40 -51.8 -59.62 4.1 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.297 1.039 . . . . 0.0 112.336 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -66.27 -50.36 63.99 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -63.92 -46.94 82.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.753 1.221 . . . . 0.0 112.034 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.09 -37.64 84.33 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.4 89.82 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 44.5 tt0 -59.77 -50.68 72.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.848 1.259 . . . . 0.0 111.419 171.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.52 -50.52 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.861 0.864 . . . . 0.0 110.298 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 5.5 m95 -57.01 -54.91 41.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.9 pt-20 -58.0 -30.21 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -74.96 -60.24 2.38 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.781 1.301 . . . . 0.0 111.862 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.13 -37.14 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.762 1.625 . . . . 0.0 113.195 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 6.9 tt -58.65 -19.66 41.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.85 1.66 . . . . 0.0 114.38 173.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.04 69.23 0.4 Allowed Glycine 0 N--CA 1.476 1.321 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.269 12.3 p 3.85 78.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 128.402 2.681 . . . . 0.0 115.611 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -121.18 -49.17 2.19 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 112.67 -2.059 . . . . 0.0 115.289 -168.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 106.1 84.42 1.72 Allowed Glycine 0 N--CA 1.48 1.628 0 O-C-N 123.748 0.655 . . . . 0.0 112.331 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.573 HD13 HD13 ' A' ' 27' ' ' LEU . 9.4 pt -113.67 153.86 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -68.25 158.44 52.16 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 113.496 -1.683 . . . . 0.0 113.27 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 10' ' ' ALA . 46.9 mm -45.45 -39.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.251 1.42 . . . . 0.0 112.261 166.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.6 tp -56.49 -31.77 64.36 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.92 1.688 . . . . 0.0 114.626 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 6.8 m-20 61.68 162.14 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.03 1.732 . . . . 0.0 111.627 -169.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -68.04 4.25 1.29 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.264 54.7 p90 48.96 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -175.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -109.11 -74.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.133 1.773 . . . . 0.0 112.558 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.411 ' HG3' HD11 ' A' ' 27' ' ' LEU . 19.7 pt20 -73.08 33.58 0.07 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -100.92 -37.4 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.97 -30.48 4.8 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.274 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.43 -172.96 7.22 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-O 122.627 1.126 . . . . 0.0 113.849 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 53.9 0.88 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.911 -1.144 . . . . 0.0 111.862 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.444 ' HB3' HD23 ' A' ' 46' ' ' LEU . 3.8 m -173.49 -166.83 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.701 1.6 . . . . 0.0 112.39 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 45' ' ' SER . 1.9 pt? -50.64 -22.5 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.579 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 12.4 mmmt -42.34 -49.41 5.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.068 1.347 . . . . 0.0 112.07 168.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.57 71.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.795 1.238 . . . . 0.0 114.132 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -69.39 -45.7 68.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.215 1.006 . . . . 0.0 112.319 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.39 91.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.584 0.754 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 68' ' ' LEU . 40.8 t -64.96 -46.65 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.701 172.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -52.58 -42.52 64.59 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -58.11 -48.26 80.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 0.0 112.28 174.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.38 -43.65 98.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 0.0 112.343 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.8 t -59.52 -34.58 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.153 1.381 . . . . 0.0 112.986 176.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -72.99 -39.55 65.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.519 HH21 ' HB1' ' A' ' 53' ' ' ALA . 2.1 ptt180 -91.12 -53.31 4.42 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.77 -29.01 22.65 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 113.041 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 54.8 m-85 -103.23 -18.24 14.98 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -38.95 0.13 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.811 2.444 . . . . 0.0 117.47 -174.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.29 -22.89 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 127.67 2.388 . . . . 0.0 115.476 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 59.74 152.33 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.862 2.465 . . . . 0.0 116.4 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt 65.9 150.26 0.12 Allowed Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 126.032 1.733 . . . . 0.0 115.47 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 83.4 Cg_endo -68.1 172.93 10.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.036 1.824 . . . . 0.0 110.881 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 69' ' ' PHE . 8.0 tt 70.25 -40.28 0.46 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.188 1.795 . . . . 0.0 114.653 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -48.92 -92.36 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.054 2.141 . . . . 0.0 112.283 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 13.8 p -89.1 62.18 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 123.431 1.586 . . . . 0.0 109.304 171.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 tp -157.51 -76.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 112.589 -2.096 . . . . 0.0 112.924 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.722 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 20.6 m-85 -77.82 -41.4 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.325 0.65 . . . . 0.0 112.508 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.22 73.18 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.08 81.92 60.51 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 166.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 44.5 Cg_endo -78.22 30.56 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.641 2.894 . . . . 0.0 116.339 -172.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -139.93 131.85 27.7 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.397 1.479 . . . . 0.0 109.835 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.285 0.4 OUTLIER -63.64 -21.69 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.65 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.3 tmmt? -57.24 -56.15 25.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.514 0.726 . . . . 0.0 110.495 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.07 73.55 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.9 mt -54.4 -48.59 71.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.432 0.693 . . . . 0.0 112.533 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.96 96.54 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -32.72 73.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -71.64 -21.69 61.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 77' ' ' LEU 0.281 29.8 m -110.27 -69.35 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.41 56.12 3.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.599 1.666 . . . . 0.0 111.797 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 m -156.55 -61.41 0.1 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.882 -1.963 . . . . 0.0 108.843 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.639 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -102.27 -32.71 9.92 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 116.201 1.926 . . . . 99.99 116.201 177.239 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 40.1 mt-10 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.45 ' HB3' ' N ' ' A' ' 33' ' ' GLY . . . -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.827 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -102.03 -40.0 7.05 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.761 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 10.7 p90 -67.75 42.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 9.6 p -86.62 90.35 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 122.018 0.913 . . . . 0.0 112.071 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -111.03 87.53 7.21 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.916 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.07 144.84 38.51 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.081 2.521 . . . . 0.0 113.223 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -75.55 0.47 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.467 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -116.58 -172.97 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.061 0.945 . . . . 0.0 112.486 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.06 57.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.157 0.983 . . . . 0.0 113.468 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -55.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.025 0.93 . . . . 0.0 110.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.5 mm-40 -51.12 -57.48 8.6 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.34 1.056 . . . . 0.0 113.597 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 t -65.1 -54.4 30.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 65.5 tttp -60.96 -46.36 91.03 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.035 0.934 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.86 -40.97 95.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.219 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 41.8 tt0 -59.64 -54.91 40.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.63 1.172 . . . . 0.0 111.545 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -52.83 -49.84 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.671 1.188 . . . . 0.0 110.593 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.491 ' HB3' HD11 ' A' ' 32' ' ' ILE . 20.1 m95 -53.71 -65.15 0.62 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.459 1.104 . . . . 0.0 111.907 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HB3' HG12 ' A' ' 32' ' ' ILE . 12.3 pt-20 -57.45 -29.63 64.36 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -72.63 -66.79 0.62 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.255 1.422 . . . . 0.0 111.919 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.31 -35.45 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.837 1.255 . . . . 0.0 113.342 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.51 -19.35 47.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.583 . . . . 0.0 114.089 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.37 71.9 0.2 Allowed Glycine 0 N--CA 1.476 1.364 0 C-N-CA 124.18 0.895 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.7 p 0.65 82.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.502 2.721 . . . . 0.0 115.878 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 21.7 m -123.38 -81.62 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.863 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.21 96.95 0.57 Allowed Glycine 0 N--CA 1.478 1.457 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 24' ' ' GLU . 11.8 pt -124.37 -177.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 114.608 -0.796 . . . . 0.0 112.312 -171.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 9' ' ' VAL . . . -112.41 166.11 12.15 Favored Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.906 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' ALA . 41.3 mm -55.16 -45.27 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.092 1.357 . . . . 0.0 112.324 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 36.3 tp -61.21 -18.27 57.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.851 1.661 . . . . 0.0 114.408 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 11.1 m-20 60.21 -163.95 0.23 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.162 1.785 . . . . 0.0 110.412 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.459 ' ND2' HE22 ' A' ' 40' ' ' GLN . 51.8 t30 -108.63 22.94 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.188 0.518 . . . . 0.0 110.967 165.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.6 p90 36.5 16.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 121.565 3.913 . . . . 0.0 121.565 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -119.83 -76.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 111.642 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.459 HE22 ' ND2' ' A' ' 37' ' ' ASN . 17.3 pm0 -73.66 31.61 0.08 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -106.22 -38.12 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.338 0.655 . . . . 0.0 112.251 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.54 -55.08 27.39 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.193 0.933 . . . . 0.0 113.359 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.87 114.22 0.01 OUTLIER Glycine 0 N--CA 1.478 1.447 0 O-C-N 125.348 1.263 . . . . 0.0 114.867 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -78.66 59.76 2.57 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.917 1.341 . . . . 0.0 112.543 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -174.96 -157.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.816 2.446 . . . . 0.0 110.358 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -54.2 -17.58 2.98 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.2 mmtt -46.1 -52.65 11.7 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.229 1.011 . . . . 0.0 113.06 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.11 -38.43 62.62 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -68.98 -48.55 62.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.454 1.102 . . . . 0.0 112.674 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.7 84.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.895 0.878 . . . . 0.0 112.47 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 63.7 t -63.9 -50.21 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.133 0.973 . . . . 0.0 110.099 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.6 63.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.522 0.729 . . . . 0.0 112.912 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.03 -57.17 13.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.896 0.878 . . . . 0.0 112.878 173.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 6.6 pt20 -66.16 -36.93 84.41 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 61.3 t -64.44 -29.52 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.298 1.039 . . . . 0.0 112.304 174.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -79.85 -67.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.8 0.44 . . . . 0.0 111.598 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.514 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -65.61 -35.98 82.38 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -171.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -107.68 -34.28 7.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.568 0.747 . . . . 0.0 112.938 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.1 m-30 -87.46 -25.73 23.6 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 69.47 -43.61 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 129.049 2.94 . . . . 0.0 115.964 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 85' ' ' SER . 12.9 p -59.54 -21.25 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HA ' HG12 ' A' ' 55' ' ' VAL . 27.5 tt0 47.62 79.56 0.06 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 2.1 pt? -136.69 83.71 29.18 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 169.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -65.75 150.05 86.41 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.328 2.686 . . . . 0.0 111.952 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.2 tt 65.65 -41.58 0.34 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.812 2.045 . . . . 0.0 114.546 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -51.1 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.935 1.694 . . . . 0.0 112.183 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 63' ' ' LEU . 9.4 p -84.69 64.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.514 1.626 . . . . 0.0 110.049 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD22 HG11 ' A' ' 51' ' ' VAL . 55.7 tp -163.48 -63.69 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.219 -175.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 22.8 m-85 -79.94 -57.47 3.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.46 1.104 . . . . 0.0 112.706 174.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.89 71.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.282 0.633 . . . . 0.0 112.696 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -123.01 82.09 50.79 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.247 1.019 . . . . 0.0 111.099 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -82.76 31.89 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.376 2.717 . . . . 0.0 115.143 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 4.1 t -148.31 135.75 20.53 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.239 1.015 . . . . 0.0 111.307 -171.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.279 0.4 OUTLIER -63.97 -23.54 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.467 -178.905 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -52.94 -62.25 1.77 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.298 1.039 . . . . 0.0 110.485 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.37 80.51 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.821 -1.082 . . . . 0.0 113.912 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD12 HG12 ' A' ' 74' ' ' ILE . 32.1 mt -58.25 -47.29 84.03 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.727 0.411 . . . . 0.0 110.934 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.03 92.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.41 1.084 . . . . 0.0 112.841 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.596 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -60.27 -36.63 78.24 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 3.1 m-85 -73.34 -39.84 64.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 171.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.627 HG11 ' CD2' ' A' ' 59' ' ' TYR 0.251 26.2 m -105.95 -28.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -170.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.71 50.71 0.94 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.982 1.373 . . . . 0.0 109.834 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 90.6 m -162.27 -61.74 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.574 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.6 -33.18 7.1 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 170.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 38.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 116.732 2.123 . . . . 99.99 116.732 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.84 -135.04 0.06 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.331 1.452 . . . . 0.0 110.163 166.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -172.55 -66.74 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.569 1.547 . . . . 0.0 108.515 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -66.75 47.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.673 2.789 . . . . 0.0 117.117 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -96.13 87.24 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 122.346 1.069 . . . . 0.0 111.871 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 83.87 15.45 Favored Pre-proline 0 N--CA 1.477 0.893 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.857 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -67.98 133.07 27.97 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.074 2.516 . . . . 0.0 113.401 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -78.49 -77.6 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.673 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.56 -174.46 2.57 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.125 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -57.21 4.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.643 1.177 . . . . 0.0 113.388 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.81 -51.66 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.722 0.809 . . . . 0.0 111.813 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HA ' HD12 ' A' ' 74' ' ' ILE . 26.0 mm-40 -52.06 -57.07 10.62 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.691 0.797 . . . . 0.0 112.504 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.2 -53.33 46.39 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.199 0.999 . . . . 0.0 113.501 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -55.6 -48.57 74.66 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 111.292 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.1 mm? -69.68 -44.21 70.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.28 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.44 78.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.4 tt0 -59.74 -59.64 5.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.306 1.442 . . . . 0.0 111.523 172.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.267 2.7 pp -61.12 -36.85 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.461 ' HB3' HD11 ' A' ' 32' ' ' ILE . 6.7 m95 -59.75 -54.91 40.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.993 172.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB3' HG12 ' A' ' 32' ' ' ILE . 13.6 pt-20 -60.49 -29.85 69.33 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -71.69 -66.84 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.682 1.593 . . . . 0.0 111.933 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 47' ' ' LYS . 62.1 t -63.86 -34.3 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.219 1.808 . . . . 0.0 113.763 -172.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 32' ' ' ILE . 7.6 tt -56.54 -24.82 49.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.598 1.159 . . . . 0.0 113.812 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.77 75.43 0.49 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.289 12.2 p -4.47 83.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 128.247 2.619 . . . . 0.0 116.208 -178.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 m -116.7 -39.04 3.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.113 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.2 91.46 1.08 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -169.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 27' ' ' LEU . 47.3 pt -111.09 -143.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.63 -174.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.41 -150.58 5.65 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 122.747 1.193 . . . . 0.0 113.772 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 58.3 mt -93.99 -61.12 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 111.685 -2.258 . . . . 0.0 108.757 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.31 -29.77 66.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.157 1.383 . . . . 0.0 113.34 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 58.33 -148.24 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.882 1.273 . . . . 0.0 109.517 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -99.49 13.9 31.74 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.64 0.587 . . . . 0.0 111.351 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.26 35.5 p90 41.23 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 121.636 3.939 . . . . 0.0 121.636 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -96.05 -79.69 0.44 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.889 1.276 . . . . 0.0 112.816 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -74.33 35.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 -174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -112.83 -35.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.61 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.27 -54.66 35.47 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 123.876 0.735 . . . . 0.0 112.546 171.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.39 97.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.122 -1.039 . . . . 0.0 115.399 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -74.41 63.55 1.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.17 1.388 . . . . 0.0 112.809 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 14.0 m -171.79 -153.03 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.838 2.455 . . . . 0.0 109.635 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.41 ' H ' ' HB3' ' A' ' 45' ' ' SER . 1.7 pt? -51.79 -22.57 3.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 26' ' ' VAL . 3.9 mmpm? -46.43 -48.55 18.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.76 -1.114 . . . . 0.0 113.814 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.27 65.3 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.95 -51.48 54.67 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.595 1.158 . . . . 0.0 112.606 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.15 92.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 0.0 112.664 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.492 HG11 HD13 ' A' ' 68' ' ' LEU . 91.2 t -63.1 -47.12 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.329 1.052 . . . . 0.0 110.007 174.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.58 -45.25 69.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.73 75.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.447 0.699 . . . . 0.0 112.707 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -64.62 -39.26 93.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.095 0.958 . . . . 0.0 113.514 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.868 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 86.3 t -69.58 -30.13 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.989 1.315 . . . . 0.0 112.882 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 17.1 t-160 -76.11 -40.18 53.49 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -76.11 -91.23 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.664 1.186 . . . . 0.0 112.575 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.92 -30.09 67.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.929 1.692 . . . . 0.0 114.381 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.868 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.2 m-30 -98.23 -18.43 18.42 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tt0 57.69 -45.16 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -170.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 59' ' ' TYR . 2.7 t -59.31 -12.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.598 1.959 . . . . 0.0 115.208 -171.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 48.41 44.88 20.65 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 167.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -113.26 88.86 13.34 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.2 Cg_endo -65.87 152.8 80.51 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.427 2.752 . . . . 0.0 112.0 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tt 64.97 -43.73 0.33 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.705 2.002 . . . . 0.0 114.833 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.45 -69.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.563 1.145 . . . . 0.0 111.889 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.15 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 123.923 1.821 . . . . 0.0 111.224 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 51' ' ' VAL . 55.1 tp -153.66 -78.06 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.32 -46.51 60.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.82 -31.56 72.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -124.71 75.65 64.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.876 0.871 . . . . 0.0 112.064 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.78 54.26 4.39 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.574 2.182 . . . . 0.0 113.396 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -169.16 131.34 1.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.161 1.384 . . . . 0.0 111.044 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.487 HG22 HG23 ' A' ' 34' ' ' ILE 0.321 0.5 OUTLIER -62.88 -20.49 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.948 179.724 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -58.64 -52.8 64.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.564 0.746 . . . . 0.0 111.022 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -40.2 77.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.69 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 73' ' ' THR . 60.6 mt -57.98 -48.51 79.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 0.0 112.582 176.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.0 96.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.01 0.924 . . . . 0.0 112.341 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 0.6 OUTLIER -62.1 -31.66 72.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 174.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.71 -35.37 62.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 169.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 77' ' ' LEU . 27.4 m -110.27 -26.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 119.023 2.971 . . . . 0.0 119.023 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.3 22.42 12.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.405 1.082 . . . . 0.0 113.816 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 79' ' ' GLN . 19.4 m -123.55 -59.39 1.54 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.499 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.624 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -98.13 -31.05 12.31 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 115.527 -2.178 . . . . 99.99 115.763 173.48 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 1.4 pm0 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.35 33.77 13.64 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -45.91 -33.86 3.52 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -177.54 -68.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.175 1.39 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t 61.2 78.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 172.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 87.23 56.46 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.941 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 149.3 82.87 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.269 2.646 . . . . 0.0 113.054 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.05 -80.77 0.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.794 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -111.89 -174.87 2.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.431 1.092 . . . . 0.0 112.089 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.9 -61.94 1.63 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.588 1.155 . . . . 0.0 113.478 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.89 -48.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.238 1.015 . . . . 0.0 111.548 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 74' ' ' ILE . 29.2 mm-40 -52.56 -58.05 8.03 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.36 1.064 . . . . 0.0 112.714 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -67.73 -48.77 65.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.001 0.92 . . . . 0.0 112.978 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 22' ' ' ILE . 49.8 tptt -55.15 -53.57 54.32 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.391 1.476 . . . . 0.0 110.961 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.549 HD21 ' HG2' ' A' ' 58' ' ' GLU . 4.6 mm? -63.96 -45.62 88.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.3 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.81 79.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 35.4 tt0 -60.29 -61.99 2.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.602 1.561 . . . . 0.0 111.551 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' LYS 0.274 37.6 pt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.3 m95 -59.22 -59.35 5.61 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.692 168.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.2 pt-20 -58.75 -32.16 69.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -65.43 -68.39 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.519 1.528 . . . . 0.0 111.112 171.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.36 -37.05 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.724 1.61 . . . . 0.0 113.482 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.35 -21.0 61.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.1 61.42 0.16 Allowed Glycine 0 N--CA 1.477 1.407 0 O-C-N 124.167 0.917 . . . . 0.0 112.265 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.259 9.2 p 19.49 66.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 127.874 2.469 . . . . 0.0 114.757 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -107.06 -61.77 1.5 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.577 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 113.94 89.42 1.72 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.557 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.3 pt -127.97 -153.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.69 -148.31 7.02 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.561 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.874 ' HA ' HG22 ' A' ' 74' ' ' ILE . 1.9 mp -47.86 -69.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 111.551 -2.324 . . . . 0.0 113.0 -172.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.49 -15.15 48.52 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.99 -143.24 0.73 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.323 1.449 . . . . 0.0 108.861 -172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -112.14 18.15 18.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 163.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 48.7 p90 39.72 15.85 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -173.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -131.03 -82.18 0.53 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.518 1.527 . . . . 0.0 111.572 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.25 -40.52 11.61 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -28.14 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.42 65.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.543 1.068 . . . . 0.0 114.039 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.84 96.39 2.46 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 123.937 0.433 . . . . 0.0 113.768 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 1.22 1.62 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.9 m 177.03 -150.02 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.87 2.468 . . . . 0.0 109.715 -165.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.83 -7.12 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.48 -31.57 6.56 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 173.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.05 45.27 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -65.26 -48.98 71.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.452 1.101 . . . . 0.0 111.722 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.64 90.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.031 0.932 . . . . 0.0 112.47 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 68' ' ' LEU . 61.6 t -61.77 -52.22 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.595 0.758 . . . . 0.0 110.014 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.51 -39.87 71.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.03 0.932 . . . . 0.0 113.152 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.39 -50.51 72.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.54 0.736 . . . . 0.0 112.481 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.88 -44.92 96.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.98 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 59.6 t -66.63 -32.28 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.081 0.952 . . . . 0.0 112.495 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 8.9 t-160 -68.89 -42.95 76.26 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -82.45 -61.98 1.74 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' HD21 ' A' ' 19' ' ' LEU . 5.1 tp10 -77.28 -32.98 55.89 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.393 1.477 . . . . 0.0 113.327 -175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 1.7 m-85 -101.59 -9.44 20.96 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 27.0 tt0 62.53 -55.39 0.15 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.076 2.551 . . . . 0.0 115.413 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.15 4.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 126.462 1.905 . . . . 0.0 115.421 -166.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.285 15.0 pt-20 54.36 -38.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 121.545 3.905 . . . . 0.0 121.545 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.4 pt? -22.32 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 128.523 2.729 . . . . 0.0 118.201 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 72.6 Cg_endo -67.21 147.37 78.67 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.026 2.484 . . . . 0.0 111.273 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 66.04 -38.58 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.584 1.954 . . . . 0.0 115.466 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -53.47 -73.84 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.22 52.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 124.043 1.877 . . . . 0.0 111.618 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 51' ' ' VAL . 56.8 tp -154.31 -79.4 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.57 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.0 -43.8 98.36 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.59 67.5 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.92 71.16 7.18 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 112.666 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 56.1 Cg_endo -79.98 40.04 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.755 2.97 . . . . 0.0 114.921 -172.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -147.9 131.26 16.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.321 1.848 . . . . 0.0 109.576 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.874 HG22 ' HA ' ' A' ' 34' ' ' ILE 0.285 0.5 OUTLIER -61.34 -21.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.865 -179.771 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.11 -60.87 2.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.583 1.153 . . . . 0.0 110.112 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 79' ' ' GLN . . . -69.59 -34.84 74.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.468 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 79.1 mt -58.86 -47.24 85.6 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.82 96.29 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.953 0.901 . . . . 0.0 112.378 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -55.92 -51.96 65.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 0.0 112.019 169.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.309 6.6 m -108.41 -72.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.42 64.46 3.51 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.371 1.557 . . . . 0.0 112.78 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 77.5 m -166.7 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.399 2.68 . . . . 0.0 108.702 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -110.19 -29.5 8.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 176.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.517 -1.706 . . . . 99.99 115.424 -177.235 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 tpt . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 122.882 1.325 . . . . 0.0 114.233 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.75 -146.44 16.35 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t 62.84 130.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 125.696 1.598 . . . . 0.0 112.233 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.522 HG23 ' HG3' ' A' ' 5' ' ' GLU . 10.0 t -104.13 -40.49 6.14 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.62 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -125.11 -166.11 1.49 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.681 0.792 . . . . 0.0 112.578 -172.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 53.86 25.05 4.93 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 118.286 2.698 . . . . 0.0 118.286 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 5.2 tp-100 -46.26 -36.04 5.81 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.1 t80 177.2 -60.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.162 0.985 . . . . 0.0 111.699 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t 57.33 79.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.139 2.176 . . . . 0.0 113.68 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -131.33 89.44 41.08 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.493 169.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.76 -152.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.596 2.864 . . . . 0.0 113.792 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.82 -83.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.666 0.786 . . . . 0.0 109.343 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -109.65 -175.19 2.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.487 1.115 . . . . 0.0 112.203 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.91 -58.24 5.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.435 1.094 . . . . 0.0 113.171 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -55.19 -49.87 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.207 1.003 . . . . 0.0 111.307 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HA ' HD12 ' A' ' 74' ' ' ILE . 19.9 mm-40 -50.6 -62.67 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.661 1.184 . . . . 0.0 113.068 175.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 t -67.98 -47.28 69.0 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.909 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 22' ' ' ILE . 45.3 tptt -61.69 -47.06 87.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.83 0.852 . . . . 0.0 111.616 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.2 mm? -68.02 -36.58 80.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.82 -43.07 85.51 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.113 0.415 . . . . 0.0 111.649 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 38.2 tt0 -58.62 -55.11 39.36 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.544 1.538 . . . . 0.0 111.829 171.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.7 mm -55.27 -51.04 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.207 1.003 . . . . 0.0 110.892 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.469 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.3 m95 -55.98 -55.95 26.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 118.399 -0.81 . . . . 0.0 112.943 177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.6 pt-20 -61.2 -28.04 68.86 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -76.69 -61.15 2.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.324 1.05 . . . . 0.0 111.59 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG12 ' HZ3' ' A' ' 47' ' ' LYS . 93.3 t -60.64 -40.69 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.602 1.561 . . . . 0.0 112.637 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 23.4 tp -61.09 -19.3 61.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.984 1.313 . . . . 0.0 114.238 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.89 86.71 0.92 Allowed Glycine 0 N--CA 1.474 1.187 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 p -13.83 90.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 127.422 2.289 . . . . 0.0 115.53 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.493 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 16.7 p -141.89 -69.37 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 112.816 -1.993 . . . . 0.0 114.501 -174.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 126.99 94.72 0.89 Allowed Glycine 0 N--CA 1.48 1.617 0 O-C-N 123.943 0.777 . . . . 0.0 112.58 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 5' ' ' GLU . 21.8 pt -101.74 -177.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.822 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -105.37 171.67 18.76 Favored Glycine 0 N--CA 1.477 1.368 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.119 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 10' ' ' ALA . 39.7 mm -57.33 -48.65 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.353 1.061 . . . . 0.0 111.884 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.2 -6.53 2.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.881 1.673 . . . . 0.0 114.399 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 54.46 -154.06 0.28 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.715 2.006 . . . . 0.0 110.059 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.47 ' CG ' HE21 ' A' ' 40' ' ' GLN . 29.0 t-20 -101.24 13.74 34.16 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.258 -0.276 . . . . 0.0 111.311 166.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.256 50.1 p90 37.56 5.38 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -116.38 -79.25 0.59 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.768 1.227 . . . . 0.0 111.741 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.47 HE21 ' CG ' ' A' ' 37' ' ' ASN . 23.2 pt20 -53.6 -31.55 47.41 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 118.588 2.811 . . . . 0.0 118.588 -171.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -32.7 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -66.93 -53.18 28.32 Favored Glycine 0 CA--C 1.538 1.488 0 O-C-N 124.076 0.86 . . . . 0.0 112.659 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.63 105.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 175.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -75.08 53.88 0.64 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.498 1.519 . . . . 0.0 114.118 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 86.5 p -163.59 -146.92 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.629 1.972 . . . . 0.0 109.002 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -54.41 -25.24 23.62 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 61.7 mmtt -50.22 -55.38 15.5 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.338 1.055 . . . . 0.0 113.72 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.92 -42.79 38.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.1 mmt -66.48 -53.02 39.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.46 1.104 . . . . 0.0 112.988 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.88 94.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.161 0.985 . . . . 0.0 112.889 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 ' CH2' ' A' ' 23' ' ' TRP . 46.1 t -66.27 -42.9 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.649 0.78 . . . . 0.0 110.18 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.05 -42.25 72.47 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -56.83 -46.67 81.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -64.09 -46.92 82.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.643 1.177 . . . . 0.0 112.579 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 59.5 t -61.45 -28.31 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 125.167 1.387 . . . . 0.0 112.318 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.24 -77.92 0.07 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.625 0.77 . . . . 0.0 110.727 166.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 9.1 ptt180 -59.72 -37.87 80.1 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -172.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -105.49 -30.51 9.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-30 -93.92 -27.44 16.38 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 61.73 1.91 0.66 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.842 2.457 . . . . 0.0 116.684 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.07 -12.44 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.94 41.53 3.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 120.076 3.362 . . . . 0.0 120.076 169.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -109.82 93.01 13.59 Favored Pre-proline 0 N--CA 1.482 1.138 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.4 Cg_endo -66.35 149.67 84.84 Favored 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.493 2.795 . . . . 0.0 111.97 177.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 68' ' ' LEU . 6.7 tt 60.98 -46.87 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.251 2.22 . . . . 0.0 114.917 -174.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -55.97 -65.47 0.59 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.722 1.209 . . . . 0.0 112.436 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -62.65 -25.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.524 HD23 ' HA2' ' A' ' 42' ' ' GLY . 7.5 mp -72.21 -41.6 66.73 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.951 1.7 . . . . 0.0 113.579 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -103.71 -39.54 6.64 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.58 -32.63 62.44 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.582 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 11.3 mp0 -119.57 61.93 6.81 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.944 0.498 . . . . 0.0 111.654 171.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.485 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 22.2 Cg_endo -79.87 38.17 0.72 Allowed 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 124.175 3.25 . . . . 0.0 114.081 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -157.15 131.72 8.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.142 2.177 . . . . 0.0 108.864 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.289 0.5 OUTLIER -62.37 -21.53 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.841 -1.072 . . . . 0.0 113.244 179.925 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -58.67 -53.62 56.25 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.343 0.657 . . . . 0.0 110.69 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.8 74.78 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 83.9 mt -55.35 -48.97 73.44 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.51 0.724 . . . . 0.0 112.579 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.35 93.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.003 0.921 . . . . 0.0 112.717 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.03 -26.93 68.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -77.72 -27.03 50.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 59' ' ' TYR . 32.8 m -116.35 -30.18 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 -174.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.42 56.13 0.8 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 123.477 1.608 . . . . 0.0 109.89 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 m -162.35 -65.55 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.988 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.645 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -101.53 -33.17 10.04 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 171.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 114.823 1.416 . . . . 99.99 114.823 172.491 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ttt . . . . . 0 CA--C 1.553 1.088 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.446 ' H ' ' NE2' ' A' ' 7' ' ' GLN . . . -97.67 77.33 0.63 Allowed Glycine 0 N--CA 1.478 1.48 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 -174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 171.43 -51.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 130.375 3.47 . . . . 0.0 110.768 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.4 t -176.09 -144.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.944 1.698 . . . . 0.0 108.91 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 8.0 mm-40 -57.05 -54.39 47.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.986 2.114 . . . . 0.0 111.481 173.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.76 -179.8 4.98 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.061 1.745 . . . . 0.0 114.508 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 2' ' ' GLY . 34.0 tt0 -168.58 -99.51 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.06 1.744 . . . . 0.0 108.903 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -61.43 -57.28 12.85 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t 56.25 71.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 126.352 1.861 . . . . 0.0 113.897 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.08 98.24 33.53 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 168.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.75 -154.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.752 2.968 . . . . 0.0 113.994 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.438 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -159.73 -85.86 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.003 0.521 . . . . 0.0 110.202 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.438 ' H ' ' HB ' ' A' ' 12' ' ' THR . 38.8 p-10 -107.9 -176.89 3.19 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.389 0.676 . . . . 0.0 111.481 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.15 -51.98 16.76 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.295 1.038 . . . . 0.0 113.071 174.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.37 -54.53 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.512 1.125 . . . . 0.0 111.46 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.541 ' HA ' HD12 ' A' ' 74' ' ' ILE . 22.3 mm-40 -49.93 -59.9 3.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.784 1.233 . . . . 0.0 112.255 176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.1 m -65.17 -44.85 87.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 22' ' ' ILE . 47.0 tptt -57.98 -58.51 8.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.413 1.485 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.81 -33.77 76.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -57.21 -45.17 84.08 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 170.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.1 -48.95 79.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.557 1.143 . . . . 0.0 111.763 172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 18' ' ' LYS . 42.0 mm -54.44 -54.77 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.099 0.96 . . . . 0.0 110.685 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.481 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 11.6 m95 -56.56 -53.32 58.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.882 0.873 . . . . 0.0 113.332 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 27' ' ' LEU . 21.1 pt-20 -60.27 -30.12 69.24 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -77.01 -63.72 1.3 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.972 1.42 . . . . 0.0 111.148 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.6 -43.45 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.498 1.519 . . . . 0.0 113.204 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -65.56 -14.98 62.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.31 72.46 0.18 Allowed Glycine 0 N--CA 1.477 1.392 0 O-C-N 124.552 1.157 . . . . 0.0 110.789 -173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.274 12.9 p -10.45 87.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 128.314 2.646 . . . . 0.0 116.968 178.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 48.9 m -139.19 -50.66 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.299 -1.773 . . . . 0.0 115.496 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 125.57 3.0 Favored Glycine 0 N--CA 1.481 1.665 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.586 HD11 ' HA ' ' A' ' 20' ' ' ALA . 2.5 pp -125.72 165.17 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 113.07 0.766 . . . . 0.0 113.07 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.34 162.4 14.41 Favored Glycine 0 N--CA 1.477 1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.295 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.97 -40.8 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.321 0.648 . . . . 0.0 111.734 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.2 -21.07 58.89 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 167.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.649 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.1 m-20 56.96 -163.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.441 1.897 . . . . 0.0 111.788 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -101.58 1.11 37.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.295 165.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.307 53.5 p90 53.97 -38.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.298 2.703 . . . . 0.0 118.298 -171.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -73.09 -81.57 0.06 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.364 1.466 . . . . 0.0 112.252 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -73.19 21.98 0.07 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -173.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 36' ' ' ASP . 2.5 pp -101.23 -44.95 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.22 -40.9 60.66 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.964 0.79 . . . . 0.0 113.642 170.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.69 116.73 0.01 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 115.671 1.029 . . . . 0.0 115.671 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.55 46.63 1.08 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.924 -1.638 . . . . 0.0 114.041 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 82.8 p -150.48 -150.51 0.35 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.848 1.659 . . . . 0.0 109.608 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.56 -18.65 7.9 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 33.3 mmtp -48.49 -51.14 28.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.055 0.942 . . . . 0.0 112.261 172.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.14 -47.03 62.15 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.8 ptm -70.53 -41.6 72.32 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.86 97.12 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.292 0.637 . . . . 0.0 112.483 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 47' ' ' LYS . 40.7 t -66.08 -47.64 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.915 0.886 . . . . 0.0 109.7 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.81 -39.84 62.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.89 -57.3 12.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.682 0.793 . . . . 0.0 112.775 173.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.32 -34.69 78.92 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.939 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 92.0 t -64.7 -27.82 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.653 1.181 . . . . 0.0 112.908 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 18.6 t-160 -77.13 -63.21 1.42 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.72 0.808 . . . . 0.0 112.166 169.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.2 ptt85 -70.92 -38.98 72.95 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.22 -36.38 6.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.625 0.77 . . . . 0.0 112.745 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.939 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m-85 -84.81 -27.92 26.48 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 34.2 tt0 65.69 -36.39 0.23 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 128.174 2.589 . . . . 0.0 116.661 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 t -57.73 -23.45 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.311 1.444 . . . . 0.0 114.646 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 55' ' ' VAL . 5.8 tm-20 45.89 67.92 0.67 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -136.96 87.4 19.16 Favored Pre-proline 0 N--CA 1.482 1.146 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.0 Cg_endo -64.82 148.05 89.81 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 123.431 2.754 . . . . 0.0 112.096 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 6.5 tt 62.37 -43.96 0.18 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.403 2.281 . . . . 0.0 114.584 -172.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -52.16 -68.76 0.14 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.248 1.419 . . . . 0.0 113.117 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.87 12.93 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.7 -41.65 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.508 1.523 . . . . 0.0 111.935 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.403 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 53.1 m-85 -106.83 -45.87 4.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.027 1.331 . . . . 0.0 113.329 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.09 -34.86 73.68 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -120.24 65.53 11.1 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 170.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 19.6 Cg_endo -80.24 27.55 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.571 2.847 . . . . 0.0 114.973 -170.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -139.68 136.31 34.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.617 1.167 . . . . 0.0 110.568 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.278 0.4 OUTLIER -61.85 -19.77 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.752 175.879 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.63 -61.9 2.28 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 0.0 110.348 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.14 -37.46 80.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 88.3 mt -58.03 -46.55 85.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.146 0.578 . . . . 0.0 112.262 172.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.62 85.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.277 1.031 . . . . 0.0 112.755 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.666 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -62.3 -40.6 96.84 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 170.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 2.8 m-85 -66.81 -39.23 87.64 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 171.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 77' ' ' LEU . 24.0 m -99.59 -40.37 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -172.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.87 50.9 0.85 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 123.174 1.464 . . . . 0.0 110.451 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.666 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 69.0 m -160.26 -55.11 0.06 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.553 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.05 -35.02 5.79 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 169.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 116.009 -1.948 . . . . 99.99 116.027 175.105 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.77 140.36 5.97 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.837 -169.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.272 16.1 m -12.94 78.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 119.46 3.133 . . . . 0.0 119.46 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 t -86.32 -37.23 18.7 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.33 -1.759 . . . . 0.0 112.638 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.2 pm0 -61.09 -174.56 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.365 164.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 67.43 -71.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.607 1.963 . . . . 0.0 111.903 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.306 4.8 pt20 46.38 -56.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -175.99 -65.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.674 1.59 . . . . 0.0 111.471 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 11' ' ' PRO . 3.7 t 57.99 95.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 126.339 1.856 . . . . 0.0 112.888 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.85 81.58 19.39 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 9' ' ' VAL . 75.9 Cg_endo -67.67 147.59 76.25 Favored 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 122.904 2.403 . . . . 0.0 112.473 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -80.31 0.59 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.475 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -113.86 -176.51 2.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 112.335 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -54.25 19.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.253 1.021 . . . . 0.0 113.585 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -55.94 -54.22 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.161 0.984 . . . . 0.0 110.424 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.566 ' HA ' HD12 ' A' ' 74' ' ' ILE . 11.1 mm-40 -49.26 -59.62 3.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.678 1.191 . . . . 0.0 113.339 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -68.34 -51.12 48.0 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 83.1 tttt -64.48 -40.68 96.13 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.976 . . . . 0.0 112.425 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.39 -43.86 84.71 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.69 172.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.06 77.74 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.0 tt0 -57.2 -57.05 14.32 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.499 1.519 . . . . 0.0 111.721 170.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.266 2.5 pp -62.64 -36.99 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 177.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.549 ' HB3' HD11 ' A' ' 32' ' ' ILE . 7.4 m95 -56.69 -58.11 9.51 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 112.119 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.499 ' HB3' ' H ' ' A' ' 32' ' ' ILE . 20.5 pt-20 -59.85 -30.02 68.68 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -71.48 -62.65 1.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.195 1.398 . . . . 0.0 112.033 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.9 -37.25 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 125.713 1.605 . . . . 0.0 113.251 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.535 HD11 ' HG3' ' A' ' 40' ' ' GLN . 7.9 tt -57.86 -23.16 51.65 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.006 1.323 . . . . 0.0 113.488 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.58 73.24 0.39 Allowed Glycine 0 N--CA 1.475 1.286 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.6 p 1.62 79.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 128.244 2.618 . . . . 0.0 116.304 -177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -123.52 -47.31 1.98 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -172.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 104.14 91.9 2.23 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 111.349 -0.701 . . . . 0.0 111.349 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 23' ' ' TRP . 6.5 pt -119.96 167.17 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 120.727 0.299 . . . . 0.0 111.117 -174.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.73 168.97 24.09 Favored Glycine 0 N--CA 1.473 1.131 0 CA-C-O 123.116 1.398 . . . . 0.0 113.901 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.7 mm -48.68 -36.6 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 111.833 -2.184 . . . . 0.0 112.804 173.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' THR . 2.9 mm? -68.12 -20.11 64.88 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.57 1.548 . . . . 0.0 114.307 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 58.77 -156.03 0.34 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.721 1.608 . . . . 0.0 109.865 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -119.1 13.38 12.92 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 p90 36.87 34.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -152.49 -81.42 0.09 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.775 -175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' HD11 ' A' ' 27' ' ' LEU . 9.5 pt20 -70.94 29.91 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.469 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.82 -40.82 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -64.34 -40.3 97.73 Favored Glycine 0 N--CA 1.48 1.603 0 O-C-N 123.813 0.696 . . . . 0.0 113.279 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.69 149.64 0.11 Allowed Glycine 0 N--CA 1.477 1.4 0 O-C-N 125.101 1.118 . . . . 0.0 114.022 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' H ' ' HD2' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -93.05 45.95 1.2 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 113.627 -1.286 . . . . 0.0 112.189 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.8 m -174.94 -159.76 0.08 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.28 1.832 . . . . 0.0 111.38 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -58.04 -5.44 0.45 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.9 mptt -52.63 -51.97 57.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.066 0.947 . . . . 0.0 110.901 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.49 -35.74 60.93 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.965 1.469 . . . . 0.0 114.965 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.0 mmt -68.74 -47.41 66.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.967 0.907 . . . . 0.0 112.896 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.99 80.69 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.497 0.719 . . . . 0.0 111.835 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 45.5 t -64.87 -47.81 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.024 171.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.37 -42.82 64.27 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.803 0.729 . . . . 0.0 112.225 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.661 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -60.48 -52.18 66.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.631 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.3 pt20 -65.01 -38.94 92.59 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.9 t -67.56 -28.64 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.498 1.119 . . . . 0.0 112.203 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -66.51 -59.25 3.82 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.327 167.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.661 HH21 ' HB1' ' A' ' 53' ' ' ALA . 11.6 ptp180 -71.84 -46.46 57.98 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -173.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -100.41 -30.69 11.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.632 1.573 . . . . 0.0 112.609 -170.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -94.65 -30.83 14.12 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.9 12.72 2.44 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.275 2.23 . . . . 0.0 115.998 -177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 59' ' ' TYR . 3.5 t -116.39 12.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 121.172 0.511 . . . . 0.0 111.867 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.61 ' HA ' HG12 ' A' ' 55' ' ' VAL . 9.1 pm0 6.99 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.0 pt? -121.31 87.18 44.38 Favored Pre-proline 0 N--CA 1.479 0.996 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 63' ' ' LEU . 69.4 Cg_endo -65.65 154.78 72.29 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 123.02 2.48 . . . . 0.0 111.214 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.5 tt 66.53 -44.45 0.42 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.639 1.976 . . . . 0.0 114.332 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.59 -61.11 2.52 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.406 0.682 . . . . 0.0 112.776 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.57 -8.93 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.622 HD13 ' HA2' ' A' ' 42' ' ' GLY . 65.7 mt -104.72 -24.49 12.93 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.306 1.443 . . . . 0.0 114.871 -174.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 74.3 m-85 -117.91 -40.92 2.94 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.41 -49.12 14.09 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.609 0.764 . . . . 0.0 112.801 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -121.43 59.18 8.86 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.2 Cg_endo -75.35 19.18 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.335 3.357 . . . . 0.0 116.777 -170.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 80.7 p -120.86 137.36 54.6 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.333 0.5 OUTLIER -63.19 -20.99 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.956 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -52.55 -66.33 0.4 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.759 1.224 . . . . 0.0 109.567 165.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.98 85.79 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.173 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 89.5 mt -58.18 -44.75 88.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.313 0.645 . . . . 0.0 112.648 173.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.31 98.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.5 0.72 . . . . 0.0 112.34 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.2 mp0 -62.35 -39.89 94.61 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 172.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -71.44 -29.84 65.34 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.467 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.275 33.4 m -116.83 -41.09 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.62 57.27 1.01 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 123.335 1.54 . . . . 0.0 109.476 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.1 m -165.46 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.205 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.561 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.2 -31.16 8.01 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 174.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.969 1.47 . . . . 99.99 114.969 176.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.11 -151.73 21.93 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 p -22.67 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 127.231 2.213 . . . . 0.0 116.444 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -115.64 -25.49 7.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.891 -1.959 . . . . 0.0 114.675 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -125.06 178.49 5.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.371 -170.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.11 72.01 0.3 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.243 1.817 . . . . 0.0 115.187 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.535 ' OE1' ' HA ' ' A' ' 37' ' ' ASN . 39.2 tt0 -78.7 -75.43 0.23 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.946 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -121.54 -44.58 2.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' H ' ' HA2' ' A' ' 33' ' ' GLY . 5.3 t 48.94 82.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 126.444 1.898 . . . . 0.0 114.057 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.36 88.47 54.27 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.865 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.48 149.97 75.07 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 122.988 2.459 . . . . 0.0 112.642 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -122.35 -84.51 0.66 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.843 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.3 p-10 -109.9 -178.02 3.42 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.606 0.762 . . . . 0.0 111.404 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.06 -45.54 43.11 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -57.87 -58.79 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.06 0.944 . . . . 0.0 110.392 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.748 ' HA ' HD12 ' A' ' 74' ' ' ILE . 52.5 mm-40 -51.08 -56.03 14.66 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.261 1.024 . . . . 0.0 112.604 177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.84 -57.85 6.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.164 0.986 . . . . 0.0 113.537 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 21.0 ttpp -66.51 -36.55 82.98 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.83 -45.94 76.68 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.601 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.71 78.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 40.8 tt0 -56.57 -58.8 6.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.474 1.51 . . . . 0.0 111.229 170.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.268 2.6 pp -60.89 -38.39 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.81 178.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 32' ' ' ILE . 11.4 m95 -55.85 -59.08 5.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.505 0.722 . . . . 0.0 112.266 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.533 ' HB3' HG12 ' A' ' 32' ' ' ILE . 11.8 pt-20 -62.43 -30.29 71.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -75.9 -58.19 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.02 0.928 . . . . 0.0 112.335 173.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.09 -35.99 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.963 1.305 . . . . 0.0 112.557 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.33 -21.34 59.62 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.51 72.1 0.29 Allowed Glycine 0 N--CA 1.476 1.333 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.274 12.4 p 0.91 80.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 128.484 2.714 . . . . 0.0 116.187 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.5 m -119.74 -70.44 0.79 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.594 -2.094 . . . . 0.0 115.098 -172.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 123.75 101.98 1.51 Allowed Glycine 0 N--CA 1.48 1.574 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.533 HG12 ' HB3' ' A' ' 24' ' ' GLU . 24.6 pt -125.05 167.52 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' H ' ' A' ' 9' ' ' VAL . . . -71.37 157.91 53.48 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.911 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -57.01 -40.99 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.727 -0.737 . . . . 0.0 112.273 164.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD23 ' HB ' ' A' ' 73' ' ' THR . 4.3 mt -68.61 13.52 0.09 Allowed 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 162.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.2 m-20 50.76 -140.48 0.84 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.143 1.777 . . . . 0.0 110.348 -176.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.535 ' HA ' ' OE1' ' A' ' 7' ' ' GLN . 17.6 t-20 -115.77 22.67 12.89 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.194 0.521 . . . . 0.0 111.05 154.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.255 53.1 p90 42.11 -0.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 1 N-CA-C 122.135 4.124 . . . . 0.0 122.135 -178.523 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -112.8 -84.02 0.59 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.065 1.346 . . . . 0.0 112.335 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -48.24 -31.84 6.41 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 36' ' ' ASP . 2.6 pp -62.42 -34.31 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.97 75.2 Favored Glycine 0 N--CA 1.478 1.447 0 O-C-N 123.9 0.75 . . . . 0.0 113.029 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.98 127.08 0.01 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 117.319 1.688 . . . . 0.0 117.319 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -89.26 53.38 2.63 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.516 -2.342 . . . . 0.0 112.555 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 17.0 m -169.89 -152.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.052 1.741 . . . . 0.0 110.369 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 49' ' ' MET . 1.9 pt? -51.32 -22.13 2.64 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 10.8 mptt -48.19 -62.1 1.65 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.917 1.287 . . . . 0.0 111.818 174.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.23 -45.66 44.89 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 2.1 ptm -69.81 -41.34 75.14 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.09 86.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.159 0.584 . . . . 0.0 112.06 171.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 68' ' ' LEU . 6.0 t -67.82 -43.75 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.576 172.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.669 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.39 -42.58 64.12 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.552 0.615 . . . . 0.0 112.385 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.612 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -59.1 -51.73 68.76 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.634 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 10.5 pt20 -66.68 -38.58 87.09 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 62' ' ' GLU . 96.3 t -67.83 -27.31 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.657 1.183 . . . . 0.0 112.254 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -70.34 -61.46 1.76 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.385 0.274 . . . . 0.0 111.445 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.634 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 15.0 ptp180 -65.38 -42.05 93.1 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -173.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -107.15 -32.74 7.69 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.868 1.267 . . . . 0.0 113.076 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.5 m-85 -94.69 -20.58 19.42 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 61.96 -47.69 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.68 28.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 55' ' ' VAL . 14.5 pt-20 -9.9 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.637 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.3 pt? -123.44 82.69 52.97 Favored Pre-proline 0 N--CA 1.48 1.037 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 69.4 Cg_endo -66.11 148.39 85.24 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 123.401 2.734 . . . . 0.0 111.52 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.0 tt 63.31 -47.84 0.23 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.731 2.012 . . . . 0.0 113.563 -172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -46.24 -66.82 0.35 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.068 1.747 . . . . 0.0 112.207 176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -68.27 -4.1 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.774 HD11 HG11 ' A' ' 51' ' ' VAL . 3.1 mm? -107.86 -31.45 8.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -175.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.51 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 58.0 m-85 -107.8 -37.27 6.17 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.78 -44.17 56.77 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.55 0.34 . . . . 0.0 111.856 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.604 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.1 pm0 -123.21 71.83 45.69 Favored Pre-proline 0 CA--C 1.554 1.124 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 170.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 62.3 Cg_endo -76.57 38.33 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 124.567 3.511 . . . . 0.0 115.924 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.414 ' HB ' HD23 ' A' ' 35' ' ' LEU . 2.6 t -144.44 133.55 22.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.569 1.548 . . . . 0.0 110.59 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.277 0.4 OUTLIER -63.91 -23.11 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.544 178.878 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.6 tmmt? -55.59 -61.96 2.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.85 0.86 . . . . 0.0 110.131 170.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.6 76.23 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.707 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 96.3 mt -56.09 -47.46 77.98 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.79 0.436 . . . . 0.0 112.154 171.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.55 94.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.523 0.729 . . . . 0.0 112.866 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.54 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.1 mp0 -61.03 -43.51 98.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 171.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.15 -26.49 67.45 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.329 7.2 m -114.98 -73.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 173.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.81 64.48 0.67 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 123.471 1.605 . . . . 0.0 112.563 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 88.4 m -169.4 -53.53 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 129.075 2.95 . . . . 0.0 108.622 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -115.97 -28.91 6.5 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 175.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 116.465 2.024 . . . . 99.99 116.465 -175.274 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.95 -133.1 40.25 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.3 m -74.26 79.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 122.631 1.205 . . . . 0.0 113.223 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.7 t -95.88 -40.15 9.45 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 112.836 -1.984 . . . . 0.0 112.585 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HG2' ' H ' ' A' ' 6' ' ' ALA . 7.9 pm0 -63.18 -76.32 0.07 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.784 1.634 . . . . 0.0 113.062 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.693 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -72.15 172.15 10.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.721 1.208 . . . . 0.0 112.957 164.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -169.54 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.739 1.616 . . . . 0.0 107.422 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -60.92 -64.03 1.1 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG22 ' HA2' ' A' ' 33' ' ' GLY . 2.8 t 57.55 82.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 126.49 1.916 . . . . 0.0 113.456 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.01 91.6 49.06 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.063 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.38 143.21 47.2 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.121 2.547 . . . . 0.0 113.696 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -106.02 -81.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.911 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -116.44 -174.36 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -170.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.91 -57.01 6.25 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.099 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.6 -52.41 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.323 1.049 . . . . 0.0 111.023 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.58 ' HA ' HD12 ' A' ' 74' ' ' ILE . 3.7 mt-10 -55.08 -60.32 3.53 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.3 t -64.33 -43.68 93.88 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.003 0.815 . . . . 0.0 113.197 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -57.74 -57.03 14.54 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 110.659 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.35 -38.71 92.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . . . -59.24 -41.99 90.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 172.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 44.9 tt0 -60.73 -50.82 71.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.734 1.214 . . . . 0.0 111.573 172.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.9 mt -54.82 -54.24 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.962 0.905 . . . . 0.0 110.357 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -56.2 -52.45 64.36 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 118.312 -0.852 . . . . 0.0 113.015 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 32' ' ' ILE . 14.9 pt-20 -60.75 -30.26 69.89 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -74.26 -62.47 1.5 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.2 t -59.2 -45.76 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.785 1.634 . . . . 0.0 113.412 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 41' ' ' ILE . 10.1 tt -56.14 -25.61 46.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.086 1.754 . . . . 0.0 113.87 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.89 81.5 0.33 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.265 13.1 p -17.02 92.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.959 2.504 . . . . 0.0 116.197 178.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.7 p -149.86 -49.0 0.14 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 113.139 -1.846 . . . . 0.0 115.933 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.36 119.01 2.32 Favored Glycine 0 N--CA 1.481 1.664 0 O-C-N 123.695 0.622 . . . . 0.0 111.758 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.62 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.4 pp -121.66 158.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -87.17 152.23 24.32 Favored Glycine 0 CA--C 1.535 1.281 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.695 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm -50.02 -40.32 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.318 1.047 . . . . 0.0 112.445 168.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.3 tp -50.46 -34.4 24.68 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.583 1.553 . . . . 0.0 113.786 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.561 ' HB3' HG21 ' A' ' 41' ' ' ILE . 8.2 m-20 61.17 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.631 1.972 . . . . 0.0 113.356 -168.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.768 ' ND2' HE21 ' A' ' 40' ' ' GLN . 26.5 t-20 -57.17 -22.04 37.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.562 169.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.282 38.0 p90 60.42 -7.47 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -109.8 -71.97 0.74 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.424 1.09 . . . . 0.0 112.261 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.768 HE21 ' ND2' ' A' ' 37' ' ' ASN . 25.8 pt20 -72.69 11.79 0.59 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -69.54 -51.48 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' A' ' 68' ' ' LEU . . . -135.01 14.85 4.32 Favored Glycine 0 CA--C 1.541 1.709 0 O-C-N 124.288 0.993 . . . . 0.0 114.559 167.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.97 62.31 4.39 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -125.18 -130.22 0.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.747 -1.226 . . . . 0.0 108.473 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 p -110.01 -86.42 0.53 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.771 0.828 . . . . 0.0 111.273 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.89 -18.95 37.8 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -56.1 -36.35 68.07 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.97 74.15 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.1 mmt -67.59 -48.2 67.51 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.906 1.282 . . . . 0.0 112.483 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.59 85.76 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.26 -49.52 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.176 0.99 . . . . 0.0 110.225 172.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.52 -41.36 66.29 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -54.52 43.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.363 1.065 . . . . 0.0 112.367 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -58.86 -43.63 90.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.338 1.055 . . . . 0.0 112.896 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.761 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 48.2 t -68.1 -25.58 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.81 1.244 . . . . 0.0 113.353 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -85.2 -27.01 26.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 172.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -97.64 -56.19 2.59 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.25 -32.17 17.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.642 1.177 . . . . 0.0 112.315 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.761 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.3 m-85 -85.72 -33.18 21.55 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 58.02 3.65 0.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.16 10.99 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HA ' HG12 ' A' ' 55' ' ' VAL . 30.4 tt0 15.47 81.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.8 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.4 pt? -128.39 77.59 76.89 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 64.8 Cg_endo -64.57 145.95 88.2 Favored 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 123.361 2.707 . . . . 0.0 111.987 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 64' ' ' PRO 0.281 3.0 pp 58.75 -39.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.843 2.457 . . . . 0.0 115.861 -170.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.71 ' HD3' ' HB2' ' A' ' 63' ' ' LEU . 75.2 tttt -52.8 -65.6 0.53 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.065 2.146 . . . . 0.0 110.517 176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.8 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 3.0 p -61.94 -22.13 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 57.3 tp -95.4 -26.88 15.69 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.803 1.641 . . . . 0.0 115.123 -166.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -114.88 -38.96 3.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.386 1.074 . . . . 0.0 113.603 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.35 49.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' CD ' ' HA ' ' A' ' 67' ' ' VAL . 10.7 pm0 -121.56 59.45 9.52 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 41.8 Cg_endo -75.63 24.32 0.42 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.953 3.769 . . . . 0.0 116.68 -168.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 9.5 t -126.0 138.85 53.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 110.159 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.258 0.4 OUTLIER -60.64 -27.39 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.548 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -55.16 -55.37 31.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.386 0.675 . . . . 0.0 110.855 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -69.87 -40.19 75.88 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 82.1 mt -55.2 -46.34 75.9 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.535 0.734 . . . . 0.0 112.173 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.51 85.38 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.179 0.992 . . . . 0.0 112.317 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.79 -32.75 74.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -69.47 -16.08 63.4 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 77' ' ' LEU 0.274 15.6 m -117.72 -71.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 175.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 61.11 3.16 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.797 1.761 . . . . 0.0 111.622 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.1 m -165.44 -57.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.616 2.367 . . . . 0.0 108.338 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.494 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -112.77 -27.88 7.98 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 177.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 116.575 -1.679 . . . . 99.99 115.149 -174.535 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 128.41 165.52 11.81 Favored Glycine 0 N--CA 1.478 1.434 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.309 -174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t 69.13 140.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.268 1.427 . . . . 0.0 112.595 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 t -115.58 -45.31 2.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.784 174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 6.6 pm0 -59.75 179.54 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.028 1.331 . . . . 0.0 114.121 168.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 56.61 21.03 5.39 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -38.76 -35.74 0.22 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 119.373 3.101 . . . . 0.0 119.373 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.8 t80 176.96 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.072 1.349 . . . . 0.0 110.697 -173.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.9 t 65.72 93.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 127.092 2.157 . . . . 0.0 112.785 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -129.68 82.15 67.8 Favored Pre-proline 0 N--CA 1.482 1.133 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.784 169.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.71 137.38 32.56 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.602 2.201 . . . . 0.0 112.539 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.6 -76.37 0.55 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.612 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -118.84 -176.49 3.11 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.618 1.167 . . . . 0.0 112.582 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.11 54.25 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -57.08 -56.22 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.346 1.058 . . . . 0.0 110.022 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' ILE . 6.3 mm-40 -48.96 -56.38 9.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.895 1.278 . . . . 0.0 113.555 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.4 t -67.42 -55.04 15.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.158 0.983 . . . . 0.0 113.561 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 37.9 ttpt -64.18 -38.67 91.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.854 0.862 . . . . 0.0 112.889 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -65.24 -45.83 83.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.759 171.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.75 76.19 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 47.8 tt0 -57.92 -58.88 6.44 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.211 1.404 . . . . 0.0 111.677 171.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.447 HG13 ' HA ' ' A' ' 19' ' ' LEU . 2.5 pp -61.5 -38.09 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.06 -57.39 12.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 0.0 112.161 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.665 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 pt-20 -61.18 -31.55 71.3 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -69.38 -62.0 1.56 Allowed 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.752 1.282 . . . . 0.0 111.927 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.498 HG12 ' HE3' ' A' ' 47' ' ' LYS . 99.4 t -61.6 -37.88 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.576 1.551 . . . . 0.0 113.193 -175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.69 -25.5 60.39 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.377 1.071 . . . . 0.0 113.623 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.4 62.19 0.14 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.155 0.909 . . . . 0.0 111.587 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.262 10.3 p 16.67 67.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 127.888 2.475 . . . . 0.0 114.997 -177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 60.6 m -109.9 -49.86 3.04 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 112.372 -2.194 . . . . 0.0 116.667 -167.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 102.96 92.07 2.21 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.665 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -117.66 159.23 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -170.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -77.24 153.3 41.15 Favored Glycine 0 N--CA 1.475 1.285 0 CA-C-N 113.889 -1.505 . . . . 0.0 113.34 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 10' ' ' ALA . 33.0 mm -48.56 -40.99 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.753 1.221 . . . . 0.0 113.121 167.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.13 -14.09 33.51 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.705 1.602 . . . . 0.0 114.753 171.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 60.04 -158.8 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.097 2.159 . . . . 0.0 110.455 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -111.25 17.92 19.79 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 171.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.3 p90 40.51 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -124.27 -85.91 0.64 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.135 1.374 . . . . 0.0 111.605 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -71.81 33.22 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 119.441 3.126 . . . . 0.0 119.441 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.455 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -113.02 -40.26 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.948 172.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 68' ' ' LEU . . . -60.64 -64.26 4.26 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.918 0.761 . . . . 0.0 112.966 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.55 100.05 0.14 Allowed Glycine 0 N--CA 1.476 1.361 0 CA-C-N 114.471 -0.865 . . . . 0.0 113.49 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -63.22 -36.91 85.21 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.34 0.656 . . . . 0.0 112.459 168.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.5 m -151.12 -90.4 0.06 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.398 1.479 . . . . 0.0 108.932 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -93.92 -11.0 31.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HE3' HG12 ' A' ' 26' ' ' VAL . 30.2 mttp -42.29 -37.21 1.45 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.21 -38.69 41.41 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 79.3 mtm -71.49 -45.37 62.69 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -39.04 88.35 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.667 0.787 . . . . 0.0 112.385 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 HD21 ' A' ' 68' ' ' LEU . 5.6 t -71.27 -42.59 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.699 173.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.55 -38.42 63.81 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.422 0.555 . . . . 0.0 112.406 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.56 -58.16 8.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.721 0.808 . . . . 0.0 112.525 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 12.0 pt20 -63.55 -37.48 87.49 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.863 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 94.3 t -66.03 -24.28 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.671 1.188 . . . . 0.0 112.93 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 12.8 t-160 -87.18 -58.35 2.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.238 0.615 . . . . 0.0 112.272 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.1 ppt_? -68.78 -37.91 79.65 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -106.64 -46.62 3.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.367 1.067 . . . . 0.0 111.759 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.863 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.9 m-85 -75.76 -32.49 59.98 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' HIS 0.25 94.6 mt-30 66.97 -31.49 0.17 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -178.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.49 -30.3 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.176 1.39 . . . . 0.0 113.47 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HA ' HG12 ' A' ' 55' ' ' VAL . 25.3 tt0 47.61 79.19 0.07 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.181 1.792 . . . . 0.0 115.368 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 1.8 pt? -142.19 83.32 12.45 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.582 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -63.87 152.82 79.01 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.132 2.555 . . . . 0.0 110.939 174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' H ' HD12 ' A' ' 68' ' ' LEU 0.303 3.7 pp 60.65 -41.43 0.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.7 2.4 . . . . 0.0 116.724 -172.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 63' ' ' LEU . 99.6 mttt -56.83 -67.01 0.35 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.89 1.276 . . . . 0.0 111.897 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.682 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 3.8 p -76.13 13.94 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 65' ' ' LEU . 94.3 mt -123.85 -35.54 2.85 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.89 -48.26 3.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.68 1.192 . . . . 0.0 110.979 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.42 76.02 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 170.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 46.3 mt-30 -121.33 55.8 5.43 Favored Pre-proline 0 N--CA 1.48 1.068 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 23.2 Cg_endo -76.32 24.54 0.45 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.387 3.391 . . . . 0.0 116.58 -167.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.6 t -132.94 141.11 48.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.092 1.357 . . . . 0.0 110.169 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.273 0.4 OUTLIER -62.99 -22.07 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.092 178.393 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -57.82 -52.0 67.26 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.283 0.633 . . . . 0.0 110.793 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.39 -38.43 74.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.211 1.005 . . . . 0.0 113.403 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.567 HD23 HG22 ' A' ' 67' ' ' VAL . 81.7 mt -56.02 -47.67 77.38 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.274 0.63 . . . . 0.0 111.897 172.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.33 98.73 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 0.0 112.705 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.549 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -54.59 -44.95 73.46 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.221 1.008 . . . . 0.0 112.796 171.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' HE2' HD11 ' A' ' 63' ' ' LEU . 2.0 m-30 -71.31 -22.54 61.92 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.28 11.6 m -108.42 -70.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.18 60.0 3.52 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.416 1.579 . . . . 0.0 111.748 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 98.8 m -166.37 -60.56 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 128.202 2.601 . . . . 0.0 108.384 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.07 -27.61 7.62 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 117.837 2.532 . . . . 0.0 117.837 178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 116.226 1.936 . . . . 99.99 116.226 -174.641 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.78 -83.04 1.63 Allowed Glycine 0 N--CA 1.477 1.379 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.914 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.2 m -1.22 87.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 118.371 2.73 . . . . 0.0 118.371 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -135.5 -71.85 0.47 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 113.29 -1.777 . . . . 0.0 112.749 -178.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -45.02 171.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.313 1.845 . . . . 0.0 114.978 173.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.94 35.13 11.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.893 2.077 . . . . 0.0 116.375 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -42.25 -46.73 4.58 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.6 t80 172.88 -59.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.775 1.23 . . . . 0.0 112.463 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 32' ' ' ILE 0.319 5.4 p 56.56 98.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 127.864 2.465 . . . . 0.0 116.199 -175.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.21 84.81 34.92 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.982 174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.08 153.15 78.6 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.151 2.567 . . . . 0.0 112.744 -178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.434 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -129.23 -82.41 0.57 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.938 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -113.2 -177.39 3.12 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.758 1.223 . . . . 0.0 112.034 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -55.74 10.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.411 1.084 . . . . 0.0 113.444 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.7 t -56.27 -51.29 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.232 1.013 . . . . 0.0 111.089 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.736 ' HA ' HD12 ' A' ' 74' ' ' ILE . 43.2 mm-40 -50.93 -58.73 5.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.345 1.058 . . . . 0.0 112.581 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -67.94 -50.35 56.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.257 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 1.7 tpmt? -57.75 -50.38 73.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.194 1.397 . . . . 0.0 112.066 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.45 -43.79 84.6 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.747 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.96 83.82 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 44.9 tt0 -57.02 -60.28 3.82 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.745 1.618 . . . . 0.0 110.673 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.264 2.6 pp -60.51 -36.75 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.95 -63.91 1.0 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.802 0.841 . . . . 0.0 111.552 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.727 ' HB3' HG12 ' A' ' 32' ' ' ILE . 17.9 pt-20 -61.44 -33.97 74.63 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -67.71 -63.29 1.09 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.137 1.375 . . . . 0.0 111.717 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.29 -30.03 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 125.038 1.335 . . . . 0.0 112.469 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.88 -34.8 70.17 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.24 61.96 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.434 1.084 . . . . 0.0 111.557 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.255 7.4 p 17.7 62.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 128.615 2.766 . . . . 0.0 115.272 -176.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -102.91 -47.36 4.4 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.121 -1.854 . . . . 0.0 115.473 -165.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.641 ' H ' ' HB2' ' A' ' 24' ' ' GLU . . . 92.55 105.22 1.59 Allowed Glycine 0 N--CA 1.48 1.6 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -174.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.727 HG12 ' HB3' ' A' ' 24' ' ' GLU . 18.3 pt -120.28 -151.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -175.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -123.89 160.41 18.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.18 -40.48 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.96 -0.69 4.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 170.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 7.5 m-20 55.95 -145.58 0.61 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.287 1.835 . . . . 0.0 111.6 -174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -139.76 42.05 1.99 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.773 0.429 . . . . 0.0 111.835 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -6.01 80.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 127.427 2.291 . . . . 0.0 117.027 -169.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 40' ' ' GLN . 25.4 t80 173.67 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.814 -171.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 39' ' ' PHE . 6.5 pt20 -70.83 19.33 0.05 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 pt -104.22 -40.55 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -72.07 -32.23 63.39 Favored Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.85 166.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.99 -162.71 26.55 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 114.445 -0.878 . . . . 0.0 111.413 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -70.8 -44.23 67.03 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.5 p -174.83 -40.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.2 -36.76 80.78 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.9 mmtp -58.87 -49.89 76.05 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.822 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -37.64 57.14 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -63.12 -50.72 69.36 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 171.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.548 0.739 . . . . 0.0 112.492 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 47' ' ' LYS . 95.5 t -59.2 -50.49 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.746 1.218 . . . . 0.0 110.077 172.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.56 -42.9 67.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.221 0.608 . . . . 0.0 112.531 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.692 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -61.2 -51.51 68.7 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 13.6 pt20 -66.98 -38.6 86.35 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 175.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 93.3 t -66.38 -30.01 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.421 1.088 . . . . 0.0 111.816 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -69.29 -68.78 0.38 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.827 0.451 . . . . 0.0 111.285 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.692 HH21 ' HB1' ' A' ' 53' ' ' ALA . 10.9 ptp180 -59.38 -42.52 91.88 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -111.55 -38.93 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -170.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -78.02 -25.04 47.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 69.92 -44.84 0.57 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.639 2.776 . . . . 0.0 114.998 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.03 27.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 C-N-CA 126.663 1.985 . . . . 0.0 116.14 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.669 ' HA ' HG12 ' A' ' 55' ' ' VAL . 13.7 pt-20 -8.93 77.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 120.335 3.457 . . . . 0.0 120.335 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.3 pt? -125.72 91.46 48.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.6 Cg_endo -66.42 152.03 81.83 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.986 2.457 . . . . 0.0 111.891 175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 tt 65.15 -42.29 0.32 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.068 2.147 . . . . 0.0 116.051 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -54.1 -71.69 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG22 HD23 ' A' ' 77' ' ' LEU 0.255 4.0 p -84.63 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 123.819 1.771 . . . . 0.0 110.464 177.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 47.6 tp -162.5 -49.76 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.402 -173.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.63 -62.59 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.527 1.131 . . . . 0.0 111.566 172.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.31 78.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.307 0.643 . . . . 0.0 112.624 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 38.4 mt-30 -120.9 83.2 36.71 Favored Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.201 170.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 27.0 Cg_endo -85.62 26.78 0.62 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.223 2.615 . . . . 0.0 114.776 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.8 t -136.21 136.08 39.64 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.033 0.533 . . . . 0.0 111.404 -171.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.264 0.4 OUTLIER -62.73 -22.34 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.911 177.268 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 18.9 tptm -58.52 -57.56 12.4 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.184 0.594 . . . . 0.0 110.097 172.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.25 -35.51 81.07 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.627 HD12 HG12 ' A' ' 74' ' ' ILE . 23.8 mt -59.24 -46.12 89.33 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.585 0.354 . . . . 0.0 110.876 173.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.19 -36.87 85.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.065 0.946 . . . . 0.0 112.844 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.676 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -59.39 -39.93 84.97 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 169.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -68.81 -38.35 79.86 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 77' ' ' LEU 0.314 28.1 m -106.59 -57.18 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -178.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.38 49.27 1.72 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 122.963 1.364 . . . . 0.0 111.369 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 86.5 m -161.38 -65.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.556 1.942 . . . . 0.0 109.212 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.08 -30.04 8.64 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 117.198 2.295 . . . . 0.0 117.198 174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 115.592 1.701 . . . . 99.99 115.592 174.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.0 118.62 4.05 Favored Glycine 0 N--CA 1.478 1.454 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.845 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.22 92.81 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.645 0.736 . . . . 0.0 110.861 -173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 t -64.66 -34.35 78.08 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.178 170.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.0 -168.93 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.511 -1.677 . . . . 0.0 111.884 -177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 64.0 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.831 2.052 . . . . 0.0 111.423 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . 0.314 5.1 pt20 46.82 -45.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 120.856 3.651 . . . . 0.0 120.856 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -175.32 -67.13 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.935 1.694 . . . . 0.0 111.757 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.15 84.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 126.573 1.949 . . . . 0.0 112.406 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.41 88.93 30.19 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.005 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.64 146.96 75.14 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.875 2.384 . . . . 0.0 112.17 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 -79.85 0.5 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.297 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -116.51 178.23 4.41 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.046 0.938 . . . . 0.0 111.304 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.24 37.06 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.88 -60.13 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.879 1.272 . . . . 0.0 110.586 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -53.08 -49.85 65.57 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.136 0.974 . . . . 0.0 112.941 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -61.68 -55.6 28.67 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.071 0.949 . . . . 0.0 113.165 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -61.24 -44.12 97.77 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.053 0.941 . . . . 0.0 112.242 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.63 -47.55 80.88 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.17 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 45.0 tt0 -57.84 -58.08 9.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.92 1.288 . . . . 0.0 111.942 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.1 pt -61.77 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -59.4 -46.55 88.38 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 21' ' ' GLU . 11.9 pt-20 -65.8 -26.83 67.87 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -46.42 20.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.314 1.045 . . . . 0.0 111.42 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.48 -42.4 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.683 1.593 . . . . 0.0 112.173 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 7.3 tt -55.77 -25.14 39.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.713 1.205 . . . . 0.0 114.096 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.63 87.13 1.46 Allowed Glycine 0 CA--C 1.531 1.074 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -166.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -18.15 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 127.288 2.235 . . . . 0.0 115.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 p -140.96 -52.44 0.47 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 112.77 -2.014 . . . . 0.0 114.873 -173.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.56 98.22 2.06 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.736 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.52 146.63 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.532 0.682 . . . . 0.0 111.732 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.22 164.27 47.61 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 113.732 -1.577 . . . . 0.0 112.758 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -50.42 -34.57 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 113.36 -1.42 . . . . 0.0 112.598 174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.87 -23.89 67.37 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.23 -175.3 0.15 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.247 1.819 . . . . 0.0 111.323 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -96.06 14.15 24.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.7 p90 32.36 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 117.291 2.33 . . . . 0.0 117.291 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -162.58 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.83 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -77.06 43.17 0.35 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 -43.19 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.128 170.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.32 -51.43 43.51 Favored Glycine 0 N--CA 1.476 1.345 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.214 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 47' ' ' LYS . . . -174.23 102.14 0.17 Allowed Glycine 0 N--CA 1.476 1.331 0 O-C-N 124.526 0.78 . . . . 0.0 114.857 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.92 -29.12 70.32 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 114.394 -0.903 . . . . 0.0 112.09 156.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.2 p 174.19 -93.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 130.723 3.609 . . . . 0.0 108.14 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -26.64 68.08 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 38.4 mttp -39.5 -38.72 0.61 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.8 -55.04 18.73 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ptm -70.96 -41.19 71.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.94 92.75 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.654 0.782 . . . . 0.0 112.989 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -71.8 -39.73 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.262 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.68 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.55 -40.69 68.95 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 174.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.37 -43.78 79.51 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.518 0.727 . . . . 0.0 112.871 173.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -69.37 -43.22 74.0 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.813 1.245 . . . . 0.0 112.372 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 57.0 t -58.41 -31.3 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.41 1.084 . . . . 0.0 111.33 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.49 -80.06 0.06 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 111.378 165.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' C ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -57.9 -31.49 66.81 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 117.265 2.321 . . . . 0.0 117.265 -168.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -109.15 -37.41 5.8 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.148 0.979 . . . . 0.0 112.983 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.852 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 4.1 m-30 -94.72 -18.8 20.95 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 68.63 -39.03 0.4 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.239 2.616 . . . . 0.0 115.722 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.84 -23.49 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 125.072 1.349 . . . . 0.0 113.712 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 50.57 23.22 1.25 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 121.271 3.804 . . . . 0.0 121.271 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 1.1 pt? -106.1 104.93 51.93 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 -174.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.68 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.0 Cg_endo -63.73 152.63 79.66 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 123.509 2.806 . . . . 0.0 112.132 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 69' ' ' PHE . 8.5 tt 63.81 -56.65 0.21 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.7 2.0 . . . . 0.0 114.241 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.12 -64.21 0.84 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.431 1.493 . . . . 0.0 113.082 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.63 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 4.7 p -60.94 -29.57 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.51 -24.24 34.23 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.444 ' CD2' ' HG ' ' A' ' 65' ' ' LEU . 63.6 m-85 -109.33 -37.51 5.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.75 77.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.726 0.41 . . . . 0.0 111.655 173.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 4.4 pm0 -123.62 73.06 52.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.063 168.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -74.71 24.63 0.37 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.62 3.547 . . . . 0.0 117.158 -170.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 t -135.2 137.0 42.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.105 1.362 . . . . 0.0 110.697 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -60.08 -26.3 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.56 175.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -58.61 -50.03 75.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.844 0.458 . . . . 0.0 110.962 172.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.91 68.48 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 91.4 mt -56.32 -43.16 78.71 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.955 0.902 . . . . 0.0 113.201 176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.7 79.11 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 112.42 176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 83' ' ' THR . 3.0 mp0 -66.61 -37.41 84.82 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 174.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -60.91 -17.85 53.33 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.267 16.5 m -110.75 -73.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 170.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.92 74.54 6.66 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.392 1.568 . . . . 0.0 111.353 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 39.0 m -173.27 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 129.409 3.084 . . . . 0.0 107.341 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.485 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -113.69 -30.18 6.88 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 116.148 1.907 . . . . 99.99 116.148 -177.388 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.96 89.01 0.23 Allowed Glycine 0 N--CA 1.479 1.56 0 CA-C-N 114.42 -1.264 . . . . 0.0 113.255 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -120.61 138.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.783 0.801 . . . . 0.0 111.993 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 t -133.96 -56.85 0.87 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 113.358 -1.747 . . . . 0.0 111.686 177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -51.18 176.77 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.817 1.647 . . . . 0.0 114.704 166.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.91 20.39 8.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -45.43 -28.11 0.83 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 120.19 3.404 . . . . 0.0 120.19 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 t80 176.2 -70.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.326 1.45 . . . . 0.0 110.921 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t 62.75 85.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 126.926 2.09 . . . . 0.0 113.009 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -122.11 90.61 48.93 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.563 171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.71 156.72 44.28 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 123.341 2.694 . . . . 0.0 113.466 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.3 -83.35 0.64 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.056 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -105.86 -171.49 1.91 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 112.457 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.79 -50.8 55.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.198 0.999 . . . . 0.0 113.467 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -55.7 -53.67 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.11 0.964 . . . . 0.0 110.235 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -51.72 -62.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.617 1.167 . . . . 0.0 113.176 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -64.58 -51.45 62.71 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 22' ' ' ILE . 27.7 ttpt -63.6 -45.73 89.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.584 0.754 . . . . 0.0 112.197 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.0 -39.3 90.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.87 85.34 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.209 0.459 . . . . 0.0 112.054 171.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 32.8 tt0 -57.33 -53.72 54.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.7 1.2 . . . . 0.0 111.068 171.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 18' ' ' LYS . 41.2 mm -53.67 -53.46 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.34 1.056 . . . . 0.0 110.638 176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HB3' HD11 ' A' ' 32' ' ' ILE . 21.3 m95 -54.28 -60.4 3.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.266 1.027 . . . . 0.0 112.779 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -58.66 -31.98 68.67 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -69.87 -63.81 1.01 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.451 1.5 . . . . 0.0 111.376 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG12 ' HE2' ' A' ' 47' ' ' LYS . 57.8 t -62.85 -36.45 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.149 1.38 . . . . 0.0 112.801 -175.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD21 HE21 ' A' ' 40' ' ' GLN . 9.4 tt -56.92 -24.5 52.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.666 1.586 . . . . 0.0 113.956 173.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.19 71.29 0.24 Allowed Glycine 0 N--CA 1.476 1.314 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.271 12.2 p 3.52 78.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 128.475 2.71 . . . . 0.0 116.127 -177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 5' ' ' GLU . 21.4 m -121.56 -67.61 0.95 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 112.597 -2.092 . . . . 0.0 116.284 -171.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 121.71 95.76 1.37 Allowed Glycine 0 N--CA 1.479 1.56 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 23' ' ' TRP . 14.8 pt -121.58 159.28 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-O 121.333 0.587 . . . . 0.0 112.526 -173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 9' ' ' VAL . . . -82.65 151.57 29.41 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.214 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 43.4 mm -45.49 -41.99 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 125.856 1.662 . . . . 0.0 112.892 171.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.49 -29.92 68.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 36.5 m-20 62.97 149.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.123 2.169 . . . . 0.0 111.858 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -70.55 24.07 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 22.9 p90 22.55 47.82 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 118.343 2.719 . . . . 0.0 118.343 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -160.12 -78.22 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.401 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.493 HE21 HD21 ' A' ' 27' ' ' LEU . 20.4 pt20 -70.0 27.47 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -115.78 -35.97 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.307 1.043 . . . . 0.0 111.698 172.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -59.26 -63.21 5.37 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 124.334 0.969 . . . . 0.0 113.398 171.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.77 121.64 0.01 OUTLIER Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.226 -1.487 . . . . 0.0 115.838 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -81.01 49.95 1.32 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.754 -1.723 . . . . 0.0 113.467 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -159.72 -154.04 0.38 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.502 1.921 . . . . 0.0 108.905 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.2 pt? -62.67 -0.87 0.7 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 26' ' ' VAL . 22.5 mmtp -56.16 -61.61 2.27 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.352 1.061 . . . . 0.0 112.748 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.65 -36.31 24.31 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 95.0 mmm -65.28 -52.3 55.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.598 1.159 . . . . 0.0 112.841 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.27 77.83 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.308 1.043 . . . . 0.0 112.668 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 47' ' ' LYS . 74.0 t -62.81 -50.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.067 0.947 . . . . 0.0 110.177 171.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.97 -42.65 65.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.321 0.648 . . . . 0.0 112.566 174.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.46 -56.28 23.92 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -65.68 -38.64 89.83 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.681 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -66.55 -27.98 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 111.951 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -71.14 -69.35 0.38 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.806 0.443 . . . . 0.0 111.222 166.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -29.4 70.55 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.93 -44.01 3.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.999 0.92 . . . . 0.0 113.243 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.681 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.2 m-85 -82.62 -20.98 35.32 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.31 -46.67 0.62 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 128.658 2.783 . . . . 0.0 114.189 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.77 26.91 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.652 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.1 pt-20 -6.72 76.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 120.29 3.441 . . . . 0.0 120.29 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -123.97 86.7 53.57 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.544 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 73.0 Cg_endo -66.24 150.8 84.64 Favored 'Trans proline' 0 N--CA 1.479 0.653 0 C-N-CA 123.17 2.58 . . . . 0.0 111.629 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.0 -48.73 0.35 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.605 1.962 . . . . 0.0 114.78 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -52.08 -69.3 0.12 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.616 1.566 . . . . 0.0 112.904 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.623 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 1.5 p -61.55 -20.46 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 HD21 ' HA2' ' A' ' 42' ' ' GLY . 59.3 tp -93.44 -29.02 15.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.258 1.823 . . . . 0.0 114.633 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -108.1 -40.33 5.24 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.607 1.163 . . . . 0.0 113.705 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.63 -43.26 73.02 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.0 pm0 -122.97 70.23 39.62 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.679 169.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -77.38 32.83 0.43 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.536 3.49 . . . . 0.0 115.097 -173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.483 ' HA ' ' OD2' ' A' ' 36' ' ' ASP . 8.6 t -139.03 137.51 36.35 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.856 1.262 . . . . 0.0 111.125 -173.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.576 HD11 ' HE1' ' A' ' 23' ' ' TRP 0.306 3.2 mm -57.86 -27.94 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -66.19 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.991 0.807 . . . . 0.0 110.169 173.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.79 -34.5 78.5 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 87.3 mt -58.2 -44.39 88.09 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.16 93.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 112.653 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.603 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.3 mp0 -60.83 -46.28 91.16 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 171.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -65.46 -26.97 68.18 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.316 9.5 m -112.07 -75.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.62 60.56 1.25 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 123.351 1.548 . . . . 0.0 113.428 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.4 m -161.69 -54.16 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.629 2.372 . . . . 0.0 109.05 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -106.03 -31.97 8.5 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 173.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 127.353 2.261 . . . . 99.99 116.436 -178.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.01 79.83 0.21 Allowed Glycine 0 N--CA 1.478 1.49 0 CA-C-N 114.409 -1.269 . . . . 0.0 113.708 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.81 129.64 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.453 -0.873 . . . . 0.0 110.424 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.9 t -125.46 -30.36 3.12 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.635 -1.62 . . . . 0.0 114.571 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 21.7 mp0 -68.35 161.44 27.44 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.721 0.809 . . . . 0.0 111.18 168.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.71 147.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.276 1.83 . . . . 0.0 113.465 -167.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.43 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.556 -173.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -118.25 -61.73 1.63 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' HD3' ' A' ' 11' ' ' PRO . 4.0 t 67.46 98.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 126.389 1.876 . . . . 0.0 111.553 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -121.58 78.86 38.06 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.018 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' HG12 ' A' ' 9' ' ' VAL . 72.5 Cg_endo -66.56 145.68 77.16 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.665 2.244 . . . . 0.0 112.013 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -122.76 -87.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.046 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' HB ' ' A' ' 12' ' ' THR . 43.9 p-10 -105.26 -176.38 3.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.49 -50.39 31.83 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.061 0.944 . . . . 0.0 113.119 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.91 -58.49 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.323 1.049 . . . . 0.0 110.504 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 74' ' ' ILE . 7.5 mm-40 -49.28 -58.89 4.27 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.745 1.218 . . . . 0.0 113.277 176.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -67.97 -54.25 20.04 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 38.2 ttpt -64.89 -41.29 95.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.713 1.205 . . . . 0.0 113.291 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.5 mm? -66.95 -43.04 84.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.494 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.2 78.35 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 30.2 tt0 -57.92 -58.71 7.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.11 1.364 . . . . 0.0 111.452 171.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.259 2.6 pp -61.35 -36.13 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 6.8 m95 -57.47 -60.74 3.19 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.485 0.714 . . . . 0.0 111.996 170.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 13.7 pt-20 -59.13 -26.8 65.03 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -73.23 -70.48 0.36 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.808 1.243 . . . . 0.0 112.289 167.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.82 -39.91 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 125.162 1.385 . . . . 0.0 113.024 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 23' ' ' TRP . 1.5 tt -61.06 -25.89 67.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.914 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.38 0.05 OUTLIER Glycine 0 N--CA 1.478 1.463 0 O-C-N 124.106 0.879 . . . . 0.0 111.38 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.27 13.3 p -20.7 88.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.39 2.676 . . . . 0.0 116.625 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 14.4 m -149.68 -51.82 0.15 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.006 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 130.02 124.14 2.59 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.804 0.69 . . . . 0.0 112.463 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.2 pt -134.11 177.38 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.411 0.685 . . . . 0.0 110.884 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 150.88 17.27 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.762 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 10' ' ' ALA . 49.2 mm -28.23 -42.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 127.672 2.389 . . . . 0.0 114.463 164.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 73' ' ' THR . 6.4 mp -62.4 -34.17 76.21 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.991 1.716 . . . . 0.0 114.742 176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 61.11 146.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.136 1.774 . . . . 0.0 113.171 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.45 25.92 0.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.1 p90 21.1 49.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -167.66 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.681 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -60.1 -14.49 17.08 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -33.04 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -173.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.47 12.57 15.98 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 123.743 0.652 . . . . 0.0 113.978 169.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 39.45 -155.68 0.03 OUTLIER Glycine 0 N--CA 1.48 1.574 0 C-N-CA 124.786 1.184 . . . . 0.0 114.759 -172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.39 52.14 1.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.332 -1.434 . . . . 0.0 110.7 171.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -171.49 -162.07 0.22 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.839 1.656 . . . . 0.0 112.02 -171.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -51.82 -21.7 3.08 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.0 mmtp -52.58 -43.68 65.42 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 174.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.17 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 172.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.9 mtp -69.95 -45.65 66.99 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.763 1.225 . . . . 0.0 112.144 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.831 0.852 . . . . 0.0 112.536 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 68' ' ' LEU . 20.7 t -67.27 -49.32 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.072 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -50.3 -39.58 45.96 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -55.9 -59.63 4.62 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.941 0.897 . . . . 0.0 112.339 172.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 8.3 pt20 -63.52 -31.95 73.26 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.011 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 76.1 t -62.24 -37.57 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.795 1.238 . . . . 0.0 112.748 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.4 -33.79 61.01 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 7.4 ptt85 -102.59 -37.65 7.86 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 118.357 2.725 . . . . 0.0 118.357 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -108.32 -35.35 6.55 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.777 0.831 . . . . 0.0 112.403 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 1.011 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.3 m-85 -80.12 -28.34 38.99 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 173.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 68.25 -30.96 0.18 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 127.521 2.328 . . . . 0.0 115.18 -175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.59 -31.04 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 127.988 2.515 . . . . 0.0 115.785 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.723 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 24.1 tt0 66.87 141.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.326 1.85 . . . . 0.0 113.185 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.723 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 97.7 mt 65.22 154.75 0.12 Allowed Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 172.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 94.5 Cg_endo -71.51 -162.81 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.314 2.009 . . . . 0.0 111.476 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.6 tp 66.92 -51.15 0.47 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.712 2.005 . . . . 0.0 115.466 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -57.75 -85.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.779 1.632 . . . . 0.0 110.52 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' A' ' 71' ' ' GLN . 11.8 m -79.07 46.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.497 1.141 . . . . 0.0 113.885 172.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 51' ' ' VAL . 13.3 mt -144.36 -50.34 0.29 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.508 -1.678 . . . . 0.0 114.839 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -109.84 -49.69 3.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.018 0.927 . . . . 0.0 111.662 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.94 79.14 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.674 0.609 . . . . 0.0 111.563 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 4.5 mp0 -116.9 87.28 21.65 Favored Pre-proline 0 N--CA 1.477 0.887 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.73 167.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.98 -26.68 1.42 Allowed 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.674 2.25 . . . . 0.0 114.653 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 44.0 p -80.5 138.0 36.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.557 0.743 . . . . 0.0 109.97 -175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.496 HG12 HD12 ' A' ' 77' ' ' LEU 0.255 0.4 OUTLIER -62.09 -23.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.913 172.584 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -59.6 -51.51 69.53 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.36 0.664 . . . . 0.0 111.818 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 -40.59 95.02 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 73' ' ' THR . 51.4 mt -57.97 -46.63 84.85 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.389 0.676 . . . . 0.0 112.254 176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -45.33 85.62 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.609 1.164 . . . . 0.0 112.97 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -68.44 -31.91 71.56 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -74.25 -22.36 59.36 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 169.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 77' ' ' LEU 0.269 32.6 m -104.25 -73.97 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 176.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.439 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -85.5 61.21 6.72 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 123.894 1.807 . . . . 0.0 111.196 -173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.4 m -161.17 -56.43 0.05 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.278 -2.237 . . . . 0.0 108.461 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -114.22 -30.87 6.49 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 175.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.595 1.702 . . . . 99.99 115.595 -175.095 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.32 -168.92 16.33 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.874 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.37 139.22 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 114.308 -0.946 . . . . 0.0 111.289 -174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -96.07 -15.38 22.24 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.372 1.082 . . . . 0.0 113.886 175.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -106.88 173.55 6.27 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.029 1.331 . . . . 0.0 110.507 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.51 92.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.68 1.592 . . . . 0.0 113.786 -171.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.563 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 4.6 tp60 -98.97 -62.86 1.18 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.052 -1.886 . . . . 0.0 113.548 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -148.75 -60.57 0.23 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.857 1.263 . . . . 0.0 111.078 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 t 65.33 84.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 126.771 2.028 . . . . 0.0 112.598 173.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -128.65 85.02 61.4 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.988 169.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.97 143.68 61.28 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.779 2.319 . . . . 0.0 112.436 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 -77.04 0.6 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.777 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' GLU . 26.1 p30 -117.04 -172.85 2.29 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.563 1.145 . . . . 0.0 112.583 -172.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.92 -63.29 1.14 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.71 1.204 . . . . 0.0 113.169 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.17 -47.17 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.401 1.081 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.608 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.3 mm-40 -50.58 -63.54 1.09 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.72 1.208 . . . . 0.0 113.173 174.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 t -67.26 -45.44 76.63 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.27 -54.11 50.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.003 1.321 . . . . 0.0 111.297 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.99 -36.81 82.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.94 -42.18 89.14 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.486 0.585 . . . . 0.0 112.437 171.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -59.36 -51.42 70.01 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.149 1.38 . . . . 0.0 111.278 171.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.1 mt -53.85 -54.19 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.276 1.03 . . . . 0.0 110.517 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.574 ' HB3' HD11 ' A' ' 32' ' ' ILE . 9.8 m95 -55.29 -53.99 49.13 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.262 1.025 . . . . 0.0 113.51 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -61.51 -30.75 70.83 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -73.75 -56.56 4.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.325 1.05 . . . . 0.0 111.93 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -61.0 -38.74 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 125.501 1.52 . . . . 0.0 113.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 40' ' ' GLN . 8.0 tt -59.81 -22.84 62.75 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.334 1.453 . . . . 0.0 113.585 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.85 74.74 0.3 Allowed Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.272 13.0 p 0.78 81.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 128.32 2.648 . . . . 0.0 116.397 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 m -127.36 -80.32 0.59 Allowed 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 112.579 -2.101 . . . . 0.0 115.17 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.88 102.37 0.67 Allowed Glycine 0 N--CA 1.479 1.523 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' ASP . 15.3 pt -125.05 166.9 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -173.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.563 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -72.22 158.84 53.5 Favored Glycine 0 N--CA 1.477 1.397 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.026 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 10' ' ' ALA . 40.5 mm -52.9 -42.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 114.179 -1.01 . . . . 0.0 111.75 164.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.16 9.23 0.33 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 166.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 32' ' ' ILE . 6.5 m-20 55.64 -137.47 1.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.677 1.591 . . . . 0.0 109.562 -176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.691 HD22 ' NE2' ' A' ' 40' ' ' GLN . 54.9 t30 -123.41 28.85 6.87 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.836 0.454 . . . . 0.0 110.276 156.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.281 53.2 p90 35.73 -0.39 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 1 N-CA-C 123.402 4.593 . . . . 0.0 123.402 -174.905 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -115.34 -74.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.922 1.689 . . . . 0.0 111.276 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.691 ' NE2' HD22 ' A' ' 37' ' ' ASN . 14.3 pt20 -67.71 31.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -112.44 -29.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.579 0.751 . . . . 0.0 112.434 171.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 68' ' ' LEU . . . -57.51 -48.08 83.61 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 123.968 0.792 . . . . 0.0 113.349 170.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.93 99.32 0.01 OUTLIER Glycine 0 N--CA 1.478 1.46 0 O-C-N 125.1 1.118 . . . . 0.0 113.673 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -70.39 54.56 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.378 1.871 . . . . 0.0 114.747 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 91.7 p -165.3 -142.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.552 2.341 . . . . 0.0 108.078 -176.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -63.31 -18.36 63.54 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -54.56 -48.5 71.97 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.15 60.52 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 78.5 mtm -69.94 -44.54 69.35 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.717 0.807 . . . . 0.0 112.952 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.83 79.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.472 0.709 . . . . 0.0 112.568 172.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' LYS . 94.3 t -62.95 -50.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.018 0.927 . . . . 0.0 109.865 170.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.678 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.46 -43.58 65.04 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.416 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -56.65 -54.37 46.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.277 1.031 . . . . 0.0 113.394 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.659 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 9.2 pt20 -66.75 -37.06 83.87 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.93 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 72.5 t -65.08 -25.22 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.373 1.069 . . . . 0.0 112.587 174.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.482 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 3.2 t60 -81.67 -54.59 5.27 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 168.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 18.8 ptp180 -71.02 -37.7 72.61 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -110.33 -31.43 7.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.933 1.293 . . . . 0.0 112.557 -173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.93 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.4 m-30 -102.84 -10.3 19.2 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tp60 62.05 -46.91 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 118.167 2.655 . . . . 0.0 118.167 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -16.61 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 126.371 1.868 . . . . 0.0 115.81 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 52.54 28.23 5.84 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 120.428 3.492 . . . . 0.0 120.428 167.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -109.21 94.89 16.44 Favored Pre-proline 0 N--CA 1.483 1.192 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -173.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.678 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 86.7 Cg_endo -66.13 151.01 84.76 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 123.709 2.94 . . . . 0.0 111.889 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 9.0 tt 63.88 -44.95 0.26 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.745 2.018 . . . . 0.0 114.087 -175.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -51.85 -69.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.984 1.714 . . . . 0.0 111.555 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.642 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 3.6 p -76.46 22.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 42' ' ' GLY . 62.9 tp -130.94 -37.22 1.31 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.018 0.927 . . . . 0.0 113.482 -169.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.554 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 26.0 m-85 -101.31 -39.41 7.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.354 1.062 . . . . 0.0 113.797 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.9 -42.42 90.22 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.642 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 1.1 pm0 -124.87 73.12 63.91 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.53 1.132 . . . . 0.0 112.005 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -77.99 34.78 0.49 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.125 3.217 . . . . 0.0 114.754 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.8 t -142.02 131.95 24.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.847 1.659 . . . . 0.0 110.502 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.285 0.5 OUTLIER -63.8 -20.33 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.594 -1.184 . . . . 0.0 113.591 178.843 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.98 -56.63 19.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.17 0.588 . . . . 0.0 110.439 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.32 -34.05 75.42 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.054 -0.975 . . . . 0.0 113.088 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.3 mt -58.89 -45.51 90.05 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 172.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.17 91.46 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.722 0.809 . . . . 0.0 111.881 172.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.556 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -59.47 -45.08 92.67 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.42 0.688 . . . . 0.0 112.74 171.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.51 -28.63 67.99 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.299 16.7 m -113.37 -68.62 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 61.53 2.67 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 123.228 1.49 . . . . 0.0 112.203 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 99.7 m -164.81 -69.9 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.951 2.501 . . . . 0.0 108.084 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.51 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -97.43 -29.08 13.7 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 115.732 -2.08 . . . . 99.99 114.336 179.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.89 -151.71 22.19 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.56 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.1 p -157.22 149.89 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.617 1.167 . . . . 0.0 109.649 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 t -55.2 -38.1 67.95 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 21.8 mm-40 -132.08 -73.01 0.52 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -167.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.07 119.1 1.88 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.692 1.197 . . . . 0.0 114.045 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.56 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 63.3 tp60 -122.77 -80.07 0.62 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.793 -1.549 . . . . 0.0 112.75 -175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.471 ' H ' ' HA3' ' A' ' 33' ' ' GLY . 46.0 t80 -135.38 -64.29 0.65 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.5 t 72.15 98.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.814 2.045 . . . . 0.0 112.394 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -144.18 82.99 10.42 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.432 167.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.05 147.52 61.16 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 122.923 2.416 . . . . 0.0 112.674 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.01 -82.78 0.58 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.007 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 p-10 -108.47 -177.36 3.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.718 0.807 . . . . 0.0 111.833 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.99 50.39 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.09 -59.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.761 1.224 . . . . 0.0 110.357 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.657 ' HA ' HD12 ' A' ' 74' ' ' ILE . 9.1 mm-40 -49.08 -59.57 3.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.981 1.312 . . . . 0.0 113.439 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.6 t -64.84 -56.37 13.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.085 0.954 . . . . 0.0 113.252 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 32.3 ttpt -67.14 -40.86 86.82 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.08 -40.64 94.92 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.913 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.83 84.6 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 33.4 tt0 -58.17 -53.14 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.581 1.152 . . . . 0.0 111.186 170.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.87 -50.96 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.327 1.051 . . . . 0.0 110.663 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -52.67 -60.11 3.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.32 1.048 . . . . 0.0 112.335 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HB3' HG13 ' A' ' 32' ' ' ILE . 15.4 pt-20 -60.13 -31.36 69.99 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -61.54 1.94 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.928 1.291 . . . . 0.0 111.865 174.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.21 -39.44 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.28 1.032 . . . . 0.0 112.669 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 34.9 tp -62.3 -32.7 73.47 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 155.67 56.44 0.01 OUTLIER Glycine 0 N--CA 1.48 1.599 0 O-C-N 124.47 1.106 . . . . 0.0 112.94 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.276 12.1 p -0.74 75.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 128.914 2.885 . . . . 0.0 116.955 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.662 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 56.3 m -138.77 -48.0 0.5 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.056 -1.884 . . . . 0.0 114.589 -177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 24' ' ' GLU . . . 125.05 112.14 1.9 Allowed Glycine 0 N--CA 1.477 1.406 0 O-C-N 123.714 0.634 . . . . 0.0 113.381 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -108.72 173.73 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 114.623 -0.789 . . . . 0.0 111.58 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 7' ' ' GLN . . . -99.46 153.17 19.61 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.839 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 10' ' ' ALA . 43.5 mm -40.97 -47.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.995 1.318 . . . . 0.0 113.803 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.08 -21.07 63.32 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 17.7 m-20 58.98 157.46 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.603 1.961 . . . . 0.0 113.324 -172.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.95 8.92 3.29 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.6 p90 39.61 22.5 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -118.59 -85.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.776 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' CD ' ' H ' ' A' ' 40' ' ' GLN . 5.5 pm0 -59.5 -16.62 25.61 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 119.025 2.972 . . . . 0.0 119.025 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -33.34 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.78 -53.08 0.6 Allowed Glycine 0 N--CA 1.476 1.326 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.344 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.32 -144.88 18.82 Favored Glycine 0 N--CA 1.478 1.485 0 O-C-N 124.506 0.768 . . . . 0.0 112.333 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -139.48 41.85 2.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.979 1.371 . . . . 0.0 112.991 172.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.3 m -130.62 -154.46 0.63 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.048 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -49.94 -33.08 16.45 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 mmtp -46.51 -73.04 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.398 1.479 . . . . 0.0 112.766 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.74 4.97 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.26 -53.56 35.45 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.97 91.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.909 0.884 . . . . 0.0 112.227 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 68' ' ' LEU . 27.6 t -66.87 -40.26 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.995 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -54.34 -45.71 72.74 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.934 0.788 . . . . 0.0 111.67 172.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -58.89 -49.87 76.14 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.387 172.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -54.56 -51.91 63.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.426 1.49 . . . . 0.0 112.446 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 60.2 t -65.68 -29.58 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.416 1.486 . . . . 0.0 112.56 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -68.1 -72.16 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.114 0.566 . . . . 0.0 111.28 167.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 6.3 ptt180 -64.5 -41.38 96.47 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 -173.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.35 -29.07 10.99 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.733 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.3 m-85 -94.62 -22.58 18.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 64.26 -33.78 0.15 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.664 2.468 . . . . 0.0 117.664 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.29 -18.83 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.774 1.23 . . . . 0.0 114.168 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 47.76 39.01 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 66' ' ' LYS . 1.1 pt? -122.47 99.52 42.52 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 63.7 Cg_endo -65.6 160.76 41.64 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.3 2.666 . . . . 0.0 111.902 174.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 68' ' ' LEU . 7.3 tt 66.09 -47.57 0.42 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.971 2.108 . . . . 0.0 114.852 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HD2' HD12 ' A' ' 63' ' ' LEU . 32.7 mttp -56.75 -55.59 32.3 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.417 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.8 t -68.21 4.16 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 51' ' ' VAL . 61.0 mt -119.2 -29.66 5.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 75.0 m-85 -112.16 -38.06 4.85 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.89 -44.78 30.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.406 0.682 . . . . 0.0 112.244 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -119.31 67.0 9.06 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 168.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' ASP . 41.5 Cg_endo -77.06 26.16 0.45 Allowed 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.057 3.172 . . . . 0.0 115.802 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.543 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.2 t -137.96 136.05 36.6 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.988 1.315 . . . . 0.0 110.714 -171.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.271 0.4 OUTLIER -62.31 -23.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.905 178.299 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -54.87 -62.81 1.41 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.373 1.069 . . . . 0.0 110.258 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.45 -35.25 80.34 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.34 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 73' ' ' THR . 81.9 mt -57.54 -45.35 85.19 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 173.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.33 85.32 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.207 1.003 . . . . 0.0 112.834 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.625 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -63.19 -47.75 81.24 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 170.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.93 -25.41 68.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.499 HG23 ' H ' ' A' ' 82' ' ' ALA 0.272 5.2 m -101.13 -81.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 168.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -80.43 65.72 5.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 123.52 1.629 . . . . 0.0 112.404 -173.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 94.8 m -165.0 -50.37 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 128.155 2.582 . . . . 0.0 108.457 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -116.69 -30.7 5.72 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 174.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 116.639 -1.648 . . . . 99.99 115.098 -174.096 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.09 -149.72 44.71 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.523 -174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -156.02 164.98 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.845 1.258 . . . . 0.0 111.765 -174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 t -52.1 -31.27 29.91 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 2.5 pp20? -152.39 -169.71 3.43 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.718 0.807 . . . . 0.0 112.881 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.14 20.96 8.94 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 119.123 3.008 . . . . 0.0 119.123 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.94 -40.62 30.9 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.746 2.498 . . . . 0.0 117.746 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 t80 174.54 -68.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.089 0.956 . . . . 0.0 111.235 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG22 ' HA2' ' A' ' 33' ' ' GLY . 10.6 t 66.33 93.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 127.339 2.256 . . . . 0.0 112.222 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -124.72 82.59 59.77 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.361 170.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -68.66 150.45 74.56 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.894 2.396 . . . . 0.0 112.696 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 -81.04 0.61 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.932 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -113.95 -174.76 2.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.612 1.165 . . . . 0.0 112.276 -175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.93 -56.56 10.1 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.197 0.999 . . . . 0.0 113.24 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.26 -52.0 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.669 1.188 . . . . 0.0 110.954 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HA ' HD12 ' A' ' 74' ' ' ILE . 15.0 mm-40 -51.02 -64.34 0.84 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.101 1.361 . . . . 0.0 113.495 175.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.0 t -66.91 -46.87 73.52 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 22' ' ' ILE . 51.2 tptt -60.76 -51.74 68.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.104 0.962 . . . . 0.0 111.053 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.98 -36.13 82.46 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.727 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.5 91.27 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.895 0.77 . . . . 0.0 112.587 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 36.7 tt0 -59.07 -50.43 74.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.753 1.221 . . . . 0.0 111.344 170.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 18' ' ' LYS . 39.4 mm -54.7 -52.17 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 110.617 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 15.8 m95 -56.7 -54.83 41.65 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.346 1.058 . . . . 0.0 113.697 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.3 pt-20 -59.16 -28.27 66.44 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -77.72 -61.53 1.96 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.794 1.638 . . . . 0.0 111.602 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -61.24 -39.62 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.517 1.927 . . . . 0.0 113.818 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 32' ' ' ILE . 5.9 tt -58.72 -24.22 61.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.385 1.474 . . . . 0.0 113.819 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.67 0.73 Allowed Glycine 0 N--CA 1.473 1.149 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.25 13.1 p -22.52 95.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 127.404 2.282 . . . . 0.0 115.474 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.609 ' HB2' ' HG2' ' A' ' 5' ' ' GLU . 24.1 p -148.19 -58.8 0.24 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 112.608 -2.087 . . . . 0.0 114.505 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 127.69 95.58 0.88 Allowed Glycine 0 N--CA 1.48 1.594 0 O-C-N 123.824 0.702 . . . . 0.0 113.37 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.4 pt -107.57 166.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 121.441 0.639 . . . . 0.0 112.501 -174.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -88.76 160.48 30.09 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.144 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 10' ' ' ALA . 47.7 mm -45.3 -51.34 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 125.319 1.448 . . . . 0.0 112.497 170.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.17 -27.66 69.52 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.412 1.485 . . . . 0.0 114.398 171.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' A' ' 32' ' ' ILE . 4.4 p-10 46.07 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.724 1.61 . . . . 0.0 114.26 -167.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -93.5 24.96 3.68 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 34.15 43.07 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -138.77 -82.4 0.3 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 113.426 -1.715 . . . . 0.0 110.426 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.39 36.77 0.06 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -110.66 -42.46 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.592 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -67.06 -48.45 59.81 Favored Glycine 0 N--CA 1.479 1.527 0 O-C-N 123.839 0.712 . . . . 0.0 114.457 171.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.33 115.13 0.01 OUTLIER Glycine 0 N--CA 1.478 1.454 0 O-C-N 125.171 1.159 . . . . 0.0 114.218 177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -75.7 56.22 0.9 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 123.282 1.515 . . . . 0.0 112.725 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -169.73 -155.93 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.439 2.296 . . . . 0.0 109.438 -172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 46' ' ' LEU . 1.8 pt? -53.98 -20.47 6.27 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 22.1 mmtp -55.42 -40.23 71.24 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.06 -41.95 65.34 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 170.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.7 mmt -68.53 -49.94 55.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.812 1.245 . . . . 0.0 112.367 175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.57 -39.87 81.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.183 0.993 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 68' ' ' LEU . 10.4 t -72.07 -42.53 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.725 173.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -52.65 -40.79 63.18 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 174.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -58.7 6.77 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.005 0.922 . . . . 0.0 112.895 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.551 ' HA ' ' HG3' ' A' ' 57' ' ' ARG . 11.7 pt20 -63.92 -36.72 84.89 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 89.0 t -68.59 -24.62 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.311 1.044 . . . . 0.0 112.791 175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -80.54 -57.54 3.53 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 54' ' ' GLN . 4.3 ppt_? -69.72 -39.26 76.94 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -174.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -103.5 -45.83 4.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.165 0.986 . . . . 0.0 111.802 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.3 m-85 -76.95 -28.6 55.26 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 57.77 19.41 5.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 118.154 2.65 . . . . 0.0 118.154 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -114.16 -29.64 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 45.98 73.88 0.16 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.927 1.691 . . . . 0.0 115.173 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.777 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.5 pt? -126.53 81.01 68.91 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 60.9 Cg_endo -63.81 148.51 91.9 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.097 2.531 . . . . 0.0 111.07 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp 64.44 -50.74 0.3 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.651 1.98 . . . . 0.0 113.958 -172.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -51.29 -60.21 3.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.011 1.324 . . . . 0.0 113.01 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.777 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -63.96 -13.68 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD11 HG11 ' A' ' 51' ' ' VAL . 2.8 mm? -102.68 -25.22 13.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -111.17 -38.03 5.15 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.83 -42.47 40.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.194 0.598 . . . . 0.0 112.085 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 3.5 pm0 -120.9 67.64 15.32 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -79.16 50.33 3.46 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 124.81 3.674 . . . . 0.0 115.111 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.424 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.6 t -161.38 137.74 8.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.754 1.221 . . . . 0.0 110.656 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.272 0.4 OUTLIER -63.87 -22.24 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.9 -179.688 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -57.43 -61.38 2.53 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . . . -64.96 -34.46 78.48 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.677 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.5 mt -57.66 -47.42 82.33 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.655 0.382 . . . . 0.0 111.971 171.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.07 99.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.924 0.89 . . . . 0.0 111.905 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' A' ' 76' ' ' ALA . 1.2 mp0 -58.03 -40.31 80.55 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.06 -29.86 69.76 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.289 15.7 m -113.76 -60.54 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.35 36.89 0.25 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.083 1.753 . . . . 0.0 114.574 -173.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -124.02 -49.33 1.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.389 1.876 . . . . 0.0 108.925 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -32.6 5.91 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 116.42 2.008 . . . . 99.99 116.42 -171.76 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.25 -83.25 1.26 Allowed Glycine 0 N--CA 1.476 1.314 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.797 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.02 144.06 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.656 -0.772 . . . . 0.0 112.661 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -125.04 -55.83 1.57 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.359 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 4.4 pm0 -57.02 174.75 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.699 1.2 . . . . 0.0 113.019 164.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.097 1.759 . . . . 0.0 112.992 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -170.77 -118.9 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 112.814 -1.994 . . . . 0.0 107.344 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.483 ' CE2' ' HB ' ' A' ' 34' ' ' ILE . 22.0 t80 -50.77 -45.03 58.85 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.304 9.2 p 2.43 56.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 -170.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -113.98 102.64 55.0 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.536 172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.28 -157.82 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.192 2.595 . . . . 0.0 112.559 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 13' ' ' ASN . 1.9 m -159.07 -100.27 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.742 0.817 . . . . 0.0 109.123 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' H ' ' HB ' ' A' ' 12' ' ' THR . 13.6 p30 -76.3 167.54 21.67 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.908 1.283 . . . . 0.0 112.978 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.27 -48.06 24.84 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.41 -60.73 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.325 1.05 . . . . 0.0 110.178 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 74' ' ' ILE . 39.3 mt-10 -58.18 -45.34 87.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.3 t -65.54 -55.81 15.74 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.621 0.768 . . . . 0.0 112.624 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.61 -43.61 98.53 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 22' ' ' ILE . 4.1 mm? -63.45 -46.52 85.84 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 174.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.56 82.01 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.2 tt0 -58.7 -59.17 5.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.291 1.436 . . . . 0.0 111.498 171.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 19' ' ' LEU . 19.9 pt -62.18 -35.75 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' HB3' HD11 ' A' ' 32' ' ' ILE . 4.8 m95 -56.62 -59.09 5.51 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.598 -0.715 . . . . 0.0 112.424 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 18.0 pt-20 -61.25 -27.77 68.69 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -64.3 0.89 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.582 1.153 . . . . 0.0 112.289 168.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.82 -37.68 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 125.921 1.689 . . . . 0.0 113.298 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.1 tt -58.6 -23.58 59.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.337 1.455 . . . . 0.0 113.707 173.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.31 84.45 0.83 Allowed Glycine 0 N--CA 1.475 1.245 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.266 13.9 p -16.16 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 127.77 2.428 . . . . 0.0 116.039 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB2' ' HG3' ' A' ' 5' ' ' GLU . 24.0 p -146.01 -74.11 0.22 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 112.81 -1.995 . . . . 0.0 115.0 -175.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 140.04 111.14 0.91 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 114.736 0.654 . . . . 0.0 114.736 176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 33' ' ' GLY . 11.1 pt -113.27 -82.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.593 ' H ' HG13 ' A' ' 32' ' ' ILE . . . 120.95 -169.37 14.25 Favored Glycine 0 N--CA 1.479 1.535 0 C-N-CA 123.871 0.748 . . . . 0.0 112.753 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.631 ' HA ' HG22 ' A' ' 74' ' ' ILE . 49.0 mt -53.71 -46.47 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.61 -24.65 67.69 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.39 -149.67 0.42 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.553 1.141 . . . . 0.0 109.014 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' HB3' ' HG2' ' A' ' 40' ' ' GLN . 5.3 t-20 -115.43 13.02 16.42 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 164.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.2 p90 41.23 14.28 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -135.77 -68.77 0.5 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.714 1.206 . . . . 0.0 112.417 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 27' ' ' LEU . 21.1 pt20 -68.53 32.21 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 118.326 2.713 . . . . 0.0 118.326 -177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -118.44 -37.69 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.386 1.074 . . . . 0.0 112.932 174.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -76.68 -44.96 14.03 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.343 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.46 -179.2 2.77 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 122.278 0.932 . . . . 0.0 113.286 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.82 56.57 1.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.67 1.224 . . . . 0.0 111.641 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 m -173.54 -159.4 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.199 1.8 . . . . 0.0 111.063 -172.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -53.3 -20.69 4.55 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 51' ' ' VAL . 21.7 mmmt -45.94 -59.8 2.62 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.356 1.062 . . . . 0.0 113.285 173.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.23 -37.77 56.14 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 173.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 93.8 mmm -65.34 -50.05 67.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.431 1.092 . . . . 0.0 112.326 175.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.34 82.04 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.432 1.093 . . . . 0.0 112.573 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 68' ' ' LEU . 26.1 t -65.98 -47.09 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 118.698 -0.667 . . . . 0.0 110.537 171.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.41 -41.94 66.52 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 118.356 0.525 . . . . 0.0 112.402 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.73 -56.1 26.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.129 0.972 . . . . 0.0 113.239 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 10.6 pt20 -64.44 -37.99 89.46 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 62' ' ' GLU . 75.0 t -64.96 -37.36 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.951 0.9 . . . . 0.0 111.629 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -63.0 -44.2 96.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 173.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 19.6 ptp180 -86.5 -44.44 11.96 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.87 -28.99 13.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.01 1.324 . . . . 0.0 112.911 -173.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.568 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -97.99 -22.81 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -48.56 0.41 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.568 2.747 . . . . 0.0 115.025 -172.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.04 32.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.648 2.379 . . . . 0.0 116.897 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.715 ' HA ' HG12 ' A' ' 55' ' ' VAL . 15.7 pt-20 -10.08 74.31 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 119.718 3.229 . . . . 0.0 119.718 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' HG ' ' HB ' ' A' ' 67' ' ' VAL . 2.2 pt? -122.11 85.09 46.08 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 61.5 Cg_endo -65.22 150.13 87.85 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 122.779 2.319 . . . . 0.0 111.105 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 68' ' ' LEU . 8.0 tp 66.05 -49.83 0.41 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.021 2.128 . . . . 0.0 114.623 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.38 -58.79 5.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.353 1.061 . . . . 0.0 113.014 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HB ' ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -63.69 -16.14 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 51' ' ' VAL . 47.5 mt -97.54 -25.39 15.17 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -116.08 -37.85 3.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.91 -49.59 19.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 4.3 pm0 -128.72 52.7 9.56 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.912 2.189 . . . . 0.0 116.912 174.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 95.9 Cg_endo -63.99 -23.59 67.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 116.214 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.5 p -68.03 132.6 47.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.348 0.659 . . . . 0.0 110.095 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.339 0.4 OUTLIER -61.27 -19.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.982 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -57.24 -63.84 1.09 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.864 0.866 . . . . 0.0 109.727 165.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 71' ' ' GLN . . . -63.0 -37.93 89.15 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.996 -1.002 . . . . 0.0 113.332 178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 90.9 mt -55.9 -46.72 78.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.139 0.576 . . . . 0.0 111.903 171.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.82 -40.08 96.3 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.602 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.5 mp0 -61.97 -43.39 98.95 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.39 -25.37 67.99 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 ' CG ' ' A' ' 59' ' ' TYR 0.303 30.8 m -114.88 -65.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.77 57.92 2.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 123.348 1.547 . . . . 0.0 111.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 92.2 m -165.65 -62.9 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.86 2.464 . . . . 0.0 108.604 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -107.67 -30.9 8.32 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 175.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 125.623 1.569 . . . . 99.99 115.072 176.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.9 mtp . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.68 144.39 31.39 Favored Glycine 0 N--CA 1.478 1.446 0 CA-C-N 114.32 -1.309 . . . . 0.0 112.007 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.16 126.41 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 114.451 -0.875 . . . . 0.0 109.085 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 5' ' ' GLU . 1.7 t -161.78 -72.47 0.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.603 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 2.7 pt-20 -119.79 -159.97 0.8 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.675 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.2 -153.35 0.55 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.947 0.499 . . . . 0.0 109.976 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -160.32 -45.27 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.187 0.995 . . . . 0.0 111.049 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 17.6 p90 -63.98 40.82 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 32' ' ' ILE . 11.5 p -80.82 89.17 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 122.131 0.967 . . . . 0.0 112.309 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.18 87.29 4.73 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.516 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.39 161.05 47.43 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.385 2.724 . . . . 0.0 112.975 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.13 -78.52 0.58 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.824 177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -114.58 -173.71 2.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 112.54 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.39 -59.31 3.56 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.603 1.161 . . . . 0.0 113.166 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.23 -50.97 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.61 1.164 . . . . 0.0 110.932 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -51.48 -59.75 3.91 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.723 1.209 . . . . 0.0 113.318 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -69.04 -45.42 70.49 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -57.33 -53.66 55.61 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.381 1.472 . . . . 0.0 110.977 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.33 -38.92 92.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -42.29 85.14 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.82 -49.97 75.64 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.55 1.14 . . . . 0.0 111.456 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -54.78 -53.88 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.16 0.984 . . . . 0.0 110.632 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -55.45 -53.12 60.22 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.17 0.988 . . . . 0.0 113.192 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.671 ' HB3' HG13 ' A' ' 32' ' ' ILE . 12.5 pt-20 -60.72 -33.12 72.42 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -70.29 -58.94 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.43 1.081 . . . . 0.0 113.097 169.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.01 -40.18 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 125.025 1.33 . . . . 0.0 113.326 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 40' ' ' GLN . 9.9 tt -60.96 -26.49 67.58 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.272 . . . . 0.0 113.986 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.55 73.47 0.12 Allowed Glycine 0 N--CA 1.477 1.423 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.278 12.7 p -2.12 80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 128.481 2.712 . . . . 0.0 116.933 -178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.4 m -134.14 -108.02 0.23 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.001 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -176.86 101.45 0.16 Allowed Glycine 0 N--CA 1.48 1.612 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 24' ' ' GLU . 2.7 pp -96.79 -163.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 32' ' ' ILE . . . -131.09 161.4 23.53 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.0 mm -55.54 -44.39 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.253 1.021 . . . . 0.0 111.777 174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 37.3 tp -58.45 -29.61 66.3 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.606 1.162 . . . . 0.0 113.79 169.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 41' ' ' ILE . 21.8 m-20 58.69 175.94 0.07 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.806 1.643 . . . . 0.0 112.389 -171.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.61 1.61 45.29 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 170.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 52.0 p90 49.8 0.9 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 120.086 3.365 . . . . 0.0 120.086 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -108.28 -84.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.913 1.285 . . . . 0.0 110.401 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.491 ' HG3' HD11 ' A' ' 27' ' ' LEU . 15.7 pt20 -68.74 22.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' A' ' 72' ' ' PRO . 2.3 pp -98.56 -31.18 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.961 0.504 . . . . 0.0 111.418 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.618 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.71 -47.09 92.91 Favored Glycine 0 N--CA 1.479 1.53 0 O-C-N 124.152 0.908 . . . . 0.0 113.706 170.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.46 104.41 0.01 OUTLIER Glycine 0 N--CA 1.479 1.51 0 CA-C-N 114.361 -0.919 . . . . 0.0 115.279 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.88 58.13 0.64 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.738 1.615 . . . . 0.0 114.286 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 m -172.64 -154.83 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.25 2.22 . . . . 0.0 110.468 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.63 -18.27 1.69 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 116.776 2.139 . . . . 0.0 116.776 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 8.8 mptt -48.48 -47.5 38.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.343 1.057 . . . . 0.0 112.01 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.33 -36.77 66.61 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -71.66 -45.92 60.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.674 1.189 . . . . 0.0 112.74 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.78 78.22 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.743 0.817 . . . . 0.0 112.22 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' GLN . 82.2 t -65.99 -48.72 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.267 1.027 . . . . 0.0 110.568 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -51.97 -41.3 62.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.36 -60.91 2.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.056 0.942 . . . . 0.0 112.937 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 51' ' ' VAL . 7.1 pt20 -60.7 -36.8 79.69 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 177.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.787 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 88.3 t -68.11 -30.36 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.632 1.173 . . . . 0.0 113.194 176.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -78.76 -55.31 5.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.113 0.565 . . . . 0.0 111.989 171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -76.35 -35.09 58.91 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -111.27 -36.94 5.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.138 0.975 . . . . 0.0 112.84 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.8 m-85 -82.69 -28.73 30.39 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 57.69 7.42 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 119.051 2.982 . . . . 0.0 119.051 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.31 -18.83 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 50.38 58.58 5.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 1.7 pt? -130.82 86.68 51.59 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.48 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 62.4 Cg_endo -64.21 151.1 86.81 Favored 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 123.098 2.532 . . . . 0.0 111.665 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.3 tp 67.75 -37.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.556 1.943 . . . . 0.0 115.26 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -55.37 -71.99 0.08 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.044 0.938 . . . . 0.0 111.213 173.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.698 HG12 HE22 ' A' ' 71' ' ' GLN . 22.5 m -76.47 58.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-O 123.162 1.458 . . . . 0.0 111.93 175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.618 ' HG ' ' HA2' ' A' ' 42' ' ' GLY . 44.5 tp -168.35 -54.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.227 -1.806 . . . . 0.0 111.242 -171.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -91.7 -45.77 8.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -38.74 88.03 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.979 0.511 . . . . 0.0 111.979 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.698 HE22 HG12 ' A' ' 67' ' ' VAL . 8.7 mp0 -115.2 81.09 7.78 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.074 168.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.63 ' HA ' HD11 ' A' ' 41' ' ' ILE . 37.9 Cg_endo -82.08 36.92 0.64 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.113 2.542 . . . . 0.0 113.974 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -160.74 134.45 6.87 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.193 1.397 . . . . 0.0 110.728 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' HA ' ' HB2' ' A' ' 77' ' ' LEU 0.273 0.5 OUTLIER -65.73 -22.92 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.842 179.8 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -59.52 -51.58 69.25 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.958 0.345 . . . . 0.0 110.973 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.03 83.97 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 93.5 mt -58.37 -44.3 88.79 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.6 89.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.142 0.977 . . . . 0.0 112.159 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.29 -31.36 72.46 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 174.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -73.22 -19.95 60.97 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 170.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 77' ' ' LEU 0.275 14.0 m -114.87 -69.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.75 61.25 4.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 123.656 1.693 . . . . 0.0 111.142 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.4 m -164.53 -61.77 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.121 2.169 . . . . 0.0 108.286 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.541 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.52 -33.19 7.12 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 176.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 116.947 2.203 . . . . 99.99 116.947 -177.277 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.7 -72.4 0.48 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-N 114.234 -1.348 . . . . 0.0 112.438 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.605 ' HB ' ' HG3' ' A' ' 5' ' ' GLU . 16.0 m -59.61 133.98 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 t -59.93 -37.39 79.38 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 113.573 -1.649 . . . . 0.0 113.511 165.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' HG3' ' HB ' ' A' ' 3' ' ' VAL . 2.9 pp20? -69.9 166.74 18.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.393 1.077 . . . . 0.0 113.438 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 61.82 25.12 15.07 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 73.7 tp60 -46.67 -33.1 3.98 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 t80 174.76 -70.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.843 1.657 . . . . 0.0 110.937 -173.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG22 ' HA2' ' A' ' 33' ' ' GLY . 3.0 t 62.73 88.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 126.904 2.081 . . . . 0.0 112.286 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -118.6 88.91 35.79 Favored Pre-proline 0 N--CA 1.48 1.049 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.054 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.09 152.29 80.24 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 123.209 2.606 . . . . 0.0 113.167 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.549 ' HB ' ' HG3' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -112.33 -85.56 0.57 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.713 179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.5 p-10 -108.93 -176.85 3.15 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.181 0.593 . . . . 0.0 111.265 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.66 -53.65 14.29 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 118.13 -0.938 . . . . 0.0 113.141 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -56.53 -52.58 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.947 0.899 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.716 ' HA ' HD12 ' A' ' 74' ' ' ILE . 53.9 mm-40 -51.8 -59.62 4.1 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.297 1.039 . . . . 0.0 112.336 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.8 t -66.27 -50.36 63.99 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -63.92 -46.94 82.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.753 1.221 . . . . 0.0 112.034 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.09 -37.64 84.33 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -39.4 89.82 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 44.5 tt0 -59.77 -50.68 72.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.848 1.259 . . . . 0.0 111.419 171.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.52 -50.52 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.861 0.864 . . . . 0.0 110.298 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.519 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 5.5 m95 -57.01 -54.91 41.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 17.9 pt-20 -58.0 -30.21 65.89 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -74.96 -60.24 2.38 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.781 1.301 . . . . 0.0 111.862 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.13 -37.14 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 125.762 1.625 . . . . 0.0 113.195 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 47' ' ' LYS . 6.9 tt -58.65 -19.66 41.14 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.85 1.66 . . . . 0.0 114.38 173.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.04 69.23 0.4 Allowed Glycine 0 N--CA 1.476 1.321 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.269 12.3 p 3.85 78.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 128.402 2.681 . . . . 0.0 115.611 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -121.18 -49.17 2.19 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 112.67 -2.059 . . . . 0.0 115.289 -168.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 106.1 84.42 1.72 Allowed Glycine 0 N--CA 1.48 1.628 0 O-C-N 123.748 0.655 . . . . 0.0 112.331 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.573 HD13 HD13 ' A' ' 27' ' ' LEU . 9.4 pt -113.67 153.86 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -170.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA2' HG22 ' A' ' 9' ' ' VAL . . . -68.25 158.44 52.16 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-N 113.496 -1.683 . . . . 0.0 113.27 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 10' ' ' ALA . 46.9 mm -45.45 -39.42 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 125.251 1.42 . . . . 0.0 112.261 166.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.6 tp -56.49 -31.77 64.36 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.92 1.688 . . . . 0.0 114.626 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 6.8 m-20 61.68 162.14 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.03 1.732 . . . . 0.0 111.627 -169.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -68.04 4.25 1.29 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 170.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' A' ' 72' ' ' PRO 0.264 54.7 p90 48.96 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 119.767 3.247 . . . . 0.0 119.767 -175.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -109.11 -74.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.133 1.773 . . . . 0.0 112.558 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.411 ' HG3' HD11 ' A' ' 27' ' ' LEU . 19.7 pt20 -73.08 33.58 0.07 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -100.92 -37.4 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.97 -30.48 4.8 Favored Glycine 0 N--CA 1.479 1.519 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.274 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.43 -172.96 7.22 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-O 122.627 1.126 . . . . 0.0 113.849 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.97 53.9 0.88 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.911 -1.144 . . . . 0.0 111.862 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.444 ' HB3' HD23 ' A' ' 46' ' ' LEU . 3.8 m -173.49 -166.83 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.701 1.6 . . . . 0.0 112.39 -173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 45' ' ' SER . 1.9 pt? -50.64 -22.5 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.579 ' NZ ' ' HA ' ' A' ' 27' ' ' LEU . 12.4 mmmt -42.34 -49.41 5.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.068 1.347 . . . . 0.0 112.07 168.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.57 71.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.795 1.238 . . . . 0.0 114.132 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -69.39 -45.7 68.66 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.215 1.006 . . . . 0.0 112.319 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.39 91.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.584 0.754 . . . . 0.0 111.889 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 68' ' ' LEU . 40.8 t -64.96 -46.65 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.701 172.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . . . -52.58 -42.52 64.59 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' HB1' HH21 ' A' ' 57' ' ' ARG . . . -58.11 -48.26 80.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 0.0 112.28 174.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.38 -43.65 98.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 0.0 112.343 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.803 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.8 t -59.52 -34.58 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.153 1.381 . . . . 0.0 112.986 176.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -72.99 -39.55 65.97 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.519 HH21 ' HB1' ' A' ' 53' ' ' ALA . 2.1 ptt180 -91.12 -53.31 4.42 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -86.77 -29.01 22.65 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.457 1.503 . . . . 0.0 113.041 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.803 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 54.8 m-85 -103.23 -18.24 14.98 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.83 -38.95 0.13 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.811 2.444 . . . . 0.0 117.47 -174.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -49.29 -22.89 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 127.67 2.388 . . . . 0.0 115.476 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 59.74 152.33 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.862 2.465 . . . . 0.0 116.4 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.7 mt 65.9 150.26 0.12 Allowed Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 126.032 1.733 . . . . 0.0 115.47 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 83.4 Cg_endo -68.1 172.93 10.17 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.036 1.824 . . . . 0.0 110.881 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.722 ' HG ' ' HB2' ' A' ' 69' ' ' PHE . 8.0 tt 70.25 -40.28 0.46 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.188 1.795 . . . . 0.0 114.653 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -48.92 -92.36 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 127.054 2.141 . . . . 0.0 112.283 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 13.8 p -89.1 62.18 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-O 123.431 1.586 . . . . 0.0 109.304 171.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 tp -157.51 -76.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 112.589 -2.096 . . . . 0.0 112.924 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.722 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 20.6 m-85 -77.82 -41.4 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.325 0.65 . . . . 0.0 112.508 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.22 73.18 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.08 81.92 60.51 Favored Pre-proline 0 N--CA 1.478 0.937 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 166.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 44.5 Cg_endo -78.22 30.56 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.641 2.894 . . . . 0.0 116.339 -172.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 2.1 t -139.93 131.85 27.7 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.397 1.479 . . . . 0.0 109.835 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.285 0.4 OUTLIER -63.64 -21.69 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -179.65 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HA ' ' OE2' ' A' ' 16' ' ' GLU . 1.3 tmmt? -57.24 -56.15 25.6 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.514 0.726 . . . . 0.0 110.495 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.73 -38.07 73.55 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 97.9 mt -54.4 -48.59 71.4 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.432 0.693 . . . . 0.0 112.533 175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.96 96.54 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.5 -32.72 73.73 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -71.64 -21.69 61.79 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 77' ' ' LEU 0.281 29.8 m -110.27 -69.35 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.41 56.12 3.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 123.599 1.666 . . . . 0.0 111.797 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 m -156.55 -61.41 0.1 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 112.882 -1.963 . . . . 0.0 108.843 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.639 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -102.27 -32.71 9.92 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 116.201 1.926 . . . . 99.99 116.201 177.239 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 mtt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.77 149.67 48.9 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.848 175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 5' ' ' GLU . 48.9 t -109.67 143.56 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -174.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 t -57.43 -33.51 67.97 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 40.1 mt-10 -75.98 151.14 37.31 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.056 1.342 . . . . 0.0 112.697 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.45 ' HB3' ' N ' ' A' ' 33' ' ' GLY . . . -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.116 -1.402 . . . . 0.0 112.827 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -102.03 -40.0 7.05 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.761 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 35' ' ' LEU . 10.7 p90 -67.75 42.63 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 ' HB ' ' HA2' ' A' ' 33' ' ' GLY . 9.6 p -86.62 90.35 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 122.018 0.913 . . . . 0.0 112.071 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -111.03 87.53 7.21 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 114.228 -1.351 . . . . 0.0 111.916 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.07 144.84 38.51 Favored 'Trans proline' 0 N--CA 1.476 0.48 0 C-N-CA 123.081 2.521 . . . . 0.0 113.223 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -75.55 0.47 Allowed 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.467 174.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -116.58 -172.97 2.29 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.061 0.945 . . . . 0.0 112.486 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.06 57.98 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.157 0.983 . . . . 0.0 113.468 173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -55.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.025 0.93 . . . . 0.0 110.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HA ' HD12 ' A' ' 74' ' ' ILE . 4.5 mm-40 -51.12 -57.48 8.6 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.34 1.056 . . . . 0.0 113.597 176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.6 t -65.1 -54.4 30.61 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 65.5 tttp -60.96 -46.36 91.03 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.035 0.934 . . . . 0.0 111.705 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.86 -40.97 95.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.219 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.75 -39.41 80.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 172.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' LYS . 41.8 tt0 -59.64 -54.91 40.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.63 1.172 . . . . 0.0 111.545 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -52.83 -49.84 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.671 1.188 . . . . 0.0 110.593 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.491 ' HB3' HD11 ' A' ' 32' ' ' ILE . 20.1 m95 -53.71 -65.15 0.62 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.459 1.104 . . . . 0.0 111.907 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HB3' HG12 ' A' ' 32' ' ' ILE . 12.3 pt-20 -57.45 -29.63 64.36 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -72.63 -66.79 0.62 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.255 1.422 . . . . 0.0 111.919 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.31 -35.45 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.837 1.255 . . . . 0.0 113.342 -173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.51 -19.35 47.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.583 . . . . 0.0 114.089 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.37 71.9 0.2 Allowed Glycine 0 N--CA 1.476 1.364 0 C-N-CA 124.18 0.895 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.275 12.7 p 0.65 82.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 128.502 2.721 . . . . 0.0 115.878 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 5' ' ' GLU . 21.7 m -123.38 -81.62 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.863 -171.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.21 96.95 0.57 Allowed Glycine 0 N--CA 1.478 1.457 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 24' ' ' GLU . 11.8 pt -124.37 -177.51 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 114.608 -0.796 . . . . 0.0 112.312 -171.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 9' ' ' VAL . . . -112.41 166.11 12.15 Favored Glycine 0 N--CA 1.474 1.189 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.906 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 10' ' ' ALA . 41.3 mm -55.16 -45.27 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 125.092 1.357 . . . . 0.0 112.324 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 36.3 tp -61.21 -18.27 57.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.851 1.661 . . . . 0.0 114.408 171.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 73' ' ' THR . 11.1 m-20 60.21 -163.95 0.23 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.162 1.785 . . . . 0.0 110.412 -171.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.459 ' ND2' HE22 ' A' ' 40' ' ' GLN . 51.8 t30 -108.63 22.94 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.188 0.518 . . . . 0.0 110.967 165.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.6 p90 36.5 16.04 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 121.565 3.913 . . . . 0.0 121.565 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -119.83 -76.29 0.58 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 111.642 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.459 HE22 ' ND2' ' A' ' 37' ' ' ASN . 17.3 pm0 -73.66 31.61 0.08 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -106.22 -38.12 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.338 0.655 . . . . 0.0 112.251 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.54 -55.08 27.39 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.193 0.933 . . . . 0.0 113.359 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.87 114.22 0.01 OUTLIER Glycine 0 N--CA 1.478 1.447 0 O-C-N 125.348 1.263 . . . . 0.0 114.867 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -78.66 59.76 2.57 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.917 1.341 . . . . 0.0 112.543 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -174.96 -157.49 0.07 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.816 2.446 . . . . 0.0 110.358 -174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.8 pt? -54.2 -17.58 2.98 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 51' ' ' VAL . 13.2 mmtt -46.1 -52.65 11.7 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.229 1.011 . . . . 0.0 113.06 173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.11 -38.43 62.62 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -68.98 -48.55 62.87 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.454 1.102 . . . . 0.0 112.674 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.7 84.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.895 0.878 . . . . 0.0 112.47 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 54' ' ' GLN . 63.7 t -63.9 -50.21 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.133 0.973 . . . . 0.0 110.099 171.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.6 63.23 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.522 0.729 . . . . 0.0 112.912 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.03 -57.17 13.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.896 0.878 . . . . 0.0 112.878 173.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 51' ' ' VAL . 6.6 pt20 -66.16 -36.93 84.41 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.687 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 61.3 t -64.44 -29.52 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.298 1.039 . . . . 0.0 112.304 174.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -79.85 -67.77 0.73 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.8 0.44 . . . . 0.0 111.598 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.514 ' HE ' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -65.61 -35.98 82.38 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -171.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -107.68 -34.28 7.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.568 0.747 . . . . 0.0 112.938 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.1 m-30 -87.46 -25.73 23.6 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 69.47 -43.61 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 129.049 2.94 . . . . 0.0 115.964 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 85' ' ' SER . 12.9 p -59.54 -21.25 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HA ' HG12 ' A' ' 55' ' ' VAL . 27.5 tt0 47.62 79.56 0.06 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 174.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' H ' ' CG1' ' A' ' 55' ' ' VAL . 2.1 pt? -136.69 83.71 29.18 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 169.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -65.75 150.05 86.41 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 123.328 2.686 . . . . 0.0 111.952 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 69' ' ' PHE . 8.2 tt 65.65 -41.58 0.34 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.812 2.045 . . . . 0.0 114.546 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -51.1 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.935 1.694 . . . . 0.0 112.183 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 63' ' ' LEU . 9.4 p -84.69 64.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 123.514 1.626 . . . . 0.0 110.049 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD22 HG11 ' A' ' 51' ' ' VAL . 55.7 tp -163.48 -63.69 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.219 -175.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.464 ' CD1' ' HG ' ' A' ' 65' ' ' LEU . 22.8 m-85 -79.94 -57.47 3.63 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.46 1.104 . . . . 0.0 112.706 174.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.87 -32.89 71.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.282 0.633 . . . . 0.0 112.696 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -123.01 82.09 50.79 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.247 1.019 . . . . 0.0 111.099 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -82.76 31.89 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.376 2.717 . . . . 0.0 115.143 -175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 4.1 t -148.31 135.75 20.53 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.239 1.015 . . . . 0.0 111.307 -171.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' A' ' 16' ' ' GLU 0.279 0.4 OUTLIER -63.97 -23.54 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.467 -178.905 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -52.94 -62.25 1.77 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.298 1.039 . . . . 0.0 110.485 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.37 80.51 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.821 -1.082 . . . . 0.0 113.912 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD12 HG12 ' A' ' 74' ' ' ILE . 32.1 mt -58.25 -47.29 84.03 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.727 0.411 . . . . 0.0 110.934 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.03 92.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.41 1.084 . . . . 0.0 112.841 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.596 ' O ' ' HB ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -60.27 -36.63 78.24 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 3.1 m-85 -73.34 -39.84 64.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 171.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.627 HG11 ' CD2' ' A' ' 59' ' ' TYR 0.251 26.2 m -105.95 -28.93 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 118.123 2.638 . . . . 0.0 118.123 -170.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.71 50.71 0.94 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.982 1.373 . . . . 0.0 109.834 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 90.6 m -162.27 -61.74 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.574 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -108.6 -33.18 7.1 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 170.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 61' ' ' VAL . 38.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 116.732 2.123 . . . . 99.99 116.732 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.25 -178.57 39.52 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.914 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.04 146.44 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.583 0.753 . . . . 0.0 112.285 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.498 HG21 HE21 ' A' ' 40' ' ' GLN . 5.9 t -54.45 -46.17 73.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 39.76 -153.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.84 -135.04 0.06 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.331 1.452 . . . . 0.0 110.163 166.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -172.55 -66.74 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.569 1.547 . . . . 0.0 108.515 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -66.75 47.83 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 128.673 2.789 . . . . 0.0 117.117 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.2 p -96.13 87.24 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 122.346 1.069 . . . . 0.0 111.871 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 83.87 15.45 Favored Pre-proline 0 N--CA 1.477 0.893 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.857 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -67.98 133.07 27.97 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.074 2.516 . . . . 0.0 113.401 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -78.49 -77.6 0.16 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.673 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -116.56 -174.46 2.57 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.339 1.055 . . . . 0.0 112.125 -173.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -57.21 4.92 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.643 1.177 . . . . 0.0 113.388 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.81 -51.66 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.722 0.809 . . . . 0.0 111.813 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HA ' HD12 ' A' ' 74' ' ' ILE . 26.0 mm-40 -52.06 -57.07 10.62 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.691 0.797 . . . . 0.0 112.504 175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -65.2 -53.33 46.39 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.199 0.999 . . . . 0.0 113.501 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -55.6 -48.57 74.66 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 111.292 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HA ' HG13 ' A' ' 22' ' ' ILE . 4.1 mm? -69.68 -44.21 70.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.28 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.44 78.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 43.4 tt0 -59.74 -59.64 5.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.306 1.442 . . . . 0.0 111.523 172.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG13 ' HA ' ' A' ' 19' ' ' LEU 0.267 2.7 pp -61.12 -36.85 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.461 ' HB3' HD11 ' A' ' 32' ' ' ILE . 6.7 m95 -59.75 -54.91 40.83 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.671 -0.68 . . . . 0.0 111.993 172.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HB3' HG12 ' A' ' 32' ' ' ILE . 13.6 pt-20 -60.49 -29.85 69.33 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -71.69 -66.84 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.682 1.593 . . . . 0.0 111.933 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.461 HG12 ' HE3' ' A' ' 47' ' ' LYS . 62.1 t -63.86 -34.3 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.219 1.808 . . . . 0.0 113.763 -172.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 32' ' ' ILE . 7.6 tt -56.54 -24.82 49.4 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.598 1.159 . . . . 0.0 113.812 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.77 75.43 0.49 Allowed Glycine 0 N--CA 1.474 1.191 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' GLU 0.289 12.2 p -4.47 83.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 128.247 2.619 . . . . 0.0 116.208 -178.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.1 m -116.7 -39.04 3.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.113 -175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.2 91.46 1.08 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -169.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 27' ' ' LEU . 47.3 pt -111.09 -143.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.63 -174.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.41 -150.58 5.65 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 122.747 1.193 . . . . 0.0 113.772 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 74' ' ' ILE . 58.3 mt -93.99 -61.12 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 111.685 -2.258 . . . . 0.0 108.757 170.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.31 -29.77 66.14 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.157 1.383 . . . . 0.0 113.34 168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 58.33 -148.24 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.882 1.273 . . . . 0.0 109.517 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -99.49 13.9 31.74 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.64 0.587 . . . . 0.0 111.351 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . 0.26 35.5 p90 41.23 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 121.636 3.939 . . . . 0.0 121.636 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -96.05 -79.69 0.44 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.889 1.276 . . . . 0.0 112.816 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.498 HE21 HG21 ' A' ' 4' ' ' THR . 8.1 pm0 -74.33 35.37 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -112.83 -35.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.61 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' HG ' ' A' ' 68' ' ' LEU . . . -60.27 -54.66 35.47 Favored Glycine 0 CA--C 1.538 1.482 0 O-C-N 123.876 0.735 . . . . 0.0 112.546 171.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.39 97.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.482 0 CA-C-N 114.122 -1.039 . . . . 0.0 115.399 172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -74.41 63.55 1.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.17 1.388 . . . . 0.0 112.809 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 14.0 m -171.79 -153.03 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.838 2.455 . . . . 0.0 109.635 -175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.41 ' H ' ' HB3' ' A' ' 45' ' ' SER . 1.7 pt? -51.79 -22.57 3.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HE3' HG12 ' A' ' 26' ' ' VAL . 3.9 mmpm? -46.43 -48.55 18.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 117.76 -1.114 . . . . 0.0 113.814 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.27 65.3 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.8 mmt -66.95 -51.48 54.67 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.595 1.158 . . . . 0.0 112.606 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.15 92.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.904 0.882 . . . . 0.0 112.664 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.492 HG11 HD13 ' A' ' 68' ' ' LEU . 91.2 t -63.1 -47.12 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.329 1.052 . . . . 0.0 110.007 174.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -53.58 -45.25 69.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.73 75.36 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.447 0.699 . . . . 0.0 112.707 174.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -64.62 -39.26 93.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.095 0.958 . . . . 0.0 113.514 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.868 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 86.3 t -69.58 -30.13 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.989 1.315 . . . . 0.0 112.882 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 17.1 t-160 -76.11 -40.18 53.49 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -76.11 -91.23 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.664 1.186 . . . . 0.0 112.575 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.92 -30.09 67.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.929 1.692 . . . . 0.0 114.381 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.868 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 5.2 m-30 -98.23 -18.43 18.42 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 4.8 tt0 57.69 -45.16 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -170.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 59' ' ' TYR . 2.7 t -59.31 -12.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 126.598 1.959 . . . . 0.0 115.208 -171.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 48.41 44.88 20.65 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 167.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.4 pt? -113.26 88.86 13.34 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 74.2 Cg_endo -65.87 152.8 80.51 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.427 2.752 . . . . 0.0 112.0 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 tt 64.97 -43.73 0.33 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 126.705 2.002 . . . . 0.0 114.833 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -56.45 -69.66 0.14 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.563 1.145 . . . . 0.0 111.889 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 p -82.15 50.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 123.923 1.821 . . . . 0.0 111.224 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.492 HD13 HG11 ' A' ' 51' ' ' VAL . 55.1 tp -153.66 -78.06 0.11 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.863 -1.971 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -71.32 -46.51 60.47 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.82 -31.56 72.84 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -124.71 75.65 64.53 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.876 0.871 . . . . 0.0 112.064 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.78 54.26 4.39 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.574 2.182 . . . . 0.0 113.396 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t -169.16 131.34 1.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.161 1.384 . . . . 0.0 111.044 -176.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.487 HG22 HG23 ' A' ' 34' ' ' ILE 0.321 0.5 OUTLIER -62.88 -20.49 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 114.521 -1.218 . . . . 0.0 113.948 179.724 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -58.64 -52.8 64.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.564 0.746 . . . . 0.0 111.022 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -40.2 77.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.69 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 73' ' ' THR . 60.6 mt -57.98 -48.51 79.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 0.0 112.582 176.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.0 96.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.01 0.924 . . . . 0.0 112.341 174.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 0.6 OUTLIER -62.1 -31.66 72.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 174.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.71 -35.37 62.69 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 169.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 77' ' ' LEU . 27.4 m -110.27 -26.95 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 119.023 2.971 . . . . 0.0 119.023 -174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.3 22.42 12.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.405 1.082 . . . . 0.0 113.816 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 79' ' ' GLN . 19.4 m -123.55 -59.39 1.54 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.499 176.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.624 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -98.13 -31.05 12.31 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 115.527 -2.178 . . . . 99.99 115.763 173.48 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.54 -149.97 13.2 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.556 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' HB ' ' OE1' ' A' ' 5' ' ' GLU . 16.5 m -110.32 141.02 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.9 t -64.11 -40.76 96.9 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.163 169.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.556 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 1.4 pm0 -72.67 175.84 6.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.077 1.351 . . . . 0.0 114.405 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.35 33.77 13.64 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -45.91 -33.86 3.52 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -177.54 -68.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.175 1.39 . . . . 0.0 111.306 -173.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t 61.2 78.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 172.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 87.23 56.46 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.941 169.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.97 149.3 82.87 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 123.269 2.646 . . . . 0.0 113.054 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.05 -80.77 0.59 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.794 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -111.89 -174.87 2.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.431 1.092 . . . . 0.0 112.089 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.9 -61.94 1.63 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.588 1.155 . . . . 0.0 113.478 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.0 t -55.89 -48.86 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.238 1.015 . . . . 0.0 111.548 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 74' ' ' ILE . 29.2 mm-40 -52.56 -58.05 8.03 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.36 1.064 . . . . 0.0 112.714 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -67.73 -48.77 65.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.001 0.92 . . . . 0.0 112.978 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 22' ' ' ILE . 49.8 tptt -55.15 -53.57 54.32 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.391 1.476 . . . . 0.0 110.961 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.549 HD21 ' HG2' ' A' ' 58' ' ' GLU . 4.6 mm? -63.96 -45.62 88.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 118.082 -0.961 . . . . 0.0 113.3 177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.81 79.89 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 35.4 tt0 -60.29 -61.99 2.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.602 1.561 . . . . 0.0 111.551 173.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' LYS 0.274 37.6 pt -62.28 -33.04 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.3 m95 -59.22 -59.35 5.61 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.692 168.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 19.2 pt-20 -58.75 -32.16 69.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -65.43 -68.39 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.519 1.528 . . . . 0.0 111.112 171.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.36 -37.05 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.724 1.61 . . . . 0.0 113.482 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 tp -60.35 -21.0 61.57 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.1 61.42 0.16 Allowed Glycine 0 N--CA 1.477 1.407 0 O-C-N 124.167 0.917 . . . . 0.0 112.265 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.259 9.2 p 19.49 66.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 127.874 2.469 . . . . 0.0 114.757 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -107.06 -61.77 1.5 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 112.563 -2.108 . . . . 0.0 114.577 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . 113.94 89.42 1.72 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.557 -176.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 23' ' ' TRP . 19.3 pt -127.97 -153.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.69 -148.31 7.02 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.561 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.874 ' HA ' HG22 ' A' ' 74' ' ' ILE . 1.9 mp -47.86 -69.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 111.551 -2.324 . . . . 0.0 113.0 -172.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.49 -15.15 48.52 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.99 -143.24 0.73 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.323 1.449 . . . . 0.0 108.861 -172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -112.14 18.15 18.92 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 163.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 72' ' ' PRO . 48.7 p90 39.72 15.85 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -173.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -131.03 -82.18 0.53 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.518 1.527 . . . . 0.0 111.572 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -46.25 -40.52 11.61 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -28.14 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 175.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.51 -30.42 65.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.543 1.068 . . . . 0.0 114.039 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.84 96.39 2.46 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 123.937 0.433 . . . . 0.0 113.768 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 1.22 1.62 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.908 1.448 . . . . 0.0 114.908 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 46' ' ' LEU . 5.9 m 177.03 -150.02 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.87 2.468 . . . . 0.0 109.715 -165.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -55.83 -7.12 0.27 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.48 -31.57 6.56 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 173.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.05 45.27 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 171.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -65.26 -48.98 71.35 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.452 1.101 . . . . 0.0 111.722 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.64 90.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.031 0.932 . . . . 0.0 112.47 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 68' ' ' LEU . 61.6 t -61.77 -52.22 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.595 0.758 . . . . 0.0 110.014 172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 64' ' ' PRO . . . -55.51 -39.87 71.06 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.03 0.932 . . . . 0.0 113.152 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.39 -50.51 72.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.54 0.736 . . . . 0.0 112.481 172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -60.88 -44.92 96.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.98 173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 59.6 t -66.63 -32.28 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.081 0.952 . . . . 0.0 112.495 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' GLN . 8.9 t-160 -68.89 -42.95 76.26 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 172.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -82.45 -61.98 1.74 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG2' HD21 ' A' ' 19' ' ' LEU . 5.1 tp10 -77.28 -32.98 55.89 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.393 1.477 . . . . 0.0 113.327 -175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 1.7 m-85 -101.59 -9.44 20.96 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' HIS . 27.0 tt0 62.53 -55.39 0.15 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.076 2.551 . . . . 0.0 115.413 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.15 4.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 126.462 1.905 . . . . 0.0 115.421 -166.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.285 15.0 pt-20 54.36 -38.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 121.545 3.905 . . . . 0.0 121.545 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 2.4 pt? -22.32 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 128.523 2.729 . . . . 0.0 118.201 -176.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 72.6 Cg_endo -67.21 147.37 78.67 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.026 2.484 . . . . 0.0 111.273 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tt 66.04 -38.58 0.29 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.584 1.954 . . . . 0.0 115.466 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -53.47 -73.84 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.22 52.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-O 124.043 1.877 . . . . 0.0 111.618 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 51' ' ' VAL . 56.8 tp -154.31 -79.4 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 112.336 -2.211 . . . . 0.0 108.57 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.0 -43.8 98.36 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.59 67.5 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 175.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -152.92 71.16 7.18 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 112.666 -176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 56.1 Cg_endo -79.98 40.04 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.755 2.97 . . . . 0.0 114.921 -172.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.5 t -147.9 131.26 16.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.321 1.848 . . . . 0.0 109.576 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.874 HG22 ' HA ' ' A' ' 34' ' ' ILE 0.285 0.5 OUTLIER -61.34 -21.34 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 114.56 -1.2 . . . . 0.0 113.865 -179.771 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.11 -60.87 2.75 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.583 1.153 . . . . 0.0 110.112 171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 79' ' ' GLN . . . -69.59 -34.84 74.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.468 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 74' ' ' ILE . 79.1 mt -58.86 -47.24 85.6 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.82 96.29 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.953 0.901 . . . . 0.0 112.378 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.607 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -55.92 -51.96 65.78 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 0.0 112.019 169.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -27.23 68.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . 0.309 6.6 m -108.41 -72.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.42 64.46 3.51 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.371 1.557 . . . . 0.0 112.78 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 77.5 m -166.7 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 128.399 2.68 . . . . 0.0 108.702 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -110.19 -29.5 8.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 176.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.517 -1.706 . . . . 99.99 115.424 -177.235 . . . . . . . . 0 0 . 1 stop_ save_